{
  "metadata": {
    "generated_at": "2025-10-08T17:34:54.672934",
    "total_interventions": 792,
    "unique_interventions": 676,
    "unique_conditions": 406,
    "unique_papers": 356,
    "semantic_interventions": 676,
    "canonical_groups": 571,
    "total_relationships": 141,
    "positive_correlations": 620,
    "negative_correlations": 65,
    "intervention_categories": {
      "medication": 234,
      "procedure": 91,
      "therapy": 90,
      "supplement": 72,
      "exercise": 58,
      "lifestyle": 58,
      "biologics": 57,
      "surgery": 29,
      "device": 25,
      "diet": 25,
      "test": 24,
      "emerging": 18,
      "gene_therapy": 11
    },
    "condition_categories": {
      "cardiac": 76,
      "neurological": 73,
      "musculoskeletal": 72,
      "psychiatric": 68,
      "infectious": 66,
      "other": 63,
      "oncological": 54,
      "rheumatological": 52,
      "renal": 50,
      "endocrine": 50,
      "dermatological": 47,
      "pulmonary": 44,
      "digestive": 31,
      "immunological": 22,
      "nutritional": 14,
      "hematological": 7,
      "toxicological": 3
    }
  },
  "top_performers": {
    "interventions": [
      {
        "name": "glp-1 receptor agonists",
        "intervention_category": "medication",
        "count": 7,
        "avg_strength": 0.5625,
        "paper_count": 5
      },
      {
        "name": "short interfering rna",
        "intervention_category": "gene_therapy",
        "count": 6,
        "avg_strength": 0.4583333333333333,
        "paper_count": 1
      },
      {
        "name": "therapeutic recommendations",
        "intervention_category": "therapy",
        "count": 6,
        "avg_strength": 0.5,
        "paper_count": 1
      },
      {
        "name": "cognitive behavioral therapy",
        "intervention_category": "therapy",
        "count": 5,
        "avg_strength": 0.79,
        "paper_count": 4
      },
      {
        "name": "probiotics",
        "intervention_category": "supplement",
        "count": 5,
        "avg_strength": 0.45,
        "paper_count": 4
      },
      {
        "name": "sodium-glucose cotransporter 2 inhibitors",
        "intervention_category": "medication",
        "count": 5,
        "avg_strength": 0.625,
        "paper_count": 3
      },
      {
        "name": "high-intensity interval training",
        "intervention_category": "exercise",
        "count": 4,
        "avg_strength": 0.5625,
        "paper_count": 3
      },
      {
        "name": "isotretinoin",
        "intervention_category": "medication",
        "count": 4,
        "avg_strength": 0.6875,
        "paper_count": 3
      },
      {
        "name": "acupuncture",
        "intervention_category": "therapy",
        "count": 3,
        "avg_strength": 0.85,
        "paper_count": 2
      },
      {
        "name": "aerobic training",
        "intervention_category": "exercise",
        "count": 3,
        "avg_strength": 0.5,
        "paper_count": 2
      }
    ],
    "conditions": [
      {
        "name": "psoriatic disease",
        "condition_category": "rheumatological",
        "count": 16,
        "intervention_count": 16,
        "paper_count": 1
      },
      {
        "name": "panic disorder",
        "condition_category": "psychiatric",
        "count": 14,
        "intervention_count": 8,
        "paper_count": 2
      },
      {
        "name": "Type 2 diabetes mellitus",
        "condition_category": "endocrine",
        "count": 13,
        "intervention_count": 13,
        "paper_count": 1
      },
      {
        "name": "Helicobacter pylori infection",
        "condition_category": "infectious",
        "count": 11,
        "intervention_count": 11,
        "paper_count": 3
      },
      {
        "name": "high-risk infants",
        "condition_category": "other",
        "count": 11,
        "intervention_count": 11,
        "paper_count": 1
      },
      {
        "name": "Lennox-Gastaut syndrome",
        "condition_category": "neurological",
        "count": 9,
        "intervention_count": 5,
        "paper_count": 1
      },
      {
        "name": "rheumatoid arthritis",
        "condition_category": "rheumatological",
        "count": 9,
        "intervention_count": 9,
        "paper_count": 2
      },
      {
        "name": "acne vulgaris",
        "condition_category": "dermatological",
        "count": 8,
        "intervention_count": 8,
        "paper_count": 3
      },
      {
        "name": "knee osteoarthritis",
        "condition_category": "musculoskeletal",
        "count": 8,
        "intervention_count": 8,
        "paper_count": 4
      },
      {
        "name": "type 2-high asthma",
        "condition_category": "pulmonary",
        "count": 8,
        "intervention_count": 4,
        "paper_count": 1
      }
    ]
  },
  "interventions": [
    {
      "id": 1958,
      "intervention": {
        "name": "bismuth-clarithromycin quadruple therapy",
        "canonical_name": "bismuth clarithromycin quadruple therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bismuth clarithromycin quadruple therapy",
          "layer_2_variant": "bismuth-clarithromycin quadruple therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibiotic treatment and bismuth to eradicate H. pylori",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients in Ardabil, Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "An Update on Eradication of",
        "journal": "Middle East journal of digestive diseases",
        "publication_date": "2024-07",
        "pubmed_id": "39386340",
        "doi": "10.34172/mejdd.2024.389"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:35:03"
    },
    {
      "id": 1959,
      "intervention": {
        "name": "bismuth-clarithromycin quadruple therapy with probiotics",
        "canonical_name": "bismuth-clarithromycin quadruple therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bismuth-clarithromycin quadruple therapy",
          "layer_2_variant": "bismuth-clarithromycin quadruple therapy with probiotics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibiotic treatment and bismuth to eradicate H. pylori, supplemented with probiotics",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients in Birjand, Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "An Update on Eradication of",
        "journal": "Middle East journal of digestive diseases",
        "publication_date": "2024-07",
        "pubmed_id": "39386340",
        "doi": "10.34172/mejdd.2024.389"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:35:03"
    },
    {
      "id": 1960,
      "intervention": {
        "name": "standard triple therapy",
        "canonical_name": "triple therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "triple therapy",
          "layer_2_variant": "standard triple therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibiotic treatment to eradicate H. pylori",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients in Ilam, Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "An Update on Eradication of",
        "journal": "Middle East journal of digestive diseases",
        "publication_date": "2024-07",
        "pubmed_id": "39386340",
        "doi": "10.34172/mejdd.2024.389"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:35:03"
    },
    {
      "id": 1961,
      "intervention": {
        "name": "bismuth quadruple therapy or bismuth triple therapy or concomitant regimen",
        "canonical_name": "bismuth quadruple therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bismuth quadruple therapy",
          "layer_2_variant": "bismuth quadruple therapy or bismuth triple therapy or concomitant regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibiotic treatment and bismuth to eradicate H. pylori",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients in Sari, Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "An Update on Eradication of",
        "journal": "Middle East journal of digestive diseases",
        "publication_date": "2024-07",
        "pubmed_id": "39386340",
        "doi": "10.34172/mejdd.2024.389"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:35:03"
    },
    {
      "id": 1962,
      "intervention": {
        "name": "sequential therapy",
        "canonical_name": "sequential therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sequential therapy",
          "layer_2_variant": "sequential therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibiotic treatment to eradicate H. pylori in a sequential regimen",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients in Tehran, Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "An Update on Eradication of",
        "journal": "Middle East journal of digestive diseases",
        "publication_date": "2024-07",
        "pubmed_id": "39386340",
        "doi": "10.34172/mejdd.2024.389"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:35:03"
    },
    {
      "id": 1963,
      "intervention": {
        "name": "bismuth quadruple therapy",
        "canonical_name": "bismuth quadruple therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bismuth quadruple therapy",
          "layer_2_variant": "bismuth quadruple therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibiotic treatment and bismuth to eradicate H. pylori",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients in Yazd, Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "An Update on Eradication of",
        "journal": "Middle East journal of digestive diseases",
        "publication_date": "2024-07",
        "pubmed_id": "39386340",
        "doi": "10.34172/mejdd.2024.389"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:35:03"
    },
    {
      "id": 1964,
      "intervention": {
        "name": "quinolone-containing regimen (levofloxacin preferred)",
        "canonical_name": "quinolones",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "quinolones",
          "layer_2_variant": "quinolone-containing regimen (levofloxacin preferred)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibiotic treatment to eradicate H. pylori resistant to other antibiotics",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with resistant H. pylori in Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "An Update on Eradication of",
        "journal": "Middle East journal of digestive diseases",
        "publication_date": "2024-07",
        "pubmed_id": "39386340",
        "doi": "10.34172/mejdd.2024.389"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:35:03"
    },
    {
      "id": 1956,
      "intervention": {
        "name": "levosimendan",
        "canonical_name": "levosimendan",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "levosimendan",
          "layer_2_variant": "levosimendan",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "septic cardiomyopathy",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cardiac function and hemodynamic stability",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 25,
        "duration": "December 2022 to March 2024",
        "population": "patients with septic cardiomyopathy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Levosimendan versus dobutamine in septic cardiomyopathy: a randomized clinical trial on cardiac function and safety.",
        "journal": "Frontiers in cardiovascular medicine",
        "publication_date": "2025",
        "pubmed_id": "41048529",
        "doi": "10.3389/fcvm.2025.1641604"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:32:06"
    },
    {
      "id": 1957,
      "intervention": {
        "name": "dobutamine",
        "canonical_name": "dobutamine",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "dobutamine",
          "layer_2_variant": "dobutamine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "septic cardiomyopathy",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cardiac function and hemodynamic stability",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 25,
        "duration": "December 2022 to March 2024",
        "population": "patients with septic cardiomyopathy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Levosimendan versus dobutamine in septic cardiomyopathy: a randomized clinical trial on cardiac function and safety.",
        "journal": "Frontiers in cardiovascular medicine",
        "publication_date": "2025",
        "pubmed_id": "41048529",
        "doi": "10.3389/fcvm.2025.1641604"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:32:06"
    },
    {
      "id": 1955,
      "intervention": {
        "name": "electroacupuncture",
        "canonical_name": "electroacupuncture",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "electroacupuncture",
          "layer_2_variant": "electroacupuncture",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulates neuroendocrine signaling, inflammatory cascades, cartilage metabolism, and local hemodynamics; engages neuromodulatory systems involving opioid, serotonergic, and cannabinoid receptors",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in Electroacupuncture for Treatment of Knee Osteoarthritis: Mechanisms, Efficacy, and Future Directions.",
        "journal": "Journal of pain research",
        "publication_date": "2025",
        "pubmed_id": "41050143",
        "doi": "10.2147/JPR.S543346"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:31:02"
    },
    {
      "id": 1954,
      "intervention": {
        "name": "minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath",
        "canonical_name": "percutaneous nephrolithotomy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "percutaneous nephrolithotomy",
          "layer_2_variant": "minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "complex kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced intraoperative renal pelvic pressure and operative time, decreased complications",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 35,
        "duration": "from June 2022 to December 2023",
        "population": "patients with complex kidney stones",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stones.",
        "journal": "Frontiers in surgery",
        "publication_date": "2025",
        "pubmed_id": "40799684",
        "doi": "10.3389/fsurg.2025.1557603"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:30:29"
    },
    {
      "id": 1953,
      "intervention": {
        "name": "intensive telehealth",
        "canonical_name": "telehealth",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "telehealth",
          "layer_2_variant": "intensive telehealth",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "glycemic control in type 1 diabetes",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "structured support and review of CGM data",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, crossover trial",
        "sample_size": 105,
        "duration": "May 2023 to June 2024",
        "population": "children and adolescents with type 1 diabetes using FreeStyle Libre 2 CGM",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of an Intensive, Integrated Telehealth Intervention on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using Continuous Glucose Monitoring: A Randomized, Crossover Trial.",
        "journal": "Pediatric diabetes",
        "publication_date": "2025",
        "pubmed_id": "41049863",
        "doi": "10.1155/pedi/7261998"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:29:55"
    },
    {
      "id": 1952,
      "intervention": {
        "name": "tranexamic acid",
        "canonical_name": "tranexamic acid",
        "category": "medication",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tranexamic acid",
          "layer_2_variant": "tranexamic acid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "perioperative bleeding",
        "canonical_name": null,
        "category": "hematological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced surgical blood loss through antifibrinolytic action",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "double-blind randomized controlled trial",
        "sample_size": 140,
        "duration": null,
        "population": "patients undergoing open prostatectomy for benign prostatic hyperplasia (BPH)",
        "adverse_effects": "one patient in the TXA group developed a pulmonary embolism",
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Intraoperative Local Administration of Tranexamic Acid on Hemorrhage in Patients Undergoing Open Prostatectomy: A Double-Blinded Randomized Parallel-Group Trial.",
        "journal": "Advances in urology",
        "publication_date": "2025",
        "pubmed_id": "40792227",
        "doi": "10.1155/aiu/9294177"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:29:19"
    },
    {
      "id": 1951,
      "intervention": {
        "name": "mobile health educational program",
        "canonical_name": "mobile health educational program",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mobile health educational program",
          "layer_2_variant": "mobile health educational program",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mental health and HIV prevention",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced mental health and HIV knowledge through digital education",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "quasi-experimental design with non-randomized controlled trial",
        "sample_size": 80,
        "duration": null,
        "population": "deaf community",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Quasi-Experimental Study Protocol on the Impact of a Mobile Health Program for HIV Counseling and Testing in the Deaf Community.",
        "journal": "F1000Research",
        "publication_date": "2025",
        "pubmed_id": "41049560",
        "doi": "10.12688/f1000research.161505.3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:28:39"
    },
    {
      "id": 1950,
      "intervention": {
        "name": "empagliflozin",
        "canonical_name": "empagliflozin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "empagliflozin",
          "layer_2_variant": "empagliflozin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetes foot",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased urine output and sodium excretion",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, single-arm study",
        "sample_size": 30,
        "duration": "up to 6 months",
        "population": "patients with type 2 diabetes mellitus and cirrhosis (Child-Pugh class A/B)",
        "adverse_effects": "no serious adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "The effects of empagliflozin on diuresis and natriuresis in patients with type 2 diabetes mellitus and liver cirrhosis.",
        "journal": "Annals of gastroenterology",
        "publication_date": "2025",
        "pubmed_id": "40937061",
        "doi": "10.20524/aog.2025.0992"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:28:08"
    },
    {
      "id": 1949,
      "intervention": {
        "name": "intravaginal artesunate",
        "canonical_name": "artesunate",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "artesunate",
          "layer_2_variant": "intravaginal artesunate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "HPV persistence following thermal ablation",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces HPV-associated lesions and induces clearance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "phase II clinical trial",
        "sample_size": 120,
        "duration": "24 weeks total, with intervention period of 6 weeks",
        "population": "HIV seropositive women in Kenya",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Feasibility of Intravaginal Artesunate as an Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.",
        "journal": "Cancer control : journal of the Moffitt Cancer Center",
        "publication_date": "2025",
        "pubmed_id": "40907021",
        "doi": "10.1177/10732748251374418"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:27:33"
    },
    {
      "id": 1947,
      "intervention": {
        "name": "isotretinoin",
        "canonical_name": "isotretinoin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isotretinoin",
          "layer_2_variant": "isotretinoin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "papulo-pustular rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and sebum production",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with rosacea",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Rosacea and treatment with retinoids: a systematic review and meta-analysis.",
        "journal": "Therapeutic advances in chronic disease",
        "publication_date": "2025",
        "pubmed_id": "40453533",
        "doi": "10.1177/20406223251339964"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:26:57"
    },
    {
      "id": 1948,
      "intervention": {
        "name": "topical retinoids",
        "canonical_name": "topical retinoids",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "topical retinoids",
          "layer_2_variant": "topical retinoids",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "papulo-pustular rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "skin cell regulation and anti-inflammatory effects",
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with rosacea",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Rosacea and treatment with retinoids: a systematic review and meta-analysis.",
        "journal": "Therapeutic advances in chronic disease",
        "publication_date": "2025",
        "pubmed_id": "40453533",
        "doi": "10.1177/20406223251339964"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:26:57"
    },
    {
      "id": 1943,
      "intervention": {
        "name": "bimekizumab",
        "canonical_name": "bimekizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bimekizumab",
          "layer_2_variant": "bimekizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced IL-17 signaling",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "heightened risk of nasopharyngitis",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41050680",
        "doi": "10.3389/fimmu.2025.1654343"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:26:04"
    },
    {
      "id": 1944,
      "intervention": {
        "name": "secukinumab",
        "canonical_name": "secukinumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "secukinumab",
          "layer_2_variant": "secukinumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced IL-17 signaling",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41050680",
        "doi": "10.3389/fimmu.2025.1654343"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:26:04"
    },
    {
      "id": 1945,
      "intervention": {
        "name": "ixekizumab",
        "canonical_name": "ixekizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ixekizumab",
          "layer_2_variant": "ixekizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced IL-17 signaling",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41050680",
        "doi": "10.3389/fimmu.2025.1654343"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:26:04"
    },
    {
      "id": 1946,
      "intervention": {
        "name": "tildrakizumab",
        "canonical_name": "tildrakizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tildrakizumab",
          "layer_2_variant": "tildrakizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced IL-12/23 signaling",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41050680",
        "doi": "10.3389/fimmu.2025.1654343"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:26:04"
    },
    {
      "id": 1942,
      "intervention": {
        "name": "Epimedium",
        "canonical_name": "epimedium",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "epimedium",
          "layer_2_variant": "epimedium",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "primary osteoporosis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "regulates bone metabolism through multiple targets",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 890,
        "duration": null,
        "population": "patients with primary osteoporosis",
        "adverse_effects": "low, mainly mild gastrointestinal reactions or skin allergies",
        "cost_category": null
      },
      "paper": {
        "title": "The efficacy and safety of Epimedium in the treatment of primary osteoporosis: a systematic review and meta-analysis.",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "41048931",
        "doi": "10.3389/fmed.2025.1675160"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:24:24"
    },
    {
      "id": 1940,
      "intervention": {
        "name": "Parents InC parenting programme",
        "canonical_name": "parenting programme",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "parenting programme",
          "layer_2_variant": "parents inc parenting programme",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ADHD in children",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "behavioral training for parents to improve child behavior",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "feasibility trial",
        "sample_size": 14,
        "duration": "up to 12 months",
        "population": "parents of children aged 5-12 years with ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Families with neurodevelopmental diagnoses are not 'Hard to Reach': Findings from a feasibility trial comparing parenting programmes for parents of children with ADHD.",
        "journal": "PloS one",
        "publication_date": "2025",
        "pubmed_id": "40961127",
        "doi": "10.1371/journal.pone.0323959"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:23:51"
    },
    {
      "id": 1941,
      "intervention": {
        "name": "Incredible Years (IY) parenting programme",
        "canonical_name": "parenting programmes",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "parenting programmes",
          "layer_2_variant": "incredible years (iy) parenting programme",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ADHD in children",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "behavioral training for parents to improve child behavior",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "feasibility trial",
        "sample_size": 16,
        "duration": "up to 12 months",
        "population": "parents of children aged 5-12 years with ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Families with neurodevelopmental diagnoses are not 'Hard to Reach': Findings from a feasibility trial comparing parenting programmes for parents of children with ADHD.",
        "journal": "PloS one",
        "publication_date": "2025",
        "pubmed_id": "40961127",
        "doi": "10.1371/journal.pone.0323959"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:23:51"
    },
    {
      "id": 1939,
      "intervention": {
        "name": "Morinda officinalis oligosaccharides combined with probiotics",
        "canonical_name": "probiotics",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "probiotics",
          "layer_2_variant": "morinda officinalis oligosaccharides combined with probiotics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "major depressive disorder with gastrointestinal symptoms",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiota modulation and reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 108,
        "duration": "8 weeks",
        "population": "individuals diagnosed with major depressive disorder who also presented with gastrointestinal symptoms",
        "adverse_effects": "mild, mainly gastrointestinal (eg, diarrhea, constipation), and occurred at the same rate in both groups",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Morinda Officinalis Oligosaccharides Combined with Probiotics as a Therapeutic Strategy for Major Depressive Disorder with Gastrointestinal Symptoms: A Randomized, Double-Blind, Controlled Clinical Trial.",
        "journal": "Neuropsychiatric disease and treatment",
        "publication_date": "2025",
        "pubmed_id": "41050503",
        "doi": "10.2147/NDT.S534858"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:22:55"
    },
    {
      "id": 1938,
      "intervention": {
        "name": "anti-oxidative stress therapies",
        "canonical_name": "anti-oxidative stress therapies",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "anti-oxidative stress therapies",
          "layer_2_variant": "anti-oxidative stress therapies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe oxaliplatin-induced peripheral neuropathy",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of oxidative stress and neuroprotection",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "colorectal cancer patients treated with oxaliplatin",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Anti-oxidative stress therapies prevent severe chemotherapy-induced peripheral neuropathy in colorectal cancer patients treated with oxaliplatin: a systematic review and meta-analysis.",
        "journal": "Frontiers in oncology",
        "publication_date": "2025",
        "pubmed_id": "41001014",
        "doi": "10.3389/fonc.2025.1642552"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:22:17"
    },
    {
      "id": 1936,
      "intervention": {
        "name": "acupuncture",
        "canonical_name": "acupuncture",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "acupuncture",
          "layer_2_variant": "acupuncture",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ovulatory dysfunction in polycystic ovary syndrome (PCOS)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved ovarian function and hormonal balance",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "meta-analysis, network meta-analysis (NMA), model-based dose-response modeling",
        "sample_size": 4827,
        "duration": null,
        "population": "women with polycystic ovary syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dose-response of acupuncture on ovulation rates in polycystic ovary syndrome: a meta-analysis and exploratory dose-response analysis.",
        "journal": "Frontiers in endocrinology",
        "publication_date": "2025",
        "pubmed_id": "40951420",
        "doi": "10.3389/fendo.2025.1610338"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:21:44"
    },
    {
      "id": 1937,
      "intervention": {
        "name": "acupuncture combined with herbal medicine",
        "canonical_name": "acupuncture",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "acupuncture",
          "layer_2_variant": "acupuncture combined with herbal medicine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ovulatory dysfunction in polycystic ovary syndrome (PCOS)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "combined effect of acupuncture and herbal medicine on hormonal regulation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "meta-analysis, network meta-analysis (NMA), model-based dose-response modeling",
        "sample_size": 4827,
        "duration": null,
        "population": "women with polycystic ovary syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dose-response of acupuncture on ovulation rates in polycystic ovary syndrome: a meta-analysis and exploratory dose-response analysis.",
        "journal": "Frontiers in endocrinology",
        "publication_date": "2025",
        "pubmed_id": "40951420",
        "doi": "10.3389/fendo.2025.1610338"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:21:44"
    },
    {
      "id": 1935,
      "intervention": {
        "name": "collagen peptide supplementation",
        "canonical_name": "collagen peptides",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "collagen peptides",
          "layer_2_variant": "collagen peptide supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "bone and muscle health",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced bone turnover and muscle function",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "meta-analysis of randomized trials",
        "sample_size": null,
        "duration": null,
        "population": "individuals with musculoskeletal concerns",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of collagen peptide supplementation on bone and muscle health: a meta-analysis.",
        "journal": "Frontiers in nutrition",
        "publication_date": "2025",
        "pubmed_id": "41049371",
        "doi": "10.3389/fnut.2025.1646090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:20:39"
    },
    {
      "id": 1934,
      "intervention": {
        "name": "electroacupuncture",
        "canonical_name": "electroacupuncture",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "electroacupuncture",
          "layer_2_variant": "electroacupuncture",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "abdominal obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "changes in lipid metabolism and intestinal microbiota",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 68,
        "duration": "32 weeks",
        "population": "adults with abdominal obesity",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Electroacupuncture Reduces Waistline in Patients with Abdominal Obesity: A Randomized Controlled Trial with Mechanistic Analysis of Lipidomic and Intestinal Microbiota.",
        "journal": "Diabetes, metabolic syndrome and obesity : targets and therapy",
        "publication_date": "2025",
        "pubmed_id": "41050180",
        "doi": "10.2147/DMSO.S551806"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:20:09"
    },
    {
      "id": 1933,
      "intervention": {
        "name": "GLP-1 receptor agonists",
        "canonical_name": "glp-1 receptor agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "glp-1 receptor agonists",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gastrointestinal adverse effects",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induces gastrointestinal side effects through GLP-1 receptor activation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "Bayesian network meta-analysis",
        "sample_size": 27729,
        "duration": null,
        "population": "adults with type 2 diabetes mellitus",
        "adverse_effects": "nausea, vomiting, diarrhea, constipation, dyspepsia, reduced appetite",
        "cost_category": null
      },
      "paper": {
        "title": "Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis.",
        "journal": "Frontiers in pharmacology",
        "publication_date": "2025",
        "pubmed_id": "41050409",
        "doi": "10.3389/fphar.2025.1613610"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:19:37"
    },
    {
      "id": 1930,
      "intervention": {
        "name": "OAC regimen",
        "canonical_name": "oral anticoagulants",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "oral anticoagulants",
          "layer_2_variant": "oac regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibacterial action against H. pylori",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 136,
        "duration": "8 weeks",
        "population": "patients with dyspepsia or peptic ulcer disease (PUD)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Efficacy of Two Triple Therapy Regimens and One Quadruple Regimen [Omeprazole, Amoxicillin, Metronidazole with Bismuth] in Eradicating",
        "journal": "Reviews on recent clinical trials",
        "publication_date": "2025",
        "pubmed_id": "39482907",
        "doi": "10.2174/0115748871306001241017050020"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:19:01"
    },
    {
      "id": 1931,
      "intervention": {
        "name": "OAL regimen",
        "canonical_name": "oal regimen",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "oal regimen",
          "layer_2_variant": "oal regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibacterial action against H. pylori",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 136,
        "duration": "8 weeks",
        "population": "patients with dyspepsia or peptic ulcer disease (PUD)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Efficacy of Two Triple Therapy Regimens and One Quadruple Regimen [Omeprazole, Amoxicillin, Metronidazole with Bismuth] in Eradicating",
        "journal": "Reviews on recent clinical trials",
        "publication_date": "2025",
        "pubmed_id": "39482907",
        "doi": "10.2174/0115748871306001241017050020"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:19:01"
    },
    {
      "id": 1932,
      "intervention": {
        "name": "OAMB regimen",
        "canonical_name": "oamb regimen",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "oamb regimen",
          "layer_2_variant": "oamb regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibacterial action against H. pylori",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 136,
        "duration": "8 weeks",
        "population": "patients with dyspepsia or peptic ulcer disease (PUD)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Efficacy of Two Triple Therapy Regimens and One Quadruple Regimen [Omeprazole, Amoxicillin, Metronidazole with Bismuth] in Eradicating",
        "journal": "Reviews on recent clinical trials",
        "publication_date": "2025",
        "pubmed_id": "39482907",
        "doi": "10.2174/0115748871306001241017050020"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:19:01"
    },
    {
      "id": 1929,
      "intervention": {
        "name": "PFO closure",
        "canonical_name": "pfo closure",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pfo closure",
          "layer_2_variant": "pfo closure",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "embolic stroke of undetermined source (ESUS)",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces right-to-left shunt and risk of recurrent stroke",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "case report",
        "sample_size": null,
        "duration": null,
        "population": "elderly subjects with PFO and ESUS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Case Report: Is there an age cutoff beyond which PFO closure should not be offered?",
        "journal": "Frontiers in cardiovascular medicine",
        "publication_date": "2025",
        "pubmed_id": "40951825",
        "doi": "10.3389/fcvm.2025.1622543"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:17:39"
    },
    {
      "id": 1927,
      "intervention": {
        "name": "Endostar",
        "canonical_name": "endostar",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "endostar",
          "layer_2_variant": "endostar",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "locally advanced cervical cancer (LACC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced tumor angiogenesis and metastasis",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "multicenter, open-label, randomized, controlled, phase II trial",
        "sample_size": 120,
        "duration": null,
        "population": "patients with locally advanced cervical cancer",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of Endostar plus concurrent chemoradiotherapy in locally advanced cervical cancer: a multicenter, phase II randomized trial.",
        "journal": "Therapeutic advances in medical oncology",
        "publication_date": "2025",
        "pubmed_id": "41049580",
        "doi": "10.1177/17588359251379397"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:17:07"
    },
    {
      "id": 1928,
      "intervention": {
        "name": "concurrent chemoradiotherapy (CCRT)",
        "canonical_name": "chemoradiotherapy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "chemoradiotherapy",
          "layer_2_variant": "concurrent chemoradiotherapy (ccrt)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "locally advanced cervical cancer (LACC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cell cycle arrest and apoptosis induction in tumor cells",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "multicenter, open-label, randomized, controlled, phase II trial",
        "sample_size": 120,
        "duration": null,
        "population": "patients with locally advanced cervical cancer",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of Endostar plus concurrent chemoradiotherapy in locally advanced cervical cancer: a multicenter, phase II randomized trial.",
        "journal": "Therapeutic advances in medical oncology",
        "publication_date": "2025",
        "pubmed_id": "41049580",
        "doi": "10.1177/17588359251379397"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:17:07"
    },
    {
      "id": 1925,
      "intervention": {
        "name": "compound glycyrrhizin",
        "canonical_name": "glycyrrhizin",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glycyrrhizin",
          "layer_2_variant": "compound glycyrrhizin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rosacea lesions",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved skin barrier function",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 54,
        "duration": "12 weeks",
        "population": "patients with rosacea lesions",
        "adverse_effects": "higher adverse reactions but not significantly different",
        "cost_category": null
      },
      "paper": {
        "title": "Effect of compound glycyrrhizin combined with fractional CO2 laser on the improvement of skin lesions and skin barrier function in rosacea.",
        "journal": "Pakistan journal of pharmaceutical sciences",
        "publication_date": "2025",
        "pubmed_id": "40501239",
        "doi": null
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:16:00"
    },
    {
      "id": 1926,
      "intervention": {
        "name": "fractional CO2 laser treatment",
        "canonical_name": "fractional co2 laser",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fractional co2 laser",
          "layer_2_variant": "fractional co2 laser treatment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rosacea lesions",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved skin barrier function",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 54,
        "duration": "12 weeks",
        "population": "patients with rosacea lesions",
        "adverse_effects": "higher adverse reactions but not significantly different",
        "cost_category": null
      },
      "paper": {
        "title": "Effect of compound glycyrrhizin combined with fractional CO2 laser on the improvement of skin lesions and skin barrier function in rosacea.",
        "journal": "Pakistan journal of pharmaceutical sciences",
        "publication_date": "2025",
        "pubmed_id": "40501239",
        "doi": null
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:16:00"
    },
    {
      "id": 1924,
      "intervention": {
        "name": "t'ai chi and qigong program",
        "canonical_name": "t'ai chi and qigong",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "t'ai chi and qigong",
          "layer_2_variant": "t'ai chi and qigong program",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic low back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "multimodal approach to health and healing, physical movement and mental attitude development",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial, qualitative study",
        "sample_size": null,
        "duration": null,
        "population": "adults with chronic low back pain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "\"No Pain, More Gain\": Subjective Responses to a T'ai Chi and Qigong Program For Back Pain.",
        "journal": "Global advances in integrative medicine and health",
        "publication_date": "2025",
        "pubmed_id": "41041080",
        "doi": "10.1177/27536130251384679"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:15:04"
    },
    {
      "id": 1923,
      "intervention": {
        "name": "cognitive behavioral therapy",
        "canonical_name": "cognitive behavioral therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive behavioral therapy",
          "layer_2_variant": "cognitive behavioral therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "depression, anxiety, trauma-related disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "psychological restructuring and improved coping skills",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "mixed-methods systematic review",
        "sample_size": 2557,
        "duration": null,
        "population": "women in the perinatal period",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of Factors Associated With Treatment Engagement and Outcome for Women in the Perinatal Period Receiving Individual Cognitive Behavioral Therapy (CBT) for Depression, Anxiety, and Trauma-Related Disorders.",
        "journal": "Depression and anxiety",
        "publication_date": "2025",
        "pubmed_id": "41019913",
        "doi": "10.1155/da/3698331"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:13:57"
    },
    {
      "id": 1922,
      "intervention": {
        "name": "vitamin D supplementation",
        "canonical_name": "vitamin d",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vitamin d",
          "layer_2_variant": "vitamin d supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "thyroid hormones and TSH levels",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of thyroid hormone regulation",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": 1127,
        "duration": null,
        "population": "participants with thyroid disorders",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of vitamin D supplementation on TSH and thyroid hormones: A systematic review of randomized controlled trials.",
        "journal": "Endocrinologia, diabetes y nutricion",
        "publication_date": "2025-01",
        "pubmed_id": "39794009",
        "doi": "10.1016/j.endien.2024.12.007"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:13:18"
    },
    {
      "id": 1921,
      "intervention": {
        "name": "semaglutide",
        "canonical_name": "glp-1 receptor agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "semaglutide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "refractory dysmenorrhea",
        "canonical_name": null,
        "category": "other",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "anti-estrogenic and anti-inflammatory properties",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "case report",
        "sample_size": null,
        "duration": null,
        "population": "women with severe refractory dysmenorrhea",
        "adverse_effects": "transient loss of appetite",
        "cost_category": null
      },
      "paper": {
        "title": "Refractory Dysmenorrhea Managed With a Glucagon-Like Peptide-1 Agonist: A Case Report.",
        "journal": "Cureus",
        "publication_date": "2025-01",
        "pubmed_id": "39944451",
        "doi": "10.7759/cureus.77387"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:12:48"
    },
    {
      "id": 1920,
      "intervention": {
        "name": "strength training targeting medial thigh muscles",
        "canonical_name": "strength training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "strength training",
          "layer_2_variant": "strength training targeting medial thigh muscles",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anterior cruciate ligament injury risk",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modifies lower extremity biomechanics and muscle activity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 35,
        "duration": "8 weeks",
        "population": "healthy participants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Strength Training Targeting Medial Thigh Muscles on Neuromuscular and Biomechanical Risk Factors for Anterior Cruciate Ligament Injury: A Randomized Controlled Trial.",
        "journal": "Sports medicine - open",
        "publication_date": "2025-01-23",
        "pubmed_id": "39847165",
        "doi": "10.1186/s40798-025-00812-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:12:17"
    },
    {
      "id": 1918,
      "intervention": {
        "name": "isokinetic muscle strength training",
        "canonical_name": "isokinetic muscle strength training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isokinetic muscle strength training",
          "layer_2_variant": "isokinetic muscle strength training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rehabilitation after anterior cruciate ligament reconstruction",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved muscle strength and joint stability",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 20,
        "duration": "6 weeks",
        "population": "patients after anterior cruciate ligament reconstruction",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Isokinetic muscle strength training combined with proprioceptive neuromuscular facilitation for rehabilitation of patients after anterior cruciate ligament reconstruction: a protocol for a randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-02-19",
        "pubmed_id": "39971608",
        "doi": "10.1136/bmjopen-2024-096036"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:11:45"
    },
    {
      "id": 1919,
      "intervention": {
        "name": "proprioceptive neuromuscular facilitation (PNF) technique",
        "canonical_name": "proprioceptive neuromuscular facilitation",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "proprioceptive neuromuscular facilitation",
          "layer_2_variant": "proprioceptive neuromuscular facilitation (pnf) technique",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rehabilitation after anterior cruciate ligament reconstruction",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced proprioception and neuromuscular control",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 20,
        "duration": "6 weeks",
        "population": "patients after anterior cruciate ligament reconstruction",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Isokinetic muscle strength training combined with proprioceptive neuromuscular facilitation for rehabilitation of patients after anterior cruciate ligament reconstruction: a protocol for a randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-02-19",
        "pubmed_id": "39971608",
        "doi": "10.1136/bmjopen-2024-096036"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:11:45"
    },
    {
      "id": 1917,
      "intervention": {
        "name": "PKD-specific digital health educational and physical activity programme",
        "canonical_name": "digital health educational and physical activity programme",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "digital health educational and physical activity programme",
          "layer_2_variant": "pkd-specific digital health educational and physical activity programme",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "physical inactivity contributing to poor HRQoL in PKD patients",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved physical activity and education for better self-management",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized waitlist-controlled trial",
        "sample_size": 60,
        "duration": "12 weeks",
        "population": "adults with a diagnosis of polycystic kidney disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease: a randomized controlled trial.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-03",
        "pubmed_id": "40065847",
        "doi": "10.1093/ckj/sfaf041"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:10:47"
    },
    {
      "id": 1914,
      "intervention": {
        "name": "liraglutide",
        "canonical_name": "glp-1 receptor agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "liraglutide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "weight management",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "glucagon-like peptide-1 receptor agonist action",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "obesity populations and type 2 diabetes patients",
        "adverse_effects": "gastrointestinal disturbances",
        "cost_category": null
      },
      "paper": {
        "title": "Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies.",
        "journal": "Diabetes, obesity & metabolism",
        "publication_date": "2025-04",
        "pubmed_id": "40196933",
        "doi": "10.1111/dom.16364"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:10:12"
    },
    {
      "id": 1915,
      "intervention": {
        "name": "semaglutide",
        "canonical_name": "glp-1 receptor agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "semaglutide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "weight management",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "glucagon-like peptide-1 receptor agonist action",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "obesity populations and type 2 diabetes patients",
        "adverse_effects": "gastrointestinal disturbances",
        "cost_category": null
      },
      "paper": {
        "title": "Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies.",
        "journal": "Diabetes, obesity & metabolism",
        "publication_date": "2025-04",
        "pubmed_id": "40196933",
        "doi": "10.1111/dom.16364"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:10:12"
    },
    {
      "id": 1916,
      "intervention": {
        "name": "tirzepatide",
        "canonical_name": "tirzepatide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tirzepatide",
          "layer_2_variant": "tirzepatide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "weight management",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "glucagon-like peptide-1 receptor agonist action",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "obesity populations and type 2 diabetes patients",
        "adverse_effects": "gastrointestinal disturbances",
        "cost_category": null
      },
      "paper": {
        "title": "Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies.",
        "journal": "Diabetes, obesity & metabolism",
        "publication_date": "2025-04",
        "pubmed_id": "40196933",
        "doi": "10.1111/dom.16364"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:10:12"
    },
    {
      "id": 1913,
      "intervention": {
        "name": "Sodium-glucose cotransporter 2 inhibitors",
        "canonical_name": "sodium-glucose cotransporter 2 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sodium-glucose cotransporter 2 inhibitors",
          "layer_2_variant": "sodium-glucose cotransporter 2 inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "aortic stenosis",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulates TGF-β, NF-κB, NLRP3 inflammasome, oxidative stress signaling; enhances mitochondrial energetics and endothelial function",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review of randomized and real-world studies",
        "sample_size": null,
        "duration": null,
        "population": "patients with aortic stenosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Sodium-Glucose Cotransporter 2 Inhibitors in Aortic Stenosis: Toward a Comprehensive Cardiometabolic Approach.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-05-08",
        "pubmed_id": "40429640",
        "doi": "10.3390/ijms26104494"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:08:52"
    },
    {
      "id": 1912,
      "intervention": {
        "name": "tolvaptan",
        "canonical_name": "tolvaptan",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tolvaptan",
          "layer_2_variant": "tolvaptan",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "autosomal dominant polycystic kidney disease",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "vasopressin type 2 receptor antagonism",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "long-term, real-world post-marketing surveillance",
        "sample_size": 1676,
        "duration": "March 2014 to March 2022",
        "population": "Japanese patients with autosomal dominant polycystic kidney disease",
        "adverse_effects": "hepatic function abnormal (9.6%), hyperuricaemia (8.3%), thirst (8.1%)",
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of tolvaptan in real‑world Japanese patients with autosomal dominant polycystic kidney disease: final results of SLOW‑PKD surveillance.",
        "journal": "Clinical and experimental nephrology",
        "publication_date": "2025-06",
        "pubmed_id": "39953249",
        "doi": "10.1007/s10157-025-02634-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:08:17"
    },
    {
      "id": 1911,
      "intervention": {
        "name": "isometric wall squat",
        "canonical_name": "isometric exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isometric exercise",
          "layer_2_variant": "isometric wall squat",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "uncomplicated stage 1 hypertension",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced blood pressure through isometric exercise",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled open-label multicentre feasibility study",
        "sample_size": 41,
        "duration": "6 months",
        "population": "unmedicated people with stage 1 hypertension aged over 18 able to perform isometric exercise",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Feasibility randomised controlled trial to assess the delivery of a novel isometric exercise intervention for people diagnosed with uncomplicated stage 1 hypertension in the National Health Service: key quantitative findings.",
        "journal": "BMJ open",
        "publication_date": "2025-06-04",
        "pubmed_id": "40467325",
        "doi": "10.1136/bmjopen-2024-091219"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:07:38"
    },
    {
      "id": 1910,
      "intervention": {
        "name": "Impella RP",
        "canonical_name": "impella rp",
        "category": "device",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "impella rp",
          "layer_2_variant": "impella rp",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "right ventricular failure",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "provides right ventricular support and improves hemodynamics",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "narrative review",
        "sample_size": 10,
        "duration": null,
        "population": "patients with acute massive pulmonary embolism and right ventricular failure",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Hemodynamic improvement with Impella RP in acute massive pulmonary embolism: a narrative review of cardiovascular outcomes and pulmonary catheter pressure assessment.",
        "journal": "Annals of medicine and surgery (2012)",
        "publication_date": "2025-07",
        "pubmed_id": "40851987",
        "doi": "10.1097/MS9.0000000000003431"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:07:02"
    },
    {
      "id": 1909,
      "intervention": {
        "name": "dual antiplatelet therapy (DAPT)",
        "canonical_name": "dual antiplatelet therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "dual antiplatelet therapy",
          "layer_2_variant": "dual antiplatelet therapy (dapt)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "major bleeding and major adverse cardiovascular and cerebrovascular events (MACCE) after PCI",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces platelet aggregation to prevent thrombosis",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "pooled analysis of randomized clinical trials",
        "sample_size": 10487,
        "duration": null,
        "population": "patients aged ≥75 years and <75 years undergoing percutaneous coronary intervention (PCI)",
        "adverse_effects": "increased risk of major bleeding in elderly patients",
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of Short-term and Standard Duration Dual Antiplatelet Therapy in Elderly Patients: A Pooled Analysis of Five Korean Randomized Clinical Trials.",
        "journal": "Korean circulation journal",
        "publication_date": "2025-07-14",
        "pubmed_id": "41044734",
        "doi": "10.4070/kcj.2025.0093"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:06:30"
    },
    {
      "id": 1907,
      "intervention": {
        "name": "febuxostat",
        "canonical_name": "febuxostat",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "febuxostat",
          "layer_2_variant": "febuxostat",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gout",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces serum uric acid levels",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": 19683,
        "duration": null,
        "population": "patients with gout",
        "adverse_effects": "lower risk of any-grade adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "The efficacy and safety of different doses of febuxostat and allopurinol: A meta-analysis.",
        "journal": "Joint diseases and related surgery",
        "publication_date": "2025-07-21",
        "pubmed_id": "40783988",
        "doi": "10.52312/jdrs.2025.1976"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:05:52"
    },
    {
      "id": 1908,
      "intervention": {
        "name": "allopurinol",
        "canonical_name": "allopurinol",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "allopurinol",
          "layer_2_variant": "allopurinol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gout",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces serum uric acid levels",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": 19683,
        "duration": null,
        "population": "patients with gout",
        "adverse_effects": "higher risk of any-grade adverse events compared to febuxostat",
        "cost_category": null
      },
      "paper": {
        "title": "The efficacy and safety of different doses of febuxostat and allopurinol: A meta-analysis.",
        "journal": "Joint diseases and related surgery",
        "publication_date": "2025-07-21",
        "pubmed_id": "40783988",
        "doi": "10.52312/jdrs.2025.1976"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:05:52"
    },
    {
      "id": 1906,
      "intervention": {
        "name": "tenofovir amibufenamide",
        "canonical_name": "tenofovir alafenamide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tenofovir alafenamide",
          "layer_2_variant": "tenofovir amibufenamide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic hepatitis B virus infection with normal ALT levels",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces HBV DNA and improves liver function markers",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, multicenter, randomized, open-label, blank-controlled clinical trial",
        "sample_size": 197,
        "duration": "48 weeks",
        "population": "chronic HBV-infected patients with normal ALT levels",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE Study.",
        "journal": "Journal of clinical and translational hepatology",
        "publication_date": "2025-07-28",
        "pubmed_id": "40937079",
        "doi": "10.14218/JCTH.2025.00162"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:04:45"
    },
    {
      "id": 1905,
      "intervention": {
        "name": "PD-1 inhibitor combined with azacitidine and HAG regimen",
        "canonical_name": "pd-1 inhibitor",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pd-1 inhibitor",
          "layer_2_variant": "pd-1 inhibitor combined with azacitidine and hag regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "relapsed/refractory acute myeloid leukemia (R/R AML)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immune checkpoint inhibition and DNA hypomethylation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "prospective, single-arm, phase II clinical trial",
        "sample_size": 20,
        "duration": "from December 2020 to August 2023",
        "population": "R/R AML patients treated at The First Affiliated Hospital of Soochow University",
        "adverse_effects": "hematologic toxicities",
        "cost_category": null
      },
      "paper": {
        "title": "[PD-1 Inhibitor Combined with Azacitidine and HAG Regimen for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia: A Prospective, Single-Arm, Phase II Clinical Study].",
        "journal": "Zhongguo shi yan xue ye xue za zhi",
        "publication_date": "2025-08",
        "pubmed_id": "40936118",
        "doi": "10.19746/j.cnki.issn.1009-2137.2025.04.007"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:04:09"
    },
    {
      "id": 1903,
      "intervention": {
        "name": "flexible ureteroscopic stone treatment",
        "canonical_name": "ureteroscopic stone treatment",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ureteroscopic stone treatment",
          "layer_2_variant": "flexible ureteroscopic stone treatment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lower pole kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "removal of renal tract stones via flexible endoscope",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "pragmatic multicentre, open-label, superiority randomised controlled trials",
        "sample_size": 690,
        "duration": "12 months",
        "population": "adults presenting with lower pole renal stones able to undergo any of the treatments and complete trial procedures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Clinical and cost-effectiveness of percutaneous nephrolithotomy, flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole stones: the PUrE RCTs.",
        "journal": "Health technology assessment (Winchester, England)",
        "publication_date": "2025-08",
        "pubmed_id": "40823754",
        "doi": "10.3310/WFRE6844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:03:32"
    },
    {
      "id": 1904,
      "intervention": {
        "name": "keyhole surgery",
        "canonical_name": "keyhole surgery",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "keyhole surgery",
          "layer_2_variant": "keyhole surgery",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lower pole kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "minimally invasive surgical removal of renal tract stones",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "pragmatic multicentre, open-label, superiority randomised controlled trials",
        "sample_size": 242,
        "duration": "12 months",
        "population": "adults presenting with lower pole renal stones able to undergo any of the treatments and complete trial procedures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Clinical and cost-effectiveness of percutaneous nephrolithotomy, flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole stones: the PUrE RCTs.",
        "journal": "Health technology assessment (Winchester, England)",
        "publication_date": "2025-08",
        "pubmed_id": "40823754",
        "doi": "10.3310/WFRE6844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:03:32"
    },
    {
      "id": 1902,
      "intervention": {
        "name": "metabolic and immunological interventions",
        "canonical_name": "metabolic and immunological interventions",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "metabolic and immunological interventions",
          "layer_2_variant": "metabolic and immunological interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "female infertility",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved hormonal profiles and fertility outcomes",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review of randomized and crossover trials",
        "sample_size": null,
        "duration": null,
        "population": "infertile women with metabolic disorders such as polycystic ovary syndrome (PCOS), insulin resistance, obesity, and metabolic syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Metabolic Dysregulation and Female Infertility: A Systematic Review of Hormonal and Reproductive Outcomes From Recent Clinical Trials.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995278",
        "doi": "10.7759/cureus.90887"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:02:18"
    },
    {
      "id": 1901,
      "intervention": {
        "name": "developmentally supportive care",
        "canonical_name": "developmentally supportive care",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "developmentally supportive care",
          "layer_2_variant": "developmentally supportive care",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "neurodevelopmental delay in high-risk infants",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "early stimulation and structured interventions",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants in the Indian context",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:01:45"
    },
    {
      "id": 1900,
      "intervention": {
        "name": "microencapsulated benzoyl peroxide",
        "canonical_name": "benzoyl peroxide",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "benzoyl peroxide",
          "layer_2_variant": "microencapsulated benzoyl peroxide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of skin microbiome and reduction in inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blind, crossover, vehicle-controlled clinical trial",
        "sample_size": 31,
        "duration": "12 weeks with a no-treatment period of four weeks (Week 16)",
        "population": "participants had facial rosacea with global severity of 3 or 4 on the Investigator's Global Assessment (IGA) scale",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Impact of Microencapsulated Benzoyl Peroxide on the Skin Microbiome and Clinical Outcomes in Rosacea: An Update on a Randomized, Double-blind, Crossover, Vehicle-controlled Clinical Trial.",
        "journal": "The Journal of clinical and aesthetic dermatology",
        "publication_date": "2025-08",
        "pubmed_id": "40843233",
        "doi": null
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 13:01:15"
    },
    {
      "id": 1896,
      "intervention": {
        "name": "RNA-based therapies",
        "canonical_name": "rna-based therapies",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rna-based therapies",
          "layer_2_variant": "rna-based therapies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rare and ultrarare kidney diseases, congenital diseases involving kidneys",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted delivery of RNA molecules to desired renal targets",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "narrative review",
        "sample_size": null,
        "duration": null,
        "population": "patients with rare and ultrarare kidney diseases, congenital renal conditions",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:59:55"
    },
    {
      "id": 1897,
      "intervention": {
        "name": "microRNA therapy",
        "canonical_name": "microRNA therapy",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "microRNA therapy",
          "layer_2_variant": "microrna therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Alport syndrome, polycystic kidney disease, renal cell carcinoma",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gene regulation and expression modification",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "narrative review",
        "sample_size": null,
        "duration": null,
        "population": "patients with Alport syndrome, polycystic kidney disease, renal cell carcinoma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:59:55"
    },
    {
      "id": 1898,
      "intervention": {
        "name": "short interfering RNA molecules",
        "canonical_name": "short interfering rna",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "short interfering rna",
          "layer_2_variant": "short interfering rna molecules",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "primary hyperoxaluria, hereditary transthyretin amyloidosis, acute kidney injury after cardiovascular intervention or kidney transplantation (i.e. delayed graft function), hypercholesterolemia",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gene silencing and regulation of protein expression",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "narrative review",
        "sample_size": null,
        "duration": null,
        "population": "patients with primary hyperoxaluria, hereditary transthyretin amyloidosis, acute kidney injury after cardiovascular intervention or kidney transplantation (i.e. delayed graft function), individuals affected by hypercholesterolemia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:59:55"
    },
    {
      "id": 1899,
      "intervention": {
        "name": "synthetic antisense oligonucleotides",
        "canonical_name": "antisense oligonucleotides",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antisense oligonucleotides",
          "layer_2_variant": "synthetic antisense oligonucleotides",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate or severe hypercholesterolemia, amyloidosis",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted gene silencing and regulation of cholesterol metabolism",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "narrative review",
        "sample_size": null,
        "duration": null,
        "population": "individuals with moderate or severe hypercholesterolemia who developed statin side effects, individuals with amyloidosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:59:55"
    },
    {
      "id": 1895,
      "intervention": {
        "name": "treat-to-target urate-lowering therapy",
        "canonical_name": "urate-lowering therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "urate-lowering therapy",
          "layer_2_variant": "treat-to-target urate-lowering therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gout",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced serum urate and inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 878,
        "duration": "72 weeks",
        "population": "participants with gout, primarily male (98.9%) aged 62.4 years on average",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Improvements in Health-Related Quality of Life with Treat-to-Target Urate-Lowering Therapy in Gout: A Post-hoc Analysis of a Randomized Multicenter Trial.",
        "journal": "Arthritis care & research",
        "publication_date": "2025-08-07",
        "pubmed_id": "40771143",
        "doi": "10.1002/acr.25618"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:58:01"
    },
    {
      "id": 1890,
      "intervention": {
        "name": "yoga",
        "canonical_name": "yoga",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "yoga",
          "layer_2_variant": "yoga",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "polycystic ovarian syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved insulin sensitivity and reduced testosterone levels",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 808,
        "duration": null,
        "population": "women with polycystic ovary syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with Polycystic Ovarian Syndrome: A Network Meta-Analysis Study.",
        "journal": "Healthcare (Basel, Switzerland)",
        "publication_date": "2025-08-27",
        "pubmed_id": "40941484",
        "doi": "10.3390/healthcare13172132"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:57:19"
    },
    {
      "id": 1891,
      "intervention": {
        "name": "moderate-intensity continuous training (MICT)",
        "canonical_name": "moderate-intensity continuous training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "moderate-intensity continuous training",
          "layer_2_variant": "moderate-intensity continuous training (mict)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "polycystic ovarian syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved insulin sensitivity and reduced testosterone levels",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 808,
        "duration": null,
        "population": "women with polycystic ovary syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with Polycystic Ovarian Syndrome: A Network Meta-Analysis Study.",
        "journal": "Healthcare (Basel, Switzerland)",
        "publication_date": "2025-08-27",
        "pubmed_id": "40941484",
        "doi": "10.3390/healthcare13172132"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:57:19"
    },
    {
      "id": 1892,
      "intervention": {
        "name": "high-intensity interval training (HIIT)",
        "canonical_name": "high-intensity interval training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "high-intensity interval training",
          "layer_2_variant": "high-intensity interval training (hiit)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "polycystic ovarian syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved insulin sensitivity and reduced testosterone levels",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 808,
        "duration": null,
        "population": "women with polycystic ovary syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with Polycystic Ovarian Syndrome: A Network Meta-Analysis Study.",
        "journal": "Healthcare (Basel, Switzerland)",
        "publication_date": "2025-08-27",
        "pubmed_id": "40941484",
        "doi": "10.3390/healthcare13172132"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:57:19"
    },
    {
      "id": 1893,
      "intervention": {
        "name": "resistance training (RT)",
        "canonical_name": "resistance training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "resistance training",
          "layer_2_variant": "resistance training (rt)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "polycystic ovarian syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved insulin sensitivity and reduced testosterone levels",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 808,
        "duration": null,
        "population": "women with polycystic ovary syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with Polycystic Ovarian Syndrome: A Network Meta-Analysis Study.",
        "journal": "Healthcare (Basel, Switzerland)",
        "publication_date": "2025-08-27",
        "pubmed_id": "40941484",
        "doi": "10.3390/healthcare13172132"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:57:19"
    },
    {
      "id": 1894,
      "intervention": {
        "name": "combined aerobic-resistance training (CT)",
        "canonical_name": "aerobic-resistance training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "aerobic-resistance training",
          "layer_2_variant": "combined aerobic-resistance training (ct)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "polycystic ovarian syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved insulin sensitivity and reduced testosterone levels",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 808,
        "duration": null,
        "population": "women with polycystic ovary syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with Polycystic Ovarian Syndrome: A Network Meta-Analysis Study.",
        "journal": "Healthcare (Basel, Switzerland)",
        "publication_date": "2025-08-27",
        "pubmed_id": "40941484",
        "doi": "10.3390/healthcare13172132"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:57:19"
    },
    {
      "id": 1889,
      "intervention": {
        "name": "nurse-led person-centered self-management intervention",
        "canonical_name": "self-management intervention",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "self-management intervention",
          "layer_2_variant": "nurse-led person-centered self-management intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "irritable bowel syndrome",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "self-directed lifestyle modifications and symptom management",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "pre-post study nested within a randomized controlled trial",
        "sample_size": 20,
        "duration": "12 weeks",
        "population": "young adults with irritable bowel syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Mechanistic Insights into a Self-Management Intervention in Young Adults with Irritable Bowel Syndrome: A Pilot Multi-Omics Study.",
        "journal": "Biomedicines",
        "publication_date": "2025-08-28",
        "pubmed_id": "41007665",
        "doi": "10.3390/biomedicines13092102"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:55:11"
    },
    {
      "id": 1888,
      "intervention": {
        "name": "vitamin D supplementation",
        "canonical_name": "vitamin d",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vitamin d",
          "layer_2_variant": "vitamin d supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic lupus erythematosus disease activity",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved immune modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 3177,
        "duration": null,
        "population": "adult patients with systemic lupus erythematosus",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review and Meta-Analysis of the Effects of Vitamin D on Systemic Lupus Erythematosus.",
        "journal": "Nutrients",
        "publication_date": "2025-08-28",
        "pubmed_id": "40944182",
        "doi": "10.3390/nu17172794"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:53:59"
    },
    {
      "id": 1887,
      "intervention": {
        "name": "wearable focal vibration therapy",
        "canonical_name": "focal vibration therapy",
        "category": "device",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "focal vibration therapy",
          "layer_2_variant": "wearable focal vibration therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gait and mobility impairment",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced neuromuscular control and proprioception",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "pilot double-blind randomized controlled trial",
        "sample_size": 22,
        "duration": "4 weeks",
        "population": "people with multiple sclerosis (PwMS)",
        "adverse_effects": "minor adjustability issues",
        "cost_category": null
      },
      "paper": {
        "title": "Feasibility and Preliminary Efficacy of Wearable Focal Vibration Therapy on Gait and Mobility in People with Multiple Sclerosis: A Pilot Study.",
        "journal": "Bioengineering (Basel, Switzerland)",
        "publication_date": "2025-08-29",
        "pubmed_id": "41007175",
        "doi": "10.3390/bioengineering12090932"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:53:25"
    },
    {
      "id": 1884,
      "intervention": {
        "name": "High-intensity interval training (HIIT)",
        "canonical_name": "high-intensity interval training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "high-intensity interval training",
          "layer_2_variant": "high-intensity interval training (hiit)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "affective symptoms",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neuroplastic adaptations and symptom alleviation through exercise",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 24,
        "duration": "8 weeks",
        "population": "participants with Parkinson's disease and multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "HIITing Anxiety and Depression in Parkinson's Disease and Multiple Sclerosis-A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT).",
        "journal": "Brain sciences",
        "publication_date": "2025-08-29",
        "pubmed_id": "41008305",
        "doi": "10.3390/brainsci15090945"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:52:51"
    },
    {
      "id": 1885,
      "intervention": {
        "name": "Continuous aerobic training (CAT)",
        "canonical_name": "aerobic training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "aerobic training",
          "layer_2_variant": "continuous aerobic training (cat)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "affective symptoms",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neuroplastic adaptations and symptom alleviation through exercise",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 24,
        "duration": "8 weeks",
        "population": "participants with Parkinson's disease and multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "HIITing Anxiety and Depression in Parkinson's Disease and Multiple Sclerosis-A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT).",
        "journal": "Brain sciences",
        "publication_date": "2025-08-29",
        "pubmed_id": "41008305",
        "doi": "10.3390/brainsci15090945"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:52:51"
    },
    {
      "id": 1886,
      "intervention": {
        "name": "Movement advice (MA)",
        "canonical_name": "movement advice",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "movement advice",
          "layer_2_variant": "movement advice (ma)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "affective symptoms",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "advice on physical activity and step goals",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 24,
        "duration": "8 weeks",
        "population": "participants with Parkinson's disease and multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "HIITing Anxiety and Depression in Parkinson's Disease and Multiple Sclerosis-A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT).",
        "journal": "Brain sciences",
        "publication_date": "2025-08-29",
        "pubmed_id": "41008305",
        "doi": "10.3390/brainsci15090945"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:52:51"
    },
    {
      "id": 1882,
      "intervention": {
        "name": "bariatric surgery",
        "canonical_name": "bariatric surgery",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bariatric surgery",
          "layer_2_variant": "bariatric surgery",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary incontinence",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "weight loss and anatomical changes",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "retrospective case-control study",
        "sample_size": 46,
        "duration": null,
        "population": "elderly obese women with urinary incontinence",
        "adverse_effects": "postoperative diarrhea",
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of the effects of bariatric surgery and pelvic floor muscle training on urinary incontinence in elderly women with obesity.",
        "journal": "Surgery in practice and science",
        "publication_date": "2025-09",
        "pubmed_id": "41048845",
        "doi": "10.1016/j.sipas.2025.100303"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:51:29"
    },
    {
      "id": 1883,
      "intervention": {
        "name": "pelvic floor muscle training",
        "canonical_name": "pelvic floor muscle training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pelvic floor muscle training",
          "layer_2_variant": "pelvic floor muscle training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary incontinence",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "muscle strengthening and improved pelvic floor function",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "retrospective case-control study",
        "sample_size": 46,
        "duration": null,
        "population": "elderly obese women with urinary incontinence",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of the effects of bariatric surgery and pelvic floor muscle training on urinary incontinence in elderly women with obesity.",
        "journal": "Surgery in practice and science",
        "publication_date": "2025-09",
        "pubmed_id": "41048845",
        "doi": "10.1016/j.sipas.2025.100303"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:51:29"
    },
    {
      "id": 1881,
      "intervention": {
        "name": "BI 1595043",
        "canonical_name": "bi 1595043",
        "category": "emerging",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bi 1595043",
          "layer_2_variant": "bi 1595043",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "epithelial cell protection and reduction of inflammatory mediators",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of vanin-1 and vanin-2 enzymes",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "double-blind, randomized, placebo-controlled trial",
        "sample_size": 30,
        "duration": "18 days",
        "population": "healthy male volunteers aged 18-50 years with BMI 18.5-29.9 kg/m2",
        "adverse_effects": "mild or moderate severity (headache, dizziness, abdominal discomfort)",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, Pharmacokinetics, and Pharmacodynamics of BI 1595043, a Selective Vanin Inhibitor, in Phase 1 Clinical Trials Involving Healthy Volunteers.",
        "journal": "Clinical and translational science",
        "publication_date": "2025-09",
        "pubmed_id": "40952900",
        "doi": "10.1111/cts.70285"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:50:35"
    },
    {
      "id": 1880,
      "intervention": {
        "name": "transcranial photobiomodulation",
        "canonical_name": "transcranial photobiomodulation",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "transcranial photobiomodulation",
          "layer_2_variant": "transcranial photobiomodulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild cognitive impairment due to Alzheimer's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased mitochondrial ATP production and enhanced cerebral blood flow",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blind, sham-controlled study",
        "sample_size": 26,
        "duration": "12 weeks",
        "population": "individuals with mild cognitive impairment due to Alzheimer's disease",
        "adverse_effects": "no serious adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "The Efficacy and Safety of Transcranial Photobiomodulation for Mild Cognitive Impairment Due to Alzheimer's Disease: A Randomized, Double-Blind, Sham-Controlled Study.",
        "journal": "Photobiomodulation, photomedicine, and laser surgery",
        "publication_date": "2025-09",
        "pubmed_id": "40939031",
        "doi": "10.1177/15578550251369575"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:49:56"
    },
    {
      "id": 1879,
      "intervention": {
        "name": "Sodium-Glucose Cotransporter-2 inhibitors",
        "canonical_name": "sodium-glucose cotransporter-2 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sodium-glucose cotransporter-2 inhibitors",
          "layer_2_variant": "sodium-glucose cotransporter-2 inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "heart failure hospitalization",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced risk of heart failure and improved left ventricular ejection fraction",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with acute myocardial infarction",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Administration of Sodium-Glucose Cotransporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review, Meta-Analysis, and Meta-Regression of Randomized Trials.",
        "journal": "Journal of lipid and atherosclerosis",
        "publication_date": "2025-09",
        "pubmed_id": "41048601",
        "doi": "10.12997/jla.2025.14.3.326"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:49:21"
    },
    {
      "id": 1878,
      "intervention": {
        "name": "arthroscopic rotator cuff repair",
        "canonical_name": "arthroscopic rotator cuff repair",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "arthroscopic rotator cuff repair",
          "layer_2_variant": "arthroscopic rotator cuff repair",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff tear",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "surgical repair and stabilization of the tendon-bone interface",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "cost-effectiveness analysis using Markov model",
        "sample_size": null,
        "duration": "1, 5, and 10 years",
        "population": "patients with small, medium, large, or massive rotator cuff tears",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of rotator cuff repair based on modern constructs, tear size, and implant cost at 1, 5, and 10 years.",
        "journal": "JSES international",
        "publication_date": "2025-09",
        "pubmed_id": "41049655",
        "doi": "10.1016/j.jseint.2025.04.038"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:48:13"
    },
    {
      "id": 1877,
      "intervention": {
        "name": "Monitored Therapeutic Alcohol Administration (MTAA)",
        "canonical_name": "therapeutic alcohol",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "therapeutic alcohol",
          "layer_2_variant": "monitored therapeutic alcohol administration (mtaa)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Alcohol Withdrawal Syndrome (AWS)-related distress",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced AWS-related psychological stress and improved compliance",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled pilot study",
        "sample_size": 12,
        "duration": "six weeks",
        "population": "adult male patients with AUD and isolated facial fractures requiring surgery",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Impact of Therapeutic Alcohol Administration on Perioperative Quality of Life (QoL) and Fracture Healing in Patients with Alcohol Use Disorder Undergoing Surgery for Maxillofacial Trauma-A Randomized Pilot Trial.",
        "journal": "Craniomaxillofacial trauma & reconstruction",
        "publication_date": "2025-09",
        "pubmed_id": "40989766",
        "doi": "10.3390/cmtr18030037"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:47:40"
    },
    {
      "id": 1876,
      "intervention": {
        "name": "amyloid beta-directed monoclonal antibodies",
        "canonical_name": "amyloid beta-directed monoclonal antibodies",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "amyloid beta-directed monoclonal antibodies",
          "layer_2_variant": "amyloid beta-directed monoclonal antibodies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Alzheimer's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces amyloid burden and inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of phase III randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with Alzheimer's disease",
        "adverse_effects": "amyloid-related imaging abnormalities, adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "The Efficacy and Safety of Amyloid Beta-Directed Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials.",
        "journal": "Human psychopharmacology",
        "publication_date": "2025-09",
        "pubmed_id": "40951935",
        "doi": "10.1002/hup.70017"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:47:06"
    },
    {
      "id": 1875,
      "intervention": {
        "name": "rituximab",
        "canonical_name": "rituximab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rituximab",
          "layer_2_variant": "rituximab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diffuse podocytopathy",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces antinephrin antibodies and inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "patients with minimal change disease and focal segmental glomerulosclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "New insights into the biology and treatment of minimal change disease and focal segmental glomerulosclerosis.",
        "journal": "Current opinion in nephrology and hypertension",
        "publication_date": "2025-09-01",
        "pubmed_id": "40726375",
        "doi": "10.1097/MNH.0000000000001102"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:45:12"
    },
    {
      "id": 1874,
      "intervention": {
        "name": "immune checkpoint inhibitors",
        "canonical_name": "immune checkpoint inhibitors",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "immune checkpoint inhibitors",
          "layer_2_variant": "immune checkpoint inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of immune response against cancer cells",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials and cohort studies",
        "sample_size": 4663,
        "duration": null,
        "population": "patients with various types of cancer",
        "adverse_effects": "cancer-specific associations with SAEs",
        "cost_category": null
      },
      "paper": {
        "title": "Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors.",
        "journal": "NPJ biofilms and microbiomes",
        "publication_date": "2025-09-02",
        "pubmed_id": "40897718",
        "doi": "10.1038/s41522-025-00819-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:44:42"
    },
    {
      "id": 1873,
      "intervention": {
        "name": "digital psychological intervention",
        "canonical_name": "digital psychological intervention",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "digital psychological intervention",
          "layer_2_variant": "digital psychological intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psychological distress",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced psychological distress and improved quality of life",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 102,
        "duration": "3 months",
        "population": "patients with inflammatory rheumatic diseases aged 18 years or older",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital Psychological Intervention for Inflammatory Rheumatic Diseases: A Pilot Randomized Clinical Trial.",
        "journal": "JAMA network open",
        "publication_date": "2025-09-02",
        "pubmed_id": "40924426",
        "doi": "10.1001/jamanetworkopen.2025.29892"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:44:10"
    },
    {
      "id": 1872,
      "intervention": {
        "name": "Sodium-glucose cotransporter 2 inhibitors",
        "canonical_name": "sodium-glucose cotransporter 2 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sodium-glucose cotransporter 2 inhibitors",
          "layer_2_variant": "sodium-glucose cotransporter 2 inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lithium-associated kidney dysfunction",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved renal outcomes and eGFR trajectory",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "historical cohort study",
        "sample_size": 56,
        "duration": "2001-2023 (historical cohort study)",
        "population": "patients with mood disorders who received lithium for ≥6 months and later used SGLT2i for ≥1 month",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Sodium-Glucose Cotransporter 2 Inhibitors for Lithium-Associated Kidney Dysfunction in Mood Disorders: A Real-World Historical Cohort Study.",
        "journal": "medRxiv : the preprint server for health sciences",
        "publication_date": "2025-09-03",
        "pubmed_id": "40950471",
        "doi": "10.1101/2025.09.02.25334914"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:43:29"
    },
    {
      "id": 1871,
      "intervention": {
        "name": "benzathine penicillin G",
        "canonical_name": "penicillin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "penicillin",
          "layer_2_variant": "benzathine penicillin g",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "early syphilis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibiotic treatment for Treponema pallidum infection",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 249,
        "duration": null,
        "population": "persons with early syphilis, some with HIV infection",
        "adverse_effects": "local injection-site pain and tenderness",
        "cost_category": null
      },
      "paper": {
        "title": "One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis.",
        "journal": "The New England journal of medicine",
        "publication_date": "2025-09-04",
        "pubmed_id": "40902161",
        "doi": "10.1056/NEJMoa2401802"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:42:51"
    },
    {
      "id": 1865,
      "intervention": {
        "name": "SSRIs",
        "canonical_name": "ssris",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ssris",
          "layer_2_variant": "ssris",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neurotransmitter modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "overview of systematic reviews",
        "sample_size": null,
        "duration": null,
        "population": "patients with panic disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:42:05"
    },
    {
      "id": 1866,
      "intervention": {
        "name": "SNRIs",
        "canonical_name": "snris",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "snris",
          "layer_2_variant": "snris",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neurotransmitter modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "overview of systematic reviews",
        "sample_size": null,
        "duration": null,
        "population": "patients with panic disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:42:05"
    },
    {
      "id": 1867,
      "intervention": {
        "name": "TCAs",
        "canonical_name": "tcas",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tcas",
          "layer_2_variant": "tcas",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neurotransmitter modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "overview of systematic reviews",
        "sample_size": null,
        "duration": null,
        "population": "patients with panic disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:42:05"
    },
    {
      "id": 1868,
      "intervention": {
        "name": "MAIOs",
        "canonical_name": "maios",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "maios",
          "layer_2_variant": "maios",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neurotransmitter modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "overview of systematic reviews",
        "sample_size": null,
        "duration": null,
        "population": "patients with panic disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:42:05"
    },
    {
      "id": 1869,
      "intervention": {
        "name": "CBT",
        "canonical_name": "cognitive behavioral therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive behavioral therapy",
          "layer_2_variant": "cbt",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cognitive restructuring and behavioral modification",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "overview of systematic reviews",
        "sample_size": null,
        "duration": null,
        "population": "patients with panic disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:42:05"
    },
    {
      "id": 1870,
      "intervention": {
        "name": "Benzodiazepines",
        "canonical_name": "benzodiazepines",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "benzodiazepines",
          "layer_2_variant": "benzodiazepines",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "GABA modulation and sedation",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "overview of systematic reviews",
        "sample_size": null,
        "duration": null,
        "population": "patients with panic disorder",
        "adverse_effects": "dependency and long-term risks",
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:42:05"
    },
    {
      "id": 1860,
      "intervention": {
        "name": "perampanel",
        "canonical_name": "perampanel",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "perampanel",
          "layer_2_variant": "perampanel",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces generalized tonic-clonic and myoclonic seizures",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials and observational studies",
        "sample_size": 307,
        "duration": null,
        "population": "patients with Lennox-Gastaut syndrome",
        "adverse_effects": "irritability, aggression",
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:39:19"
    },
    {
      "id": 1861,
      "intervention": {
        "name": "brivaracetam",
        "canonical_name": "brivaracetam",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "brivaracetam",
          "layer_2_variant": "brivaracetam",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces seizures with better behavioral tolerability than levetiracetam",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational studies",
        "sample_size": 59,
        "duration": null,
        "population": "patients with Lennox-Gastaut syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:39:19"
    },
    {
      "id": 1862,
      "intervention": {
        "name": "cenobamate",
        "canonical_name": "cenobamate",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cenobamate",
          "layer_2_variant": "cenobamate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces seizures and allows polypharmacy reduction",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational studies",
        "sample_size": 223,
        "duration": null,
        "population": "patients with Lennox-Gastaut syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:39:19"
    },
    {
      "id": 1863,
      "intervention": {
        "name": "ganaxolone",
        "canonical_name": "ganaxolone",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ganaxolone",
          "layer_2_variant": "ganaxolone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome-like CDKL5 deficiency phenotypes",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces drop seizures",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": 0.25
      },
      "study": {
        "type": "observational studies",
        "sample_size": null,
        "duration": null,
        "population": "patients with CDKL5 deficiency phenotypes similar to Lennox-Gastaut syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:39:19"
    },
    {
      "id": 1864,
      "intervention": {
        "name": "stiripentol",
        "canonical_name": "stiripentol",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "stiripentol",
          "layer_2_variant": "stiripentol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "potential benefit for generalized seizures",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": 0.25
      },
      "study": {
        "type": "observational studies",
        "sample_size": null,
        "duration": null,
        "population": "patients with Lennox-Gastaut syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:39:19"
    },
    {
      "id": 1859,
      "intervention": {
        "name": "bronchiectasis action management plan (BAMP)",
        "canonical_name": "bronchiectasis action management plan",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bronchiectasis action management plan",
          "layer_2_variant": "bronchiectasis action management plan (bamp)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic suppurative lung disease (CSLD)/bronchiectasis",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved patient management and adherence to care plans",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 194,
        "duration": "2 years (June 2018 to December 2020)",
        "population": "children and adolescents aged < 19 years with CSLD/bronchiectasis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pediatric Bronchiectasis Action Management Plan to Improve Clinical Outcomes: A Randomized Controlled Trial.",
        "journal": "Chest",
        "publication_date": "2025-09-08",
        "pubmed_id": "40930343",
        "doi": "10.1016/j.chest.2025.08.021"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:37:10"
    },
    {
      "id": 1858,
      "intervention": {
        "name": "laparoscopic fundoplication",
        "canonical_name": "fundoplication",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fundoplication",
          "layer_2_variant": "laparoscopic fundoplication",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gastroesophageal reflux disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "surgical correction of anatomical defects causing GERD",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis of clinical practice guidelines, randomized controlled trials, systematic reviews and foundational papers",
        "sample_size": null,
        "duration": null,
        "population": "surgeons performing laparoscopic fundoplication",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The SAGES masters program: top 10 seminal articles for laparoscopic fundoplication.",
        "journal": "Surgical endoscopy",
        "publication_date": "2025-09-08",
        "pubmed_id": "40921834",
        "doi": "10.1007/s00464-025-12141-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:36:34"
    },
    {
      "id": 1857,
      "intervention": {
        "name": "comprehensive cancer care",
        "canonical_name": "comprehensive cancer care",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "comprehensive cancer care",
          "layer_2_variant": "comprehensive cancer care",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cancer survival",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced patient outcomes through coordinated, personalized care and state-of-the-art therapies",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "retrospective cohort study with propensity score matching",
        "sample_size": null,
        "duration": "2004-2020",
        "population": "patients diagnosed with incident cancer from an NCI-designated Comprehensive Cancer Center (COH) compared to the U.S. Surveillance, Epidemiology, and End Results (SEER) national database",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cancer Survival at a Comprehensive Cancer Center Compared with Surveillance, Epidemiology, and End Results (SEER) Estimates.",
        "journal": "medRxiv : the preprint server for health sciences",
        "publication_date": "2025-09-08",
        "pubmed_id": "40963747",
        "doi": "10.1101/2025.09.05.25335204"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:36:01"
    },
    {
      "id": 1856,
      "intervention": {
        "name": "brivaracetam",
        "canonical_name": "brivaracetam",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "brivaracetam",
          "layer_2_variant": "brivaracetam",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "focal-onset seizures",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces seizure activity",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 448,
        "duration": "12 weeks",
        "population": "adult Asian patients with focal-onset seizures",
        "adverse_effects": "mild to moderate treatment-emergent adverse events, primarily somnolence and dizziness",
        "cost_category": null
      },
      "paper": {
        "title": "Temporal Profile of Treatment-Emergent Adverse Events in Adult Asian Patients with Focal-Onset Seizures During Adjunctive Brivaracetam Treatment: Post Hoc Analysis of a Phase 3, Randomized Trial.",
        "journal": "Advances in therapy",
        "publication_date": "2025-09-13",
        "pubmed_id": "40944847",
        "doi": "10.1007/s12325-025-03357-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:35:12"
    },
    {
      "id": 1853,
      "intervention": {
        "name": "digital health platforms",
        "canonical_name": "digital health platforms",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "digital health platforms",
          "layer_2_variant": "digital health platforms",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis treatment",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced adherence and monitoring",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "network meta-analysis of randomized controlled trials",
        "sample_size": 23283,
        "duration": "varied across studies",
        "population": "patients with tuberculosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative Effectiveness of Digital Health Technologies in Tuberculosis Treatment: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957002",
        "doi": "10.2196/75424"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:34:36"
    },
    {
      "id": 1854,
      "intervention": {
        "name": "video directly observed treatment (VDOT)",
        "canonical_name": "directly observed treatment",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "directly observed treatment",
          "layer_2_variant": "video directly observed treatment (vdot)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis treatment",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced adherence and monitoring through video observation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "network meta-analysis of randomized controlled trials",
        "sample_size": 23283,
        "duration": "varied across studies",
        "population": "patients with tuberculosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative Effectiveness of Digital Health Technologies in Tuberculosis Treatment: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957002",
        "doi": "10.2196/75424"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:34:36"
    },
    {
      "id": 1855,
      "intervention": {
        "name": "medication event reminder monitors",
        "canonical_name": "medication event reminder monitors",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "medication event reminder monitors",
          "layer_2_variant": "medication event reminder monitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis treatment adherence",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced medication adherence through reminders",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "network meta-analysis of randomized controlled trials",
        "sample_size": 23283,
        "duration": "varied across studies",
        "population": "patients with tuberculosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative Effectiveness of Digital Health Technologies in Tuberculosis Treatment: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957002",
        "doi": "10.2196/75424"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:34:36"
    },
    {
      "id": 1852,
      "intervention": {
        "name": "systematic PROM assessment",
        "canonical_name": "patient-reported outcome measures",
        "category": "test",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "patient-reported outcome measures",
          "layer_2_variant": "systematic prom assessment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "noncommunicable diseases",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced patient-clinician communication and decision-making",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": 56,
        "duration": null,
        "population": "adult patients with diabetes, COPD, heart disease, RA, or IBD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Evidence for the Use of Patient-Reported Outcome Measures in the Treatment of Patients With Noncommunicable Diseases: Systematic Review.",
        "journal": "JMIR medical informatics",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957012",
        "doi": "10.2196/66160"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:33:39"
    },
    {
      "id": 1851,
      "intervention": {
        "name": "mixed amphetamine salts-extended release (MAS-XR)",
        "canonical_name": "amphetamine",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "amphetamine",
          "layer_2_variant": "mixed amphetamine salts-extended release (mas-xr)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "attention-deficit/hyperactivity disorder (ADHD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced left uncinate fasciculus microstructural integrity in high-risk ADHD youth",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "diffusion tensor imaging study",
        "sample_size": 137,
        "duration": "12 weeks",
        "population": "ADHD youth with and without a first-degree relative with bipolar I disorder, healthy controls",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Psychostimulant treatment uniquely reduces left uncinate fasciculus microstructural integrity in ADHD youth with a familial risk for bipolar I disorder: a 12-week DTI study.",
        "journal": "Journal of child psychology and psychiatry, and allied disciplines",
        "publication_date": "2025-09-17",
        "pubmed_id": "40960004",
        "doi": "10.1111/jcpp.70053"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:32:06"
    },
    {
      "id": 1850,
      "intervention": {
        "name": "adapted therapeutic recommendations",
        "canonical_name": "therapeutic recommendations",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "therapeutic recommendations",
          "layer_2_variant": "adapted therapeutic recommendations",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "childhood cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced toxicity while maintaining cure rates",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective evaluation",
        "sample_size": null,
        "duration": null,
        "population": "children with cancer in sub-Saharan countries",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "[Therapeutic adaptations: Rationale, achievements and limits. Experience of GFAOP].",
        "journal": "Bulletin du cancer",
        "publication_date": "2025-09-17",
        "pubmed_id": "40967945",
        "doi": "10.1016/j.bulcan.2025.07.011"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:31:30"
    },
    {
      "id": 1849,
      "intervention": {
        "name": "corticosteroids",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "corticosteroids",
          "layer_2_variant": "corticosteroids",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "community-acquired pneumonia",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation",
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "ICU patients and specific pathogen groups",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Glucocorticoid Treatment in Community-Acquired Pneumonia.",
        "journal": "Seminars in respiratory and critical care medicine",
        "publication_date": "2025-09-18",
        "pubmed_id": "40967602",
        "doi": "10.1055/a-2704-6851"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:31:01"
    },
    {
      "id": 1848,
      "intervention": {
        "name": "blood flow restriction with low-intensity exercise",
        "canonical_name": "blood flow restriction with low-intensity exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "blood flow restriction with low-intensity exercise",
          "layer_2_variant": "blood flow restriction with low-intensity exercise",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lower limb muscle weakness",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased muscular strength through restricted blood flow",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 41,
        "duration": "six weeks",
        "population": "relapsing-remitting multiple sclerosis patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of blood flow restriction with low-intensity exercise on lower limb muscle strength and gait in people with multiple sclerosis: A randomized controlled trial.",
        "journal": "Multiple sclerosis and related disorders",
        "publication_date": "2025-09-20",
        "pubmed_id": "41046656",
        "doi": "10.1016/j.msard.2025.106774"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:30:33"
    },
    {
      "id": 1841,
      "intervention": {
        "name": "TYK2 inhibitors",
        "canonical_name": "tyk2 inhibitors",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tyk2 inhibitors",
          "layer_2_variant": "tyk2 inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and immune modulation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:30:01"
    },
    {
      "id": 1842,
      "intervention": {
        "name": "JAK1 inhibitors",
        "canonical_name": "jak1 inhibitors",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "jak1 inhibitors",
          "layer_2_variant": "jak1 inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and immune modulation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:30:01"
    },
    {
      "id": 1843,
      "intervention": {
        "name": "next-generation IL-17 inhibitors",
        "canonical_name": "il-17 inhibitors",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "il-17 inhibitors",
          "layer_2_variant": "next-generation il-17 inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and immune modulation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:30:01"
    },
    {
      "id": 1844,
      "intervention": {
        "name": "IL-23-targeted therapies",
        "canonical_name": "il-23-targeted therapies",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "il-23-targeted therapies",
          "layer_2_variant": "il-23-targeted therapies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and immune modulation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:30:01"
    },
    {
      "id": 1845,
      "intervention": {
        "name": "novel immune-modulating agents",
        "canonical_name": "immune-modulating agents",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "immune-modulating agents",
          "layer_2_variant": "novel immune-modulating agents",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and immune modulation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:30:01"
    },
    {
      "id": 1846,
      "intervention": {
        "name": "microbiome-targeted therapies",
        "canonical_name": "microbiome-targeted therapies",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "microbiome-targeted therapies",
          "layer_2_variant": "microbiome-targeted therapies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation and immune regulation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:30:01"
    },
    {
      "id": 1847,
      "intervention": {
        "name": "GLP-1 receptor agonists",
        "canonical_name": "glp-1 receptor agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "glp-1 receptor agonists",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "metabolic regulation and inflammation reduction",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:30:01"
    },
    {
      "id": 1840,
      "intervention": {
        "name": "HEPA air cleaner",
        "canonical_name": "air purifier",
        "category": "device",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "air purifier",
          "layer_2_variant": "hepa air cleaner",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced indoor air pollution and particulate matter exposure",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 60,
        "duration": "three months",
        "population": "children with asthma in South King County, Washington State",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Airport, Air Quality and Asthma (AAA) Indoor Air Intervention Trial for Children with Asthma: Protocol for a Community Based Study in South King County, Washington State.",
        "journal": "Research square",
        "publication_date": "2025-09-22",
        "pubmed_id": "41041530",
        "doi": "10.21203/rs.3.rs-7181465/v1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:26:37"
    },
    {
      "id": 1839,
      "intervention": {
        "name": "radical prostatectomy",
        "canonical_name": "radical prostatectomy",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "radical prostatectomy",
          "layer_2_variant": "radical prostatectomy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "prostate cancer recurrence",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "surgical removal of tumor and associated tissue",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "post-hoc study nested in a prospective, controlled trial",
        "sample_size": 3444,
        "duration": null,
        "population": "patients undergoing radical prostatectomy by robot assisted laparoscopic or open retropubic approach in Sweden",
        "adverse_effects": "intraoperative extensive bleeding and difficulties during dissection",
        "cost_category": null
      },
      "paper": {
        "title": "Adverse events during radical prostatectomy and their association with recurrence and death.",
        "journal": "World journal of urology",
        "publication_date": "2025-09-23",
        "pubmed_id": "40987849",
        "doi": "10.1007/s00345-025-05932-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:26:06"
    },
    {
      "id": 1838,
      "intervention": {
        "name": "CDS nudges for deprescribing glycemic medications",
        "canonical_name": "glycemic medications",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glycemic medications",
          "layer_2_variant": "cds nudges for deprescribing glycemic medications",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "overprescription of glycemic medications in older adults",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "promotes guideline-concordant care through EHR alerts",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized trial with mixed methods evaluation",
        "sample_size": null,
        "duration": null,
        "population": "older adults with Type 2 Diabetes and their clinicians",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "When Nudges Don't Budge: A Mixed Methods Study of Why EHR-Based Deprescribing Nudges Failed to Change Provider Behavior.",
        "journal": "Research square",
        "publication_date": "2025-09-23",
        "pubmed_id": "41041570",
        "doi": "10.21203/rs.3.rs-7466262/v1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:25:32"
    },
    {
      "id": 1837,
      "intervention": {
        "name": "allogeneic human bone marrow-derived mesenchymal stem cells (allo-hMSCs)",
        "canonical_name": "mesenchymal stem cells",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mesenchymal stem cells",
          "layer_2_variant": "allogeneic human bone marrow-derived mesenchymal stem cells (allo-hmscs)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "aging kidney function decline in Parkinson's disease patients",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immunomodulatory effects and preservation of renal function",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 45,
        "duration": "88 weeks",
        "population": "subjects with Parkinson's disease aged 50-79 years with preserved renal function",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson's disease clinical trial.",
        "journal": "Stem cell research & therapy",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993774",
        "doi": "10.1186/s13287-025-04577-y"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:24:58"
    },
    {
      "id": 1836,
      "intervention": {
        "name": "amiodarone",
        "canonical_name": "amiodarone",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "amiodarone",
          "layer_2_variant": "amiodarone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atrial fibrillation recurrence",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "electrophysiological modulation to prevent arrhythmias",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 108,
        "duration": "6 months",
        "population": "patients undergoing catheter ablation for atrial fibrillation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Amiodarone after Catheter Ablation According to Left Atrial Structure and Function: The AMIO-CAT Trial.",
        "journal": "The American journal of cardiology",
        "publication_date": "2025-09-24",
        "pubmed_id": "41005596",
        "doi": "10.1016/j.amjcard.2025.09.017"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:24:20"
    },
    {
      "id": 1835,
      "intervention": {
        "name": "dupilumab",
        "canonical_name": "dupilumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "dupilumab",
          "layer_2_variant": "dupilumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe atopic dermatitis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced type 2 inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "placebo-controlled, randomized clinical trials and long-term open-label extensions",
        "sample_size": null,
        "duration": "> 5 years",
        "population": "infants, children, adolescents, and adults with moderate-to-severe atopic dermatitis",
        "adverse_effects": "mild to moderate treatment-emergent adverse events (TEAEs), injection-site reactions, conjunctivitis",
        "cost_category": null
      },
      "paper": {
        "title": "The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults.",
        "journal": "American journal of clinical dermatology",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993471",
        "doi": "10.1007/s40257-025-00952-w"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:21:14"
    },
    {
      "id": 1834,
      "intervention": {
        "name": "restrictive fluid strategy with early de-escalation",
        "canonical_name": "restrictive fluid strategy",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "restrictive fluid strategy",
          "layer_2_variant": "restrictive fluid strategy with early de-escalation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "circulatory shock",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "near-zero fluid balance maintenance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "feasibility randomized controlled trial",
        "sample_size": 100,
        "duration": "7 days",
        "population": "patients with shock requiring fluid resuscitation in the medical intensive care unit",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Restrictive fluid management with early de-escalation versus usual care in critically ill patients (reduce trial): a feasibility randomized controlled trial.",
        "journal": "Critical care (London, England)",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999428",
        "doi": "10.1186/s13054-025-05624-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:19:38"
    },
    {
      "id": 1833,
      "intervention": {
        "name": "low-intensity focused ultrasound",
        "canonical_name": "low-intensity focused ultrasound",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "low-intensity focused ultrasound",
          "layer_2_variant": "low-intensity focused ultrasound",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "refractory depression",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulates white matter tracts in ALIC by operating mechanosensitive potassium channels in nodes of Ranvier",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "cross-over, randomized, sham-controlled, double-blind design",
        "sample_size": 21,
        "duration": null,
        "population": "patients with Major Depressive Disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Reversible modulation of a deep white matter surgical target for depression with low-intensity focused ultrasound.",
        "journal": "Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999237",
        "doi": "10.1038/s41386-025-02252-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:18:19"
    },
    {
      "id": 1832,
      "intervention": {
        "name": "Chinese Herbal Medicine (CHM)",
        "canonical_name": "chinese herbal medicine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "chinese herbal medicine",
          "layer_2_variant": "chinese herbal medicine (chm)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anxiety disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced anxiety symptoms",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "participants with generalized anxiety disorder and obsessive-compulsive disorder",
        "adverse_effects": "fewer adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Chinese herbal medicine for anxiety disorders and obsessive-compulsive disorder: A systematic review with meta-analysis.",
        "journal": "Journal of psychiatric research",
        "publication_date": "2025-09-26",
        "pubmed_id": "41045767",
        "doi": "10.1016/j.jpsychires.2025.09.045"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:12:35"
    },
    {
      "id": 1831,
      "intervention": {
        "name": "tezepelumab",
        "canonical_name": "tezepelumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tezepelumab",
          "layer_2_variant": "tezepelumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced TSLP signaling and inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, multicenter, observational study",
        "sample_size": 30,
        "duration": "6 months",
        "population": "patients with severe asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of tezepelumab in severe asthma: A multicenter real-world study.",
        "journal": "European journal of internal medicine",
        "publication_date": "2025-09-26",
        "pubmed_id": "41015715",
        "doi": "10.1016/j.ejim.2025.106528"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:11:20"
    },
    {
      "id": 1830,
      "intervention": {
        "name": "fibrates",
        "canonical_name": "fibrates",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fibrates",
          "layer_2_variant": "fibrates",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetic retinopathy",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved lipid profile",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with diabetes",
        "adverse_effects": "no significant difference in adverse events compared to placebo",
        "cost_category": null
      },
      "paper": {
        "title": "Can fibrate therapy redefine the management of diabetic retinopathy? A comprehensive systematic review and meta-analysis of efficacy and safety.",
        "journal": "Journal of diabetes and its complications",
        "publication_date": "2025-09-27",
        "pubmed_id": "41038126",
        "doi": "10.1016/j.jdiacomp.2025.109178"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:07:06"
    },
    {
      "id": 1829,
      "intervention": {
        "name": "cognitive stimulation",
        "canonical_name": "cognitive stimulation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive stimulation",
          "layer_2_variant": "cognitive stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild cognitive impairment in Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cognitive function improvement through multi-domain training",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 45,
        "duration": "6 months (including follow-up)",
        "population": "patients with Parkinson's disease and mild cognitive impairment",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cognitive stimulation in Parkinson's disease with mild cognitive impairment.",
        "journal": "Journal of neurology",
        "publication_date": "2025-09-27",
        "pubmed_id": "41015632",
        "doi": "10.1007/s00415-025-13374-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:05:33"
    },
    {
      "id": 1826,
      "intervention": {
        "name": "immunotherapy",
        "canonical_name": "immunotherapy",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "immunotherapy",
          "layer_2_variant": "immunotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "non-small cell lung cancer (NSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immune system activation against tumor cells",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials (OAK and POPLAR)",
        "sample_size": null,
        "duration": null,
        "population": "advanced NSCLC patients treated with immunotherapy or chemotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dissection of immunotherapeutic predictive versus prognostic transcriptional programs identifies SLC22A5-centric carnitine metabolism-driven resistance to anti-PD-(L)1 treatment in non-small cell lung cancer.",
        "journal": "Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41045681",
        "doi": "10.1016/j.drup.2025.101313"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:04:21"
    },
    {
      "id": 1827,
      "intervention": {
        "name": "chemotherapy",
        "canonical_name": "chemotherapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "chemotherapy",
          "layer_2_variant": "chemotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "non-small cell lung cancer (NSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cell cycle inhibition and apoptosis induction in tumor cells",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials (OAK and POPLAR)",
        "sample_size": null,
        "duration": null,
        "population": "advanced NSCLC patients treated with immunotherapy or chemotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dissection of immunotherapeutic predictive versus prognostic transcriptional programs identifies SLC22A5-centric carnitine metabolism-driven resistance to anti-PD-(L)1 treatment in non-small cell lung cancer.",
        "journal": "Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41045681",
        "doi": "10.1016/j.drup.2025.101313"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:04:21"
    },
    {
      "id": 1828,
      "intervention": {
        "name": "SLC22A5 inhibitor (meldonium)",
        "canonical_name": "slc22a5 inhibitor",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "slc22a5 inhibitor",
          "layer_2_variant": "slc22a5 inhibitor (meldonium)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "non-small cell lung cancer (NSCLC) resistant to immunotherapy",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces carnitine metabolism and reshapes tumor microenvironment towards inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "preclinical models",
        "sample_size": null,
        "duration": null,
        "population": "mice with Slc22a5-overexpressing LLC cells",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dissection of immunotherapeutic predictive versus prognostic transcriptional programs identifies SLC22A5-centric carnitine metabolism-driven resistance to anti-PD-(L)1 treatment in non-small cell lung cancer.",
        "journal": "Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41045681",
        "doi": "10.1016/j.drup.2025.101313"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:04:21"
    },
    {
      "id": 1825,
      "intervention": {
        "name": "energy therapies",
        "canonical_name": "energy therapies",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "energy therapies",
          "layer_2_variant": "energy therapies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic obstructive pulmonary disease (COPD)",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced exercise capacity and reduced stress/anxiety",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": null,
        "duration": "varied across studies (June 2024-January 2025)",
        "population": "COPD patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Unveiling the Healing Potential of Energy Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis With Implications for Nursing Practice.",
        "journal": "Holistic nursing practice",
        "publication_date": "2025-09-29",
        "pubmed_id": "41020360",
        "doi": "10.1097/HNP.0000000000000755"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:01:12"
    },
    {
      "id": 1824,
      "intervention": {
        "name": "interpersonal and social rhythm therapy",
        "canonical_name": "interpersonal and social rhythm therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "interpersonal and social rhythm therapy",
          "layer_2_variant": "interpersonal and social rhythm therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "suicidal ideation",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "psychosocial intervention for mood stabilization and social rhythm regulation",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 92,
        "duration": "20 weeks",
        "population": "adults with bipolar II depression",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Interpersonal and Social Rhythm Therapy on Suicidal Ideation in Adults With Bipolar II Depression.",
        "journal": "The Journal of clinical psychiatry",
        "publication_date": "2025-09-29",
        "pubmed_id": "41037752",
        "doi": "10.4088/JCP.24m15768"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 12:00:01"
    },
    {
      "id": 1823,
      "intervention": {
        "name": "acetazolamide",
        "canonical_name": "acetazolamide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "acetazolamide",
          "layer_2_variant": "acetazolamide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "nocturnal cerebral deoxygenation",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "mitigates altitude-related hypoxemia and deoxygenation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 43,
        "duration": null,
        "population": "patients with moderate to severe COPD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nocturnal cerebral oxygenation in patients with COPD at altitude: data from a randomized clinical trial of acetazolamide.",
        "journal": "Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41025408",
        "doi": "10.5664/jcsm.11868"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:58:50"
    },
    {
      "id": 1819,
      "intervention": {
        "name": "biologics",
        "canonical_name": "biologics",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "biologics",
          "layer_2_variant": "biologics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2-high asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted cytokine inhibition and reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "patients with severe asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in type 2-high asthma therapy: what remains missing?",
        "journal": "Expert review of respiratory medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029975",
        "doi": "10.1080/17476348.2025.2569844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:57:39"
    },
    {
      "id": 1820,
      "intervention": {
        "name": "small-molecule drugs",
        "canonical_name": "small-molecule drugs",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "small-molecule drugs",
          "layer_2_variant": "small-molecule drugs",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2-high asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved airway function",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "patients with severe asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in type 2-high asthma therapy: what remains missing?",
        "journal": "Expert review of respiratory medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029975",
        "doi": "10.1080/17476348.2025.2569844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:57:39"
    },
    {
      "id": 1821,
      "intervention": {
        "name": "cell-based interventions",
        "canonical_name": "cell-based interventions",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cell-based interventions",
          "layer_2_variant": "cell-based interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2-high asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of immune response and reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.1,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "patients with severe asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in type 2-high asthma therapy: what remains missing?",
        "journal": "Expert review of respiratory medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029975",
        "doi": "10.1080/17476348.2025.2569844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:57:39"
    },
    {
      "id": 1822,
      "intervention": {
        "name": "microbiome-directed interventions",
        "canonical_name": "probiotics",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "probiotics",
          "layer_2_variant": "microbiome-directed interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2-high asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation and reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.1,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "patients with severe asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in type 2-high asthma therapy: what remains missing?",
        "journal": "Expert review of respiratory medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029975",
        "doi": "10.1080/17476348.2025.2569844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:57:39"
    },
    {
      "id": 1817,
      "intervention": {
        "name": "romosozumab",
        "canonical_name": "romosozumab",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "romosozumab",
          "layer_2_variant": "romosozumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "low bone mineral density",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increases bone formation and decreases resorption",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 11,
        "duration": "one year",
        "population": "postmenopausal women aged 55-85 years with low bone mineral density",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Romosozumab significantly improves vertebral cortical bone mass and structure compared with teriparatide, whereas both treatments increase vertebral trabecular bone mass similarly: high-resolution quantitative computed tomography analyses of randomized controlled trial results in postmenopausal women with low bone mineral density.",
        "journal": "JBMR plus",
        "publication_date": "2025-10",
        "pubmed_id": "40978126",
        "doi": "10.1093/jbmrpl/ziaf119"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:53:54"
    },
    {
      "id": 1818,
      "intervention": {
        "name": "teriparatide",
        "canonical_name": "teriparatide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "teriparatide",
          "layer_2_variant": "teriparatide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "low bone mineral density",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increases bone formation and decreases resorption",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 12,
        "duration": "one year",
        "population": "postmenopausal women aged 55-85 years with low bone mineral density",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Romosozumab significantly improves vertebral cortical bone mass and structure compared with teriparatide, whereas both treatments increase vertebral trabecular bone mass similarly: high-resolution quantitative computed tomography analyses of randomized controlled trial results in postmenopausal women with low bone mineral density.",
        "journal": "JBMR plus",
        "publication_date": "2025-10",
        "pubmed_id": "40978126",
        "doi": "10.1093/jbmrpl/ziaf119"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:53:54"
    },
    {
      "id": 1815,
      "intervention": {
        "name": "isoniazid",
        "canonical_name": "isoniazid",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isoniazid",
          "layer_2_variant": "isoniazid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tubercular infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibacterial action against Mycobacterium tuberculosis",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "2 years",
        "population": "children aged 6-14 years, household contacts of bacteriologically confirmed tuberculosis patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of 6 months isoniazid versus 3 months isoniazid - rifampicin therapy for prevention of tuberculosis in children suffering from tuberculosis infection - A randomized controlled trial.",
        "journal": "The Indian journal of tuberculosis",
        "publication_date": "2025-10",
        "pubmed_id": "40975579",
        "doi": "10.1016/j.ijtb.2025.02.014"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:51:39"
    },
    {
      "id": 1816,
      "intervention": {
        "name": "isoniazid-rifampicin combination therapy",
        "canonical_name": "isoniazid-rifampicin combination therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isoniazid-rifampicin combination therapy",
          "layer_2_variant": "isoniazid-rifampicin combination therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tubercular infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "combined antibacterial action against Mycobacterium tuberculosis",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "2 years",
        "population": "children aged 6-14 years, household contacts of bacteriologically confirmed tuberculosis patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of 6 months isoniazid versus 3 months isoniazid - rifampicin therapy for prevention of tuberculosis in children suffering from tuberculosis infection - A randomized controlled trial.",
        "journal": "The Indian journal of tuberculosis",
        "publication_date": "2025-10",
        "pubmed_id": "40975579",
        "doi": "10.1016/j.ijtb.2025.02.014"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:51:39"
    },
    {
      "id": 1814,
      "intervention": {
        "name": "Platelet-rich plasma",
        "canonical_name": "platelet-rich plasma",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "platelet-rich plasma",
          "layer_2_variant": "platelet-rich plasma",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "meniscal injury",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "promotes healing and reduces inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 1143,
        "duration": "mean follow-up duration of 3 to 12 months",
        "population": "adult patients with meniscal injury",
        "adverse_effects": "no significant difference in complications",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Platelet-Rich Plasma for Patients With Meniscal Injury: A Systematic Review and Meta-analysis of Randomized Controlled Trials.",
        "journal": "Orthopaedic journal of sports medicine",
        "publication_date": "2025-10",
        "pubmed_id": "41049599",
        "doi": "10.1177/23259671251371233"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:49:30"
    },
    {
      "id": 1812,
      "intervention": {
        "name": "nafithromycin",
        "canonical_name": "nafithromycin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nafithromycin",
          "layer_2_variant": "nafithromycin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "community-acquired bacterial pneumonia",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "high and sustained pulmonary concentrations allowing for once-daily dosing",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase III, randomized, double-blind controlled trial",
        "sample_size": 244,
        "duration": "February 2021 to June 2023",
        "population": "adults with community-acquired bacterial pneumonia (PORT risk class II, III, IV)",
        "adverse_effects": "abdominal pain, diarrhoea, headache and nausea",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial.",
        "journal": "The Lancet regional health. Southeast Asia",
        "publication_date": "2025-10",
        "pubmed_id": "41050437",
        "doi": "10.1016/j.lansea.2025.100666"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:48:13"
    },
    {
      "id": 1813,
      "intervention": {
        "name": "moxifloxacin",
        "canonical_name": "moxifloxacin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "moxifloxacin",
          "layer_2_variant": "moxifloxacin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "community-acquired bacterial pneumonia",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "unknown specific mechanism provided in abstract",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase III, randomized, double-blind controlled trial",
        "sample_size": 244,
        "duration": "February 2021 to June 2023",
        "population": "adults with community-acquired bacterial pneumonia (PORT risk class II, III, IV)",
        "adverse_effects": "abdominal pain, diarrhoea, headache and nausea",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial.",
        "journal": "The Lancet regional health. Southeast Asia",
        "publication_date": "2025-10",
        "pubmed_id": "41050437",
        "doi": "10.1016/j.lansea.2025.100666"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:48:13"
    },
    {
      "id": 1811,
      "intervention": {
        "name": "astegolimab",
        "canonical_name": "astegolimab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "astegolimab",
          "layer_2_variant": "astegolimab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammatory diseases",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "blocks ST2/interleukin-33 binding and subsequent inflammatory cascades",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blind, placebo-controlled Phase I studies",
        "sample_size": 152,
        "duration": null,
        "population": "healthy participants and patients with mild atopic asthma, healthy Japanese and White adults",
        "adverse_effects": "no clinically meaningful differences in incidence of TEAEs",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti-ST2 Monoclonal Antibody, in Randomized, Phase I Clinical Studies.",
        "journal": "Clinical and translational science",
        "publication_date": "2025-10",
        "pubmed_id": "41036707",
        "doi": "10.1111/cts.70338"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:45:43"
    },
    {
      "id": 1810,
      "intervention": {
        "name": "simvastatin",
        "canonical_name": "statins",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "statins",
          "layer_2_variant": "simvastatin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "disability progression in secondary progressive multiple sclerosis (SPMS)",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced brain atrophy and neurodegeneration",
      "correlation": {
        "type": "neutral",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 964,
        "duration": "up to 4.5 years",
        "population": "participants aged 18-65 years with SPMS and an EDSS of between 4.0 and 6.5",
        "adverse_effects": "rhabdomyolysis, cardiovascular serious adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.",
        "journal": "Lancet (London, England)",
        "publication_date": "2025-10-01",
        "pubmed_id": "41045938",
        "doi": "10.1016/S0140-6736(25)01039-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:43:01"
    },
    {
      "id": 1809,
      "intervention": {
        "name": "selective laser trabeculoplasty",
        "canonical_name": "selective laser trabeculoplasty",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "selective laser trabeculoplasty",
          "layer_2_variant": "selective laser trabeculoplasty",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "open angle glaucoma",
        "canonical_name": null,
        "category": "other",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces intraocular pressure",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 482,
        "duration": "6 years",
        "population": "patients with newly diagnosed OHT/OAG",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Six-year rate of visual field progression in the Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial.",
        "journal": "Ophthalmology",
        "publication_date": "2025-10-01",
        "pubmed_id": "41043781",
        "doi": "10.1016/j.ophtha.2025.09.023"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:37:39"
    },
    {
      "id": 1808,
      "intervention": {
        "name": "sequential dorsolateral prefrontal cortex (dlPFC)-dorsomedial prefrontal cortex (dmPFC) accelerated repetitive transcranial magnetic stimulation",
        "canonical_name": "repetitive transcranial magnetic stimulation",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "repetitive transcranial magnetic stimulation",
          "layer_2_variant": "sequential dorsolateral prefrontal cortex (dlpfc)-dorsomedial prefrontal cortex (dmpfc) accelerated repetitive transcranial magnetic stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "major depressive disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased dlPFC-frontoparietal and decreased dmPFC-amygdalo-subcallosal cingulate functional connectivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": "4 weeks",
        "population": "patients with major depressive disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A sequential dual-site repetitive transcranial magnetic stimulation for major depressive disorder: A randomized clinical trial.",
        "journal": "Cell reports. Medicine",
        "publication_date": "2025-10-01",
        "pubmed_id": "41038161",
        "doi": "10.1016/j.xcrm.2025.102402"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:36:29"
    },
    {
      "id": 1807,
      "intervention": {
        "name": "mindfulness-based meditation",
        "canonical_name": "mindfulness-based meditation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mindfulness-based meditation",
          "layer_2_variant": "mindfulness-based meditation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "immune function in cancer patients",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reducing inflammation, increasing immune cell counts and activity, promoting telomere length and activity",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "primarily breast cancer patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Mindfulness-Based Meditation on the Immune Function of Breast Cancer Patients: A Systematic Review and Three-Level Meta-Analysis.",
        "journal": "Neuroscience and biobehavioral reviews",
        "publication_date": "2025-10-02",
        "pubmed_id": "41046005",
        "doi": "10.1016/j.neubiorev.2025.106396"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:34:40"
    },
    {
      "id": 1806,
      "intervention": {
        "name": "propofol-supplemented cardioplegia",
        "canonical_name": "propofol",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "propofol",
          "layer_2_variant": "propofol-supplemented cardioplegia",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiac injury during coronary artery bypass grafting",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced myocardial ischemia-reperfusion injury",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 240,
        "duration": null,
        "population": "adults undergoing first-time coronary artery bypass grafting surgery",
        "adverse_effects": "96 adverse events reported, including prolonged hospital stay and life-threatening conditions",
        "cost_category": null
      },
      "paper": {
        "title": "Propofol-supplemented cardioplegia: a multi-center blinded three-group randomized trial (ProMPT2).",
        "journal": "The Journal of thoracic and cardiovascular surgery",
        "publication_date": "2025-10-02",
        "pubmed_id": "41046123",
        "doi": "10.1016/j.jtcvs.2025.09.040"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:33:32"
    },
    {
      "id": 1805,
      "intervention": {
        "name": "DialBetesPlus mHealth app",
        "canonical_name": "mhealth app",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mhealth app",
          "layer_2_variant": "dialbetesplus mhealth app",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2 diabetes dietary management",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "dietary behavior change support through meal logging and nutrient feedback",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 47,
        "duration": "12 months",
        "population": "patients with type 2 diabetes in Japan",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dietary Fiber Estimate of DialBetesPlus App Users: Secondary Analysis of Data From a Randomized Controlled Trial.",
        "journal": "JMIR formative research",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037783",
        "doi": "10.2196/69340"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:32:13"
    },
    {
      "id": 1804,
      "intervention": {
        "name": "Graded Motor Imagery (GMI)",
        "canonical_name": "graded motor imagery",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "graded motor imagery",
          "layer_2_variant": "graded motor imagery (gmi)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "central sensitisation low back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "retraining brain's body representation and neural adaptation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": null,
        "duration": "6 weeks therapy phase followed by a 6-month maintenance phase",
        "population": "adults aged 20-50 years with persistent low back pain for at least 6 months and exhibiting central sensitisation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of remote graded motor imagery therapy for patients with central sensitisation low back pain: study protocol for a randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-10-02",
        "pubmed_id": "41043843",
        "doi": "10.1136/bmjopen-2024-097693"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:29:53"
    },
    {
      "id": 1803,
      "intervention": {
        "name": "gut microbiota-based interventions",
        "canonical_name": "gut microbiota-based interventions",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "gut microbiota-based interventions",
          "layer_2_variant": "gut microbiota-based interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "neurodevelopmental conditions (ASD and ADHD)",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "participants with ASD or ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of gut microbiota-based therapy for autism Spectrum Disorder and attention Deficit Hyperactivity Disorder: a systematic review and meta-analysis.",
        "journal": "Psychology, health & medicine",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037658",
        "doi": "10.1080/13548506.2025.2565181"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:28:28"
    },
    {
      "id": 1802,
      "intervention": {
        "name": "Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis synbiotic",
        "canonical_name": "probiotics",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "probiotics",
          "layer_2_variant": "lactiplantibacillus plantarum and bifidobacterium longum subspecies infantis synbiotic",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "infection-related morbidity and mortality",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation and reduced infection risk",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 240,
        "duration": "6 months (follow-up)",
        "population": "healthy neonates in Papua New Guinea",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial.",
        "journal": "JMIR research protocols",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037809",
        "doi": "10.2196/73926"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:27:20"
    },
    {
      "id": 1801,
      "intervention": {
        "name": "transjugular intrahepatic portosystemic shunt (TIPS) implantation",
        "canonical_name": "transjugular intrahepatic portosystemic shunt",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "transjugular intrahepatic portosystemic shunt",
          "layer_2_variant": "transjugular intrahepatic portosystemic shunt (tips) implantation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ascites",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces portal hypertension and fluid accumulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with liver cirrhosis and ascites",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Early implantation of a transjugular intrahepatic portosystemic shunt (TIPS) in patients with liver cirrhosis and ascites (eTIPS): a multicentre, randomised controlled trial.",
        "journal": "Trials",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039580",
        "doi": "10.1186/s13063-025-09038-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:26:00"
    },
    {
      "id": 1800,
      "intervention": {
        "name": "saffron extract",
        "canonical_name": "saffron extract",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "saffron extract",
          "layer_2_variant": "saffron extract",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "subclinical depressive symptoms",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of N-acetyl-phenylalanine",
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 51,
        "duration": "6 weeks",
        "population": "healthy adults with subclinical neuropsychiatric symptoms",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of saffron extract supplementation on mood in healthy adults with subclinical symptoms of depression: A randomized, double-blind placebo-controlled study.",
        "journal": "The American journal of clinical nutrition",
        "publication_date": "2025-10-03",
        "pubmed_id": "41047129",
        "doi": "10.1016/j.ajcnut.2025.09.050"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:24:35"
    },
    {
      "id": 1798,
      "intervention": {
        "name": "radical prostatectomy",
        "canonical_name": "radical prostatectomy",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "radical prostatectomy",
          "layer_2_variant": "radical prostatectomy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "oligometastatic prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "local tumor removal and pelvic lymph-node dissection",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 132,
        "duration": null,
        "population": "patients with oligometastatic prostate cancer (1-5 bone metastases with/without nodal involvement)",
        "adverse_effects": "Clavien-Dindo grade ≥III surgery-related complications occurred in nine of 66 (14%) patients",
        "cost_category": null
      },
      "paper": {
        "title": "Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial.",
        "journal": "European urology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41046179",
        "doi": "10.1016/j.eururo.2025.09.4144"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:23:26"
    },
    {
      "id": 1799,
      "intervention": {
        "name": "best systemic therapy",
        "canonical_name": "systemic therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "systemic therapy",
          "layer_2_variant": "best systemic therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "oligometastatic prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "systemic treatment targeting metastases and primary tumor",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 132,
        "duration": null,
        "population": "patients with oligometastatic prostate cancer (1-5 bone metastases with/without nodal involvement)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial.",
        "journal": "European urology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41046179",
        "doi": "10.1016/j.eururo.2025.09.4144"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:23:26"
    },
    {
      "id": 1797,
      "intervention": {
        "name": "vitamin C supplementation",
        "canonical_name": "vitamin c",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vitamin c",
          "layer_2_variant": "vitamin c supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "respiratory outcomes in children of pregnant smokers",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved respiratory outcomes and DNAm alteration",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 137,
        "duration": null,
        "population": "children of pregnant smokers",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Vitamin C supplementation to pregnant smokers alters asthma- and allergy-associated CpGs in child buccal DNA at 5 years of age.",
        "journal": "Clinical epigenetics",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044653",
        "doi": "10.1186/s13148-025-01965-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:21:13"
    },
    {
      "id": 1796,
      "intervention": {
        "name": "family-centered training and counselling",
        "canonical_name": "family-centered training and counselling",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "family-centered training and counselling",
          "layer_2_variant": "family-centered training and counselling",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetes foot",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved foot care practices through family education",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 54,
        "duration": "nine months",
        "population": "persons with diabetes mellitus aged 18-60 years and their family members",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Family-centered training and counselling for enhancing foot self-care knowledge and practices towards prevention of diabetes foot - a randomized controlled trial in urban Jodhpur.",
        "journal": "BMC public health",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044716",
        "doi": "10.1186/s12889-025-24652-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:20:06"
    },
    {
      "id": 1795,
      "intervention": {
        "name": "indexed oxygen delivery (DO2i) during cardiopulmonary bypass",
        "canonical_name": "indexed oxygen delivery",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "indexed oxygen delivery",
          "layer_2_variant": "indexed oxygen delivery (do2i) during cardiopulmonary bypass",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic inflammatory response syndrome (SIRS)",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation during CPB",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective observational study",
        "sample_size": 908,
        "duration": null,
        "population": "patients undergoing cardiac surgery with CPB",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Inadequate oxygen delivery during cardiopulmonary bypass drives inflammatory reaction after cardiac surgery.",
        "journal": "European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042893",
        "doi": "10.1093/ejcts/ezaf340"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:18:56"
    },
    {
      "id": 1794,
      "intervention": {
        "name": "pulsed electromagnetic field (PEMF) therapy",
        "canonical_name": "pulsed electromagnetic field therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pulsed electromagnetic field therapy",
          "layer_2_variant": "pulsed electromagnetic field (pemf) therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved joint mobility",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 21,
        "duration": "six weeks",
        "population": "dogs with chronic osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Influence of pulsed electromagnetic field (PEMF) therapy on osteoarthritis in dogs.",
        "journal": "BMC veterinary research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044566",
        "doi": "10.1186/s12917-025-05036-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:17:48"
    },
    {
      "id": 1793,
      "intervention": {
        "name": "high-frequency repetitive transcranial magnetic stimulation",
        "canonical_name": "repetitive transcranial magnetic stimulation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "repetitive transcranial magnetic stimulation",
          "layer_2_variant": "high-frequency repetitive transcranial magnetic stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "fibromyalgia pain",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neural modulation and antinociceptive effects",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "secondary analysis of a randomized controlled trial",
        "sample_size": 32,
        "duration": null,
        "population": "women with fibromyalgia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Investigation of predictors of pain relief with high-frequency repetitive motor cortex transcranial magnetic stimulation among people with fibromyalgia.",
        "journal": "Neurophysiologie clinique = Clinical neurophysiology",
        "publication_date": "2025-10-04",
        "pubmed_id": "41046849",
        "doi": "10.1016/j.neucli.2025.103109"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:16:42"
    },
    {
      "id": 1792,
      "intervention": {
        "name": "postoperative home-based pulmonary rehabilitation",
        "canonical_name": "pulmonary rehabilitation",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pulmonary rehabilitation",
          "layer_2_variant": "postoperative home-based pulmonary rehabilitation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lung cancer postoperative recovery",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved respiratory function and patient well-being through structured exercises and education",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "Delphi-based study",
        "sample_size": null,
        "duration": null,
        "population": "postoperative lung cancer patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Construction of a postoperative home-based pulmonary rehabilitation program protocol for lung cancer patients delivered using the internet: A Delphi-based study.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-10-04",
        "pubmed_id": "41045360",
        "doi": "10.1007/s00520-025-09916-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:15:35"
    },
    {
      "id": 1791,
      "intervention": {
        "name": "empagliflozin",
        "canonical_name": "empagliflozin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "empagliflozin",
          "layer_2_variant": "empagliflozin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "all-cause hospitalizations",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced risk of hospitalization and improved renal function",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 6609,
        "duration": null,
        "population": "participants with chronic kidney disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Empagliflozin Reduces Risk of Hospitalization in Patients With Chronic Kidney Disease in the EMPA-KIDNEY Trial.",
        "journal": "Clinical therapeutics",
        "publication_date": "2025-10-04",
        "pubmed_id": "41047325",
        "doi": "10.1016/j.clinthera.2025.09.005"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:14:29"
    },
    {
      "id": 1790,
      "intervention": {
        "name": "spinal cord stimulation",
        "canonical_name": "spinal cord stimulation",
        "category": "device",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "spinal cord stimulation",
          "layer_2_variant": "spinal cord stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "non-surgical, refractory back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neuromodulation of pain pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial followed by crossover",
        "sample_size": 147,
        "duration": "12 months",
        "population": "patients with non-surgical, refractory back pain (with or without leg pain)",
        "adverse_effects": "serious adverse events related to SCS, including implant site infections resulting in explant",
        "cost_category": null
      },
      "paper": {
        "title": "Spinal cord stimulation plus conventional medical management versus conventional medical management alone for severe, non-surgical, refractory back pain: a randomized clinical trial followed by crossover.",
        "journal": "Regional anesthesia and pain medicine",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047246",
        "doi": "10.1136/rapm-2024-106335"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:13:20"
    },
    {
      "id": 1789,
      "intervention": {
        "name": "remote rehabilitation training",
        "canonical_name": "rehabilitation training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rehabilitation training",
          "layer_2_variant": "remote rehabilitation training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "stroke recovery",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "continuous therapist-guided exercises to enhance motor function and self-efficacy",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 168,
        "duration": null,
        "population": "stroke patients in China",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of remote rehabilitation weekend training for stroke patients in China: a randomised controlled trial protocol.",
        "journal": "BMJ open",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047267",
        "doi": "10.1136/bmjopen-2025-105002"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:12:01"
    },
    {
      "id": 1788,
      "intervention": {
        "name": "telmisartan",
        "canonical_name": "angiotensin ii receptor antagonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "angiotensin ii receptor antagonists",
          "layer_2_variant": "telmisartan",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic low-grade inflammation",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 70,
        "duration": "12 weeks",
        "population": "patients with diabetes and newly diagnosed hypertension",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Anti-inflammatory potential of telmisartan compared to other antihypertensives: secondary outcomes from a randomized trial.",
        "journal": "Inflammopharmacology",
        "publication_date": "2025-10-05",
        "pubmed_id": "41046489",
        "doi": "10.1007/s10787-025-01995-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:10:55"
    },
    {
      "id": 1787,
      "intervention": {
        "name": "low-dose ketamine infusion therapy",
        "canonical_name": "ketamine",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ketamine",
          "layer_2_variant": "low-dose ketamine infusion therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic refractory pain",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced neural sensitization and modulation of descending inhibitory pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "retrospective observational study",
        "sample_size": 1034,
        "duration": "May 2021 to October 2024",
        "population": "adult patients with chronic refractory pain",
        "adverse_effects": "no adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "Standardized ketamine infusion protocol for chronic refractory pain: a retrospective study of preliminary effectiveness and treatment completion.",
        "journal": "Regional anesthesia and pain medicine",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047247",
        "doi": "10.1136/rapm-2025-106907"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:09:45"
    },
    {
      "id": 1786,
      "intervention": {
        "name": "bedside critical care ultrasound-guided ultrafiltration",
        "canonical_name": "ultrafiltration",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ultrafiltration",
          "layer_2_variant": "bedside critical care ultrasound-guided ultrafiltration",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "fluid overload in acute kidney injury patients receiving CRRT",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "accurate fluid status assessment and ultrafiltration guidance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 132,
        "duration": "until the end of CRRT",
        "population": "AKI patients receiving CRRT due to fluid overload in an intensive care unit",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "BEdside ultraSound-guided ulTrafiltration for Acute Kidney Injury patients receiving CRRT: protocol for a randomised controlled trial (the BEST-AKI study).",
        "journal": "BMJ open",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047266",
        "doi": "10.1136/bmjopen-2024-093198"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:08:23"
    },
    {
      "id": 1785,
      "intervention": {
        "name": "modified Mediterranean diet",
        "canonical_name": "modified mediterranean diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "modified mediterranean diet",
          "layer_2_variant": "modified mediterranean diet",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Parkinson's disease motor and non-motor symptoms",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of immune system, microbiome, metabolomics",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 44,
        "duration": "6 months",
        "population": "PD patients aged between 40 years and 85 years",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modified Mediterranean diet effects on Parkinson's disease (MED-PARK): a single-centre randomised controlled trial protocol.",
        "journal": "BMJ open",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047258",
        "doi": "10.1136/bmjopen-2025-101946"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:07:05"
    },
    {
      "id": 1784,
      "intervention": {
        "name": "iMAPS therapy",
        "canonical_name": "imaps therapy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "imaps therapy",
          "layer_2_variant": "imaps therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psychosis with hallucinations or delusions and distressing intrusive mental imagery",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "addresses maintenance factors of psychotic experiences through imagery focused therapy",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "assessor-blind randomized controlled trial",
        "sample_size": 45,
        "duration": "28 weeks",
        "population": "help-seeking individuals with hallucinations or delusions and distressing intrusive mental imagery",
        "adverse_effects": "two serious adverse events in the iMAPS therapy arm deemed unrelated to treatment",
        "cost_category": null
      },
      "paper": {
        "title": "iMAgery Focused Therapy for PSychosis (iMAPS-2): An Assessor-blind Feasibility Randomized Controlled Clinical Trial.",
        "journal": "Schizophrenia bulletin",
        "publication_date": "2025-10-06",
        "pubmed_id": "41051872",
        "doi": "10.1093/schbul/sbaf060"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:05:54"
    },
    {
      "id": 1783,
      "intervention": {
        "name": "Continuing Care Program (CCP)",
        "canonical_name": "continuing care program",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "continuing care program",
          "layer_2_variant": "continuing care program (ccp)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "self-efficacy in breast cancer patients",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced education and support for better self-management",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 38,
        "duration": null,
        "population": "women aged 20-60 with stage two, three, or four breast cancer",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Empowering outpatients with breast cancer: The impact of a Continuous Care Program on self-efficacy-a randomized clinical trial.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-10-06",
        "pubmed_id": "41051405",
        "doi": "10.1007/s00520-025-09951-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:04:37"
    },
    {
      "id": 1781,
      "intervention": {
        "name": "combination therapy",
        "canonical_name": "combination therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "combination therapy",
          "layer_2_variant": "combination therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ischemic stroke or transient ischemic attack",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces thrombotic risk through dual anticoagulant and antiplatelet action",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 316,
        "duration": "2 years",
        "population": "patients with ischemic stroke or transient ischemic attack and concurrent nonvalvular atrial fibrillation and atherosclerotic cardiovascular disease",
        "adverse_effects": "higher bleeding risk",
        "cost_category": null
      },
      "paper": {
        "title": "Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.",
        "journal": "JAMA neurology",
        "publication_date": "2025-10-06",
        "pubmed_id": "41051787",
        "doi": "10.1001/jamaneurol.2025.3662"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:03:25"
    },
    {
      "id": 1782,
      "intervention": {
        "name": "anticoagulant monotherapy",
        "canonical_name": "anticoagulants",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "anticoagulants",
          "layer_2_variant": "anticoagulant monotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ischemic stroke or transient ischemic attack",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces thrombotic risk through anticoagulant action alone",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 316,
        "duration": "2 years",
        "population": "patients with ischemic stroke or transient ischemic attack and concurrent nonvalvular atrial fibrillation and atherosclerotic cardiovascular disease",
        "adverse_effects": "lower bleeding risk",
        "cost_category": null
      },
      "paper": {
        "title": "Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.",
        "journal": "JAMA neurology",
        "publication_date": "2025-10-06",
        "pubmed_id": "41051787",
        "doi": "10.1001/jamaneurol.2025.3662"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:03:25"
    },
    {
      "id": 1780,
      "intervention": {
        "name": "tagraxofusp",
        "canonical_name": "tagraxofusp",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tagraxofusp",
          "layer_2_variant": "tagraxofusp",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic myelomonocytic leukemia (CMML)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "CD123-targeted therapy",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "phase 1/2 trial",
        "sample_size": 37,
        "duration": null,
        "population": "patients with CMML, treatment-naïve or relapsed/refractory disease",
        "adverse_effects": "fatigue, hypoalbuminemia, nausea, hypokalemia, decreased appetite, capillary leak syndrome, tumor lysis syndrome",
        "cost_category": null
      },
      "paper": {
        "title": "Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study.",
        "journal": "Blood neoplasia",
        "publication_date": "2025-11",
        "pubmed_id": "40919483",
        "doi": "10.1016/j.bneo.2025.100115"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 11:01:02"
    },
    {
      "id": 1779,
      "intervention": {
        "name": "alteplase",
        "canonical_name": "alteplase",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "alteplase",
          "layer_2_variant": "alteplase",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "minor ischemic stroke",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "thrombolysis and improved blood flow",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective cohort study",
        "sample_size": 2489,
        "duration": "from August 2015 to March 2018",
        "population": "patients with minor ischemic stroke",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Alteplase treatment in patients with minor ischemic stroke: a nationwide registry analysis.",
        "journal": "EClinicalMedicine",
        "publication_date": "2025-11",
        "pubmed_id": "41048664",
        "doi": "10.1016/j.eclinm.2025.103523"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 10:59:41"
    },
    {
      "id": 1778,
      "intervention": {
        "name": "dapagliflozin",
        "canonical_name": "sodium-glucose cotransporter 2 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sodium-glucose cotransporter 2 inhibitors",
          "layer_2_variant": "dapagliflozin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "symptomatic myxomatous mitral valve disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "promotes reverse remodeling and improves cardiac function",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, randomized, single-blind study",
        "sample_size": 5,
        "duration": null,
        "population": "dogs with stage C MMVD",
        "adverse_effects": "glucosuria",
        "cost_category": null
      },
      "paper": {
        "title": "Pilot study on the effects of dapagliflozin on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease.",
        "journal": "Veterinary and animal science",
        "publication_date": "2025-12",
        "pubmed_id": "41050558",
        "doi": "10.1016/j.vas.2025.100510"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 10:56:30"
    },
    {
      "id": 1776,
      "intervention": {
        "name": "alpha-tocopherol",
        "canonical_name": "alpha-tocopherol",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "alpha-tocopherol",
          "layer_2_variant": "alpha-tocopherol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff muscle degeneration",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced oxidative stress and inflammation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "controlled animal study",
        "sample_size": 40,
        "duration": null,
        "population": "male Wistar rats with massive rotator cuff tears",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of alpha-tocopherol and OTR-4131 on muscle degeneration after rotator cuff tear in rats: An experimental protocol.",
        "journal": "World journal of methodology",
        "publication_date": "2025-12-20",
        "pubmed_id": "40900878",
        "doi": "10.5662/wjm.v15.i4.106216"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 10:53:46"
    },
    {
      "id": 1777,
      "intervention": {
        "name": "OTR-4131",
        "canonical_name": "otr-4131",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "otr-4131",
          "layer_2_variant": "otr-4131",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff muscle degeneration",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced oxidative stress and inflammation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "controlled animal study",
        "sample_size": 40,
        "duration": null,
        "population": "male Wistar rats with massive rotator cuff tears",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of alpha-tocopherol and OTR-4131 on muscle degeneration after rotator cuff tear in rats: An experimental protocol.",
        "journal": "World journal of methodology",
        "publication_date": "2025-12-20",
        "pubmed_id": "40900878",
        "doi": "10.5662/wjm.v15.i4.106216"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 10:53:46"
    },
    {
      "id": 1775,
      "intervention": {
        "name": "therapeutic plasma exchange",
        "canonical_name": "therapeutic plasma exchange",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "therapeutic plasma exchange",
          "layer_2_variant": "therapeutic plasma exchange",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute liver failure",
        "canonical_name": null,
        "category": "digestive",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "removal of harmful substances and replacement with fresh plasma and albumin",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 20,
        "duration": null,
        "population": "adults with acute liver failure",
        "adverse_effects": "rates of infection and electrolyte disturbances were similar",
        "cost_category": null
      },
      "paper": {
        "title": "Therapeutic Plasma Exchange in Patients With Acute Liver Failure: A Pilot Randomized Controlled Trial.",
        "journal": "Journal of clinical and experimental hepatology",
        "publication_date": "2026",
        "pubmed_id": "41048887",
        "doi": "10.1016/j.jceh.2025.103178"
      },
      "supporting_quote": null,
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-07 10:51:42"
    },
    {
      "id": 1774,
      "intervention": {
        "name": "adjuvant hormonal therapy (HT)",
        "canonical_name": "hormonal therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "hormonal therapy",
          "layer_2_variant": "adjuvant hormonal therapy (ht)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "biochemical recurrence after radical prostatectomy",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "suppression of testosterone to reduce cancer cell proliferation",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2 randomized clinical trial",
        "sample_size": 130,
        "duration": "37 months",
        "population": "patients with biochemical recurrence following radical prostatectomy eligible for standard-of-care salvage radiotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical Trial.",
        "journal": "JAMA oncology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037308",
        "doi": "10.1001/jamaoncol.2025.3746"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 10:16:32"
    },
    {
      "id": 1772,
      "intervention": {
        "name": "hypomethylating therapy",
        "canonical_name": "hypomethylating agents",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "hypomethylating agents",
          "layer_2_variant": "hypomethylating therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute myeloid leukemia",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "epigenetic modification to restore normal gene expression",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized placebo-controlled phase 2 trial",
        "sample_size": null,
        "duration": null,
        "population": "elderly patients with acute myeloid leukemia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.",
        "journal": "American journal of hematology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41036595",
        "doi": "10.1002/ajh.70091"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 10:05:14"
    },
    {
      "id": 1773,
      "intervention": {
        "name": "eltrombopag",
        "canonical_name": "eltrombopag",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "eltrombopag",
          "layer_2_variant": "eltrombopag",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute myeloid leukemia",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "platelet production stimulation and potential anti-leukemic effects",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized placebo-controlled phase 2 trial",
        "sample_size": null,
        "duration": null,
        "population": "elderly patients with acute myeloid leukemia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.",
        "journal": "American journal of hematology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41036595",
        "doi": "10.1002/ajh.70091"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 10:05:14"
    },
    {
      "id": 1771,
      "intervention": {
        "name": "30% supramolecular salicylic acid",
        "canonical_name": "salicylic acid",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "salicylic acid",
          "layer_2_variant": "30% supramolecular salicylic acid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "papulopustular rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "anti-inflammatory properties",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "multicenter randomized double-blind placebo-controlled superiority study",
        "sample_size": 480,
        "duration": "six weeks",
        "population": "patients aged 18 to 60 years with papulopustular rosacea",
        "adverse_effects": "no significant difference in adverse event rates",
        "cost_category": null
      },
      "paper": {
        "title": "Study on the efficacy and safety of supramolecular salicylic acid in the treatment of papulopustular rosacea: results from a multicenter randomized double-blind placebo-controlled superiority study.",
        "journal": "Clinical and experimental dermatology",
        "publication_date": "2025-07-24",
        "pubmed_id": "40701547",
        "doi": "10.1093/ced/llaf316"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:50:45"
    },
    {
      "id": 1770,
      "intervention": {
        "name": "tenofovir amibufenamide",
        "canonical_name": "tenofovir alafenamide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tenofovir alafenamide",
          "layer_2_variant": "tenofovir amibufenamide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic hepatitis B",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of HBV DNA levels and improvement of liver function markers",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 197,
        "duration": "48 weeks",
        "population": "chronic HBV-infected patients with normal ALT levels",
        "adverse_effects": "no significant differences in creatinine, glomerular filtration rate, bone turnover biomarkers, lipid profiles, or phosphorus levels",
        "cost_category": null
      },
      "paper": {
        "title": "Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE Study.",
        "journal": "Journal of clinical and translational hepatology",
        "publication_date": "2025-07-28",
        "pubmed_id": "40937079",
        "doi": "10.14218/JCTH.2025.00162"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:35:39"
    },
    {
      "id": 1767,
      "intervention": {
        "name": "combined oral isotretinoin and desloratadine",
        "canonical_name": "isotretinoin and desloratadine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isotretinoin and desloratadine",
          "layer_2_variant": "combined oral isotretinoin and desloratadine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced tolerability and reduced mucocutaneous adverse events",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 675,
        "duration": null,
        "population": "predominantly from Asia and the Middle East",
        "adverse_effects": "acne flare-ups, pruritus, cheilitis",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of Combined Oral Isotretinoin and Desloratadine or Levocetirizine vs. Isotretinoin Monotherapy in Treating Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.",
        "journal": "Biomedicines",
        "publication_date": "2025-07-30",
        "pubmed_id": "40868102",
        "doi": "10.3390/biomedicines13081847"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:22:20"
    },
    {
      "id": 1768,
      "intervention": {
        "name": "combined oral isotretinoin and levocetirizine",
        "canonical_name": "isotretinoin and levocetirizine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isotretinoin and levocetirizine",
          "layer_2_variant": "combined oral isotretinoin and levocetirizine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced tolerability and reduced mucocutaneous adverse events",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 675,
        "duration": null,
        "population": "predominantly from Asia and the Middle East",
        "adverse_effects": "acne flare-ups, pruritus, cheilitis",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of Combined Oral Isotretinoin and Desloratadine or Levocetirizine vs. Isotretinoin Monotherapy in Treating Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.",
        "journal": "Biomedicines",
        "publication_date": "2025-07-30",
        "pubmed_id": "40868102",
        "doi": "10.3390/biomedicines13081847"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:22:20"
    },
    {
      "id": 1769,
      "intervention": {
        "name": "isotretinoin monotherapy",
        "canonical_name": "isotretinoin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isotretinoin",
          "layer_2_variant": "isotretinoin monotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of inflammatory and non-inflammatory lesions",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 675,
        "duration": null,
        "population": "predominantly from Asia and the Middle East",
        "adverse_effects": "acne flare-ups, pruritus, cheilitis, xerosis",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of Combined Oral Isotretinoin and Desloratadine or Levocetirizine vs. Isotretinoin Monotherapy in Treating Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.",
        "journal": "Biomedicines",
        "publication_date": "2025-07-30",
        "pubmed_id": "40868102",
        "doi": "10.3390/biomedicines13081847"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:22:20"
    },
    {
      "id": 1766,
      "intervention": {
        "name": "PD-1 inhibitor combined with azacitidine and HAG regimen",
        "canonical_name": "pd-1 inhibitor",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pd-1 inhibitor",
          "layer_2_variant": "pd-1 inhibitor combined with azacitidine and hag regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "relapsed/refractory acute myeloid leukemia",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immunomodulation and induction of remission through synergistic antileukemic effects",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, single-arm, phase II clinical trial",
        "sample_size": 20,
        "duration": "from December 2020 to August 2023",
        "population": "relapsed/refractory acute myeloid leukemia patients treated at The First Affiliated Hospital of Soochow University",
        "adverse_effects": "hematologic toxicities",
        "cost_category": null
      },
      "paper": {
        "title": "[PD-1 Inhibitor Combined with Azacitidine and HAG Regimen for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia: A Prospective, Single-Arm, Phase II Clinical Study].",
        "journal": "Zhongguo shi yan xue ye xue za zhi",
        "publication_date": "2025-08",
        "pubmed_id": "40936118",
        "doi": "10.19746/j.cnki.issn.1009-2137.2025.04.007"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:14:40"
    },
    {
      "id": 1763,
      "intervention": {
        "name": "flexible ureteroscopic stone treatment",
        "canonical_name": "ureteroscopic stone treatment",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ureteroscopic stone treatment",
          "layer_2_variant": "flexible ureteroscopic stone treatment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lower pole kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct removal of stones via flexible ureteroscope",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 304,
        "duration": "12 weeks",
        "population": "adults presenting with lower pole renal stones, able to undergo any of the treatments and complete trial procedures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Clinical and cost-effectiveness of percutaneous nephrolithotomy, flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole stones: the PUrE RCTs.",
        "journal": "Health technology assessment (Winchester, England)",
        "publication_date": "2025-08",
        "pubmed_id": "40823754",
        "doi": "10.3310/WFRE6844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:09:42"
    },
    {
      "id": 1764,
      "intervention": {
        "name": "shockwave lithotripsy",
        "canonical_name": "shockwave lithotripsy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "shockwave lithotripsy",
          "layer_2_variant": "shockwave lithotripsy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lower pole kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "fragmentation of stones using extracorporeal shockwaves",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 304,
        "duration": "12 weeks",
        "population": "adults presenting with lower pole renal stones, able to undergo any of the treatments and complete trial procedures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Clinical and cost-effectiveness of percutaneous nephrolithotomy, flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole stones: the PUrE RCTs.",
        "journal": "Health technology assessment (Winchester, England)",
        "publication_date": "2025-08",
        "pubmed_id": "40823754",
        "doi": "10.3310/WFRE6844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:09:42"
    },
    {
      "id": 1765,
      "intervention": {
        "name": "keyhole surgery (percutaneous nephrolithotomy)",
        "canonical_name": "percutaneous nephrolithotomy",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "percutaneous nephrolithotomy",
          "layer_2_variant": "keyhole surgery (percutaneous nephrolithotomy)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lower pole kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "removal of stones via minimally invasive surgical access",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 238,
        "duration": "12 weeks",
        "population": "adults presenting with lower pole renal stones, able to undergo any of the treatments and complete trial procedures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Clinical and cost-effectiveness of percutaneous nephrolithotomy, flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole stones: the PUrE RCTs.",
        "journal": "Health technology assessment (Winchester, England)",
        "publication_date": "2025-08",
        "pubmed_id": "40823754",
        "doi": "10.3310/WFRE6844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:09:42"
    },
    {
      "id": 1761,
      "intervention": {
        "name": "mono-segment fixation",
        "canonical_name": "mono-segment fixation",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mono-segment fixation",
          "layer_2_variant": "mono-segment fixation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "thoracolumbar spine fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "instrumenting only the fractured vertebra and one adjacent vertebra to reduce surgical morbidity",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 26,
        "duration": "one year",
        "population": "adult patients with thoracolumbar spine fractures",
        "adverse_effects": "implant failure",
        "cost_category": null
      },
      "paper": {
        "title": "Mono-Segment Fixation Versus Short-Segment Fixation in Adult Patients With Thoracolumbar Spine Fractures: A Randomized Controlled Trial.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41001316",
        "doi": "10.7759/cureus.90939"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:05:39"
    },
    {
      "id": 1762,
      "intervention": {
        "name": "short-segment fixation",
        "canonical_name": "short-segment fixation",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "short-segment fixation",
          "layer_2_variant": "short-segment fixation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "thoracolumbar spine fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "instrumenting one vertebra above and below the fracture to provide stability",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 26,
        "duration": "one year",
        "population": "adult patients with thoracolumbar spine fractures",
        "adverse_effects": "implant failure",
        "cost_category": null
      },
      "paper": {
        "title": "Mono-Segment Fixation Versus Short-Segment Fixation in Adult Patients With Thoracolumbar Spine Fractures: A Randomized Controlled Trial.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41001316",
        "doi": "10.7759/cureus.90939"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:05:39"
    },
    {
      "id": 1760,
      "intervention": {
        "name": "pegloticase-induced intensive urate-lowering therapy",
        "canonical_name": "urate-lowering therapy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "urate-lowering therapy",
          "layer_2_variant": "pegloticase-induced intensive urate-lowering therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gout",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of serum urate levels and resolution of tophi",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "post hoc clinical trial analysis",
        "sample_size": 145,
        "duration": "52 weeks",
        "population": "patients with uncontrolled gout receiving pegloticase",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial Analysis.",
        "journal": "ACR open rheumatology",
        "publication_date": "2025-08",
        "pubmed_id": "40810458",
        "doi": "10.1002/acr2.70080"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:03:15"
    },
    {
      "id": 1755,
      "intervention": {
        "name": "tamsulosin",
        "canonical_name": "alpha adrenergic blockers",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "alpha adrenergic blockers",
          "layer_2_variant": "tamsulosin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved stone clearance post-SWL",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 27286,
        "duration": null,
        "population": "patients undergoing extracorporeal shock wave lithotripsy (SWL)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.",
        "journal": "Minerva urology and nephrology",
        "publication_date": "2025-08",
        "pubmed_id": "40891477",
        "doi": "10.23736/S2724-6051.25.06296-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:01:45"
    },
    {
      "id": 1756,
      "intervention": {
        "name": "thiazides",
        "canonical_name": "thiazides",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "thiazides",
          "layer_2_variant": "thiazides",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "recurrent kidney calculi",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced renal stone formation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 571,
        "duration": null,
        "population": "patients affected by recurrent kidney calculi",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.",
        "journal": "Minerva urology and nephrology",
        "publication_date": "2025-08",
        "pubmed_id": "40891477",
        "doi": "10.23736/S2724-6051.25.06296-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:01:45"
    },
    {
      "id": 1757,
      "intervention": {
        "name": "potassium citrate",
        "canonical_name": "potassium citrate",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "potassium citrate",
          "layer_2_variant": "potassium citrate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "nephrolithiasis recurrence",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prevention of stone formation through urinary citrate increase",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.",
        "journal": "Minerva urology and nephrology",
        "publication_date": "2025-08",
        "pubmed_id": "40891477",
        "doi": "10.23736/S2724-6051.25.06296-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:01:45"
    },
    {
      "id": 1758,
      "intervention": {
        "name": "vitamin D",
        "canonical_name": "vitamin d",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vitamin d",
          "layer_2_variant": "vitamin d",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "primary prevention of kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "calcium absorption regulation",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.",
        "journal": "Minerva urology and nephrology",
        "publication_date": "2025-08",
        "pubmed_id": "40891477",
        "doi": "10.23736/S2724-6051.25.06296-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:01:45"
    },
    {
      "id": 1759,
      "intervention": {
        "name": "calcium supplementation",
        "canonical_name": "calcium",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "calcium",
          "layer_2_variant": "calcium supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "primary prevention of kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "calcium absorption regulation",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.",
        "journal": "Minerva urology and nephrology",
        "publication_date": "2025-08",
        "pubmed_id": "40891477",
        "doi": "10.23736/S2724-6051.25.06296-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 08:01:45"
    },
    {
      "id": 1752,
      "intervention": {
        "name": "pharmacological agents",
        "canonical_name": "pharmacological agents",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pharmacological agents",
          "layer_2_variant": "pharmacological agents",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "female infertility",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of hormonal and metabolic pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized and crossover trials",
        "sample_size": null,
        "duration": null,
        "population": "infertile women with metabolic disorders such as polycystic ovary syndrome (PCOS), insulin resistance, obesity, and metabolic syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Metabolic Dysregulation and Female Infertility: A Systematic Review of Hormonal and Reproductive Outcomes From Recent Clinical Trials.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995278",
        "doi": "10.7759/cureus.90887"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:59:15"
    },
    {
      "id": 1753,
      "intervention": {
        "name": "dietary modifications",
        "canonical_name": "dietary modifications",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "dietary modifications",
          "layer_2_variant": "dietary modifications",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "female infertility",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improvement of metabolic and hormonal profiles",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized and crossover trials",
        "sample_size": null,
        "duration": null,
        "population": "infertile women with metabolic disorders such as polycystic ovary syndrome (PCOS), insulin resistance, obesity, and metabolic syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Metabolic Dysregulation and Female Infertility: A Systematic Review of Hormonal and Reproductive Outcomes From Recent Clinical Trials.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995278",
        "doi": "10.7759/cureus.90887"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:59:15"
    },
    {
      "id": 1754,
      "intervention": {
        "name": "experimentally induced metabolic states",
        "canonical_name": "experimentally induced metabolic states",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "experimentally induced metabolic states",
          "layer_2_variant": "experimentally induced metabolic states",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "female infertility",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "alteration of metabolic and hormonal parameters",
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized and crossover trials",
        "sample_size": null,
        "duration": null,
        "population": "infertile women with metabolic disorders such as polycystic ovary syndrome (PCOS), insulin resistance, obesity, and metabolic syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Metabolic Dysregulation and Female Infertility: A Systematic Review of Hormonal and Reproductive Outcomes From Recent Clinical Trials.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995278",
        "doi": "10.7759/cureus.90887"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:59:15"
    },
    {
      "id": 1743,
      "intervention": {
        "name": "microneedling with tacrolimus",
        "canonical_name": "microneedling with tacrolimus",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "microneedling with tacrolimus",
          "layer_2_variant": "microneedling with tacrolimus",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "vitiligo",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced topical drug penetration and immune modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "participants with vitiligo, hyperhidrosis, melasma, acne vulgaris, and actinic keratoses",
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:54:12"
    },
    {
      "id": 1744,
      "intervention": {
        "name": "microneedling with 5-fluorouracil (5-FU)",
        "canonical_name": "microneedling with 5-fluorouracil",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "microneedling with 5-fluorouracil",
          "layer_2_variant": "microneedling with 5-fluorouracil (5-fu)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "vitiligo",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced topical drug penetration and immune modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "participants with vitiligo, hyperhidrosis, melasma, acne vulgaris, and actinic keratoses",
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:54:12"
    },
    {
      "id": 1745,
      "intervention": {
        "name": "fractional microneedle radiofrequency (FMR)",
        "canonical_name": "fractional microneedle radiofrequency",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fractional microneedle radiofrequency",
          "layer_2_variant": "fractional microneedle radiofrequency (fmr)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hyperhidrosis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "thermal destruction of sweat glands",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "participants with vitiligo, hyperhidrosis, melasma, acne vulgaris, and actinic keratoses",
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:54:12"
    },
    {
      "id": 1746,
      "intervention": {
        "name": "botulinum toxin A",
        "canonical_name": "botulinum toxin",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "botulinum toxin",
          "layer_2_variant": "botulinum toxin a",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hyperhidrosis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of acetylcholine release",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "participants with vitiligo, hyperhidrosis, melasma, acne vulgaris, and actinic keratoses",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:54:12"
    },
    {
      "id": 1747,
      "intervention": {
        "name": "microneedling with tranexamic acid",
        "canonical_name": "microneedling with tranexamic acid",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "microneedling with tranexamic acid",
          "layer_2_variant": "microneedling with tranexamic acid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "melasma",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of plasminogen activation and reduced melanin transfer",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "participants with vitiligo, hyperhidrosis, melasma, acne vulgaris, and actinic keratoses",
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:54:12"
    },
    {
      "id": 1748,
      "intervention": {
        "name": "microneedling with cysteamine",
        "canonical_name": "microneedling with cysteamine",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "microneedling with cysteamine",
          "layer_2_variant": "microneedling with cysteamine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "melasma",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of tyrosinase activity and reduced melanin production",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "participants with vitiligo, hyperhidrosis, melasma, acne vulgaris, and actinic keratoses",
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:54:12"
    },
    {
      "id": 1749,
      "intervention": {
        "name": "microneedle radiofrequency (MRF)",
        "canonical_name": "microneedle radiofrequency",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "microneedle radiofrequency",
          "layer_2_variant": "microneedle radiofrequency (mrf)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "thermal destruction of sebaceous glands and comedones",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "participants with vitiligo, hyperhidrosis, melasma, acne vulgaris, and actinic keratoses",
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:54:12"
    },
    {
      "id": 1750,
      "intervention": {
        "name": "photodynamic therapy (PDT)",
        "canonical_name": "photodynamic therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "photodynamic therapy",
          "layer_2_variant": "photodynamic therapy (pdt)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "phototoxicity-induced destruction of Propionibacterium acnes and comedones",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "participants with vitiligo, hyperhidrosis, melasma, acne vulgaris, and actinic keratoses",
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:54:12"
    },
    {
      "id": 1751,
      "intervention": {
        "name": "microneedling-assisted PDT",
        "canonical_name": "photodynamic therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "photodynamic therapy",
          "layer_2_variant": "microneedling-assisted pdt",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "actinic keratoses",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced drug penetration and phototoxicity-induced keratinocyte destruction",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "participants with vitiligo, hyperhidrosis, melasma, acne vulgaris, and actinic keratoses",
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:54:12"
    },
    {
      "id": 1742,
      "intervention": {
        "name": "Extracorporeal shock wave lithotripsy (ESWL)",
        "canonical_name": "extracorporeal shock wave lithotripsy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "extracorporeal shock wave lithotripsy",
          "layer_2_variant": "extracorporeal shock wave lithotripsy (eswl)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "renal injury",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "non-invasive stone fragmentation",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review",
        "sample_size": 412,
        "duration": null,
        "population": "adults undergoing ESWL",
        "adverse_effects": "renal injury",
        "cost_category": null
      },
      "paper": {
        "title": "Urinary Biomarkers for Early Detection of Kidney Injury Following Extracorporeal Shock Wave Lithotripsy: A Systematic Review.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40978830",
        "doi": "10.7759/cureus.90688"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:50:26"
    },
    {
      "id": 1731,
      "intervention": {
        "name": "color-coded system",
        "canonical_name": "color-coded system",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "color-coded system",
          "layer_2_variant": "color-coded system",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "monitoring and risk stratification",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1732,
      "intervention": {
        "name": "early stimulation",
        "canonical_name": "early stimulation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "early stimulation",
          "layer_2_variant": "early stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "promotes neurodevelopmental growth",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1733,
      "intervention": {
        "name": "structured interventions",
        "canonical_name": "structured interventions",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "structured interventions",
          "layer_2_variant": "structured interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted developmental support",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1734,
      "intervention": {
        "name": "parental involvement",
        "canonical_name": "parental involvement",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "parental involvement",
          "layer_2_variant": "parental involvement",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhances care consistency and support",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1735,
      "intervention": {
        "name": "validated screening tools",
        "canonical_name": "screening tools",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "screening tools",
          "layer_2_variant": "validated screening tools",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "accurate early detection of developmental issues",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1736,
      "intervention": {
        "name": "comprehensive follow-ups",
        "canonical_name": "follow-ups",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "follow-ups",
          "layer_2_variant": "comprehensive follow-ups",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "systematic monitoring of developmental and medical outcomes",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1737,
      "intervention": {
        "name": "screening for retinopathy of prematurity",
        "canonical_name": "screening for retinopathy of prematurity",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "screening for retinopathy of prematurity",
          "layer_2_variant": "screening for retinopathy of prematurity",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "early detection of ocular complications",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1738,
      "intervention": {
        "name": "screening for thyroid disorders",
        "canonical_name": "screening for thyroid disorders",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "screening for thyroid disorders",
          "layer_2_variant": "screening for thyroid disorders",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "early identification of metabolic issues",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1739,
      "intervention": {
        "name": "screening for developmental dysplasia of hip",
        "canonical_name": "screening for developmental dysplasia of hip",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "screening for developmental dysplasia of hip",
          "layer_2_variant": "screening for developmental dysplasia of hip",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "early detection of musculoskeletal abnormalities",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1740,
      "intervention": {
        "name": "screening for hearing impairments",
        "canonical_name": "screening for hearing impairments",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "screening for hearing impairments",
          "layer_2_variant": "screening for hearing impairments",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "early identification of auditory deficits",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1741,
      "intervention": {
        "name": "specialized therapies",
        "canonical_name": "specialized therapies",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "specialized therapies",
          "layer_2_variant": "specialized therapies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk infants",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "tailored interventions for specific developmental needs",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk infants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Consensus Guidelines of the Indian Academy of Pediatrics (IAP)-Neurodevelopmental Pediatrics Chapter on Developmentally Supportive Follow-Up for High-Risk Infants.",
        "journal": "Indian pediatrics",
        "publication_date": "2025-08",
        "pubmed_id": "40493113",
        "doi": "10.1007/s13312-025-00110-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:47:08"
    },
    {
      "id": 1730,
      "intervention": {
        "name": "topical application of povidone-iodine oral care",
        "canonical_name": "povidone-iodine",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "povidone-iodine",
          "layer_2_variant": "topical application of povidone-iodine oral care",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ventilator-associated pneumonia",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of viable bacterial load in the lower respiratory tract",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 20,
        "duration": null,
        "population": "intubated ICU patients undergoing mechanical ventilation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Topical Application of Povidone-Iodine on the Number of Bacteria Entering the Lower Respiratory Tract of Intubated Patients: A Randomized Controlled Trial.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030697",
        "doi": "10.7759/cureus.91274"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:43:37"
    },
    {
      "id": 1729,
      "intervention": {
        "name": "microencapsulated benzoyl peroxide",
        "canonical_name": "benzoyl peroxide",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "benzoyl peroxide",
          "layer_2_variant": "microencapsulated benzoyl peroxide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "alteration of skin microbiome biodiversity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blind, single-center, crossover, vehicle-controlled trial",
        "sample_size": 31,
        "duration": "12 weeks",
        "population": "facial rosacea with global severity of 3 or 4 on the Investigator's Global Assessment (IGA) scale",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Impact of Microencapsulated Benzoyl Peroxide on the Skin Microbiome and Clinical Outcomes in Rosacea: An Update on a Randomized, Double-blind, Crossover, Vehicle-controlled Clinical Trial.",
        "journal": "The Journal of clinical and aesthetic dermatology",
        "publication_date": "2025-08",
        "pubmed_id": "40843233",
        "doi": null
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:42:14"
    },
    {
      "id": 1726,
      "intervention": {
        "name": "high-dose isotretinoin regimen",
        "canonical_name": "isotretinoin",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isotretinoin",
          "layer_2_variant": "high-dose isotretinoin regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of sebum production and inflammatory pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": 15,
        "duration": null,
        "population": "patients with moderate to severe acne vulgaris",
        "adverse_effects": "mucocutaneous reactions, including cheilitis and xerosis",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness and safety of different dosing regimens of isotretinoin for acne vulgaris: a systematic review.",
        "journal": "Postepy dermatologii i alergologii",
        "publication_date": "2025-08",
        "pubmed_id": "41001139",
        "doi": "10.5114/ada.2025.153322"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:40:43"
    },
    {
      "id": 1727,
      "intervention": {
        "name": "low-dose isotretinoin regimen",
        "canonical_name": "isotretinoin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isotretinoin",
          "layer_2_variant": "low-dose isotretinoin regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of sebum production and inflammatory pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": 15,
        "duration": null,
        "population": "patients with moderate to severe acne vulgaris",
        "adverse_effects": "reduced mucocutaneous reactions compared to high-dose regimen",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness and safety of different dosing regimens of isotretinoin for acne vulgaris: a systematic review.",
        "journal": "Postepy dermatologii i alergologii",
        "publication_date": "2025-08",
        "pubmed_id": "41001139",
        "doi": "10.5114/ada.2025.153322"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:40:43"
    },
    {
      "id": 1728,
      "intervention": {
        "name": "intermittent isotretinoin regimen",
        "canonical_name": "isotretinoin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isotretinoin",
          "layer_2_variant": "intermittent isotretinoin regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of sebum production and inflammatory pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": 15,
        "duration": null,
        "population": "patients with moderate to severe acne vulgaris",
        "adverse_effects": "reduced mucocutaneous reactions compared to high-dose regimen",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness and safety of different dosing regimens of isotretinoin for acne vulgaris: a systematic review.",
        "journal": "Postepy dermatologii i alergologii",
        "publication_date": "2025-08",
        "pubmed_id": "41001139",
        "doi": "10.5114/ada.2025.153322"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:40:43"
    },
    {
      "id": 1722,
      "intervention": {
        "name": "Upadacitinib",
        "canonical_name": "upadacitinib",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "upadacitinib",
          "layer_2_variant": "upadacitinib",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Giant Cell Arteritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of JAK-signal transducer and activator of transcription (STAT) pathway",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "double-blind randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with Giant Cell Arteritis",
        "adverse_effects": "infections",
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:37:18"
    },
    {
      "id": 1723,
      "intervention": {
        "name": "Tofacitinib",
        "canonical_name": "janus kinase inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "janus kinase inhibitors",
          "layer_2_variant": "tofacitinib",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Takayasu Arteritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of JAK-signal transducer and activator of transcription (STAT) pathway",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "cohort study",
        "sample_size": null,
        "duration": null,
        "population": "patients with Takayasu Arteritis",
        "adverse_effects": "infections",
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:37:18"
    },
    {
      "id": 1724,
      "intervention": {
        "name": "Baricitinib",
        "canonical_name": "janus kinase inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "janus kinase inhibitors",
          "layer_2_variant": "baricitinib",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Takayasu Arteritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of JAK-signal transducer and activator of transcription (STAT) pathway",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "case report",
        "sample_size": null,
        "duration": null,
        "population": "patients with Takayasu Arteritis",
        "adverse_effects": "infections",
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:37:18"
    },
    {
      "id": 1725,
      "intervention": {
        "name": "Ruxolitinib",
        "canonical_name": "ruxolitinib",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ruxolitinib",
          "layer_2_variant": "ruxolitinib",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Takayasu Arteritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of JAK-signal transducer and activator of transcription (STAT) pathway",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "cohort study",
        "sample_size": null,
        "duration": null,
        "population": "patients with Takayasu Arteritis",
        "adverse_effects": "infections",
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:37:18"
    },
    {
      "id": 1715,
      "intervention": {
        "name": "short interfering RNA molecules",
        "canonical_name": "short interfering rna",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "short interfering rna",
          "layer_2_variant": "short interfering rna molecules",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "primary hyperoxaluria",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted gene silencing",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:35:05"
    },
    {
      "id": 1716,
      "intervention": {
        "name": "short interfering RNA molecules",
        "canonical_name": "short interfering rna",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "short interfering rna",
          "layer_2_variant": "short interfering rna molecules",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hereditary transthyretin amyloidosis",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted gene silencing",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:35:05"
    },
    {
      "id": 1717,
      "intervention": {
        "name": "short interfering RNA molecules",
        "canonical_name": "short interfering rna",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "short interfering rna",
          "layer_2_variant": "short interfering rna molecules",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute kidney injury after cardiovascular intervention",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted gene silencing",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:35:05"
    },
    {
      "id": 1718,
      "intervention": {
        "name": "short interfering RNA molecules",
        "canonical_name": "short interfering rna",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "short interfering rna",
          "layer_2_variant": "short interfering rna molecules",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "delayed graft function",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted gene silencing",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:35:05"
    },
    {
      "id": 1719,
      "intervention": {
        "name": "short interfering RNA molecules",
        "canonical_name": "short interfering rna",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "short interfering rna",
          "layer_2_variant": "short interfering rna molecules",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hypercholesterolemia",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted gene silencing",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:35:05"
    },
    {
      "id": 1720,
      "intervention": {
        "name": "synthetic antisense oligonucleotides",
        "canonical_name": "antisense oligonucleotides",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antisense oligonucleotides",
          "layer_2_variant": "synthetic antisense oligonucleotides",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate or severe hypercholesterolemia",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted gene modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:35:05"
    },
    {
      "id": 1721,
      "intervention": {
        "name": "synthetic antisense oligonucleotides",
        "canonical_name": "antisense oligonucleotides",
        "category": "gene_therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antisense oligonucleotides",
          "layer_2_variant": "synthetic antisense oligonucleotides",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "amyloidosis",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted gene modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "RNA therapeutics in kidney diseases: prospects and current status.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-08",
        "pubmed_id": "40755967",
        "doi": "10.1093/ckj/sfaf214"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:35:05"
    },
    {
      "id": 1711,
      "intervention": {
        "name": "Warfarin",
        "canonical_name": "anticoagulants",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "anticoagulants",
          "layer_2_variant": "warfarin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "thromboembolic events in patients with mechanical heart valves",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of vitamin K-dependent clotting factors",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "patients with mechanical heart valves",
        "adverse_effects": "drug-drug interactions, frequent monitoring requirements",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40932963",
        "doi": "10.7759/cureus.89736"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:32:32"
    },
    {
      "id": 1712,
      "intervention": {
        "name": "Apixaban",
        "canonical_name": "apixaban",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "apixaban",
          "layer_2_variant": "apixaban",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "thromboembolic events in patients with mechanical heart valves",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct factor Xa inhibition",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "patients with mechanical heart valves",
        "adverse_effects": "relatively inferior outcomes compared to warfarin",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40932963",
        "doi": "10.7759/cureus.89736"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:32:32"
    },
    {
      "id": 1713,
      "intervention": {
        "name": "Rivaroxaban",
        "canonical_name": "rivaroxaban",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rivaroxaban",
          "layer_2_variant": "rivaroxaban",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "thromboembolic events in patients with mechanical heart valves",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct factor Xa inhibition",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "patients with mechanical heart valves",
        "adverse_effects": "relatively inferior outcomes compared to warfarin",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40932963",
        "doi": "10.7759/cureus.89736"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:32:32"
    },
    {
      "id": 1714,
      "intervention": {
        "name": "Dabigatran",
        "canonical_name": "direct thrombin inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "direct thrombin inhibitors",
          "layer_2_variant": "dabigatran",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "thromboembolic events in patients with mechanical heart valves",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct thrombin inhibition",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "patients with mechanical heart valves",
        "adverse_effects": "relatively inferior outcomes compared to warfarin",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40932963",
        "doi": "10.7759/cureus.89736"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:32:32"
    },
    {
      "id": 1709,
      "intervention": {
        "name": "Firsekibart",
        "canonical_name": "firsekibart",
        "category": "emerging",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "firsekibart",
          "layer_2_variant": "firsekibart",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute gout flare",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of interleukin-1β, reducing inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized phase 3 trial",
        "sample_size": 311,
        "duration": "12 weeks",
        "population": "patients with frequent acute gout flares unsuitable for standard therapy",
        "adverse_effects": "71.2% of Firsekibart-treated patients experienced treatment-emergent adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial.",
        "journal": "Innovation (Cambridge (Mass.))",
        "publication_date": "2025-08-04",
        "pubmed_id": "40814346",
        "doi": "10.1016/j.xinn.2025.101015"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:30:03"
    },
    {
      "id": 1710,
      "intervention": {
        "name": "compound betamethasone",
        "canonical_name": "betamethasone",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "betamethasone",
          "layer_2_variant": "compound betamethasone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute gout flare",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "corticosteroid-mediated anti-inflammatory effects",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized phase 3 trial",
        "sample_size": 311,
        "duration": "12 weeks",
        "population": "patients with frequent acute gout flares unsuitable for standard therapy",
        "adverse_effects": "69.9% of CB-treated patients experienced treatment-emergent adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial.",
        "journal": "Innovation (Cambridge (Mass.))",
        "publication_date": "2025-08-04",
        "pubmed_id": "40814346",
        "doi": "10.1016/j.xinn.2025.101015"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:30:03"
    },
    {
      "id": 1708,
      "intervention": {
        "name": "treat-to-target urate-lowering therapy",
        "canonical_name": "urate-lowering therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "urate-lowering therapy",
          "layer_2_variant": "treat-to-target urate-lowering therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gout",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "urate reduction and improved inflammation control",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "post-hoc analysis of randomized multicenter trial",
        "sample_size": 878,
        "duration": "72 weeks",
        "population": "male participants, mean age 62.4 years, 67.4% self-reported White race",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Improvements in Health-Related Quality of Life with Treat-to-Target Urate-Lowering Therapy in Gout: A Post-hoc Analysis of a Randomized Multicenter Trial.",
        "journal": "Arthritis care & research",
        "publication_date": "2025-08-07",
        "pubmed_id": "40771143",
        "doi": "10.1002/acr.25618"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:28:05"
    },
    {
      "id": 1706,
      "intervention": {
        "name": "Catheter-directed thrombectomy (CDT)",
        "canonical_name": "catheter-directed thrombectomy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "catheter-directed thrombectomy",
          "layer_2_variant": "catheter-directed thrombectomy (cdt)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct reduction of pulmonary artery clot burden",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 111,
        "duration": null,
        "population": "adults with confirmed acute PE, high risk for mortality, and technically feasible CDT",
        "adverse_effects": "major bleeding, stroke",
        "cost_category": null
      },
      "paper": {
        "title": "Thrombectomy in high-risk pulmonary embolism - device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial.",
        "journal": "Thrombosis research",
        "publication_date": "2025-08-07",
        "pubmed_id": "41027123",
        "doi": "10.1016/j.thromres.2025.109420"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:26:35"
    },
    {
      "id": 1707,
      "intervention": {
        "name": "systemic thrombolysis",
        "canonical_name": "systemic thrombolysis",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "systemic thrombolysis",
          "layer_2_variant": "systemic thrombolysis",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "high-risk pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "clot dissolution through systemic administration of thrombolytic agents",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 111,
        "duration": null,
        "population": "adults with confirmed acute PE, high risk for mortality, and technically feasible CDT",
        "adverse_effects": "major bleeding, stroke",
        "cost_category": null
      },
      "paper": {
        "title": "Thrombectomy in high-risk pulmonary embolism - device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial.",
        "journal": "Thrombosis research",
        "publication_date": "2025-08-07",
        "pubmed_id": "41027123",
        "doi": "10.1016/j.thromres.2025.109420"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:26:35"
    },
    {
      "id": 1705,
      "intervention": {
        "name": "iscalimab (CFZ533)",
        "canonical_name": "iscalimab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "iscalimab",
          "layer_2_variant": "iscalimab (cfz533)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "proliferative lupus nephritis",
        "canonical_name": null,
        "category": "immunological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of CD40 signaling pathway",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised, double-blind, placebo-controlled, phase II study",
        "sample_size": 57,
        "duration": "49 weeks",
        "population": "patients with systemic lupus erythematosus with active proliferative lupus nephritis",
        "adverse_effects": "mild to moderate adverse events; severe infections and macrophage-activation syndrome in immunosuppressed and comorbid patients",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study.",
        "journal": "RMD open",
        "publication_date": "2025-08-14",
        "pubmed_id": "40813108",
        "doi": "10.1136/rmdopen-2025-005557"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:24:44"
    },
    {
      "id": 1703,
      "intervention": {
        "name": "rivaroxaban anticoagulation",
        "canonical_name": "rivaroxaban",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rivaroxaban",
          "layer_2_variant": "rivaroxaban anticoagulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "post-TAVR antithrombotic management",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of factor Xa to reduce thrombosis risk",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 454,
        "duration": "12 months",
        "population": "patients who have successfully undergone TAVR and do not have indications for long-term anticoagulation or dual antiplatelet therapy",
        "adverse_effects": "life-threatening, disabling or major bleeding",
        "cost_category": null
      },
      "paper": {
        "title": "Rationale and design of SCOPE trial: a prospective, multicentre, open-label, randomised controlled trial to evaluate the overall efficacy and safety of a",
        "journal": "BMJ open",
        "publication_date": "2025-08-16",
        "pubmed_id": "40819859",
        "doi": "10.1136/bmjopen-2024-098551"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:21:36"
    },
    {
      "id": 1704,
      "intervention": {
        "name": "antiplatelet monotherapy",
        "canonical_name": "antiplatelet agents",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antiplatelet agents",
          "layer_2_variant": "antiplatelet monotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "post-TAVR antithrombotic management",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of platelet aggregation to reduce thrombosis risk",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 454,
        "duration": "12 months",
        "population": "patients who have successfully undergone TAVR and do not have indications for long-term anticoagulation or dual antiplatelet therapy",
        "adverse_effects": "life-threatening, disabling or major bleeding",
        "cost_category": null
      },
      "paper": {
        "title": "Rationale and design of SCOPE trial: a prospective, multicentre, open-label, randomised controlled trial to evaluate the overall efficacy and safety of a",
        "journal": "BMJ open",
        "publication_date": "2025-08-16",
        "pubmed_id": "40819859",
        "doi": "10.1136/bmjopen-2024-098551"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:21:36"
    },
    {
      "id": 1699,
      "intervention": {
        "name": "catheter-directed thrombolysis",
        "canonical_name": "thrombolysis",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "thrombolysis",
          "layer_2_variant": "catheter-directed thrombolysis",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "deep venous thrombosis",
        "canonical_name": null,
        "category": "hematological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "restoration of venous patency and reduction of thrombus",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "patients with iliofemoral DVT",
        "adverse_effects": "variable complication profiles",
        "cost_category": null
      },
      "paper": {
        "title": "Interventional Procedures in Deep Venous Thrombosis Treatment: A Review of Techniques, Outcomes, and Patient Selection.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-18",
        "pubmed_id": "40870521",
        "doi": "10.3390/medicina61081476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:18:12"
    },
    {
      "id": 1700,
      "intervention": {
        "name": "pharmacomechanical thrombectomy",
        "canonical_name": "pharmacomechanical thrombectomy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pharmacomechanical thrombectomy",
          "layer_2_variant": "pharmacomechanical thrombectomy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "deep venous thrombosis",
        "canonical_name": null,
        "category": "hematological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "combination of mechanical clot removal and pharmacological thrombolysis",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "patients with iliofemoral DVT",
        "adverse_effects": "device-specific complication profiles",
        "cost_category": null
      },
      "paper": {
        "title": "Interventional Procedures in Deep Venous Thrombosis Treatment: A Review of Techniques, Outcomes, and Patient Selection.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-18",
        "pubmed_id": "40870521",
        "doi": "10.3390/medicina61081476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:18:12"
    },
    {
      "id": 1701,
      "intervention": {
        "name": "mechanical thrombectomy",
        "canonical_name": "mechanical thrombectomy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mechanical thrombectomy",
          "layer_2_variant": "mechanical thrombectomy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "deep venous thrombosis",
        "canonical_name": null,
        "category": "hematological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "mechanical clot removal with high thrombus clearance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "patients with iliofemoral DVT",
        "adverse_effects": "device-specific complication profiles",
        "cost_category": null
      },
      "paper": {
        "title": "Interventional Procedures in Deep Venous Thrombosis Treatment: A Review of Techniques, Outcomes, and Patient Selection.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-18",
        "pubmed_id": "40870521",
        "doi": "10.3390/medicina61081476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:18:12"
    },
    {
      "id": 1702,
      "intervention": {
        "name": "venous stenting",
        "canonical_name": "venous stenting",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "venous stenting",
          "layer_2_variant": "venous stenting",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "deep venous thrombosis",
        "canonical_name": null,
        "category": "hematological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "restoration of venous patency by addressing underlying obstructions",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "patients with iliofemoral DVT",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interventional Procedures in Deep Venous Thrombosis Treatment: A Review of Techniques, Outcomes, and Patient Selection.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-18",
        "pubmed_id": "40870521",
        "doi": "10.3390/medicina61081476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:18:12"
    },
    {
      "id": 1698,
      "intervention": {
        "name": "low-dose colchicine prophylaxis",
        "canonical_name": "colchicine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "colchicine",
          "layer_2_variant": "low-dose colchicine prophylaxis",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gout flares",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prevention of gout flares during urate-lowering therapy initiation",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised double-blind placebo-controlled trial",
        "sample_size": 200,
        "duration": "1 year",
        "population": "participants with gout fulfilling the American College of Rheumatology recommendations for starting urate-lowering therapy and with serum urate ≥0.36 mmol/L (6mg/dL)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of low dose colchicine prophylaxis when starting allopurinol using the \"start-low go-slow\" approach for gout: evidence from a non-inferiority randomised double-blind placebo-controlled trial.",
        "journal": "Arthritis care & research",
        "publication_date": "2025-08-18",
        "pubmed_id": "40827007",
        "doi": "10.1002/acr.25631"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:15:36"
    },
    {
      "id": 1697,
      "intervention": {
        "name": "mycophenolate mofetil",
        "canonical_name": "mycophenolate mofetil",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mycophenolate mofetil",
          "layer_2_variant": "mycophenolate mofetil",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "IgA nephropathy",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced intraglomerular inflammation and delayed progression to ESKD",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review of clinical studies",
        "sample_size": null,
        "duration": null,
        "population": "patients with IgA nephropathy, particularly those with recent disease onset and active proliferative lesions",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Intraglomerular Inflammation as a Guide for Mycophenolate Mofetil-Based Treatment in IgA Nephropathy.",
        "journal": "Diagnostics (Basel, Switzerland)",
        "publication_date": "2025-08-20",
        "pubmed_id": "40870953",
        "doi": "10.3390/diagnostics15162101"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:14:00"
    },
    {
      "id": 1695,
      "intervention": {
        "name": "reverse total shoulder arthroplasty",
        "canonical_name": "reverse total shoulder arthroplasty",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "reverse total shoulder arthroplasty",
          "layer_2_variant": "reverse total shoulder arthroplasty",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff tear arthropathy",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "restoration of shoulder joint function and alignment",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 102,
        "duration": "12 months",
        "population": "patients with rotator cuff tear arthropathy who are eligible for reverse total shoulder arthroplasty",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prosthesis versus exercise for rotator cuff tear arthropathy - protocol of a randomised controlled trial.",
        "journal": "Danish medical journal",
        "publication_date": "2025-08-22",
        "pubmed_id": "40927835",
        "doi": "10.61409/A09240645"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:12:11"
    },
    {
      "id": 1696,
      "intervention": {
        "name": "exercise intervention",
        "canonical_name": "exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise",
          "layer_2_variant": "exercise intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff tear arthropathy",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved shoulder mobility and muscle strength",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 102,
        "duration": "12 months",
        "population": "patients with rotator cuff tear arthropathy who are eligible for reverse total shoulder arthroplasty",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prosthesis versus exercise for rotator cuff tear arthropathy - protocol of a randomised controlled trial.",
        "journal": "Danish medical journal",
        "publication_date": "2025-08-22",
        "pubmed_id": "40927835",
        "doi": "10.61409/A09240645"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:12:11"
    },
    {
      "id": 1693,
      "intervention": {
        "name": "Nintendo Switch-based therapy",
        "canonical_name": "nintendo switch-based therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nintendo switch-based therapy",
          "layer_2_variant": "nintendo switch-based therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cognitive and motor processes in ADHD",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced motivation and adherence through digital engagement",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 33,
        "duration": "8 weeks",
        "population": "children and adolescents aged 6-17 years with ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preliminary Research: Effectiveness of an Intervention Program Based on New Technologies for the Improvement of Cognitive and Motor Processes in Children and Adolescents with ADHD: A Randomized Controlled Trial.",
        "journal": "European journal of investigation in health, psychology and education",
        "publication_date": "2025-08-22",
        "pubmed_id": "41002748",
        "doi": "10.3390/ejihpe15090167"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:10:20"
    },
    {
      "id": 1694,
      "intervention": {
        "name": "traditional board game therapy",
        "canonical_name": "board game therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "board game therapy",
          "layer_2_variant": "traditional board game therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cognitive and motor processes in ADHD",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "engagement through structured physical and cognitive activities",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 33,
        "duration": "8 weeks",
        "population": "children and adolescents aged 6-17 years with ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preliminary Research: Effectiveness of an Intervention Program Based on New Technologies for the Improvement of Cognitive and Motor Processes in Children and Adolescents with ADHD: A Randomized Controlled Trial.",
        "journal": "European journal of investigation in health, psychology and education",
        "publication_date": "2025-08-22",
        "pubmed_id": "41002748",
        "doi": "10.3390/ejihpe15090167"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:10:20"
    },
    {
      "id": 1692,
      "intervention": {
        "name": "metformin",
        "canonical_name": "metformin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "metformin",
          "layer_2_variant": "metformin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "kidney function decline",
        "canonical_name": null,
        "category": "renal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "slowing the rate of kidney function decline",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase III, multi-centre, randomized, placebo-controlled trial",
        "sample_size": 1174,
        "duration": "2 years",
        "population": "adults with autosomal dominant polycystic kidney disease (ADPKD)",
        "adverse_effects": "not explicitly mentioned",
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.",
        "journal": "Trials",
        "publication_date": "2025-08-25",
        "pubmed_id": "40855441",
        "doi": "10.1186/s13063-025-09010-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:08:32"
    },
    {
      "id": 1691,
      "intervention": {
        "name": "social media advertising",
        "canonical_name": "social media advertising",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "social media advertising",
          "layer_2_variant": "social media advertising",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted demographic, geographic, and interest-based outreach to recruit diverse participants",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "mixed-methods observational study",
        "sample_size": 238,
        "duration": null,
        "population": "individuals with acne of varying severity, duration, and ethnicity",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Social media recruitment enhances participant diversity in dermatology clinical trial: findings from the SAFA trial.",
        "journal": "Trials",
        "publication_date": "2025-08-27",
        "pubmed_id": "40866885",
        "doi": "10.1186/s13063-025-08994-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:05:44"
    },
    {
      "id": 1689,
      "intervention": {
        "name": "yoga",
        "canonical_name": "yoga",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "yoga",
          "layer_2_variant": "yoga",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "insulin resistance",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved insulin sensitivity",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 808,
        "duration": null,
        "population": "women with polycystic ovary syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with Polycystic Ovarian Syndrome: A Network Meta-Analysis Study.",
        "journal": "Healthcare (Basel, Switzerland)",
        "publication_date": "2025-08-27",
        "pubmed_id": "40941484",
        "doi": "10.3390/healthcare13172132"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:04:21"
    },
    {
      "id": 1690,
      "intervention": {
        "name": "yoga",
        "canonical_name": "yoga",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "yoga",
          "layer_2_variant": "yoga",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "elevated testosterone",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "hormonal regulation",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 808,
        "duration": null,
        "population": "women with polycystic ovary syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with Polycystic Ovarian Syndrome: A Network Meta-Analysis Study.",
        "journal": "Healthcare (Basel, Switzerland)",
        "publication_date": "2025-08-27",
        "pubmed_id": "40941484",
        "doi": "10.3390/healthcare13172132"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:04:21"
    },
    {
      "id": 1687,
      "intervention": {
        "name": "resveratrol",
        "canonical_name": "resveratrol",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "resveratrol",
          "layer_2_variant": "resveratrol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "metabolic conditions",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of anti-inflammatory factors and improved insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review",
        "sample_size": 63,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "New Perspectives on the Use of Resveratrol in the Treatment of Metabolic and Estrogen-Dependent Conditions Through Hormonal Modulation and Anti-Inflammatory Effects.",
        "journal": "Current issues in molecular biology",
        "publication_date": "2025-08-27",
        "pubmed_id": "41020814",
        "doi": "10.3390/cimb47090692"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:00:30"
    },
    {
      "id": 1688,
      "intervention": {
        "name": "resveratrol",
        "canonical_name": "resveratrol",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "resveratrol",
          "layer_2_variant": "resveratrol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "estrogen-dependent conditions",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of estrogen receptor activity and reduction of oxidative stress",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review",
        "sample_size": 63,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "New Perspectives on the Use of Resveratrol in the Treatment of Metabolic and Estrogen-Dependent Conditions Through Hormonal Modulation and Anti-Inflammatory Effects.",
        "journal": "Current issues in molecular biology",
        "publication_date": "2025-08-27",
        "pubmed_id": "41020814",
        "doi": "10.3390/cimb47090692"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 07:00:30"
    },
    {
      "id": 1686,
      "intervention": {
        "name": "nurse-led person-centered self-management intervention",
        "canonical_name": "self-management intervention",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "self-management intervention",
          "layer_2_variant": "nurse-led person-centered self-management intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "irritable bowel syndrome",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of host transcriptomic and microbial pathways related to pain, anxiety, fatigue, and sleep disturbance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "pre-post study nested within a randomized controlled trial",
        "sample_size": 20,
        "duration": "12 weeks",
        "population": "young adults with IBS (75% non-Hispanic, 75% White, 65% female)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Mechanistic Insights into a Self-Management Intervention in Young Adults with Irritable Bowel Syndrome: A Pilot Multi-Omics Study.",
        "journal": "Biomedicines",
        "publication_date": "2025-08-28",
        "pubmed_id": "41007665",
        "doi": "10.3390/biomedicines13092102"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:58:51"
    },
    {
      "id": 1685,
      "intervention": {
        "name": "vitamin D supplementation",
        "canonical_name": "vitamin d",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vitamin d",
          "layer_2_variant": "vitamin d supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic lupus erythematosus disease activity",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immunomodulatory effects and reduction of inflammatory markers",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 3177,
        "duration": null,
        "population": "adult patients with systemic lupus erythematosus",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review and Meta-Analysis of the Effects of Vitamin D on Systemic Lupus Erythematosus.",
        "journal": "Nutrients",
        "publication_date": "2025-08-28",
        "pubmed_id": "40944182",
        "doi": "10.3390/nu17172794"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:55:41"
    },
    {
      "id": 1684,
      "intervention": {
        "name": "wearable focal vibration therapy",
        "canonical_name": "focal vibration therapy",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "focal vibration therapy",
          "layer_2_variant": "wearable focal vibration therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gait and mobility impairment",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced neuromuscular control and proprioception",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "double-blind randomized controlled trial",
        "sample_size": 22,
        "duration": "4 weeks",
        "population": "people with multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Feasibility and Preliminary Efficacy of Wearable Focal Vibration Therapy on Gait and Mobility in People with Multiple Sclerosis: A Pilot Study.",
        "journal": "Bioengineering (Basel, Switzerland)",
        "publication_date": "2025-08-29",
        "pubmed_id": "41007175",
        "doi": "10.3390/bioengineering12090932"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:54:06"
    },
    {
      "id": 1681,
      "intervention": {
        "name": "HIIT",
        "canonical_name": "high intensity interval training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "high intensity interval training",
          "layer_2_variant": "hiit",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anxiety and depression",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neuroplastic adaptations",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 48,
        "duration": "8 weeks",
        "population": "participants with Parkinson's disease and multiple sclerosis with clinically significant affective symptoms (HADS ≥ 8)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "HIITing Anxiety and Depression in Parkinson's Disease and Multiple Sclerosis-A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT).",
        "journal": "Brain sciences",
        "publication_date": "2025-08-29",
        "pubmed_id": "41008305",
        "doi": "10.3390/brainsci15090945"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:52:37"
    },
    {
      "id": 1682,
      "intervention": {
        "name": "continuous aerobic training",
        "canonical_name": "aerobic training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "aerobic training",
          "layer_2_variant": "continuous aerobic training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anxiety and depression",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "neuroplastic adaptations",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 48,
        "duration": "8 weeks",
        "population": "participants with Parkinson's disease and multiple sclerosis with clinically significant affective symptoms (HADS ≥ 8)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "HIITing Anxiety and Depression in Parkinson's Disease and Multiple Sclerosis-A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT).",
        "journal": "Brain sciences",
        "publication_date": "2025-08-29",
        "pubmed_id": "41008305",
        "doi": "10.3390/brainsci15090945"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:52:37"
    },
    {
      "id": 1683,
      "intervention": {
        "name": "movement advice",
        "canonical_name": "movement advice",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "movement advice",
          "layer_2_variant": "movement advice",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anxiety and depression",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "behavioral engagement and physical education",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 48,
        "duration": "8 weeks",
        "population": "participants with Parkinson's disease and multiple sclerosis with clinically significant affective symptoms (HADS ≥ 8)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "HIITing Anxiety and Depression in Parkinson's Disease and Multiple Sclerosis-A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT).",
        "journal": "Brain sciences",
        "publication_date": "2025-08-29",
        "pubmed_id": "41008305",
        "doi": "10.3390/brainsci15090945"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:52:37"
    },
    {
      "id": 1680,
      "intervention": {
        "name": "statin use",
        "canonical_name": "statins",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "statins",
          "layer_2_variant": "statin use",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "sepsis mortality",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved endothelial function",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "septic patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Impact of Statin Use on Sepsis Mortality: A Systematic Review and Meta-Analysis.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-30",
        "pubmed_id": "41010954",
        "doi": "10.3390/medicina61091563"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:50:25"
    },
    {
      "id": 1674,
      "intervention": {
        "name": "sodium bicarbonate",
        "canonical_name": "sodium bicarbonate",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sodium bicarbonate",
          "layer_2_variant": "sodium bicarbonate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary alkalinization",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased urinary pH through bicarbonate excretion",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:49:00"
    },
    {
      "id": 1675,
      "intervention": {
        "name": "Citro-Soda®",
        "canonical_name": "sodium bicarbonate",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sodium bicarbonate",
          "layer_2_variant": "citro-soda®",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary alkalinization",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased urinary pH through citrate and bicarbonate excretion",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:49:00"
    },
    {
      "id": 1676,
      "intervention": {
        "name": "lacto-ovo-vegetarian diet",
        "canonical_name": "vegetarian diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vegetarian diet",
          "layer_2_variant": "lacto-ovo-vegetarian diet",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary alkalinization",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased urinary pH through dietary alkaline load",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:49:00"
    },
    {
      "id": 1677,
      "intervention": {
        "name": "ammonium chloride",
        "canonical_name": "ammonium chloride",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ammonium chloride",
          "layer_2_variant": "ammonium chloride",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary acidification",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "decreased urinary pH through acid excretion",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:49:00"
    },
    {
      "id": 1678,
      "intervention": {
        "name": "methionine",
        "canonical_name": "methionine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "methionine",
          "layer_2_variant": "methionine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary acidification",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "decreased urinary pH through sulfur metabolism",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:49:00"
    },
    {
      "id": 1679,
      "intervention": {
        "name": "high protein diet",
        "canonical_name": "high protein diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "high protein diet",
          "layer_2_variant": "high protein diet",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary acidification",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "decreased urinary pH through increased acid load",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:49:00"
    },
    {
      "id": 1673,
      "intervention": {
        "name": "SGLT2 inhibitors",
        "canonical_name": "sglt2 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sglt2 inhibitors",
          "layer_2_variant": "sglt2 inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic kidney disease",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced renal hyperfiltration, improved metabolic profile, anti-inflammatory and antifibrotic effects, osmotic diuresis, and restored tubulo-glomerular feedback",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "narrative review",
        "sample_size": null,
        "duration": null,
        "population": "patients with chronic kidney disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nephroprotective Mechanisms of SGLT2i: Beyond the Glucose-Lowering Effect.",
        "journal": "Biomedicines",
        "publication_date": "2025-08-30",
        "pubmed_id": "41007686",
        "doi": "10.3390/biomedicines13092123"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:46:32"
    },
    {
      "id": 1672,
      "intervention": {
        "name": "IKAP theory-based digital health management",
        "canonical_name": "digital health management",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "digital health management",
          "layer_2_variant": "ikap theory-based digital health management",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "upper limb dysfunction",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced psychological adaptation and improved functional recovery",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 200,
        "duration": "12 weeks",
        "population": "postmastectomy breast cancer survivors",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital Health Management via IKAP Theory Improves Upper Limb Function and Psychological Adaptation in Postmastectomy Patients: A Randomized Controlled Trial.",
        "journal": "Clinical breast cancer",
        "publication_date": "2025-08-31",
        "pubmed_id": "41033915",
        "doi": "10.1016/j.clbc.2025.08.017"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:45:05"
    },
    {
      "id": 1670,
      "intervention": {
        "name": "bariatric surgery",
        "canonical_name": "bariatric surgery",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bariatric surgery",
          "layer_2_variant": "bariatric surgery",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary incontinence",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "weight loss and reduction of intra-abdominal pressure",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "retrospective case-control study",
        "sample_size": 46,
        "duration": null,
        "population": "elderly women with obesity and urinary incontinence",
        "adverse_effects": "postoperative diarrhea",
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of the effects of bariatric surgery and pelvic floor muscle training on urinary incontinence in elderly women with obesity.",
        "journal": "Surgery in practice and science",
        "publication_date": "2025-09",
        "pubmed_id": "41048845",
        "doi": "10.1016/j.sipas.2025.100303"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:43:41"
    },
    {
      "id": 1671,
      "intervention": {
        "name": "pelvic floor muscle training",
        "canonical_name": "pelvic floor muscle training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pelvic floor muscle training",
          "layer_2_variant": "pelvic floor muscle training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urinary incontinence",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "strengthening of pelvic floor muscles",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "retrospective case-control study",
        "sample_size": 46,
        "duration": null,
        "population": "elderly women with obesity and urinary incontinence",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of the effects of bariatric surgery and pelvic floor muscle training on urinary incontinence in elderly women with obesity.",
        "journal": "Surgery in practice and science",
        "publication_date": "2025-09",
        "pubmed_id": "41048845",
        "doi": "10.1016/j.sipas.2025.100303"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:43:41"
    },
    {
      "id": 1669,
      "intervention": {
        "name": "BI 1595043",
        "canonical_name": "bi 1595043",
        "category": "emerging",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bi 1595043",
          "layer_2_variant": "bi 1595043",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammatory mediators",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of the conversion of pantetheine to pantothenic acid",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "double-blind, randomized, placebo-controlled, multiple rising dose study",
        "sample_size": 30,
        "duration": "18 days",
        "population": "healthy male volunteers (18-50 years of age; body mass index: 18.5-29.9 kg/m2)",
        "adverse_effects": "mild or moderate severity, e.g., headache, dizziness, and abdominal discomfort; ophthalmologic adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, Pharmacokinetics, and Pharmacodynamics of BI 1595043, a Selective Vanin Inhibitor, in Phase 1 Clinical Trials Involving Healthy Volunteers.",
        "journal": "Clinical and translational science",
        "publication_date": "2025-09",
        "pubmed_id": "40952900",
        "doi": "10.1111/cts.70285"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:41:55"
    },
    {
      "id": 1668,
      "intervention": {
        "name": "Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i)",
        "canonical_name": "sodium-glucose cotransporter-2 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sodium-glucose cotransporter-2 inhibitors",
          "layer_2_variant": "sodium-glucose cotransporter-2 inhibitors (sglt-2i)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "heart failure (HF) hospitalization",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved left ventricular ejection fraction and reduced cardiac stress",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 7,
        "duration": null,
        "population": "patients with acute myocardial infarction (AMI)",
        "adverse_effects": "no significant differences in serious adverse events, diabetic ketoacidosis, or urinary tract infections",
        "cost_category": null
      },
      "paper": {
        "title": "Administration of Sodium-Glucose Cotransporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review, Meta-Analysis, and Meta-Regression of Randomized Trials.",
        "journal": "Journal of lipid and atherosclerosis",
        "publication_date": "2025-09",
        "pubmed_id": "41048601",
        "doi": "10.12997/jla.2025.14.3.326"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:38:45"
    },
    {
      "id": 1667,
      "intervention": {
        "name": "tapinarof cream 1%",
        "canonical_name": "tapinarof",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tapinarof",
          "layer_2_variant": "tapinarof cream 1%",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atopic dermatitis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improvement in skin condition",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1191,
        "duration": "8 weeks",
        "population": "patients with mild-to-severe atopic dermatitis",
        "adverse_effects": "modest but statistically significant increase in the overall incidence of adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Tapinarof for Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.",
        "journal": "Cureus",
        "publication_date": "2025-09",
        "pubmed_id": "41050042",
        "doi": "10.7759/cureus.91549"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:37:12"
    },
    {
      "id": 1664,
      "intervention": {
        "name": "arthroscopic rotator cuff repair (RCR) with DR knotted Corkscrew Biocomposite/Swivelock Biocomposite",
        "canonical_name": "arthroscopic rotator cuff repair",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "arthroscopic rotator cuff repair",
          "layer_2_variant": "arthroscopic rotator cuff repair (rcr) with dr knotted corkscrew biocomposite/swivelock biocomposite",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff tear",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "repair of the rotator cuff using double row knotted constructs to reduce retear rates and improve long-term outcomes",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "Markov model analysis",
        "sample_size": null,
        "duration": "1, 5, and 10 years",
        "population": "patients with small and medium-sized rotator cuff tears",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of rotator cuff repair based on modern constructs, tear size, and implant cost at 1, 5, and 10 years.",
        "journal": "JSES international",
        "publication_date": "2025-09",
        "pubmed_id": "41049655",
        "doi": "10.1016/j.jseint.2025.04.038"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:35:39"
    },
    {
      "id": 1665,
      "intervention": {
        "name": "arthroscopic rotator cuff repair (RCR) with DR knotless Swivelock Biocomposite",
        "canonical_name": "arthroscopic rotator cuff repair",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "arthroscopic rotator cuff repair",
          "layer_2_variant": "arthroscopic rotator cuff repair (rcr) with dr knotless swivelock biocomposite",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff tear",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "repair of the rotator cuff using double row knotless constructs to reduce retear rates and improve long-term outcomes",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "Markov model analysis",
        "sample_size": null,
        "duration": "1, 5, and 10 years",
        "population": "patients with large rotator cuff tears",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of rotator cuff repair based on modern constructs, tear size, and implant cost at 1, 5, and 10 years.",
        "journal": "JSES international",
        "publication_date": "2025-09",
        "pubmed_id": "41049655",
        "doi": "10.1016/j.jseint.2025.04.038"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:35:39"
    },
    {
      "id": 1666,
      "intervention": {
        "name": "arthroscopic rotator cuff repair (RCR) with DR knotless Healicoil PEEK/Footprint Ultra polyether ether ketone",
        "canonical_name": "arthroscopic rotator cuff repair",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "arthroscopic rotator cuff repair",
          "layer_2_variant": "arthroscopic rotator cuff repair (rcr) with dr knotless healicoil peek/footprint ultra polyether ether ketone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff tear",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "repair of the rotator cuff using double row knotless constructs to reduce retear rates and improve long-term outcomes",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "Markov model analysis",
        "sample_size": null,
        "duration": "1, 5, and 10 years",
        "population": "patients with massive rotator cuff tears",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of rotator cuff repair based on modern constructs, tear size, and implant cost at 1, 5, and 10 years.",
        "journal": "JSES international",
        "publication_date": "2025-09",
        "pubmed_id": "41049655",
        "doi": "10.1016/j.jseint.2025.04.038"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:35:39"
    },
    {
      "id": 1663,
      "intervention": {
        "name": "Monitored Therapeutic Alcohol Administration",
        "canonical_name": "therapeutic alcohol",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "therapeutic alcohol",
          "layer_2_variant": "monitored therapeutic alcohol administration",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Alcohol Withdrawal Syndrome",
        "canonical_name": null,
        "category": "toxicological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of perioperative stress and improvement of psychological well-being",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled pilot trial",
        "sample_size": 24,
        "duration": "six weeks",
        "population": "adult male patients with Alcohol Use Disorder and isolated facial fractures requiring surgery",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Impact of Therapeutic Alcohol Administration on Perioperative Quality of Life (QoL) and Fracture Healing in Patients with Alcohol Use Disorder Undergoing Surgery for Maxillofacial Trauma-A Randomized Pilot Trial.",
        "journal": "Craniomaxillofacial trauma & reconstruction",
        "publication_date": "2025-09",
        "pubmed_id": "40989766",
        "doi": "10.3390/cmtr18030037"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:33:21"
    },
    {
      "id": 1662,
      "intervention": {
        "name": "Amyloid beta-directed monoclonal antibodies",
        "canonical_name": "amyloid beta-directed monoclonal antibodies",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "amyloid beta-directed monoclonal antibodies",
          "layer_2_variant": "amyloid beta-directed monoclonal antibodies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Alzheimer's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of amyloid beta accumulation and improvement of cognitive function",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of phase III randomized controlled trials",
        "sample_size": 24,
        "duration": null,
        "population": "patients with Alzheimer's disease",
        "adverse_effects": "increased risk of amyloid-related imaging abnormalities (ARIA-E, ARIA-H) and adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "The Efficacy and Safety of Amyloid Beta-Directed Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials.",
        "journal": "Human psychopharmacology",
        "publication_date": "2025-09",
        "pubmed_id": "40951935",
        "doi": "10.1002/hup.70017"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:31:55"
    },
    {
      "id": 1660,
      "intervention": {
        "name": "Rifampin-based tuberculosis preventive treatment regimen (4R10)",
        "canonical_name": "rifampin based tuberculosis preventive treatment",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rifampin based tuberculosis preventive treatment",
          "layer_2_variant": "rifampin-based tuberculosis preventive treatment regimen (4r10)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prevention of tuberculosis progression through antimicrobial action",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 454,
        "duration": "4 months",
        "population": "participants aged ≥10 years from Canada, Indonesia, and Viet Nam",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial.",
        "journal": "Open forum infectious diseases",
        "publication_date": "2025-09",
        "pubmed_id": "40980570",
        "doi": "10.1093/ofid/ofaf563"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:30:20"
    },
    {
      "id": 1661,
      "intervention": {
        "name": "Rifampin-based tuberculosis preventive treatment regimen (2R20)",
        "canonical_name": "rifampin-based tuberculosis preventive treatment",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rifampin-based tuberculosis preventive treatment",
          "layer_2_variant": "rifampin-based tuberculosis preventive treatment regimen (2r20)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prevention of tuberculosis progression through antimicrobial action",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 461,
        "duration": "2 months",
        "population": "participants aged ≥10 years from Canada, Indonesia, and Viet Nam",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial.",
        "journal": "Open forum infectious diseases",
        "publication_date": "2025-09",
        "pubmed_id": "40980570",
        "doi": "10.1093/ofid/ofaf563"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:30:20"
    },
    {
      "id": 1659,
      "intervention": {
        "name": "Cucumis sativus L. powder (Q-actinTM)",
        "canonical_name": "cucumis sativus",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cucumis sativus",
          "layer_2_variant": "cucumis sativus l. powder (q-actintm)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild to moderate joint pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced joint pain and improved functional outcomes",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blind, placebo-controlled trial",
        "sample_size": 80,
        "duration": "60 days",
        "population": "adults with mild to moderate joint pain (mean age = 50.10)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Cucumis sativus L. Supplementation on Mild to Moderate Joint Pain: A Randomized, Double-Blind, Placebo-Controlled Study.",
        "journal": "Cureus",
        "publication_date": "2025-09",
        "pubmed_id": "41040766",
        "doi": "10.7759/cureus.93507"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:28:26"
    },
    {
      "id": 1658,
      "intervention": {
        "name": "visual art therapy",
        "canonical_name": "visual art therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "visual art therapy",
          "layer_2_variant": "visual art therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anxiety",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of anxiety through creative expression and emotional processing",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": 1686,
        "duration": "October 2017-June 2025",
        "population": "adults (18-65 years) with anxiety",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "THE IMPACT OF VISUAL ART THERAPY ON ANXIETY: A SYSTEMATIC REVIEW.",
        "journal": "Psychiatria Danubina",
        "publication_date": "2025-09",
        "pubmed_id": "40982872",
        "doi": null
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:26:55"
    },
    {
      "id": 1657,
      "intervention": {
        "name": "antiviral drugs",
        "canonical_name": "antiviral drugs",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antiviral drugs",
          "layer_2_variant": "antiviral drugs",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "colitis",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of CMV replication",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective cohort study",
        "sample_size": 50,
        "duration": null,
        "population": "children with colitis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cytomegalovirus Detection by PCR on Fresh and Formalin-Fixed Colon Tissue Biopsies of Children with Colitis: A Prospective Cohort Study.",
        "journal": "Iranian journal of medical sciences",
        "publication_date": "2025-09",
        "pubmed_id": "40977955",
        "doi": "10.30476/ijms.2025.103842.3741"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:25:28"
    },
    {
      "id": 1656,
      "intervention": {
        "name": "donanemab",
        "canonical_name": "donanemab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "donanemab",
          "layer_2_variant": "donanemab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "preclinical Alzheimer's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeting amyloid pathology",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "double-blind, placebo-controlled trial",
        "sample_size": 2196,
        "duration": null,
        "population": "participants 55-80 years of age in the United States and Japan",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3.",
        "journal": "Alzheimer's & dementia : the journal of the Alzheimer's Association",
        "publication_date": "2025-09",
        "pubmed_id": "40955720",
        "doi": "10.1002/alz.70662"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:24:03"
    },
    {
      "id": 1655,
      "intervention": {
        "name": "stochastic gradient boosting",
        "canonical_name": "stochastic gradient boosting",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "stochastic gradient boosting",
          "layer_2_variant": "stochastic gradient boosting",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "preclinical Alzheimer's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "predictive modeling using multimodal data to forecast cognitive decline",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "asymptomatic preclinical Alzheimer's disease patients from the A4 study",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Multimodal prognostic modeling of individual cognitive trajectories to enhance trial efficiency in preclinical Alzheimer's disease.",
        "journal": "Alzheimer's & dementia : the journal of the Alzheimer's Association",
        "publication_date": "2025-09",
        "pubmed_id": "40990131",
        "doi": "10.1002/alz.70702"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:20:52"
    },
    {
      "id": 1654,
      "intervention": {
        "name": "antiretroviral therapy",
        "canonical_name": "antiretroviral therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antiretroviral therapy",
          "layer_2_variant": "antiretroviral therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "management of HIV infection and its associated metabolic and immunological complications",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis protocol",
        "sample_size": null,
        "duration": null,
        "population": "diabetic human immunodeficiency virus-infected individuals",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Prevalence of Cardiovascular Disease Risk Factors on Diabetic Human Immunodeficiency Virus-Infected Individuals on Antiretroviral Treatment: A Systematic Review and Meta-Analysis Protocol.",
        "journal": "Health science reports",
        "publication_date": "2025-09",
        "pubmed_id": "40970105",
        "doi": "10.1002/hsr2.71274"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:18:00"
    },
    {
      "id": 1651,
      "intervention": {
        "name": "Percutaneous coronary intervention (PCI)",
        "canonical_name": "percutaneous coronary intervention",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "percutaneous coronary intervention",
          "layer_2_variant": "percutaneous coronary intervention (pci)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ischemic left ventricular systolic dysfunction",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "revascularization of coronary arteries",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "post hoc analysis of randomized controlled trial",
        "sample_size": 666,
        "duration": null,
        "population": "patients with ischemic left ventricular systolic dysfunction and multivessel coronary disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction.",
        "journal": "Journal of the Society for Cardiovascular Angiography & Interventions",
        "publication_date": "2025-09",
        "pubmed_id": "41040436",
        "doi": "10.1016/j.jscai.2025.103820"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:16:38"
    },
    {
      "id": 1652,
      "intervention": {
        "name": "Coronary artery bypass grafting (CABG)",
        "canonical_name": "coronary artery bypass grafting",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "coronary artery bypass grafting",
          "layer_2_variant": "coronary artery bypass grafting (cabg)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ischemic left ventricular systolic dysfunction",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "revascularization of coronary arteries through surgical bypass",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "post hoc analysis of randomized controlled trial",
        "sample_size": 1200,
        "duration": null,
        "population": "patients with ischemic left ventricular systolic dysfunction and multivessel coronary disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction.",
        "journal": "Journal of the Society for Cardiovascular Angiography & Interventions",
        "publication_date": "2025-09",
        "pubmed_id": "41040436",
        "doi": "10.1016/j.jscai.2025.103820"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:16:38"
    },
    {
      "id": 1653,
      "intervention": {
        "name": "Optimal medical therapy (OMT)",
        "canonical_name": "optimal medical therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "optimal medical therapy",
          "layer_2_variant": "optimal medical therapy (omt)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ischemic left ventricular systolic dysfunction",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "pharmacological and lifestyle management of cardiovascular risk factors",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "post hoc analysis of randomized controlled trial",
        "sample_size": 1866,
        "duration": null,
        "population": "patients with ischemic left ventricular systolic dysfunction and multivessel coronary disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction.",
        "journal": "Journal of the Society for Cardiovascular Angiography & Interventions",
        "publication_date": "2025-09",
        "pubmed_id": "41040436",
        "doi": "10.1016/j.jscai.2025.103820"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:16:38"
    },
    {
      "id": 1650,
      "intervention": {
        "name": "oral glutathione",
        "canonical_name": "glutathione",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glutathione",
          "layer_2_variant": "oral glutathione",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild to moderate acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "attenuation of oxidative and nitrosative stress and modulation of inflammatory pathways",
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 40,
        "duration": "4 weeks",
        "population": "subjects diagnosed with mild to moderate acne vulgaris",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of oral glutathione in reducing nitric oxide and IL-1α concentrations for clinical improvement in mild to moderate acne vulgaris: a randomized controlled trial.",
        "journal": "Acta dermatovenerologica Alpina, Pannonica, et Adriatica",
        "publication_date": "2025-09",
        "pubmed_id": "41014073",
        "doi": null
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:14:20"
    },
    {
      "id": 1649,
      "intervention": {
        "name": "biologic therapy",
        "canonical_name": "biologic therapy",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "biologic therapy",
          "layer_2_variant": "biologic therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeting type 2 inflammatory endotype",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "patients with severe asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Current data on biologics: Evaluating clinical remission in asthma.",
        "journal": "The Journal of allergy and clinical immunology",
        "publication_date": "2025-09",
        "pubmed_id": "41033735",
        "doi": "10.1016/j.jaci.2025.05.034"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:12:55"
    },
    {
      "id": 1648,
      "intervention": {
        "name": "Rituximab",
        "canonical_name": "rituximab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rituximab",
          "layer_2_variant": "rituximab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "podocytopathy",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeting B-cells to reduce immune-mediated damage",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational",
        "sample_size": null,
        "duration": null,
        "population": "patients with minimal change disease and focal segmental glomerulosclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "New insights into the biology and treatment of minimal change disease and focal segmental glomerulosclerosis.",
        "journal": "Current opinion in nephrology and hypertension",
        "publication_date": "2025-09-01",
        "pubmed_id": "40726375",
        "doi": "10.1097/MNH.0000000000001102"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:11:39"
    },
    {
      "id": 1647,
      "intervention": {
        "name": "zinc therapy",
        "canonical_name": "zinc",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "zinc",
          "layer_2_variant": "zinc therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild cognitive impairment",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "promotes enterocyte copper sequestration, reducing systemic copper",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized, double-blind, placebo-controlled phase II trial",
        "sample_size": 48,
        "duration": "24 weeks",
        "population": "individuals with mild cognitive impairment due to Alzheimer's disease",
        "adverse_effects": "mild gastrointestinal symptoms",
        "cost_category": null
      },
      "paper": {
        "title": "Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial.",
        "journal": "Biomolecules",
        "publication_date": "2025-09-01",
        "pubmed_id": "41008575",
        "doi": "10.3390/biom15091268"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:10:19"
    },
    {
      "id": 1646,
      "intervention": {
        "name": "surgical left atrial appendage occlusion",
        "canonical_name": "surgical left atrial appendage occlusion",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "surgical left atrial appendage occlusion",
          "layer_2_variant": "surgical left atrial appendage occlusion",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "post-operative thrombo-embolic events",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prevention of blood clot formation in the left atrial appendage",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "multicentre, open-label, randomized, superiority trial",
        "sample_size": 2118,
        "duration": "1 year",
        "population": "non-AF patients with CHA₂DS₂-VASc ≥2 undergoing valvular surgery",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial.",
        "journal": "European heart journal",
        "publication_date": "2025-09-01",
        "pubmed_id": "40888584",
        "doi": "10.1093/eurheartj/ehaf674"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:08:43"
    },
    {
      "id": 1645,
      "intervention": {
        "name": "microbiome modulation",
        "canonical_name": "microbiome modulation",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "microbiome modulation",
          "layer_2_variant": "microbiome modulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "immune checkpoint inhibitors response",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome diversity and specific bacterial enrichment",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "meta-analysis",
        "sample_size": 4663,
        "duration": null,
        "population": "patients receiving immune checkpoint inhibitors",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors.",
        "journal": "NPJ biofilms and microbiomes",
        "publication_date": "2025-09-02",
        "pubmed_id": "40897718",
        "doi": "10.1038/s41522-025-00819-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:07:08"
    },
    {
      "id": 1644,
      "intervention": {
        "name": "self-guided digital psychological intervention",
        "canonical_name": "digital psychological intervention",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "digital psychological intervention",
          "layer_2_variant": "self-guided digital psychological intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psychological distress",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of psychological distress and improvement of quality of life through structured digital support",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 102,
        "duration": "3 months",
        "population": "individuals with inflammatory rheumatic diseases (rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus) aged 18 years or older with psychological distress and reduced quality of life",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital Psychological Intervention for Inflammatory Rheumatic Diseases: A Pilot Randomized Clinical Trial.",
        "journal": "JAMA network open",
        "publication_date": "2025-09-02",
        "pubmed_id": "40924426",
        "doi": "10.1001/jamanetworkopen.2025.29892"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:05:48"
    },
    {
      "id": 1643,
      "intervention": {
        "name": "Tranexamic acid",
        "canonical_name": "tranexamic acid",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tranexamic acid",
          "layer_2_variant": "tranexamic acid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postoperative opioid consumption after arthroscopic rotator cuff repair",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced fibrinolysis and blood loss",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, double-blind, randomized, controlled trial",
        "sample_size": 165,
        "duration": null,
        "population": "patients scheduled to have arthroscopic rotator cuff repair",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Use of Tranexamic Acid Reduces Opioid Consumption After Arthroscopic Rotator Cuff Repair.",
        "journal": "Journal of shoulder and elbow surgery",
        "publication_date": "2025-09-02",
        "pubmed_id": "40907869",
        "doi": "10.1016/j.jse.2025.07.023"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:04:10"
    },
    {
      "id": 1641,
      "intervention": {
        "name": "electroacupuncture",
        "canonical_name": "electroacupuncture",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "electroacupuncture",
          "layer_2_variant": "electroacupuncture",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "early urinary incontinence after radical prostatectomy",
        "canonical_name": null,
        "category": "renal",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "stimulation of acupoints to improve urinary continence",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 110,
        "duration": "20 weeks",
        "population": "men with localized prostate cancer who underwent robot-assisted radical prostatectomy and experienced urinary incontinence 4 to 6 weeks postoperatively",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Electroacupuncture in Patients With Early Urinary Incontinence After Radical Prostatectomy: A Randomized Clinical Trial.",
        "journal": "JAMA network open",
        "publication_date": "2025-09-02",
        "pubmed_id": "41026492",
        "doi": "10.1001/jamanetworkopen.2025.34491"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:02:36"
    },
    {
      "id": 1642,
      "intervention": {
        "name": "sham stimulation",
        "canonical_name": "sham stimulation",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sham stimulation",
          "layer_2_variant": "sham stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "early urinary incontinence after radical prostatectomy",
        "canonical_name": null,
        "category": "renal",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "placebo effect with nonpuncturing needles at non-acupoints",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 110,
        "duration": "20 weeks",
        "population": "men with localized prostate cancer who underwent robot-assisted radical prostatectomy and experienced urinary incontinence 4 to 6 weeks postoperatively",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Electroacupuncture in Patients With Early Urinary Incontinence After Radical Prostatectomy: A Randomized Clinical Trial.",
        "journal": "JAMA network open",
        "publication_date": "2025-09-02",
        "pubmed_id": "41026492",
        "doi": "10.1001/jamanetworkopen.2025.34491"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:02:36"
    },
    {
      "id": 1640,
      "intervention": {
        "name": "nurse-led cardiac rehabilitation programme",
        "canonical_name": "cardiac rehabilitation",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cardiac rehabilitation",
          "layer_2_variant": "nurse-led cardiac rehabilitation programme",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "physical capacity and mental health",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "combining exercise and psychological support based on broaden-and-build theory",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "non-blinded randomised controlled trial",
        "sample_size": 86,
        "duration": "6 months",
        "population": "adults diagnosed with heart valve disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nurse-led cardiac rehabilitation programme on physical capacity and mental health for heart valve patients: study protocol of a quasi-experimental study.",
        "journal": "BMJ open",
        "publication_date": "2025-09-02",
        "pubmed_id": "40897479",
        "doi": "10.1136/bmjopen-2024-096823"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 06:00:27"
    },
    {
      "id": 1639,
      "intervention": {
        "name": "vestibular assessments",
        "canonical_name": "vestibular assessments",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vestibular assessments",
          "layer_2_variant": "vestibular assessments",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "vestibular dysfunction",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved diagnosis and guided rehabilitation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.5,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "individuals with schizophrenia and bipolar disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessment of vestibular dysfunctions in schizophrenia and bipolar disorder - A comprehensive systematic review.",
        "journal": "Asian journal of psychiatry",
        "publication_date": "2025-09-03",
        "pubmed_id": "40934744",
        "doi": "10.1016/j.ajp.2025.104679"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:59:03"
    },
    {
      "id": 1638,
      "intervention": {
        "name": "Sodium-glucose cotransporter 2 inhibitors",
        "canonical_name": "sodium-glucose cotransporter 2 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sodium-glucose cotransporter 2 inhibitors",
          "layer_2_variant": "sodium-glucose cotransporter 2 inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lithium-associated kidney dysfunction",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved estimated glomerular filtration rate (eGFR) trajectory",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "historical cohort study",
        "sample_size": 56,
        "duration": "2001-2023",
        "population": "patients with mood disorders who received lithium for ≥6 months and later used SGLT2i for ≥1 month",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Sodium-Glucose Cotransporter 2 Inhibitors for Lithium-Associated Kidney Dysfunction in Mood Disorders: A Real-World Historical Cohort Study.",
        "journal": "medRxiv : the preprint server for health sciences",
        "publication_date": "2025-09-03",
        "pubmed_id": "40950471",
        "doi": "10.1101/2025.09.02.25334914"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:57:42"
    },
    {
      "id": 1632,
      "intervention": {
        "name": "aerobic exercise",
        "canonical_name": "aerobic exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "aerobic exercise",
          "layer_2_variant": "aerobic exercise",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved functional capacity and reduced dyspnea",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational",
        "sample_size": null,
        "duration": null,
        "population": "patients with acute pulmonary embolism",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:56:10"
    },
    {
      "id": 1633,
      "intervention": {
        "name": "resistance exercise",
        "canonical_name": "resistance exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "resistance exercise",
          "layer_2_variant": "resistance exercise",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved functional capacity and reduced dyspnea",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational",
        "sample_size": null,
        "duration": null,
        "population": "patients with acute pulmonary embolism",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:56:10"
    },
    {
      "id": 1634,
      "intervention": {
        "name": "inspiratory muscle training",
        "canonical_name": "inspiratory muscle training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "inspiratory muscle training",
          "layer_2_variant": "inspiratory muscle training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved functional capacity and reduced dyspnea",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational",
        "sample_size": null,
        "duration": null,
        "population": "patients with acute pulmonary embolism",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:56:10"
    },
    {
      "id": 1635,
      "intervention": {
        "name": "psychological support",
        "canonical_name": "psychological support",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "psychological support",
          "layer_2_variant": "psychological support",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved quality of life and reduced psychological distress",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational",
        "sample_size": null,
        "duration": null,
        "population": "patients with acute pulmonary embolism",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:56:10"
    },
    {
      "id": 1636,
      "intervention": {
        "name": "omega-3 fatty acids",
        "canonical_name": "omega-3 fatty acids",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "omega-3 fatty acids",
          "layer_2_variant": "omega-3 fatty acids",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced thromboembolic risk through anti-inflammatory pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.5,
        "study_confidence": 0.25
      },
      "study": {
        "type": "observational",
        "sample_size": null,
        "duration": null,
        "population": "patients with acute pulmonary embolism",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:56:10"
    },
    {
      "id": 1637,
      "intervention": {
        "name": "vitamin D supplementation",
        "canonical_name": "vitamin d",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vitamin d",
          "layer_2_variant": "vitamin d supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced thromboembolic risk through anti-inflammatory pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.5,
        "study_confidence": 0.25
      },
      "study": {
        "type": "observational",
        "sample_size": null,
        "duration": null,
        "population": "patients with acute pulmonary embolism",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:56:10"
    },
    {
      "id": 1631,
      "intervention": {
        "name": "benzathine penicillin G injection",
        "canonical_name": "penicillin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "penicillin",
          "layer_2_variant": "benzathine penicillin g injection",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "early syphilis",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibacterial action against Treponema pallidum",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "multicenter, randomized, controlled, noninferiority trial",
        "sample_size": 249,
        "duration": "6 months",
        "population": "persons with early syphilis (primary, secondary, or early latent), with or without HIV infection",
        "adverse_effects": "local injection-site pain and tenderness",
        "cost_category": null
      },
      "paper": {
        "title": "One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis.",
        "journal": "The New England journal of medicine",
        "publication_date": "2025-09-04",
        "pubmed_id": "40902161",
        "doi": "10.1056/NEJMoa2401802"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:53:40"
    },
    {
      "id": 1630,
      "intervention": {
        "name": "ECG monitoring for atrial fibrillation prediction",
        "canonical_name": "ecg monitoring",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ecg monitoring",
          "layer_2_variant": "ecg monitoring for atrial fibrillation prediction",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atrial fibrillation",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "identification of ECG markers such as P wave dispersion, P wave peak time, and left atrial volume index",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "retrospective non-randomized study",
        "sample_size": 62,
        "duration": null,
        "population": "patients with mitral valve prolapse undergoing mitral valve repair surgery",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Evaluation of Atrial Fibrillation Predictors in ECG After Mitral Valve Repair Surgery in Patients with Mitral Valve Prolapse.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-09-04",
        "pubmed_id": "41010984",
        "doi": "10.3390/medicina61091593"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:52:01"
    },
    {
      "id": 1623,
      "intervention": {
        "name": "SSRIs",
        "canonical_name": "ssris",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ssris",
          "layer_2_variant": "ssris",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of serotonin levels to reduce anxiety and panic symptoms",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:50:35"
    },
    {
      "id": 1624,
      "intervention": {
        "name": "SNRIs",
        "canonical_name": "snris",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "snris",
          "layer_2_variant": "snris",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased serotonin and norepinephrine levels to reduce panic symptoms",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:50:35"
    },
    {
      "id": 1625,
      "intervention": {
        "name": "TCAs",
        "canonical_name": "tcas",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tcas",
          "layer_2_variant": "tcas",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antagonism of serotonin and norepinephrine reuptake to reduce anxiety and panic symptoms",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:50:35"
    },
    {
      "id": 1626,
      "intervention": {
        "name": "MAIOs",
        "canonical_name": "maios",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "maios",
          "layer_2_variant": "maios",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of monoamine oxidase to increase neurotransmitter levels and reduce panic symptoms",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:50:35"
    },
    {
      "id": 1627,
      "intervention": {
        "name": "CBT",
        "canonical_name": "cognitive behavioral therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive behavioral therapy",
          "layer_2_variant": "cbt",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cognitive restructuring and behavioral modification to reduce panic symptoms",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:50:35"
    },
    {
      "id": 1628,
      "intervention": {
        "name": "Combined psychotherapy and antidepressants",
        "canonical_name": "psychotherapy and antidepressants",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "psychotherapy and antidepressants",
          "layer_2_variant": "combined psychotherapy and antidepressants",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "synergistic effect of pharmacological and psychological interventions to enhance treatment outcomes",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:50:35"
    },
    {
      "id": 1629,
      "intervention": {
        "name": "Benzodiazepines",
        "canonical_name": "benzodiazepines",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "benzodiazepines",
          "layer_2_variant": "benzodiazepines",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced GABA activity to reduce anxiety and panic symptoms",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "dependency and long-term risks",
        "cost_category": null
      },
      "paper": {
        "title": "Brazilian Psychiatric Association guidelines for the treatment of panic disorder. An overview of systematic reviews.",
        "journal": "Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41046453",
        "doi": "10.47626/1516-4446-2025-4349"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:50:35"
    },
    {
      "id": 1622,
      "intervention": {
        "name": "individualized treatment plans",
        "canonical_name": "individualized treatment plans",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "individualized treatment plans",
          "layer_2_variant": "individualized treatment plans",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "adverse outcomes in chronic liver diseases",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "consideration of age, gender, comorbidities, and liver disease severity to mitigate MRP and pDDI",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "narrative literature review",
        "sample_size": null,
        "duration": null,
        "population": "patients with chronic liver disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prevalence of Polypharmacy Among Patients with Chronic Liver Disease-A Narrative Literature Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-05",
        "pubmed_id": "40944021",
        "doi": "10.3390/jcm14176263"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:47:42"
    },
    {
      "id": 1621,
      "intervention": {
        "name": "moxibustion with aconite cake combined with earlobe acupressure",
        "canonical_name": "moxibustion with aconite cake combined with earlobe acupressure",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "moxibustion with aconite cake combined with earlobe acupressure",
          "layer_2_variant": "moxibustion with aconite cake combined with earlobe acupressure",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anxiety and depression",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "alleviation of psychological distress and enhancement of immune function",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 90,
        "duration": "3 months",
        "population": "newly diagnosed human immunodeficiency virus patients",
        "adverse_effects": "no significant adverse reactions",
        "cost_category": null
      },
      "paper": {
        "title": "Observation on the efficacy of moxibustion with fuzi cake combined with auricular point pressing in treating anxiety and depression in newly diagnosed people living with HIV: A randomized controlled trial.",
        "journal": "Medicine",
        "publication_date": "2025-09-05",
        "pubmed_id": "40922288",
        "doi": "10.1097/MD.0000000000044437"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:46:22"
    },
    {
      "id": 1618,
      "intervention": {
        "name": "music therapy",
        "canonical_name": "music therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "music therapy",
          "layer_2_variant": "music therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cognitive function in Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cognitive engagement and neural stimulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 469,
        "duration": null,
        "population": "individuals with Parkinson's disease, Traumatic Brain Injury, stroke, Huntington's disease, and multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Music Therapy on Psychological Outcomes for Neurological Conditions: A Systematic Review.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41011002",
        "doi": "10.3390/medicina61091611"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:44:56"
    },
    {
      "id": 1619,
      "intervention": {
        "name": "music therapy",
        "canonical_name": "music therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "music therapy",
          "layer_2_variant": "music therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "emotional well-being in stroke survivors",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "emotional stimulation and mood regulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 469,
        "duration": null,
        "population": "individuals with Parkinson's disease, Traumatic Brain Injury, stroke, Huntington's disease, and multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Music Therapy on Psychological Outcomes for Neurological Conditions: A Systematic Review.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41011002",
        "doi": "10.3390/medicina61091611"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:44:56"
    },
    {
      "id": 1620,
      "intervention": {
        "name": "music therapy",
        "canonical_name": "music therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "music therapy",
          "layer_2_variant": "music therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "quality of life in multiple sclerosis",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced psychological and social engagement",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 469,
        "duration": null,
        "population": "individuals with Parkinson's disease, Traumatic Brain Injury, stroke, Huntington's disease, and multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Music Therapy on Psychological Outcomes for Neurological Conditions: A Systematic Review.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41011002",
        "doi": "10.3390/medicina61091611"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:44:56"
    },
    {
      "id": 1613,
      "intervention": {
        "name": "perampanel",
        "canonical_name": "perampanel",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "perampanel",
          "layer_2_variant": "perampanel",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of glutamate receptors",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational studies and randomized controlled trials",
        "sample_size": 300,
        "duration": null,
        "population": "patients with Lennox-Gastaut syndrome",
        "adverse_effects": "behavioral side effects (irritability, aggression) dose-related",
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:42:47"
    },
    {
      "id": 1614,
      "intervention": {
        "name": "brivaracetam",
        "canonical_name": "brivaracetam",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "brivaracetam",
          "layer_2_variant": "brivaracetam",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of synaptic transmission",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational studies",
        "sample_size": 59,
        "duration": null,
        "population": "patients with Lennox-Gastaut syndrome",
        "adverse_effects": "better behavioral tolerability than levetiracetam",
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:42:47"
    },
    {
      "id": 1615,
      "intervention": {
        "name": "cenobamate",
        "canonical_name": "cenobamate",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cenobamate",
          "layer_2_variant": "cenobamate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced GABAergic activity and sodium channel blockade",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational studies",
        "sample_size": 223,
        "duration": null,
        "population": "patients with Lennox-Gastaut syndrome",
        "adverse_effects": "requires careful titration",
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:42:47"
    },
    {
      "id": 1616,
      "intervention": {
        "name": "ganaxolone",
        "canonical_name": "ganaxolone",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ganaxolone",
          "layer_2_variant": "ganaxolone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of GABA-A receptors",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational studies",
        "sample_size": null,
        "duration": null,
        "population": "patients with LGS-like CDKL5 deficiency phenotypes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:42:47"
    },
    {
      "id": 1617,
      "intervention": {
        "name": "stiripentol",
        "canonical_name": "stiripentol",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "stiripentol",
          "layer_2_variant": "stiripentol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Lennox-Gastaut syndrome",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced GABAergic activity",
      "correlation": {
        "type": "positive",
        "strength": 0.1,
        "extraction_confidence": 0.5,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational studies",
        "sample_size": null,
        "duration": null,
        "population": "limited LGS data",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Perampanel, Brivaracetam, Cenobamate, Stiripentol, and Ganaxolone in Lennox-Gastaut Syndrome: A Comprehensive Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-06",
        "pubmed_id": "40944069",
        "doi": "10.3390/jcm14176302"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:42:47"
    },
    {
      "id": 1612,
      "intervention": {
        "name": "personalized bronchiectasis action management plan (BAMP)",
        "canonical_name": "bronchiectasis action management plan",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bronchiectasis action management plan",
          "layer_2_variant": "personalized bronchiectasis action management plan (bamp)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic suppurative lung disease (CSLD)/bronchiectasis exacerbations",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced self-management and timely medical intervention during exacerbations",
      "correlation": {
        "type": "inconclusive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "multicenter, double-blind, superiority, randomized controlled trial",
        "sample_size": 194,
        "duration": "June 2018 to December 2020",
        "population": "children and adolescents aged <19 years with CSLD/bronchiectasis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pediatric Bronchiectasis Action Management Plan to Improve Clinical Outcomes: A Randomized Controlled Trial.",
        "journal": "Chest",
        "publication_date": "2025-09-08",
        "pubmed_id": "40930343",
        "doi": "10.1016/j.chest.2025.08.021"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:40:25"
    },
    {
      "id": 1611,
      "intervention": {
        "name": "laparoscopic fundoplication",
        "canonical_name": "fundoplication",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fundoplication",
          "layer_2_variant": "laparoscopic fundoplication",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gastroesophageal reflux disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "surgical correction of gastroesophageal reflux by wrapping the fundus around the lower esophagus",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with gastroesophageal reflux disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The SAGES masters program: top 10 seminal articles for laparoscopic fundoplication.",
        "journal": "Surgical endoscopy",
        "publication_date": "2025-09-08",
        "pubmed_id": "40921834",
        "doi": "10.1007/s00464-025-12141-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:38:46"
    },
    {
      "id": 1610,
      "intervention": {
        "name": "state-of-the-art therapies and modern care",
        "canonical_name": "state of the art therapies and modern care",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "state of the art therapies and modern care",
          "layer_2_variant": "state-of-the-art therapies and modern care",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved patient outcomes through comprehensive, coordinated, and personalized care",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "patients diagnosed with incident cancer from 2004 to 2020",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cancer Survival at a Comprehensive Cancer Center Compared with Surveillance, Epidemiology, and End Results (SEER) Estimates.",
        "journal": "medRxiv : the preprint server for health sciences",
        "publication_date": "2025-09-08",
        "pubmed_id": "40963747",
        "doi": "10.1101/2025.09.05.25335204"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:37:23"
    },
    {
      "id": 1609,
      "intervention": {
        "name": "bioinductive collagen patch",
        "canonical_name": "collagen patch",
        "category": "device",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "collagen patch",
          "layer_2_variant": "bioinductive collagen patch",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff retear",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced tendon healing and improved structural integrity",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational, prospective multicenter study",
        "sample_size": 21,
        "duration": "25.9 months",
        "population": "patients with rotator cuff retear after prior arthroscopic rotator cuff repair",
        "adverse_effects": "no intraoperative or immediate postoperative complications",
        "cost_category": null
      },
      "paper": {
        "title": "Biological augmentation in revision surgery: effect of a bioinductive collagen patch in patients with rotator cuff retear and a previous arthroscopic rotator cuff repair.",
        "journal": "Journal of shoulder and elbow surgery",
        "publication_date": "2025-09-10",
        "pubmed_id": "40939824",
        "doi": "10.1016/j.jse.2025.07.031"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:35:48"
    },
    {
      "id": 1608,
      "intervention": {
        "name": "glabellar botulinum toxin type A injections",
        "canonical_name": "botulinum toxin type a",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "botulinum toxin type a",
          "layer_2_variant": "glabellar botulinum toxin type a injections",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "major depressive disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "peripheral modulation of emotional expression and reduced amygdala hyperactivity",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "patients with major depressive disorder and treatment-resistant depression",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Botulinum Toxin: An Unconventional Tool for the Treatment of Depression?",
        "journal": "Brain sciences",
        "publication_date": "2025-09-10",
        "pubmed_id": "41008331",
        "doi": "10.3390/brainsci15090971"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:34:13"
    },
    {
      "id": 1607,
      "intervention": {
        "name": "GLP-1 Receptor Agonists",
        "canonical_name": "glp-1 receptor agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "glp-1 receptor agonists",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mood disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of dopaminergic reward pathways, enhancement of hippocampal neurogenesis, attenuation of neuroinflammation, and regulation of appetite and energy balance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational and preclinical studies",
        "sample_size": null,
        "duration": null,
        "population": "patients with metabolic disorders and mood disorders",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-10",
        "pubmed_id": "41010364",
        "doi": "10.3390/life15091422"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:32:47"
    },
    {
      "id": 1606,
      "intervention": {
        "name": "guided physical and nutritional intervention",
        "canonical_name": "physical and nutritional intervention",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "physical and nutritional intervention",
          "layer_2_variant": "guided physical and nutritional intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "frailty",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved physical function and nutritional status",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 66,
        "duration": "12 weeks",
        "population": "patients with cirrhosis listed for liver transplantation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Simultaneous physical and nutritional intervention reduces frailty in patients with cirrhosis listed for liver transplantation: a randomized controlled trial.",
        "journal": "Annals of hepatology",
        "publication_date": "2025-09-11",
        "pubmed_id": "40945851",
        "doi": "10.1016/j.aohep.2025.102114"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:28:32"
    },
    {
      "id": 1605,
      "intervention": {
        "name": "Antiviral agents",
        "canonical_name": "antiviral agents",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antiviral agents",
          "layer_2_variant": "antiviral agents",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "viral infectious diseases",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of viral replication through molecular targeting",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "AntiviralDB: an expert-curated database of antiviral agents against human infectious diseases.",
        "journal": "mBio",
        "publication_date": "2025-09-11",
        "pubmed_id": "40932285",
        "doi": "10.1128/mbio.02013-25"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:27:01"
    },
    {
      "id": 1604,
      "intervention": {
        "name": "combination of traditional Chinese and Western medicine",
        "canonical_name": "traditional chinese and western medicine",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "traditional chinese and western medicine",
          "layer_2_variant": "combination of traditional chinese and western medicine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "refractory epilepsy",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "multi-target mechanisms and higher compliance",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": 1521,
        "duration": null,
        "population": "patients with refractory epilepsy",
        "adverse_effects": "no statistically significant difference in incidence of adverse effects",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety in treating refractory epilepsy with a combination of traditional Chinese and Western medicine: A meta-analysis of randomized controlled trials.",
        "journal": "Medicine",
        "publication_date": "2025-09-12",
        "pubmed_id": "40958268",
        "doi": "10.1097/MD.0000000000044484"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:25:37"
    },
    {
      "id": 1602,
      "intervention": {
        "name": "nivolumab plus relatlimab",
        "canonical_name": "nivolumab plus relatlimab",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nivolumab plus relatlimab",
          "layer_2_variant": "nivolumab plus relatlimab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "advanced melanoma",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immune checkpoint inhibition",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2/3 trial",
        "sample_size": 714,
        "duration": "48 months",
        "population": "patients with advanced melanoma",
        "adverse_effects": "grade ≥3 treatment-related adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047.",
        "journal": "Journal for immunotherapy of cancer",
        "publication_date": "2025-09-12",
        "pubmed_id": "40940136",
        "doi": "10.1136/jitc-2025-012747"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:24:00"
    },
    {
      "id": 1603,
      "intervention": {
        "name": "nivolumab monotherapy",
        "canonical_name": "nivolumab",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nivolumab",
          "layer_2_variant": "nivolumab monotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "advanced melanoma",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immune checkpoint inhibition",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2/3 trial",
        "sample_size": 714,
        "duration": "48 months",
        "population": "patients with advanced melanoma",
        "adverse_effects": "grade ≥3 treatment-related adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047.",
        "journal": "Journal for immunotherapy of cancer",
        "publication_date": "2025-09-12",
        "pubmed_id": "40940136",
        "doi": "10.1136/jitc-2025-012747"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:24:00"
    },
    {
      "id": 1601,
      "intervention": {
        "name": "brivaracetam",
        "canonical_name": "brivaracetam",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "brivaracetam",
          "layer_2_variant": "brivaracetam",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "focal-onset seizures",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of synaptic transmission and reduction of neuronal hyperexcitability",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 448,
        "duration": "12 weeks",
        "population": "adult Asian patients (≥16-80 years) with focal-onset seizures in Thailand, Japan, China, Philippines, Malaysia, Singapore, and Taiwan",
        "adverse_effects": "mild to moderate somnolence, dizziness, and other mild adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Temporal Profile of Treatment-Emergent Adverse Events in Adult Asian Patients with Focal-Onset Seizures During Adjunctive Brivaracetam Treatment: Post Hoc Analysis of a Phase 3, Randomized Trial.",
        "journal": "Advances in therapy",
        "publication_date": "2025-09-13",
        "pubmed_id": "40944847",
        "doi": "10.1007/s12325-025-03357-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:22:10"
    },
    {
      "id": 1600,
      "intervention": {
        "name": "HBV biomarkers-guided NAs withdrawal strategy",
        "canonical_name": "nucleoside analogs",
        "category": "test",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nucleoside analogs",
          "layer_2_variant": "hbv biomarkers-guided nas withdrawal strategy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "HBsAg clearance",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "monitoring HBV RNA and hepatitis core-related antigen to guide discontinuation of NAs",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 90,
        "duration": "144 weeks",
        "population": "Asian chronic hepatitis B patients with long-term HBV suppression",
        "adverse_effects": "no serious adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Novel HBV biomarkers-guided NAs withdrawal strategy promotes HBsAg clearance in Asian CHB patients: a randomized controlled trial.",
        "journal": "Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association",
        "publication_date": "2025-09-13",
        "pubmed_id": "40953786",
        "doi": "10.1016/j.cgh.2025.09.009"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:20:29"
    },
    {
      "id": 1594,
      "intervention": {
        "name": "infliximab",
        "canonical_name": "infliximab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "infliximab",
          "layer_2_variant": "infliximab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "heart failure",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased cardiac stress and arrhythmias",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "patients with pre-existing cardiac disease",
        "adverse_effects": "increased reporting of HF and arrhythmias",
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:18:59"
    },
    {
      "id": 1595,
      "intervention": {
        "name": "ustekinumab",
        "canonical_name": "ustekinumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ustekinumab",
          "layer_2_variant": "ustekinumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular complications",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced systemic inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "IBD patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:18:59"
    },
    {
      "id": 1596,
      "intervention": {
        "name": "vedolizumab",
        "canonical_name": "vedolizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vedolizumab",
          "layer_2_variant": "vedolizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular complications",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted gut inflammation reduction",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "IBD patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:18:59"
    },
    {
      "id": 1597,
      "intervention": {
        "name": "risankizumab",
        "canonical_name": "risankizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "risankizumab",
          "layer_2_variant": "risankizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atrial fibrillation",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of IL-23 pathways",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.5,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "IBD patients",
        "adverse_effects": "signals for atrial fibrillation",
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:18:59"
    },
    {
      "id": 1598,
      "intervention": {
        "name": "Janus kinase inhibitors",
        "canonical_name": "janus kinase inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "janus kinase inhibitors",
          "layer_2_variant": "janus kinase inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular complications",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of JAK-STAT signaling pathways",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "high-risk individuals",
        "adverse_effects": "class-specific CV warnings",
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:18:59"
    },
    {
      "id": 1599,
      "intervention": {
        "name": "sphingosine-1-phosphate receptor modulators",
        "canonical_name": "sphingosine-1-phosphate receptor modulators",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sphingosine-1-phosphate receptor modulators",
          "layer_2_variant": "sphingosine-1-phosphate receptor modulators",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular complications",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of sphingosine-1-phosphate receptors",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "high-risk individuals",
        "adverse_effects": "class-specific CV warnings",
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:18:59"
    },
    {
      "id": 1592,
      "intervention": {
        "name": "absorbable suture (PDS®, Vicryl®)",
        "canonical_name": "absorbable suture",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "absorbable suture",
          "layer_2_variant": "absorbable suture (pds®, vicryl®)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "esophageal atresia",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "suture material influence on healing and fibrosis",
      "correlation": {
        "type": "neutral",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": 97,
        "duration": "January 2015 to December 2022",
        "population": "patients who underwent primary EA repair",
        "adverse_effects": "anastomotic leakage",
        "cost_category": null
      },
      "paper": {
        "title": "Outcome of esophageal atresia: What choice of suture material?",
        "journal": "Journal of pediatric surgery",
        "publication_date": "2025-09-15",
        "pubmed_id": "40962172",
        "doi": "10.1016/j.jpedsurg.2025.162669"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:16:30"
    },
    {
      "id": 1593,
      "intervention": {
        "name": "non-absorbable suture (Prolene®)",
        "canonical_name": "non-absorbable suture",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "non-absorbable suture",
          "layer_2_variant": "non-absorbable suture (prolene®)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "esophageal atresia",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "suture material influence on healing and fibrosis",
      "correlation": {
        "type": "neutral",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": 97,
        "duration": "January 2015 to December 2022",
        "population": "patients who underwent primary EA repair",
        "adverse_effects": "anastomotic leakage",
        "cost_category": null
      },
      "paper": {
        "title": "Outcome of esophageal atresia: What choice of suture material?",
        "journal": "Journal of pediatric surgery",
        "publication_date": "2025-09-15",
        "pubmed_id": "40962172",
        "doi": "10.1016/j.jpedsurg.2025.162669"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:16:30"
    },
    {
      "id": 1591,
      "intervention": {
        "name": "empirical antifungal treatment with posaconazole",
        "canonical_name": "antifungal",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antifungal",
          "layer_2_variant": "empirical antifungal treatment with posaconazole",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "influenza-associated pulmonary aspergillosis (IAPA)",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prevention of fungal infection development",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational multicenter study",
        "sample_size": 172,
        "duration": "September 1, 2016, to March 1, 2025",
        "population": "critically ill patients with influenza-associated acute respiratory distress syndrome (ARDS) admitted to intensive care units (ICUs)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study.",
        "journal": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
        "publication_date": "2025-09-15",
        "pubmed_id": "40971881",
        "doi": "10.1093/cid/ciaf507"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:14:36"
    },
    {
      "id": 1590,
      "intervention": {
        "name": "azetukalner",
        "canonical_name": "azetukalner",
        "category": "emerging",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "azetukalner",
          "layer_2_variant": "azetukalner",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anhedonia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "positive allosteric modulation of Kv7 channels",
      "correlation": {
        "type": "inconclusive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 60,
        "duration": "8 weeks",
        "population": "individuals with Major Depressive Disorder and anhedonia in a current major depressive episode",
        "adverse_effects": "low discontinuation rates due to adverse events, no significant differences between groups",
        "cost_category": null
      },
      "paper": {
        "title": "A Randomized, Controlled Trial of the Novel, Potent Kv7 Channel Opener Azetukalner in Individuals with Major Depressive Disorder and Anhedonia: Neural Response to Reward, Clinical Outcomes, and Safety.",
        "journal": "Research square",
        "publication_date": "2025-09-15",
        "pubmed_id": "41001561",
        "doi": "10.21203/rs.3.rs-7448148/v1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:13:04"
    },
    {
      "id": 1587,
      "intervention": {
        "name": "digital health platforms",
        "canonical_name": "digital health platforms",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "digital health platforms",
          "layer_2_variant": "digital health platforms",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis treatment",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved treatment outcomes and adherence through digital support",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 23283,
        "duration": null,
        "population": "patients with tuberculosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative Effectiveness of Digital Health Technologies in Tuberculosis Treatment: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957002",
        "doi": "10.2196/75424"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:11:35"
    },
    {
      "id": 1588,
      "intervention": {
        "name": "video directly observed treatment (VDOT)",
        "canonical_name": "directly observed treatment",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "directly observed treatment",
          "layer_2_variant": "video directly observed treatment (vdot)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis treatment",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct monitoring of medication intake to improve adherence",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 23283,
        "duration": null,
        "population": "patients with tuberculosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative Effectiveness of Digital Health Technologies in Tuberculosis Treatment: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957002",
        "doi": "10.2196/75424"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:11:35"
    },
    {
      "id": 1589,
      "intervention": {
        "name": "medication event reminder monitors",
        "canonical_name": "medication event reminder monitors",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "medication event reminder monitors",
          "layer_2_variant": "medication event reminder monitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis treatment",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reminders to improve medication adherence",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 23283,
        "duration": null,
        "population": "patients with tuberculosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative Effectiveness of Digital Health Technologies in Tuberculosis Treatment: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957002",
        "doi": "10.2196/75424"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:11:35"
    },
    {
      "id": 1584,
      "intervention": {
        "name": "systematic PROM assessment with predefined PROM-based decision-making method",
        "canonical_name": "patient-reported outcome measures",
        "category": "test",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "patient-reported outcome measures",
          "layer_2_variant": "systematic prom assessment with predefined prom-based decision-making method",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic disease management",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced clinical decision-making through patient-reported data",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "adults with diabetes, COPD, heart disease, RA, or IBD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Evidence for the Use of Patient-Reported Outcome Measures in the Treatment of Patients With Noncommunicable Diseases: Systematic Review.",
        "journal": "JMIR medical informatics",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957012",
        "doi": "10.2196/66160"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:09:32"
    },
    {
      "id": 1585,
      "intervention": {
        "name": "systematic PROM assessment with PROM-based dialogue",
        "canonical_name": "patient-reported outcome measures",
        "category": "test",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "patient-reported outcome measures",
          "layer_2_variant": "systematic prom assessment with prom-based dialogue",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic disease management",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved patient-clinician communication through PROM data",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "adults with diabetes, COPD, heart disease, RA, or IBD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Evidence for the Use of Patient-Reported Outcome Measures in the Treatment of Patients With Noncommunicable Diseases: Systematic Review.",
        "journal": "JMIR medical informatics",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957012",
        "doi": "10.2196/66160"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:09:32"
    },
    {
      "id": 1586,
      "intervention": {
        "name": "systematic PROM assessment with substitution of face-to-face consultations",
        "canonical_name": "prom assessment",
        "category": "test",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "prom assessment",
          "layer_2_variant": "systematic prom assessment with substitution of face-to-face consultations",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic disease management",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction in in-person consultations through PROM data collection",
      "correlation": {
        "type": "neutral",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "adults with diabetes, COPD, heart disease, RA, or IBD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Evidence for the Use of Patient-Reported Outcome Measures in the Treatment of Patients With Noncommunicable Diseases: Systematic Review.",
        "journal": "JMIR medical informatics",
        "publication_date": "2025-09-16",
        "pubmed_id": "40957012",
        "doi": "10.2196/66160"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:09:32"
    },
    {
      "id": 1581,
      "intervention": {
        "name": "Telitacicept",
        "canonical_name": "telitacicept",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "telitacicept",
          "layer_2_variant": "telitacicept",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe systemic lupus erythematosus",
        "canonical_name": null,
        "category": "immunological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved complement levels",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, open-label, randomized controlled trial",
        "sample_size": 84,
        "duration": "24 weeks",
        "population": "patients with active SLE (SLEDAI-2K≥10) enrolled at Shanxi Provincial People's Hospital from June 2023 to June 2024",
        "adverse_effects": "lower incidence of infections",
        "cost_category": null
      },
      "paper": {
        "title": "[Efficacy of Telitacicept combined with low-dose mycophenolate mofetil in the treatment of moderate-to-severe systemic lupus erythematosus].",
        "journal": "Zhonghua yi xue za zhi",
        "publication_date": "2025-09-16",
        "pubmed_id": "40953977",
        "doi": "10.3760/cma.j.cn112137-20250125-00215"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:04:57"
    },
    {
      "id": 1582,
      "intervention": {
        "name": "low-dose mycophenolate mofetil",
        "canonical_name": "mycophenolate mofetil",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mycophenolate mofetil",
          "layer_2_variant": "low-dose mycophenolate mofetil",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe systemic lupus erythematosus",
        "canonical_name": null,
        "category": "immunological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immunosuppression and reduced disease activity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, open-label, randomized controlled trial",
        "sample_size": 84,
        "duration": "24 weeks",
        "population": "patients with active SLE (SLEDAI-2K≥10) enrolled at Shanxi Provincial People's Hospital from June 2023 to June 2024",
        "adverse_effects": "higher incidence of infections",
        "cost_category": null
      },
      "paper": {
        "title": "[Efficacy of Telitacicept combined with low-dose mycophenolate mofetil in the treatment of moderate-to-severe systemic lupus erythematosus].",
        "journal": "Zhonghua yi xue za zhi",
        "publication_date": "2025-09-16",
        "pubmed_id": "40953977",
        "doi": "10.3760/cma.j.cn112137-20250125-00215"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:04:57"
    },
    {
      "id": 1583,
      "intervention": {
        "name": "high-dose mycophenolate mofetil",
        "canonical_name": "mycophenolate mofetil",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mycophenolate mofetil",
          "layer_2_variant": "high-dose mycophenolate mofetil",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe systemic lupus erythematosus",
        "canonical_name": null,
        "category": "immunological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immunosuppression and reduced disease activity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, open-label, randomized controlled trial",
        "sample_size": 84,
        "duration": "24 weeks",
        "population": "patients with active SLE (SLEDAI-2K≥10) enrolled at Shanxi Provincial People's Hospital from June 2023 to June 2024",
        "adverse_effects": "higher incidence of infections",
        "cost_category": null
      },
      "paper": {
        "title": "[Efficacy of Telitacicept combined with low-dose mycophenolate mofetil in the treatment of moderate-to-severe systemic lupus erythematosus].",
        "journal": "Zhonghua yi xue za zhi",
        "publication_date": "2025-09-16",
        "pubmed_id": "40953977",
        "doi": "10.3760/cma.j.cn112137-20250125-00215"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:04:57"
    },
    {
      "id": 1580,
      "intervention": {
        "name": "hydroxychloroquine",
        "canonical_name": "hydroxychloroquine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "hydroxychloroquine",
          "layer_2_variant": "hydroxychloroquine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "incomplete lupus",
        "canonical_name": null,
        "category": "immunological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced accumulation of SLE features defined by SLICC criteria",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blind, placebo-controlled trial",
        "sample_size": 180,
        "duration": "24 months",
        "population": "patients aged 15-49 years with incomplete lupus (ANA positivity with 1-2 additional criteria)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomized, placebo-controlled trial of hydroxychloroquine in incomplete lupus.",
        "journal": "Arthritis & rheumatology (Hoboken, N.J.)",
        "publication_date": "2025-09-16",
        "pubmed_id": "40955637",
        "doi": "10.1002/art.43391"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:02:14"
    },
    {
      "id": 1576,
      "intervention": {
        "name": "Mohs Micrographic Surgery (MMS)",
        "canonical_name": "mohs micrographic surgery",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mohs micrographic surgery",
          "layer_2_variant": "mohs micrographic surgery (mms)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "non-melanoma skin cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "100% margin evaluation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:00:46"
    },
    {
      "id": 1577,
      "intervention": {
        "name": "Imiquimod",
        "canonical_name": "imiquimod",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "imiquimod",
          "layer_2_variant": "imiquimod",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "superficial basal cell carcinoma (sBCC)",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "activation of Toll-like receptors 7 and 8 (TLR7/8) leading to production of pro-inflammatory cytokines",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:00:46"
    },
    {
      "id": 1578,
      "intervention": {
        "name": "Radiation therapy (RTh)",
        "canonical_name": "radiation therapy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "radiation therapy",
          "layer_2_variant": "radiation therapy (rth)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "basal cell carcinoma (BCC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct and indirect DNA damage and generation of reactive oxygen species (ROS) leading to tumor cell death",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:00:46"
    },
    {
      "id": 1579,
      "intervention": {
        "name": "Cemiplimab",
        "canonical_name": "cemiplimab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cemiplimab",
          "layer_2_variant": "cemiplimab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "locally advanced and metastatic cutaneous squamous cell carcinoma (SCC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "blocking programmed cell death 1 (PD-1) to trigger anti-tumor immune response",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 05:00:46"
    },
    {
      "id": 1575,
      "intervention": {
        "name": "mixed amphetamine salts-extended release (MAS-XR)",
        "canonical_name": "amphetamine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "amphetamine",
          "layer_2_variant": "mixed amphetamine salts-extended release (mas-xr)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "attention-deficit/hyperactivity disorder (ADHD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "alteration of white matter microstructural integrity in the uncinate fasciculus",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "diffusion tensor imaging study",
        "sample_size": 137,
        "duration": "12 weeks",
        "population": "ADHD youth with and without a first-degree relative with bipolar I disorder, and healthy controls",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Psychostimulant treatment uniquely reduces left uncinate fasciculus microstructural integrity in ADHD youth with a familial risk for bipolar I disorder: a 12-week DTI study.",
        "journal": "Journal of child psychology and psychiatry, and allied disciplines",
        "publication_date": "2025-09-17",
        "pubmed_id": "40960004",
        "doi": "10.1111/jcpp.70053"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:58:29"
    },
    {
      "id": 1573,
      "intervention": {
        "name": "tenofovir alafenamide",
        "canonical_name": "tenofovir alafenamide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tenofovir alafenamide",
          "layer_2_variant": "tenofovir alafenamide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hepatitis B virus recurrence after liver transplantation",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of hepatitis B virus replication",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2 randomized trial",
        "sample_size": 51,
        "duration": "192 weeks",
        "population": "patients with chronic kidney disease maintained on tenofovir disoproxil fumarate post-liver transplantation",
        "adverse_effects": "no grade 3/4 adverse events or serious adverse events deemed treatment-related",
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of tenofovir alafenamide in preventing hepatitis B virus recurrence after liver transplantation in patients with chronic kidney disease maintained on tenofovir disoproxil fumarate: results from a phase 2 randomized trial.",
        "journal": "American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons",
        "publication_date": "2025-09-17",
        "pubmed_id": "40972902",
        "doi": "10.1016/j.ajt.2025.09.012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:56:59"
    },
    {
      "id": 1574,
      "intervention": {
        "name": "tenofovir disoproxil fumarate",
        "canonical_name": "tenofovir disoproxil fumarate",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tenofovir disoproxil fumarate",
          "layer_2_variant": "tenofovir disoproxil fumarate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hepatitis B virus recurrence after liver transplantation",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of hepatitis B virus replication",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2 randomized trial",
        "sample_size": 51,
        "duration": "192 weeks",
        "population": "patients with chronic kidney disease maintained on tenofovir disoproxil fumarate post-liver transplantation",
        "adverse_effects": "no grade 3/4 adverse events or serious adverse events deemed treatment-related",
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of tenofovir alafenamide in preventing hepatitis B virus recurrence after liver transplantation in patients with chronic kidney disease maintained on tenofovir disoproxil fumarate: results from a phase 2 randomized trial.",
        "journal": "American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons",
        "publication_date": "2025-09-17",
        "pubmed_id": "40972902",
        "doi": "10.1016/j.ajt.2025.09.012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:56:59"
    },
    {
      "id": 1572,
      "intervention": {
        "name": "probiotics",
        "canonical_name": "probiotics",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "probiotics",
          "layer_2_variant": "probiotics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammatory bowel disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trials",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Probiotics in IBD: Evidence and Perspectives on Patient Health and Disease Management.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-17",
        "pubmed_id": "41009629",
        "doi": "10.3390/ijms26189065"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:55:00"
    },
    {
      "id": 1570,
      "intervention": {
        "name": "Living with the Sun educational programme",
        "canonical_name": "educational programme",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "educational programme",
          "layer_2_variant": "living with the sun educational programme",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "sun protection behaviour",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved knowledge and awareness of sun protection practices",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster randomized controlled trial",
        "sample_size": 1452,
        "duration": "6 months",
        "population": "primary school pupils aged 7-11 in 100 classes from 20 primary schools on the island of Réunion",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of sun risk prevention programmes in primary schools in a tropical region: The PRESOLRE trial.",
        "journal": "Journal of the European Academy of Dermatology and Venereology : JEADV",
        "publication_date": "2025-09-17",
        "pubmed_id": "40960198",
        "doi": "10.1111/jdv.70049"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:53:50"
    },
    {
      "id": 1571,
      "intervention": {
        "name": "Peer Intervention (PI)",
        "canonical_name": "peer intervention",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "peer intervention",
          "layer_2_variant": "peer intervention (pi)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "sun protection behaviour",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "peer-led reinforcement of sun protection knowledge and attitudes",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster randomized controlled trial",
        "sample_size": 1452,
        "duration": "6 months",
        "population": "primary school pupils aged 7-11 in 100 classes from 20 primary schools on the island of Réunion",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of sun risk prevention programmes in primary schools in a tropical region: The PRESOLRE trial.",
        "journal": "Journal of the European Academy of Dermatology and Venereology : JEADV",
        "publication_date": "2025-09-17",
        "pubmed_id": "40960198",
        "doi": "10.1111/jdv.70049"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:53:50"
    },
    {
      "id": 1565,
      "intervention": {
        "name": "adapted therapeutic recommendations",
        "canonical_name": "therapeutic recommendations",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "therapeutic recommendations",
          "layer_2_variant": "adapted therapeutic recommendations",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Burkitt lymphoma",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced toxicity while maintaining cure rates through localized treatment adaptations",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective evaluation",
        "sample_size": null,
        "duration": null,
        "population": "children in sub-Saharan countries",
        "adverse_effects": "absence of health coverage and late arrival in specialized units",
        "cost_category": null
      },
      "paper": {
        "title": "[Therapeutic adaptations: Rationale, achievements and limits. Experience of GFAOP].",
        "journal": "Bulletin du cancer",
        "publication_date": "2025-09-17",
        "pubmed_id": "40967945",
        "doi": "10.1016/j.bulcan.2025.07.011"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:51:35"
    },
    {
      "id": 1566,
      "intervention": {
        "name": "adapted therapeutic recommendations",
        "canonical_name": "therapeutic recommendations",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "therapeutic recommendations",
          "layer_2_variant": "adapted therapeutic recommendations",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "nephroblastoma",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced toxicity while maintaining cure rates through localized treatment adaptations",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective evaluation",
        "sample_size": null,
        "duration": null,
        "population": "children in sub-Saharan countries",
        "adverse_effects": "absence of health coverage and late arrival in specialized units",
        "cost_category": null
      },
      "paper": {
        "title": "[Therapeutic adaptations: Rationale, achievements and limits. Experience of GFAOP].",
        "journal": "Bulletin du cancer",
        "publication_date": "2025-09-17",
        "pubmed_id": "40967945",
        "doi": "10.1016/j.bulcan.2025.07.011"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:51:35"
    },
    {
      "id": 1567,
      "intervention": {
        "name": "adapted therapeutic recommendations",
        "canonical_name": "therapeutic recommendations",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "therapeutic recommendations",
          "layer_2_variant": "adapted therapeutic recommendations",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Hodgkin lymphoma",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced toxicity while maintaining cure rates through localized treatment adaptations",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective evaluation",
        "sample_size": null,
        "duration": null,
        "population": "children in sub-Saharan countries",
        "adverse_effects": "absence of health coverage and late arrival in specialized units",
        "cost_category": null
      },
      "paper": {
        "title": "[Therapeutic adaptations: Rationale, achievements and limits. Experience of GFAOP].",
        "journal": "Bulletin du cancer",
        "publication_date": "2025-09-17",
        "pubmed_id": "40967945",
        "doi": "10.1016/j.bulcan.2025.07.011"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:51:35"
    },
    {
      "id": 1568,
      "intervention": {
        "name": "adapted therapeutic recommendations",
        "canonical_name": "therapeutic recommendations",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "therapeutic recommendations",
          "layer_2_variant": "adapted therapeutic recommendations",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lymphoblastic leukemia",
        "canonical_name": null,
        "category": "hematological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced toxicity while maintaining cure rates through localized treatment adaptations",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective evaluation",
        "sample_size": null,
        "duration": null,
        "population": "children in sub-Saharan countries",
        "adverse_effects": "absence of health coverage and late arrival in specialized units",
        "cost_category": null
      },
      "paper": {
        "title": "[Therapeutic adaptations: Rationale, achievements and limits. Experience of GFAOP].",
        "journal": "Bulletin du cancer",
        "publication_date": "2025-09-17",
        "pubmed_id": "40967945",
        "doi": "10.1016/j.bulcan.2025.07.011"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:51:35"
    },
    {
      "id": 1569,
      "intervention": {
        "name": "adapted therapeutic recommendations",
        "canonical_name": "therapeutic recommendations",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "therapeutic recommendations",
          "layer_2_variant": "adapted therapeutic recommendations",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "retinoblastoma",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced toxicity while maintaining cure rates through localized treatment adaptations",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective evaluation",
        "sample_size": null,
        "duration": null,
        "population": "children in sub-Saharan countries",
        "adverse_effects": "absence of health coverage and late arrival in specialized units",
        "cost_category": null
      },
      "paper": {
        "title": "[Therapeutic adaptations: Rationale, achievements and limits. Experience of GFAOP].",
        "journal": "Bulletin du cancer",
        "publication_date": "2025-09-17",
        "pubmed_id": "40967945",
        "doi": "10.1016/j.bulcan.2025.07.011"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:51:35"
    },
    {
      "id": 1563,
      "intervention": {
        "name": "Glucocorticoid treatment",
        "canonical_name": "glucocorticoids",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glucocorticoids",
          "layer_2_variant": "glucocorticoid treatment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "community-acquired pneumonia",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation",
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Glucocorticoid Treatment in Community-Acquired Pneumonia.",
        "journal": "Seminars in respiratory and critical care medicine",
        "publication_date": "2025-09-18",
        "pubmed_id": "40967602",
        "doi": "10.1055/a-2704-6851"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:48:44"
    },
    {
      "id": 1564,
      "intervention": {
        "name": "Glucocorticoid treatment",
        "canonical_name": "glucocorticoids",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glucocorticoids",
          "layer_2_variant": "glucocorticoid treatment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "COVID-19 pneumonia",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Glucocorticoid Treatment in Community-Acquired Pneumonia.",
        "journal": "Seminars in respiratory and critical care medicine",
        "publication_date": "2025-09-18",
        "pubmed_id": "40967602",
        "doi": "10.1055/a-2704-6851"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:48:44"
    },
    {
      "id": 1561,
      "intervention": {
        "name": "methylphenidate",
        "canonical_name": "methylphenidate",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "methylphenidate",
          "layer_2_variant": "methylphenidate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "attention-deficit/hyperactivity disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhances dopamine and norepinephrine activity in the brain",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 102,
        "duration": "8 weeks",
        "population": "preschool children (<6 years) with ADHD in Brazil",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Moderators of Response to Stimulants for Preschool Attention-Deficit/Hyperactivity Disorder.",
        "journal": "Journal of the American Academy of Child and Adolescent Psychiatry",
        "publication_date": "2025-09-18",
        "pubmed_id": "40975435",
        "doi": "10.1016/j.jaac.2025.09.012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:47:21"
    },
    {
      "id": 1562,
      "intervention": {
        "name": "lisdexamfetamine",
        "canonical_name": "lisdexamfetamine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "lisdexamfetamine",
          "layer_2_variant": "lisdexamfetamine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "attention-deficit/hyperactivity disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increases dopamine and norepinephrine levels in the brain",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 148,
        "duration": "6 weeks",
        "population": "preschool children (<6 years) with ADHD in the US",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Moderators of Response to Stimulants for Preschool Attention-Deficit/Hyperactivity Disorder.",
        "journal": "Journal of the American Academy of Child and Adolescent Psychiatry",
        "publication_date": "2025-09-18",
        "pubmed_id": "40975435",
        "doi": "10.1016/j.jaac.2025.09.012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:47:21"
    },
    {
      "id": 1558,
      "intervention": {
        "name": "Benzoyl peroxide wash preparation",
        "canonical_name": "benzoyl peroxide",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "benzoyl peroxide",
          "layer_2_variant": "benzoyl peroxide wash preparation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Cutibacterium acnes burden in the pilosebaceous unit",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of C. acnes through antimicrobial action",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 122,
        "duration": null,
        "population": "patients undergoing shoulder arthroplasty",
        "adverse_effects": "none reported",
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Pretreatment of the Pilosebaceous Unit on Cutibacterium acnes Burden during Shoulder Arthroplasty: A Randomized Controlled Trial.",
        "journal": "Journal of shoulder and elbow surgery",
        "publication_date": "2025-09-18",
        "pubmed_id": "40975210",
        "doi": "10.1016/j.jse.2025.08.008"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:45:32"
    },
    {
      "id": 1559,
      "intervention": {
        "name": "Blue light phototherapy",
        "canonical_name": "blue light phototherapy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "blue light phototherapy",
          "layer_2_variant": "blue light phototherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Cutibacterium acnes burden in the pilosebaceous unit",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "photodynamic destruction of C. acnes",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 122,
        "duration": null,
        "population": "patients undergoing shoulder arthroplasty",
        "adverse_effects": "none reported",
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Pretreatment of the Pilosebaceous Unit on Cutibacterium acnes Burden during Shoulder Arthroplasty: A Randomized Controlled Trial.",
        "journal": "Journal of shoulder and elbow surgery",
        "publication_date": "2025-09-18",
        "pubmed_id": "40975210",
        "doi": "10.1016/j.jse.2025.08.008"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:45:32"
    },
    {
      "id": 1560,
      "intervention": {
        "name": "Combination of benzoyl peroxide wash and blue light phototherapy",
        "canonical_name": "benzoyl peroxide and blue light phototherapy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "benzoyl peroxide and blue light phototherapy",
          "layer_2_variant": "combination of benzoyl peroxide wash and blue light phototherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Cutibacterium acnes burden in the pilosebaceous unit",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "synergistic reduction of C. acnes through antimicrobial and photodynamic effects",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 122,
        "duration": null,
        "population": "patients undergoing shoulder arthroplasty",
        "adverse_effects": "none reported",
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Pretreatment of the Pilosebaceous Unit on Cutibacterium acnes Burden during Shoulder Arthroplasty: A Randomized Controlled Trial.",
        "journal": "Journal of shoulder and elbow surgery",
        "publication_date": "2025-09-18",
        "pubmed_id": "40975210",
        "doi": "10.1016/j.jse.2025.08.008"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:45:32"
    },
    {
      "id": 1557,
      "intervention": {
        "name": "continuous positive airway pressure",
        "canonical_name": "continuous positive airway pressure",
        "category": "device",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "continuous positive airway pressure",
          "layer_2_variant": "continuous positive airway pressure",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "refractory hypertension",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of sympathetic nervous system hyperactivation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "patients with refractory hypertension and obstructive sleep apnea",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Refractory hypertension and obstructive sleep apnea.",
        "journal": "Journal of hypertension",
        "publication_date": "2025-09-18",
        "pubmed_id": "41036995",
        "doi": "10.1097/HJH.0000000000004166"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:43:06"
    },
    {
      "id": 1555,
      "intervention": {
        "name": "Vonoprazan 10 mg",
        "canonical_name": "vonoprazan",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vonoprazan",
          "layer_2_variant": "vonoprazan 10 mg",
          "layer_3_detail": "10 mg"
        }
      },
      "condition": {
        "name": "non-erosive reflux disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of gastric acid secretion",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 2540,
        "duration": null,
        "population": "patients with non-erosive reflux disease (50.3% females)",
        "adverse_effects": "no significant difference in treatment-related or serious adverse events compared to placebo",
        "cost_category": null
      },
      "paper": {
        "title": "Reassessing Vonoprazan for Endoscopy-Negative Reflux Disease: A Systematic Review and Meta-Analysis.",
        "journal": "Digestive diseases and sciences",
        "publication_date": "2025-09-18",
        "pubmed_id": "40965559",
        "doi": "10.1007/s10620-025-09399-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:41:48"
    },
    {
      "id": 1556,
      "intervention": {
        "name": "Vonoprazan 20 mg",
        "canonical_name": "vonoprazan",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vonoprazan",
          "layer_2_variant": "vonoprazan 20 mg",
          "layer_3_detail": "20 mg"
        }
      },
      "condition": {
        "name": "non-erosive reflux disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of gastric acid secretion",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 2540,
        "duration": null,
        "population": "patients with non-erosive reflux disease (50.3% females)",
        "adverse_effects": "no significant difference in treatment-related or serious adverse events compared to placebo",
        "cost_category": null
      },
      "paper": {
        "title": "Reassessing Vonoprazan for Endoscopy-Negative Reflux Disease: A Systematic Review and Meta-Analysis.",
        "journal": "Digestive diseases and sciences",
        "publication_date": "2025-09-18",
        "pubmed_id": "40965559",
        "doi": "10.1007/s10620-025-09399-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:41:48"
    },
    {
      "id": 1553,
      "intervention": {
        "name": "Eggshell membrane (ESM) supplementation",
        "canonical_name": "eggshell membrane",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "eggshell membrane",
          "layer_2_variant": "eggshell membrane (esm) supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiota modulation and reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 54,
        "duration": "8 weeks",
        "population": "healthy adults; murine model of IBD; human subjects with IBD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacokinetic Profiling Using",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-18",
        "pubmed_id": "41009682",
        "doi": "10.3390/ijms26189102"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:39:48"
    },
    {
      "id": 1554,
      "intervention": {
        "name": "Lysozyme C (LYZ) supplementation",
        "canonical_name": "lysozyme",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "lysozyme",
          "layer_2_variant": "lysozyme c (lyz) supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiota modulation and reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "experimental study",
        "sample_size": null,
        "duration": null,
        "population": "murine model of IBD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacokinetic Profiling Using",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-18",
        "pubmed_id": "41009682",
        "doi": "10.3390/ijms26189102"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:39:48"
    },
    {
      "id": 1552,
      "intervention": {
        "name": "metacognitive training",
        "canonical_name": "metacognitive training",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "metacognitive training",
          "layer_2_variant": "metacognitive training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psychosocial functional outcome",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improvement in social cognition and emotional processing",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 55,
        "duration": "10 weeks",
        "population": "euthymic patients with bipolar disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The causal relationship between social cognition and psychosocial functional outcome over time in bipolar disorder: A latent change score model approach.",
        "journal": "Journal of affective disorders",
        "publication_date": "2025-09-19",
        "pubmed_id": "40976343",
        "doi": "10.1016/j.jad.2025.120346"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:37:51"
    },
    {
      "id": 1548,
      "intervention": {
        "name": "Curcuma longa",
        "canonical_name": "curcuma longa",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "curcuma longa",
          "layer_2_variant": "curcuma longa",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved disease activity indices",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials.",
        "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
        "publication_date": "2025-09-19",
        "pubmed_id": "41005054",
        "doi": "10.1016/j.phymed.2025.157285"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:36:27"
    },
    {
      "id": 1549,
      "intervention": {
        "name": "Zingiber officinale",
        "canonical_name": "zingiber officinale",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "zingiber officinale",
          "layer_2_variant": "zingiber officinale",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved disease activity indices",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials.",
        "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
        "publication_date": "2025-09-19",
        "pubmed_id": "41005054",
        "doi": "10.1016/j.phymed.2025.157285"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:36:27"
    },
    {
      "id": 1550,
      "intervention": {
        "name": "Tripterygium wilfordii",
        "canonical_name": "tripterygium wilfordii",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tripterygium wilfordii",
          "layer_2_variant": "tripterygium wilfordii",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved disease activity indices",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials.",
        "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
        "publication_date": "2025-09-19",
        "pubmed_id": "41005054",
        "doi": "10.1016/j.phymed.2025.157285"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:36:27"
    },
    {
      "id": 1551,
      "intervention": {
        "name": "Salvia miltiorrhiza",
        "canonical_name": "salvia miltiorrhiza",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "salvia miltiorrhiza",
          "layer_2_variant": "salvia miltiorrhiza",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved disease activity indices",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials.",
        "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
        "publication_date": "2025-09-19",
        "pubmed_id": "41005054",
        "doi": "10.1016/j.phymed.2025.157285"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:36:27"
    },
    {
      "id": 1547,
      "intervention": {
        "name": "auricular acupressure",
        "canonical_name": "acupuncture",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "acupuncture",
          "layer_2_variant": "auricular acupressure",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "neuropathy symptoms",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of neuropathic pain and improvement of quality of life",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "double-blind, randomized clinical trial",
        "sample_size": 41,
        "duration": "six weeks",
        "population": "patients with type 2 diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of auricular acupressure on neuropathy symptoms and quality of life in patients with type 2 diabetes: A double-blind, randomized clinical trial.",
        "journal": "Explore (New York, N.Y.)",
        "publication_date": "2025-09-19",
        "pubmed_id": "41033250",
        "doi": "10.1016/j.explore.2025.103264"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:34:19"
    },
    {
      "id": 1545,
      "intervention": {
        "name": "blood flow restriction with low-intensity resisted exercise",
        "canonical_name": "blood flow restriction with low-intensity resisted exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "blood flow restriction with low-intensity resisted exercise",
          "layer_2_variant": "blood flow restriction with low-intensity resisted exercise",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lower limb muscle weakness",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced muscle strength through increased metabolic stress and muscle fiber activation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 41,
        "duration": "6 weeks",
        "population": "relapsing-remitting multiple sclerosis patients of both sexes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of blood flow restriction with low-intensity exercise on lower limb muscle strength and gait in people with multiple sclerosis: A randomized controlled trial.",
        "journal": "Multiple sclerosis and related disorders",
        "publication_date": "2025-09-20",
        "pubmed_id": "41046656",
        "doi": "10.1016/j.msard.2025.106774"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:32:50"
    },
    {
      "id": 1546,
      "intervention": {
        "name": "low-intensity strengthening program for lower extremities",
        "canonical_name": "strengthening program",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "strengthening program",
          "layer_2_variant": "low-intensity strengthening program for lower extremities",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lower limb muscle weakness",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved muscular strength through progressive resistance training",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 41,
        "duration": "6 weeks",
        "population": "relapsing-remitting multiple sclerosis patients of both sexes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of blood flow restriction with low-intensity exercise on lower limb muscle strength and gait in people with multiple sclerosis: A randomized controlled trial.",
        "journal": "Multiple sclerosis and related disorders",
        "publication_date": "2025-09-20",
        "pubmed_id": "41046656",
        "doi": "10.1016/j.msard.2025.106774"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:32:50"
    },
    {
      "id": 1544,
      "intervention": {
        "name": "peripheral perfusion-targeted resuscitation",
        "canonical_name": "peripheral perfusion-targeted resuscitation",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "peripheral perfusion-targeted resuscitation",
          "layer_2_variant": "peripheral perfusion-targeted resuscitation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved microcirculatory perfusion and lactate clearance",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective randomized controlled trial",
        "sample_size": 200,
        "duration": "30 days",
        "population": "patients with sepsis and septic shock in the emergency department",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Peripheral Perfusion vs Standard Management in Sepsis/Septic Shock: A Prospective Randomized ED Study.",
        "journal": "The American journal of emergency medicine",
        "publication_date": "2025-09-20",
        "pubmed_id": "41033063",
        "doi": "10.1016/j.ajem.2025.09.024"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:28:49"
    },
    {
      "id": 1543,
      "intervention": {
        "name": "Sincrolab Adults",
        "canonical_name": "sincrolab",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sincrolab",
          "layer_2_variant": "sincrolab adults",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Attention-deficit/hyperactivity disorder (ADHD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cognitive stimulation and improved cognitive performance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 104,
        "duration": "12 weeks",
        "population": "adults diagnosed with ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Randomized Controlled Trial of an Intelligent Cognitive Stimulation Program for Adults with ADHD: Study Protocol.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-20",
        "pubmed_id": "41010833",
        "doi": "10.3390/jcm14186629"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:27:22"
    },
    {
      "id": 1540,
      "intervention": {
        "name": "PD-1 antibody",
        "canonical_name": "pd-1 antibody",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pd-1 antibody",
          "layer_2_variant": "pd-1 antibody",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic hepatitis B",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immune checkpoint inhibition to enhance antiviral immune response",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "48 weeks",
        "population": "nucleos(t)ide analogues (NAs)-treated chronic hepatitis B patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-21",
        "pubmed_id": "40976664",
        "doi": "10.1136/bmjopen-2025-105710"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:25:57"
    },
    {
      "id": 1541,
      "intervention": {
        "name": "pegylated interferon α",
        "canonical_name": "pegylated interferon alpha",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pegylated interferon alpha",
          "layer_2_variant": "pegylated interferon α",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic hepatitis B",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antiviral and immunomodulatory effects to suppress viral replication",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "48 weeks",
        "population": "nucleos(t)ide analogues (NAs)-treated chronic hepatitis B patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-21",
        "pubmed_id": "40976664",
        "doi": "10.1136/bmjopen-2025-105710"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:25:57"
    },
    {
      "id": 1542,
      "intervention": {
        "name": "PD-1 antibody combined with pegylated interferon α",
        "canonical_name": "pd-1 antibody",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pd-1 antibody",
          "layer_2_variant": "pd-1 antibody combined with pegylated interferon α",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic hepatitis B",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "synergistic immune activation and antiviral effects to promote functional cure",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "48 weeks",
        "population": "nucleos(t)ide analogues (NAs)-treated chronic hepatitis B patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-21",
        "pubmed_id": "40976664",
        "doi": "10.1136/bmjopen-2025-105710"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:25:57"
    },
    {
      "id": 1531,
      "intervention": {
        "name": "TYK2 inhibitor",
        "canonical_name": "tyk2 inhibitors",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tyk2 inhibitors",
          "layer_2_variant": "tyk2 inhibitor",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of JAK-STAT signaling pathway",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:23:39"
    },
    {
      "id": 1532,
      "intervention": {
        "name": "JAK1 inhibitor",
        "canonical_name": "jak1 inhibitors",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "jak1 inhibitors",
          "layer_2_variant": "jak1 inhibitor",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of JAK-STAT signaling pathway",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:23:39"
    },
    {
      "id": 1533,
      "intervention": {
        "name": "next-generation IL-17 inhibitor",
        "canonical_name": "il-17 inhibitor",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "il-17 inhibitor",
          "layer_2_variant": "next-generation il-17 inhibitor",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of IL-17 signaling pathway",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:23:39"
    },
    {
      "id": 1534,
      "intervention": {
        "name": "IL-23-targeted therapy",
        "canonical_name": "il-23-targeted therapy",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "il-23-targeted therapy",
          "layer_2_variant": "il-23-targeted therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of IL-23 signaling pathway",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:23:39"
    },
    {
      "id": 1535,
      "intervention": {
        "name": "novel immune-modulating agent",
        "canonical_name": "immune-modulating agents",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "immune-modulating agents",
          "layer_2_variant": "novel immune-modulating agent",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of immune response",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:23:39"
    },
    {
      "id": 1536,
      "intervention": {
        "name": "combination therapy (dual biologic and small-molecule)",
        "canonical_name": "combination therapy",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "combination therapy",
          "layer_2_variant": "combination therapy (dual biologic and small-molecule)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "synergistic effect of dual mechanisms of action",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:23:39"
    },
    {
      "id": 1537,
      "intervention": {
        "name": "microbiome-targeted therapy",
        "canonical_name": "microbiome-targeted therapy",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "microbiome-targeted therapy",
          "layer_2_variant": "microbiome-targeted therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of gut microbiome composition",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:23:39"
    },
    {
      "id": 1538,
      "intervention": {
        "name": "GLP-1 receptor agonist",
        "canonical_name": "glp-1 receptor agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "glp-1 receptor agonist",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "metabolic regulation and immune modulation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:23:39"
    },
    {
      "id": 1539,
      "intervention": {
        "name": "probiotics",
        "canonical_name": "probiotics",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "probiotics",
          "layer_2_variant": "probiotics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation",
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pipeline treatments on psoriatic disease.",
        "journal": "Best practice & research. Clinical rheumatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40987667",
        "doi": "10.1016/j.berh.2025.102090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:23:39"
    },
    {
      "id": 1530,
      "intervention": {
        "name": "lebrikizumab",
        "canonical_name": "lebrikizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "lebrikizumab",
          "layer_2_variant": "lebrikizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe atopic dermatitis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved skin condition",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "placebo-controlled, randomized phase IIIb clinical study",
        "sample_size": 331,
        "duration": "52 weeks",
        "population": "adults and adolescents with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A",
        "adverse_effects": "62.3% in the lebrikizumab plus TCS group vs. 53.2% in the placebo plus TCS group at week 16; 76.9% in the lebrikizumab group at week 52",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage).",
        "journal": "The British journal of dermatology",
        "publication_date": "2025-09-22",
        "pubmed_id": "40985295",
        "doi": "10.1093/bjd/ljaf285"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:20:40"
    },
    {
      "id": 1528,
      "intervention": {
        "name": "delamanid",
        "canonical_name": "delamanid",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "delamanid",
          "layer_2_variant": "delamanid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of mycolic acid synthesis in Mycobacterium tuberculosis",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 3 clinical trial",
        "sample_size": 3452,
        "duration": "96 weeks",
        "population": "high-risk household contacts of adults with pulmonary MDR-TB, including young children <5 years, people living with HIV or non-HIV immunosuppression, or people with evidence of M. tb infection",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.",
        "journal": "Contemporary clinical trials",
        "publication_date": "2025-09-22",
        "pubmed_id": "40992540",
        "doi": "10.1016/j.cct.2025.108084"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:18:42"
    },
    {
      "id": 1529,
      "intervention": {
        "name": "isoniazid",
        "canonical_name": "isoniazid",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isoniazid",
          "layer_2_variant": "isoniazid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of mycolic acid synthesis in Mycobacterium tuberculosis",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 3 clinical trial",
        "sample_size": 3452,
        "duration": "96 weeks",
        "population": "high-risk household contacts of adults with pulmonary MDR-TB, including young children <5 years, people living with HIV or non-HIV immunosuppression, or people with evidence of M. tb infection",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.",
        "journal": "Contemporary clinical trials",
        "publication_date": "2025-09-22",
        "pubmed_id": "40992540",
        "doi": "10.1016/j.cct.2025.108084"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:18:42"
    },
    {
      "id": 1527,
      "intervention": {
        "name": "second-generation virtual reality intervention",
        "canonical_name": "virtual reality intervention",
        "category": "emerging",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "virtual reality intervention",
          "layer_2_variant": "second-generation virtual reality intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hot and cold executive functions in children with attention-deficit/hyperactivity disorder",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cognitive engagement and executive function training through immersive virtual environments",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "single-blind randomized controlled study",
        "sample_size": 70,
        "duration": "8 weeks",
        "population": "children with attention-deficit/hyperactivity disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Investigation of the Effect of Second-Generation Virtual Reality Interventions on Hot and Cold Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder: Single-Blind Randomized Controlled Study.",
        "journal": "Games for health journal",
        "publication_date": "2025-09-22",
        "pubmed_id": "40977258",
        "doi": "10.1177/2161783X251378645"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:16:45"
    },
    {
      "id": 1526,
      "intervention": {
        "name": "use of a portable air cleaner with a high-efficiency particle air (HEPA) filter",
        "canonical_name": "air purifier",
        "category": "device",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "air purifier",
          "layer_2_variant": "use of a portable air cleaner with a high-efficiency particle air (hepa) filter",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of indoor air pollution and improvement of airway health",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 60,
        "duration": "three months",
        "population": "children with asthma in South King County, Washington State",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Airport, Air Quality and Asthma (AAA) Indoor Air Intervention Trial for Children with Asthma: Protocol for a Community Based Study in South King County, Washington State.",
        "journal": "Research square",
        "publication_date": "2025-09-22",
        "pubmed_id": "41041530",
        "doi": "10.21203/rs.3.rs-7181465/v1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:13:52"
    },
    {
      "id": 1525,
      "intervention": {
        "name": "physical activity intervention",
        "canonical_name": "physical activity",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "physical activity",
          "layer_2_variant": "physical activity intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "physical activity adherence",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced self-efficacy leading to improved intention to engage in physical activity",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 302,
        "duration": "12 months",
        "population": "African American men living with HIV who are 40 years or older",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessing Mediation and Moderation of an Efficacious Physical Activity Intervention for African American Men Living with HIV: The Influence of Self-Efficacy in Behavior Change.",
        "journal": "AIDS and behavior",
        "publication_date": "2025-09-22",
        "pubmed_id": "40976796",
        "doi": "10.1007/s10461-025-04871-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:12:21"
    },
    {
      "id": 1521,
      "intervention": {
        "name": "rituximab",
        "canonical_name": "rituximab",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rituximab",
          "layer_2_variant": "rituximab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "antibody-mediated glomerular nephropathy",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeting B-cells to reduce antibody production",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-22",
        "pubmed_id": "41010890",
        "doi": "10.3390/jcm14186686"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:10:54"
    },
    {
      "id": 1522,
      "intervention": {
        "name": "complement inhibitors",
        "canonical_name": "complement inhibitors",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "complement inhibitors",
          "layer_2_variant": "complement inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "C3 glomerulopathy",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibiting complement system activation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-22",
        "pubmed_id": "41010890",
        "doi": "10.3390/jcm14186686"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:10:54"
    },
    {
      "id": 1523,
      "intervention": {
        "name": "standard immunosuppression",
        "canonical_name": "immunosuppression",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "immunosuppression",
          "layer_2_variant": "standard immunosuppression",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "recurrent glomerular disease",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "suppressing immune response to prevent disease recurrence",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-22",
        "pubmed_id": "41010890",
        "doi": "10.3390/jcm14186686"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:10:54"
    },
    {
      "id": 1524,
      "intervention": {
        "name": "induction therapy",
        "canonical_name": "induction therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "induction therapy",
          "layer_2_variant": "induction therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "recurrent glomerular disease",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhancing initial immunosuppressive effect to reduce recurrence risk",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.5,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-22",
        "pubmed_id": "41010890",
        "doi": "10.3390/jcm14186686"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:10:54"
    },
    {
      "id": 1519,
      "intervention": {
        "name": "robot assisted laparoscopic radical prostatectomy",
        "canonical_name": "robot assisted laparoscopic radical prostatectomy",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "robot assisted laparoscopic radical prostatectomy",
          "layer_2_variant": "robot assisted laparoscopic radical prostatectomy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "surgical removal of prostate gland",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "post-hoc study nested in a prospective, controlled trial",
        "sample_size": 3444,
        "duration": null,
        "population": "patients undergoing radical prostatectomy in Sweden",
        "adverse_effects": "intraoperative extensive bleeding, difficulties during dissection",
        "cost_category": null
      },
      "paper": {
        "title": "Adverse events during radical prostatectomy and their association with recurrence and death.",
        "journal": "World journal of urology",
        "publication_date": "2025-09-23",
        "pubmed_id": "40987849",
        "doi": "10.1007/s00345-025-05932-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:08:54"
    },
    {
      "id": 1520,
      "intervention": {
        "name": "open retropubic radical prostatectomy",
        "canonical_name": "open retropubic radical prostatectomy",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "open retropubic radical prostatectomy",
          "layer_2_variant": "open retropubic radical prostatectomy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "surgical removal of prostate gland",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "post-hoc study nested in a prospective, controlled trial",
        "sample_size": 3444,
        "duration": null,
        "population": "patients undergoing radical prostatectomy in Sweden",
        "adverse_effects": "intraoperative extensive bleeding, difficulties during dissection",
        "cost_category": null
      },
      "paper": {
        "title": "Adverse events during radical prostatectomy and their association with recurrence and death.",
        "journal": "World journal of urology",
        "publication_date": "2025-09-23",
        "pubmed_id": "40987849",
        "doi": "10.1007/s00345-025-05932-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:08:54"
    },
    {
      "id": 1518,
      "intervention": {
        "name": "EHR-based deprescribing nudges",
        "canonical_name": "deprescribing nudges",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "deprescribing nudges",
          "layer_2_variant": "ehr-based deprescribing nudges",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "relaxed glycemic control in older adults with Type 2 Diabetes",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "promoting guideline-concordant deprescribing of glycemic medications via clinical decision support alerts",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "retrospective cohort analysis and logistic regression",
        "sample_size": 67412,
        "duration": null,
        "population": "clinicians receiving alerts about glycemic control in older adults with Type 2 Diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "When Nudges Don't Budge: A Mixed Methods Study of Why EHR-Based Deprescribing Nudges Failed to Change Provider Behavior.",
        "journal": "Research square",
        "publication_date": "2025-09-23",
        "pubmed_id": "41041570",
        "doi": "10.21203/rs.3.rs-7466262/v1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:07:12"
    },
    {
      "id": 1517,
      "intervention": {
        "name": "Percutaneous Mechanical Aspiration (PMA)",
        "canonical_name": "percutaneous mechanical aspiration",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "percutaneous mechanical aspiration",
          "layer_2_variant": "percutaneous mechanical aspiration (pma)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "right-sided infective endocarditis (RSIE)",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "debulking of infective vegetations",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "multicenter retrospective registry",
        "sample_size": 256,
        "duration": "January 2014 to January 2024",
        "population": "patients with right-sided infective endocarditis who underwent PMA",
        "adverse_effects": "in-hospital mortality, new pulmonary embolism, emergency surgery",
        "cost_category": null
      },
      "paper": {
        "title": "Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: A Multicenter Registry.",
        "journal": "Journal of the American College of Cardiology",
        "publication_date": "2025-09-23",
        "pubmed_id": "40864007",
        "doi": "10.1016/j.jacc.2025.06.054"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:05:38"
    },
    {
      "id": 1516,
      "intervention": {
        "name": "self-paced overground gait training",
        "canonical_name": "gait training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "gait training",
          "layer_2_variant": "self-paced overground gait training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mobility impairment",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved walking function through self-paced overground movement",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 24,
        "duration": "three-month follow-up",
        "population": "people with progressive multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Low intensity interval robot-assisted gait training improves mobility in people with progressive multiple sclerosis: the PROGR-EX randomized controlled trial.",
        "journal": "Multiple sclerosis and related disorders",
        "publication_date": "2025-09-23",
        "pubmed_id": "41005019",
        "doi": "10.1016/j.msard.2025.106777"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:03:59"
    },
    {
      "id": 1515,
      "intervention": {
        "name": "ultrasound-guided suprascapular nerve block",
        "canonical_name": "suprascapular nerve block",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "suprascapular nerve block",
          "layer_2_variant": "ultrasound-guided suprascapular nerve block",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "traumatic scapular fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "local anesthetic administration to block pain signals from the suprascapular nerve",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "case series",
        "sample_size": 10,
        "duration": null,
        "population": "ten adult patients with traumatic scapular fractures presenting to the ED with severe pain (Defense and Veterans Pain Rating Scale ≥7) and a mean Injury Severity Score (ISS) of 30",
        "adverse_effects": "no complications such as pneumothorax, vascular puncture, or local anesthetic toxicity were observed",
        "cost_category": null
      },
      "paper": {
        "title": "Suprascapular nerve block for analgesia in traumatic scapular fractures performed by emergency physicians: A case series.",
        "journal": "The American journal of emergency medicine",
        "publication_date": "2025-09-23",
        "pubmed_id": "41016085",
        "doi": "10.1016/j.ajem.2025.09.041"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:01:47"
    },
    {
      "id": 1514,
      "intervention": {
        "name": "Epilepto mobile application",
        "canonical_name": "epilepto mobile application",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "epilepto mobile application",
          "layer_2_variant": "epilepto mobile application",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "medication non-adherence in drug-resistant epilepsy",
        "canonical_name": null,
        "category": "neurological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved medication adherence through regular reminders",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 100,
        "duration": "6 months",
        "population": "children with drug-resistant epilepsy aged 3 months to 18 years",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Enhancing medication adherence in drug-resistant epilepsy using \"Epilepto\": A pilot randomized controlled trial (EMPOWER-E).",
        "journal": "Epileptic disorders : international epilepsy journal with videotape",
        "publication_date": "2025-09-23",
        "pubmed_id": "40985745",
        "doi": "10.1002/epd2.70103"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 04:00:13"
    },
    {
      "id": 1513,
      "intervention": {
        "name": "antiretroviral regimens",
        "canonical_name": "antiretroviral agents",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antiretroviral agents",
          "layer_2_variant": "antiretroviral regimens",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "HIV drug resistance",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "influence on the intrinsic barrier to resistance of the regimen",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": "randomized trials",
        "sample_size": null,
        "duration": null,
        "population": "individuals undergoing antiretroviral treatment",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Emergent Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.",
        "journal": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
        "publication_date": "2025-09-23",
        "pubmed_id": "40985680",
        "doi": "10.1093/cid/ciaf471"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:58:43"
    },
    {
      "id": 1512,
      "intervention": {
        "name": "allogeneic human bone marrow-derived mesenchymal stem cells (allo-hMSCs) infusions",
        "canonical_name": "mesenchymal stem cells",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mesenchymal stem cells",
          "layer_2_variant": "allogeneic human bone marrow-derived mesenchymal stem cells (allo-hmscs) infusions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "aging kidney function decline",
        "canonical_name": null,
        "category": "renal",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immunomodulatory effects reducing chronic low-grade inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 45,
        "duration": "88 weeks",
        "population": "older adults with Parkinson's disease and preserved kidney function (aged 50-79 years with eGFR > 60 mL/min/1.73 m2)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson's disease clinical trial.",
        "journal": "Stem cell research & therapy",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993774",
        "doi": "10.1186/s13287-025-04577-y"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:57:25"
    },
    {
      "id": 1510,
      "intervention": {
        "name": "amiodarone",
        "canonical_name": "amiodarone",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "amiodarone",
          "layer_2_variant": "amiodarone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atrial fibrillation recurrence",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "electrophysiological stabilization of cardiac rhythm",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 212,
        "duration": "6 months",
        "population": "patients undergoing catheter ablation for atrial fibrillation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Amiodarone after Catheter Ablation According to Left Atrial Structure and Function: The AMIO-CAT Trial.",
        "journal": "The American journal of cardiology",
        "publication_date": "2025-09-24",
        "pubmed_id": "41005596",
        "doi": "10.1016/j.amjcard.2025.09.017"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:55:46"
    },
    {
      "id": 1511,
      "intervention": {
        "name": "placebo",
        "canonical_name": "placebo",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "placebo",
          "layer_2_variant": "placebo",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atrial fibrillation recurrence",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "no pharmacological effect",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 212,
        "duration": "6 months",
        "population": "patients undergoing catheter ablation for atrial fibrillation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Amiodarone after Catheter Ablation According to Left Atrial Structure and Function: The AMIO-CAT Trial.",
        "journal": "The American journal of cardiology",
        "publication_date": "2025-09-24",
        "pubmed_id": "41005596",
        "doi": "10.1016/j.amjcard.2025.09.017"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:55:46"
    },
    {
      "id": 1509,
      "intervention": {
        "name": "psychological intervention",
        "canonical_name": "psychological intervention",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "psychological intervention",
          "layer_2_variant": "psychological intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "somatic symptom disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of psychological distress and symptom-related disability",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 236,
        "duration": null,
        "population": "patients with irritable bowel syndrome or ulcerative colitis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Somatic symptom disorder in patients with irritable bowel syndrome or ulcerative colitis - Cross-sectional baseline findings from the SOMA.GUT-RCT.",
        "journal": "Journal of psychosomatic research",
        "publication_date": "2025-09-24",
        "pubmed_id": "41045809",
        "doi": "10.1016/j.jpsychores.2025.112395"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:53:58"
    },
    {
      "id": 1508,
      "intervention": {
        "name": "Mediterranean diet program",
        "canonical_name": "mediterranean diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mediterranean diet",
          "layer_2_variant": "mediterranean diet program",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriasis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved cardiometabolic parameters",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 38,
        "duration": "16 weeks",
        "population": "adults with mild to moderate psoriasis receiving stable topical therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial.",
        "journal": "JAMA dermatology",
        "publication_date": "2025-09-24",
        "pubmed_id": "40991259",
        "doi": "10.1001/jamadermatol.2025.3410"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:52:32"
    },
    {
      "id": 1506,
      "intervention": {
        "name": "denosumab biosimilar",
        "canonical_name": "denosumab",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "denosumab",
          "layer_2_variant": "denosumab biosimilar",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postmenopausal osteoporosis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "bone mineral density preservation",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": 1784,
        "duration": null,
        "population": "postmenopausal osteoporosis patients",
        "adverse_effects": "comparable to originator in terms of adverse events, serious adverse events, and infections",
        "cost_category": null
      },
      "paper": {
        "title": "Comparative efficacy and safety of denosumab biosimilar and originator in postmenopausal osteoporosis: a meta-analysis of randomized controlled trials.",
        "journal": "Zeitschrift fur Rheumatologie",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993439",
        "doi": "10.1007/s00393-025-01737-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:50:55"
    },
    {
      "id": 1507,
      "intervention": {
        "name": "denosumab originator",
        "canonical_name": "denosumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "denosumab",
          "layer_2_variant": "denosumab originator",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postmenopausal osteoporosis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "bone mineral density preservation",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": 1784,
        "duration": null,
        "population": "postmenopausal osteoporosis patients",
        "adverse_effects": "comparable to biosimilar in terms of adverse events, serious adverse events, and infections",
        "cost_category": null
      },
      "paper": {
        "title": "Comparative efficacy and safety of denosumab biosimilar and originator in postmenopausal osteoporosis: a meta-analysis of randomized controlled trials.",
        "journal": "Zeitschrift fur Rheumatologie",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993439",
        "doi": "10.1007/s00393-025-01737-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:50:55"
    },
    {
      "id": 1505,
      "intervention": {
        "name": "MCP-Mod",
        "canonical_name": "mcp",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mcp",
          "layer_2_variant": "mcp-mod",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis treatment duration",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "model-based statistical method for duration-ranging",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "simulation study",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of methods for identifying the optimal treatment duration in randomized trials for antibiotics.",
        "journal": "Trials",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993799",
        "doi": "10.1186/s13063-025-09050-y"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:49:02"
    },
    {
      "id": 1504,
      "intervention": {
        "name": "videoconference-based cognitive behavioral therapy",
        "canonical_name": "cognitive behavioral therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive behavioral therapy",
          "layer_2_variant": "videoconference-based cognitive behavioral therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "psychological restructuring and symptom reduction through remote therapy sessions",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, assessor-blinded, controlled trial",
        "sample_size": 30,
        "duration": "16 weeks",
        "population": "symptomatic patients with panic disorder following primary pharmacotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Videoconference-delivered cognitive behavioral therapy in patients with symptomatic panic disorder following primary pharmacotherapy: a randomized, assessor-blinded, controlled trial.",
        "journal": "BMC psychiatry",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993573",
        "doi": "10.1186/s12888-025-07320-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:47:42"
    },
    {
      "id": 1503,
      "intervention": {
        "name": "synbiotics",
        "canonical_name": "synbiotics",
        "category": "diet",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "synbiotics",
          "layer_2_variant": "synbiotics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Alzheimer's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation, enhanced production of neuroprotective short-chain fatty acids, reduced inflammation, improved gut barrier integrity, immunomodulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Synbiotics in Alzheimer's disease: mechanisms, clinical evidence, and therapeutic prospects.",
        "journal": "Journal of translational medicine",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993787",
        "doi": "10.1186/s12967-025-07064-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:46:11"
    },
    {
      "id": 1502,
      "intervention": {
        "name": "cirrhosis detection and hepatocellular carcinoma surveillance pathway",
        "canonical_name": "cirrhosis detection and hepatocellular carcinoma surveillance",
        "category": "test",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cirrhosis detection and hepatocellular carcinoma surveillance",
          "layer_2_variant": "cirrhosis detection and hepatocellular carcinoma surveillance pathway",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hepatocellular carcinoma",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "early detection of cirrhosis and increased participation in HCC surveillance programmes",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 2470,
        "duration": "12 months",
        "population": "45-75 year olds with risk factors for chronic liver disease from regional and urban general practice clinics across four Australian states",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The IC3 trial: protocol for a multicentre individually randomised controlled trial to compare a cirrhosis detection and hepatocellular carcinoma surveillance pathway vs usual care in Australian general practice for 45-75 years old with risk factors for chronic liver disease.",
        "journal": "Trials",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993832",
        "doi": "10.1186/s13063-025-09037-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:43:05"
    },
    {
      "id": 1501,
      "intervention": {
        "name": "bone marrow aspirate concentrate injection",
        "canonical_name": "bone marrow aspirate concentrate injection",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bone marrow aspirate concentrate injection",
          "layer_2_variant": "bone marrow aspirate concentrate injection",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tendon-bone healing in chronic rotator cuff tear",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced bone-tendon interface regeneration through increased platelet, nucleated cell, stem cell, TGFβ1, and IGF1 concentrations",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "experimental study",
        "sample_size": 152,
        "duration": "8 weeks",
        "population": "Wistar rats with chronic supraspinatus tendon tears",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Optimal timing of bone marrow aspiration concentrate injection for tendon-bone healing in a chronic rat rotator cuff tear model.",
        "journal": "Journal of orthopaedic surgery and research",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993702",
        "doi": "10.1186/s13018-025-06253-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:41:31"
    },
    {
      "id": 1498,
      "intervention": {
        "name": "The Wren project (listening support)",
        "canonical_name": "listening support",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "listening support",
          "layer_2_variant": "the wren project (listening support)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psychosocial distress",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "provision of a safe space for emotional expression and support",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 124,
        "duration": "8-12 weeks",
        "population": "people with lupus",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trial.",
        "journal": "Rheumatology international",
        "publication_date": "2025-09-24",
        "pubmed_id": "40991063",
        "doi": "10.1007/s00296-025-05959-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:36:28"
    },
    {
      "id": 1499,
      "intervention": {
        "name": "online Pilates classes",
        "canonical_name": "pilates",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pilates",
          "layer_2_variant": "online pilates classes",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "physical and mental health decline",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improvement of physical function and mental well-being through exercise",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 124,
        "duration": "8-12 weeks",
        "population": "people with lupus",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trial.",
        "journal": "Rheumatology international",
        "publication_date": "2025-09-24",
        "pubmed_id": "40991063",
        "doi": "10.1007/s00296-025-05959-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:36:28"
    },
    {
      "id": 1500,
      "intervention": {
        "name": "text message and video support programme",
        "canonical_name": "text message and video support programme",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "text message and video support programme",
          "layer_2_variant": "text message and video support programme",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psychosocial distress",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "provision of tailored psychosocial support through digital communication",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 124,
        "duration": "8-12 weeks",
        "population": "people with lupus",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trial.",
        "journal": "Rheumatology international",
        "publication_date": "2025-09-24",
        "pubmed_id": "40991063",
        "doi": "10.1007/s00296-025-05959-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:36:28"
    },
    {
      "id": 1497,
      "intervention": {
        "name": "self-compassion based writing",
        "canonical_name": "self-compassion based writing",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "self-compassion based writing",
          "layer_2_variant": "self-compassion based writing",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "body image disturbance",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "psychological restructuring and improved self-perception",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 86,
        "duration": "2022-2023",
        "population": "women with systemic lupus erythematosus",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of writing based on self-compassion on body image and psychological distress among women with systemic lupus erythematosus: a randomized clinical trial.",
        "journal": "BMC rheumatology",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993830",
        "doi": "10.1186/s41927-025-00565-0"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:34:15"
    },
    {
      "id": 1496,
      "intervention": {
        "name": "restrictive fluid strategy with early de-escalation",
        "canonical_name": "restrictive fluid strategy",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "restrictive fluid strategy",
          "layer_2_variant": "restrictive fluid strategy with early de-escalation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "circulatory shock",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "limiting fluid intake and using diuretics or mechanical fluid removal to reduce fluid accumulation",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "feasibility randomized controlled trial",
        "sample_size": 100,
        "duration": "up to 7 days",
        "population": "patients with shock who required fluid resuscitation and were admitted in the medical intensive care unit",
        "adverse_effects": "no significant differences in acute kidney injury or renal replacement therapy",
        "cost_category": null
      },
      "paper": {
        "title": "Restrictive fluid management with early de-escalation versus usual care in critically ill patients (reduce trial): a feasibility randomized controlled trial.",
        "journal": "Critical care (London, England)",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999428",
        "doi": "10.1186/s13054-025-05624-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:32:42"
    },
    {
      "id": 1495,
      "intervention": {
        "name": "low-intensity focused ultrasound (LIFU)",
        "canonical_name": "low-intensity focused ultrasound",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "low-intensity focused ultrasound",
          "layer_2_variant": "low-intensity focused ultrasound (lifu)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "refractory depression",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of white matter tracts by operating mechanosensitive potassium channels in nodes of Ranvier",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cross-over, randomized, sham-controlled, double-blind study",
        "sample_size": 21,
        "duration": null,
        "population": "patients with Major Depressive Disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Reversible modulation of a deep white matter surgical target for depression with low-intensity focused ultrasound.",
        "journal": "Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999237",
        "doi": "10.1038/s41386-025-02252-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:31:07"
    },
    {
      "id": 1494,
      "intervention": {
        "name": "lymph node dissection based on 18F-PSMA PET/CT",
        "canonical_name": "lymph node dissection",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "lymph node dissection",
          "layer_2_variant": "lymph node dissection based on 18f-psma pet/ct",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lymph node metastasis",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "detection of lymph node metastasis using PSMA PET/CT imaging",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, randomized study",
        "sample_size": 120,
        "duration": "1 year (September 2022 to August 2023)",
        "population": "biopsy-confirmed prostate cancer patients with intermediate or high risk",
        "adverse_effects": "longer surgical times, hospital stays, and higher complication rates",
        "cost_category": null
      },
      "paper": {
        "title": "Lymph node dissection based on 18F-PSMA PET/CT during radical prostatectomy for intermediate and high risk prostate cancer: interim results of a prospective, randomized study.",
        "journal": "Prostate cancer and prostatic diseases",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999072",
        "doi": "10.1038/s41391-025-01029-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:29:33"
    },
    {
      "id": 1493,
      "intervention": {
        "name": "continuous care model-based program",
        "canonical_name": "continuous care model-based program",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "continuous care model-based program",
          "layer_2_variant": "continuous care model-based program",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "fatigue",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "education and empowerment through structured care stages",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 80,
        "duration": "nine weeks",
        "population": "patients with Parkinson's disease in Isfahan, Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of a continuous care model-based program on fatigue, self-efficacy, and quality of life in patients with Parkinson's disease: study protocol for a randomized controlled trial.",
        "journal": "Trials",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999495",
        "doi": "10.1186/s13063-025-09057-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:28:01"
    },
    {
      "id": 1492,
      "intervention": {
        "name": "androgen-receptor pathway inhibitors",
        "canonical_name": "androgen receptor pathway inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "androgen receptor pathway inhibitors",
          "layer_2_variant": "androgen-receptor pathway inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "metastatic hormone-sensitive prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of androgen-receptor signaling pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with metastatic hormone-sensitive prostate cancer",
        "adverse_effects": "hypertension and any grade cardiac adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Addition of androgen-receptor pathway inhibitors to standard of care in metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.",
        "journal": "Urologic oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41006128",
        "doi": "10.1016/j.urolonc.2025.08.017"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:26:32"
    },
    {
      "id": 1487,
      "intervention": {
        "name": "lubiprostone",
        "canonical_name": "lubiprostone",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "lubiprostone",
          "layer_2_variant": "lubiprostone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "activates chloride channels in the intestinal epithelium to increase fluid secretion",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:23:35"
    },
    {
      "id": 1488,
      "intervention": {
        "name": "plecanatide",
        "canonical_name": "plecanatide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "plecanatide",
          "layer_2_variant": "plecanatide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "activates guanylate cyclase-C receptors to increase intestinal fluid secretion",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:23:35"
    },
    {
      "id": 1489,
      "intervention": {
        "name": "tenapanor",
        "canonical_name": "tenapanor",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tenapanor",
          "layer_2_variant": "tenapanor",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibits sodium/hydrogen exchanger isoform 3 (NHE3) to reduce intestinal sodium absorption",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:23:35"
    },
    {
      "id": 1490,
      "intervention": {
        "name": "prucalopride",
        "canonical_name": "prucalopride",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "prucalopride",
          "layer_2_variant": "prucalopride",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "activates serotonin 5-hydroxytryptamine receptor 4 (5-HT4) to enhance gastrointestinal motility",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:23:35"
    },
    {
      "id": 1491,
      "intervention": {
        "name": "elobixibat",
        "canonical_name": "elobixibat",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "elobixibat",
          "layer_2_variant": "elobixibat",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibits bile acid reabsorption to increase intestinal motility and reduce constipation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:23:35"
    },
    {
      "id": 1486,
      "intervention": {
        "name": "linaclotide",
        "canonical_name": "linaclotide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "linaclotide",
          "layer_2_variant": "linaclotide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "stimulates intestinal secretion and increases bowel movement frequency",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:23:34"
    },
    {
      "id": 1485,
      "intervention": {
        "name": "Cognitive behavioral therapy for insomnia",
        "canonical_name": "cognitive behavioral therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive behavioral therapy",
          "layer_2_variant": "cognitive behavioral therapy for insomnia",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "insomnia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved sleep continuity and reduced arousal",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "waitlist control pilot trial",
        "sample_size": 26,
        "duration": "12 weeks",
        "population": "patients with insomnia and mild-to-moderate Crohn's disease symptoms",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cognitive Behavioral Therapy for Insomnia May Improve Sleep and Pain in Crohn's Disease: A Waitlist Control Pilot Trial.",
        "journal": "Inflammatory bowel diseases",
        "publication_date": "2025-09-25",
        "pubmed_id": "40997125",
        "doi": "10.1093/ibd/izaf210"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:21:06"
    },
    {
      "id": 1484,
      "intervention": {
        "name": "participant adherence monitoring",
        "canonical_name": "participant adherence monitoring",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "participant adherence monitoring",
          "layer_2_variant": "participant adherence monitoring",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriasis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improves trial outcome reliability by ensuring consistent treatment follow-up",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.5,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 1714,
        "duration": null,
        "population": "participants in psoriasis randomized clinical trials",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Participant heterogeneity of psoriasis interventional trials.",
        "journal": "Dermatology (Basel, Switzerland)",
        "publication_date": "2025-09-25",
        "pubmed_id": "40996934",
        "doi": "10.1159/000548168"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:19:41"
    },
    {
      "id": 1483,
      "intervention": {
        "name": "self-care education based on conceptual mapping",
        "canonical_name": "self-care education",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "self-care education",
          "layer_2_variant": "self-care education based on conceptual mapping",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pain severity in rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced understanding and application of self-care strategies through structured conceptual mapping",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "non-randomized quasi-experimental study",
        "sample_size": 70,
        "duration": "one month",
        "population": "patients with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Studying the effect of self-care education based on conceptual mapping on the pain severity of patients with rheumatoid arthritis: A non-randomized quasi-experimental study.",
        "journal": "BMC rheumatology",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999538",
        "doi": "10.1186/s41927-025-00553-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:18:20"
    },
    {
      "id": 1482,
      "intervention": {
        "name": "placebo solution",
        "canonical_name": "placebo",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "placebo",
          "layer_2_variant": "placebo solution",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "actinic keratosis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "no therapeutic effect",
      "correlation": {
        "type": "negative",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 631,
        "duration": "up to 6 months",
        "population": "patients with mild or moderate actinic keratosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCT.",
        "journal": "Journal of the European Academy of Dermatology and Venereology : JEADV",
        "publication_date": "2025-09-25",
        "pubmed_id": "40996107",
        "doi": "10.1111/jdv.70069"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:16:48"
    },
    {
      "id": 1480,
      "intervention": {
        "name": "KOH 5% solution",
        "canonical_name": "koh",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "koh",
          "layer_2_variant": "koh 5% solution",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "actinic keratosis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct keratolytic effect on abnormal cells",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 631,
        "duration": "up to 6 months",
        "population": "patients with mild or moderate actinic keratosis",
        "adverse_effects": "mild and localized",
        "cost_category": null
      },
      "paper": {
        "title": "KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCT.",
        "journal": "Journal of the European Academy of Dermatology and Venereology : JEADV",
        "publication_date": "2025-09-25",
        "pubmed_id": "40996107",
        "doi": "10.1111/jdv.70069"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:16:47"
    },
    {
      "id": 1481,
      "intervention": {
        "name": "diclofenac 3% gel",
        "canonical_name": "diclofenac",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "diclofenac",
          "layer_2_variant": "diclofenac 3% gel",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "actinic keratosis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "nonsteroidal anti-inflammatory action",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 631,
        "duration": "60 days",
        "population": "patients with mild or moderate actinic keratosis",
        "adverse_effects": "mild and localized",
        "cost_category": null
      },
      "paper": {
        "title": "KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCT.",
        "journal": "Journal of the European Academy of Dermatology and Venereology : JEADV",
        "publication_date": "2025-09-25",
        "pubmed_id": "40996107",
        "doi": "10.1111/jdv.70069"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:16:47"
    },
    {
      "id": 1476,
      "intervention": {
        "name": "all-trans retinoic acid (ATRA)",
        "canonical_name": "all-trans retinoic acid",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "all-trans retinoic acid",
          "layer_2_variant": "all-trans retinoic acid (atra)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute promyelocytic leukemia (APL)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induction of differentiation and apoptosis in leukemic cells",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk acute promyelocytic leukemia patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Curative strategies for high-risk acute promyelocytic leukemia.",
        "journal": "Current opinion in oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41029961",
        "doi": "10.1097/CCO.0000000000001171"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:14:31"
    },
    {
      "id": 1477,
      "intervention": {
        "name": "arsenic trioxide (ATO)",
        "canonical_name": "arsenic trioxide",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "arsenic trioxide",
          "layer_2_variant": "arsenic trioxide (ato)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute promyelocytic leukemia (APL)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induction of apoptosis and differentiation in leukemic cells",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk acute promyelocytic leukemia patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Curative strategies for high-risk acute promyelocytic leukemia.",
        "journal": "Current opinion in oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41029961",
        "doi": "10.1097/CCO.0000000000001171"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:14:31"
    },
    {
      "id": 1478,
      "intervention": {
        "name": "idarubicin (IDA)",
        "canonical_name": "idarubicin",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "idarubicin",
          "layer_2_variant": "idarubicin (ida)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute promyelocytic leukemia (APL)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induction of apoptosis and inhibition of DNA synthesis in leukemic cells",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk acute promyelocytic leukemia patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Curative strategies for high-risk acute promyelocytic leukemia.",
        "journal": "Current opinion in oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41029961",
        "doi": "10.1097/CCO.0000000000001171"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:14:31"
    },
    {
      "id": 1479,
      "intervention": {
        "name": "gemtuzumab ozogamicin (GO)",
        "canonical_name": "gemtuzumab ozogamicin",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "gemtuzumab ozogamicin",
          "layer_2_variant": "gemtuzumab ozogamicin (go)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute promyelocytic leukemia (APL)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted delivery of cytotoxic agents to leukemic cells via CD33 receptor",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "high-risk acute promyelocytic leukemia patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Curative strategies for high-risk acute promyelocytic leukemia.",
        "journal": "Current opinion in oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41029961",
        "doi": "10.1097/CCO.0000000000001171"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:14:31"
    },
    {
      "id": 1474,
      "intervention": {
        "name": "Postural Drainage Lithotripsy (PDLS) combined with Retrograde Intrarenal Ureteral Lithotripsy (RIRS)",
        "canonical_name": "lithotripsy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "lithotripsy",
          "layer_2_variant": "postural drainage lithotripsy (pdls) combined with retrograde intrarenal ureteral lithotripsy (rirs)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "residual kidney stones after RIRS",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced stone expulsion through postural drainage and lithotripsy",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective study",
        "sample_size": 136,
        "duration": "20 days",
        "population": "patients with residual fragments after RIRS surgery",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Clinical study of the postural drainage lithotripsy system for the treatment of residual fragments after retrograde intrarenal surgery.",
        "journal": "World journal of urology",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999120",
        "doi": "10.1007/s00345-025-05956-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:12:25"
    },
    {
      "id": 1475,
      "intervention": {
        "name": "Retrograde Intrarenal Ureteral Lithotripsy (RIRS)",
        "canonical_name": "ureteral lithotripsy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ureteral lithotripsy",
          "layer_2_variant": "retrograde intrarenal ureteral lithotripsy (rirs)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "residual kidney stones after RIRS",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "stone fragmentation using endoscopic lithotripsy",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective study",
        "sample_size": 136,
        "duration": "20 days",
        "population": "patients with residual fragments after RIRS surgery",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Clinical study of the postural drainage lithotripsy system for the treatment of residual fragments after retrograde intrarenal surgery.",
        "journal": "World journal of urology",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999120",
        "doi": "10.1007/s00345-025-05956-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:12:25"
    },
    {
      "id": 1471,
      "intervention": {
        "name": "percutaneous nephrolithotomy",
        "canonical_name": "percutaneous nephrolithotomy",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "percutaneous nephrolithotomy",
          "layer_2_variant": "percutaneous nephrolithotomy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urolithiasis",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct stone removal through minimally invasive surgical access",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with chronic kidney disease undergoing surgical interventions for urolithiasis",
        "adverse_effects": "bleeding, infection, acute kidney injury",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, feasibility, and efficacy of surgical intervention for Urolithiasis in patients with chronic kidney disease: A systematic review.",
        "journal": "World journal of nephrology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41024960",
        "doi": "10.5527/wjn.v14.i3.105288"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:10:30"
    },
    {
      "id": 1472,
      "intervention": {
        "name": "ureteroscopy",
        "canonical_name": "ureteroscopy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ureteroscopy",
          "layer_2_variant": "ureteroscopy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urolithiasis",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "endoscopic removal of stones from the ureter",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with chronic kidney disease undergoing surgical interventions for urolithiasis",
        "adverse_effects": "bleeding, infection, acute kidney injury",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, feasibility, and efficacy of surgical intervention for Urolithiasis in patients with chronic kidney disease: A systematic review.",
        "journal": "World journal of nephrology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41024960",
        "doi": "10.5527/wjn.v14.i3.105288"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:10:30"
    },
    {
      "id": 1473,
      "intervention": {
        "name": "extracorporeal shock wave lithotripsy",
        "canonical_name": "extracorporeal shock wave lithotripsy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "extracorporeal shock wave lithotripsy",
          "layer_2_variant": "extracorporeal shock wave lithotripsy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "urolithiasis",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "fragmentation of kidney stones using shock waves",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with chronic kidney disease undergoing surgical interventions for urolithiasis",
        "adverse_effects": "bleeding, infection, acute kidney injury",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, feasibility, and efficacy of surgical intervention for Urolithiasis in patients with chronic kidney disease: A systematic review.",
        "journal": "World journal of nephrology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41024960",
        "doi": "10.5527/wjn.v14.i3.105288"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:10:30"
    },
    {
      "id": 1470,
      "intervention": {
        "name": "Chinese Herbal Medicine (CHM)",
        "canonical_name": "chinese herbal medicine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "chinese herbal medicine",
          "layer_2_variant": "chinese herbal medicine (chm)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "generalised anxiety disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced anxiety symptoms through natural pharmacological effects",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 92,
        "duration": null,
        "population": "participants with generalised anxiety disorder",
        "adverse_effects": "fewer adverse events compared to anxiolytic medication",
        "cost_category": null
      },
      "paper": {
        "title": "Chinese herbal medicine for anxiety disorders and obsessive-compulsive disorder: A systematic review with meta-analysis.",
        "journal": "Journal of psychiatric research",
        "publication_date": "2025-09-26",
        "pubmed_id": "41045767",
        "doi": "10.1016/j.jpsychires.2025.09.045"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:08:15"
    },
    {
      "id": 1469,
      "intervention": {
        "name": "tezepelumab",
        "canonical_name": "tezepelumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tezepelumab",
          "layer_2_variant": "tezepelumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "TSLP blockade, reducing inflammation and improving airflow limitation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": 30,
        "duration": "6 months",
        "population": "patients with severe asthma diagnosed per ERS and GINA 2024 guidelines and inadequate control despite maximal inhaled therapy",
        "adverse_effects": "no serious adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of tezepelumab in severe asthma: A multicenter real-world study.",
        "journal": "European journal of internal medicine",
        "publication_date": "2025-09-26",
        "pubmed_id": "41015715",
        "doi": "10.1016/j.ejim.2025.106528"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:06:48"
    },
    {
      "id": 1468,
      "intervention": {
        "name": "AKI care bundle",
        "canonical_name": "aki care bundle",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "aki care bundle",
          "layer_2_variant": "aki care bundle",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute kidney injury",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved clinical management and early intervention",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 30152,
        "duration": null,
        "population": "hospitalized patients with acute kidney injury",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of acute kidney injury care bundles on patient prognosis: a systematic review and meta-analysis.",
        "journal": "BMC nephrology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013306",
        "doi": "10.1186/s12882-025-04349-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:03:26"
    },
    {
      "id": 1466,
      "intervention": {
        "name": "fractional flow reserve guided percutaneous coronary intervention",
        "canonical_name": "percutaneous coronary intervention",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "percutaneous coronary intervention",
          "layer_2_variant": "fractional flow reserve guided percutaneous coronary intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "multivessel coronary artery disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "selective treatment of artery blockages based on fractional flow reserve measurements",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with multivessel coronary artery disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Fractional flow reserve guided percutaneous coronary intervention",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024968",
        "doi": "10.4330/wjc.v17.i9.111044"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:01:59"
    },
    {
      "id": 1467,
      "intervention": {
        "name": "coronary artery bypass grafting",
        "canonical_name": "coronary artery bypass grafting",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "coronary artery bypass grafting",
          "layer_2_variant": "coronary artery bypass grafting",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "multivessel coronary artery disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "surgical bypass of blocked coronary arteries",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with multivessel coronary artery disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Fractional flow reserve guided percutaneous coronary intervention",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024968",
        "doi": "10.4330/wjc.v17.i9.111044"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:01:59"
    },
    {
      "id": 1463,
      "intervention": {
        "name": "Deprescribing model",
        "canonical_name": "deprescribing",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "deprescribing",
          "layer_2_variant": "deprescribing model",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "injurious falls",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "medication optimization through deprescribing to reduce fall risk",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster crossover randomized controlled trial",
        "sample_size": 3780,
        "duration": "6-month periods",
        "population": "patients with recent fractures admitted to skilled nursing facilities for post-acute care",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "PReventing Injury in Skilled nursing facilities through optimizing Medications (PRISM), a protocol for a cluster randomized trial to reduce injurious falls in post-acute care.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013714",
        "doi": "10.1186/s13063-025-09122-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:00:14"
    },
    {
      "id": 1464,
      "intervention": {
        "name": "Bone Health model",
        "canonical_name": "bone health",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bone health",
          "layer_2_variant": "bone health model",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "injurious falls",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improving bone health through targeted medication management to reduce fall risk",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster crossover randomized controlled trial",
        "sample_size": 3780,
        "duration": "6-month periods",
        "population": "patients with recent fractures admitted to skilled nursing facilities for post-acute care",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "PReventing Injury in Skilled nursing facilities through optimizing Medications (PRISM), a protocol for a cluster randomized trial to reduce injurious falls in post-acute care.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013714",
        "doi": "10.1186/s13063-025-09122-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:00:14"
    },
    {
      "id": 1465,
      "intervention": {
        "name": "Injury Prevention model (combined model)",
        "canonical_name": "injury prevention model",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "injury prevention model",
          "layer_2_variant": "injury prevention model (combined model)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "injurious falls",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "combined deprescribing and bone health strategies to optimize medication and reduce fall risk",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster crossover randomized controlled trial",
        "sample_size": 3780,
        "duration": "6-month periods",
        "population": "patients with recent fractures admitted to skilled nursing facilities for post-acute care",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "PReventing Injury in Skilled nursing facilities through optimizing Medications (PRISM), a protocol for a cluster randomized trial to reduce injurious falls in post-acute care.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013714",
        "doi": "10.1186/s13063-025-09122-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 03:00:14"
    },
    {
      "id": 1459,
      "intervention": {
        "name": "coronary computed tomography angiography",
        "canonical_name": "computed tomography angiography",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "computed tomography angiography",
          "layer_2_variant": "coronary computed tomography angiography",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "stable angina pectoris",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct visualization of coronary artery stenoses and plaque burden",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 5551,
        "duration": null,
        "population": "adult patients (≥ 18 years) with stable angina or low-risk chest pain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Coronary computed tomography angiography",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024970",
        "doi": "10.4330/wjc.v17.i9.110061"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:57:58"
    },
    {
      "id": 1460,
      "intervention": {
        "name": "exercise electrocardiography",
        "canonical_name": "exercise electrocardiography",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise electrocardiography",
          "layer_2_variant": "exercise electrocardiography",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "stable angina pectoris",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "assessment of cardiac response during physical exertion",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 5551,
        "duration": null,
        "population": "adult patients (≥ 18 years) with stable angina or low-risk chest pain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Coronary computed tomography angiography",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024970",
        "doi": "10.4330/wjc.v17.i9.110061"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:57:58"
    },
    {
      "id": 1461,
      "intervention": {
        "name": "myocardial perfusion imaging",
        "canonical_name": "myocardial perfusion imaging",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "myocardial perfusion imaging",
          "layer_2_variant": "myocardial perfusion imaging",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "stable angina pectoris",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "evaluation of myocardial blood flow during stress",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 5551,
        "duration": null,
        "population": "adult patients (≥ 18 years) with stable angina or low-risk chest pain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Coronary computed tomography angiography",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024970",
        "doi": "10.4330/wjc.v17.i9.110061"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:57:58"
    },
    {
      "id": 1462,
      "intervention": {
        "name": "stress echocardiography",
        "canonical_name": "stress echocardiography",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "stress echocardiography",
          "layer_2_variant": "stress echocardiography",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "stable angina pectoris",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "assessment of left ventricular function during stress",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 5551,
        "duration": null,
        "population": "adult patients (≥ 18 years) with stable angina or low-risk chest pain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Coronary computed tomography angiography",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024970",
        "doi": "10.4330/wjc.v17.i9.110061"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:57:58"
    },
    {
      "id": 1457,
      "intervention": {
        "name": "dexamethasone",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "corticosteroids",
          "layer_2_variant": "dexamethasone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe influenza infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immunomodulation and reduction of inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 243,
        "duration": "7 days",
        "population": "adult patients (over 18 years of age) hospitalised with severe influenza",
        "adverse_effects": "serious adverse effects",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of dexamethasone compared to placebo in patients with severe influenza infection. (FLUDEX study): a study protocol for a randomised controlled trial in Spain.",
        "journal": "BMJ open",
        "publication_date": "2025-09-26",
        "pubmed_id": "41005772",
        "doi": "10.1136/bmjopen-2025-103119"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:55:22"
    },
    {
      "id": 1458,
      "intervention": {
        "name": "oseltamivir",
        "canonical_name": "oseltamivir",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "oseltamivir",
          "layer_2_variant": "oseltamivir",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe influenza infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of viral replication",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 243,
        "duration": "5 days",
        "population": "adult patients (over 18 years of age) hospitalised with severe influenza",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of dexamethasone compared to placebo in patients with severe influenza infection. (FLUDEX study): a study protocol for a randomised controlled trial in Spain.",
        "journal": "BMJ open",
        "publication_date": "2025-09-26",
        "pubmed_id": "41005772",
        "doi": "10.1136/bmjopen-2025-103119"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:55:22"
    },
    {
      "id": 1455,
      "intervention": {
        "name": "continuous infusion of β-lactam antibiotics",
        "canonical_name": "beta-lactam antibiotics",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "intravenous",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "beta-lactam antibiotics",
          "layer_2_variant": "continuous infusion of β-lactam antibiotics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "sustained antibiotic concentration in bloodstream",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 9166,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": "no significant differences in adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Continuous versus intermittent infusion of β-lactams in patients with sepsis and septic shock: a systematic review and meta-analysis.",
        "journal": "BMC infectious diseases",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013406",
        "doi": "10.1186/s12879-025-11504-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:53:20"
    },
    {
      "id": 1456,
      "intervention": {
        "name": "intermittent infusion of β-lactam antibiotics",
        "canonical_name": "beta-lactam antibiotics",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "intravenous",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "beta-lactam antibiotics",
          "layer_2_variant": "intermittent infusion of β-lactam antibiotics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "periodic antibiotic concentration in bloodstream",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 9166,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Continuous versus intermittent infusion of β-lactams in patients with sepsis and septic shock: a systematic review and meta-analysis.",
        "journal": "BMC infectious diseases",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013406",
        "doi": "10.1186/s12879-025-11504-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:53:20"
    },
    {
      "id": 1454,
      "intervention": {
        "name": "assertive community treatment (ACT)",
        "canonical_name": "assertive community treatment",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "assertive community treatment",
          "layer_2_variant": "assertive community treatment (act)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe mental illness",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced community support and continuous care coordination",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "7 years",
        "population": "individuals with severe mental disorders",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Long-term outcomes of assertive community treatment in Japan: 7-year follow-up of a randomized controlled trial.",
        "journal": "BMC psychiatry",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013335",
        "doi": "10.1186/s12888-025-07311-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:51:28"
    },
    {
      "id": 1453,
      "intervention": {
        "name": "bundled intervention",
        "canonical_name": "bundled intervention",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bundled intervention",
          "layer_2_variant": "bundled intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tuberculosis transmission in household contacts",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced respiratory exposure through education, mask use, ventilation, and patient separation",
      "correlation": {
        "type": "neutral",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "cluster-randomized controlled trial",
        "sample_size": 384,
        "duration": "12 weeks",
        "population": "household contacts of newly diagnosed pulmonary tuberculosis patients in Santiago, Chile",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial.",
        "journal": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
        "publication_date": "2025-09-26",
        "pubmed_id": "41003685",
        "doi": "10.1093/cid/ciaf526"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:49:58"
    },
    {
      "id": 1452,
      "intervention": {
        "name": "gut microbiota-targeted therapy",
        "canonical_name": "gut microbiota-targeted therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "gut microbiota-targeted therapy",
          "layer_2_variant": "gut microbiota-targeted therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriasis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 409,
        "duration": null,
        "population": "patients with psoriasis",
        "adverse_effects": "no significant differences observed",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of gut microbiota-targeted therapy in patients with psoriasis: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "BMC immunology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013260",
        "doi": "10.1186/s12865-025-00747-y"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:48:30"
    },
    {
      "id": 1451,
      "intervention": {
        "name": "multimodal interventions",
        "canonical_name": "multimodal interventions",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "multimodal interventions",
          "layer_2_variant": "multimodal interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic pain",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "incorporation of psychological outcomes alongside pharmacological approaches",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Global trends and hotspots of randomized controlled trials in chronic pain therapy (1989-2024): A 35-year bibliometric analysis.",
        "journal": "Medicine",
        "publication_date": "2025-09-26",
        "pubmed_id": "41029136",
        "doi": "10.1097/MD.0000000000043936"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:46:59"
    },
    {
      "id": 1450,
      "intervention": {
        "name": "prucalopride",
        "canonical_name": "prucalopride",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "prucalopride",
          "layer_2_variant": "prucalopride",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "activation of 5-HT4 receptors to enhance gastrointestinal motility",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 57,
        "duration": "8 weeks",
        "population": "Parkinson's disease patients with chronic constipation",
        "adverse_effects": "no serious adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "Role of Prucalopride in the Treatment of Chronic Constipation in Parkinson's Disease: A Randomized Controlled Trial.",
        "journal": "The American journal of gastroenterology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41002195",
        "doi": "10.14309/ajg.0000000000003771"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:45:39"
    },
    {
      "id": 1448,
      "intervention": {
        "name": "guided transdiagnostic iCBT",
        "canonical_name": "internet based cognitive behavioral therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "internet based cognitive behavioral therapy",
          "layer_2_variant": "guided transdiagnostic icbt",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "depression and anxiety",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "structured cognitive-behavioral techniques delivered online with practitioner support",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 720,
        "duration": "3 months",
        "population": "UK university students aged over 16 with elevated symptoms of depression and/or anxiety",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomized controlled trial of Internet-delivered guided and unguided cognitive behaviour therapy for treating depression and anxiety in UK university students: study protocol for the Nurture-U Internet CBT trial.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013730",
        "doi": "10.1186/s13063-025-09023-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:44:12"
    },
    {
      "id": 1449,
      "intervention": {
        "name": "unguided transdiagnostic iCBT",
        "canonical_name": "internet-based cognitive behavioral therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "internet-based cognitive behavioral therapy",
          "layer_2_variant": "unguided transdiagnostic icbt",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "depression and anxiety",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "structured cognitive-behavioral techniques delivered online without practitioner support",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 720,
        "duration": "3 months",
        "population": "UK university students aged over 16 with elevated symptoms of depression and/or anxiety",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomized controlled trial of Internet-delivered guided and unguided cognitive behaviour therapy for treating depression and anxiety in UK university students: study protocol for the Nurture-U Internet CBT trial.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013730",
        "doi": "10.1186/s13063-025-09023-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:44:12"
    },
    {
      "id": 1445,
      "intervention": {
        "name": "continuous hypoxia",
        "canonical_name": "hypoxia",
        "category": "emerging",
        "details": "{}",
        "delivery_method": "inhalation",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "hypoxia",
          "layer_2_variant": "continuous hypoxia",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induction of erythropoietin and neurotrophic factors",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled multiple N-of-1 trials",
        "sample_size": 20,
        "duration": "multiple N-of-1 trials",
        "population": "individuals with Parkinson's disease (mean age 62, 10 women, Hoehn-Yahr 1.5-3)",
        "adverse_effects": "95 adverse events occurred, including one moderate and three serious events",
        "cost_category": null
      },
      "paper": {
        "title": "Hypoxic conditioning in Parkinson's disease: randomized controlled multiple N-of-1 trials.",
        "journal": "Nature communications",
        "publication_date": "2025-09-26",
        "pubmed_id": "41006236",
        "doi": "10.1038/s41467-025-63324-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:42:18"
    },
    {
      "id": 1446,
      "intervention": {
        "name": "intermittent hypoxia",
        "canonical_name": "intermittent hypoxia",
        "category": "emerging",
        "details": "{}",
        "delivery_method": "inhalation",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "intermittent hypoxia",
          "layer_2_variant": "intermittent hypoxia",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induction of erythropoietin and neurotrophic factors",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled multiple N-of-1 trials",
        "sample_size": 20,
        "duration": "multiple N-of-1 trials",
        "population": "individuals with Parkinson's disease (mean age 62, 10 women, Hoehn-Yahr 1.5-3)",
        "adverse_effects": "95 adverse events occurred, including one moderate and three serious events",
        "cost_category": null
      },
      "paper": {
        "title": "Hypoxic conditioning in Parkinson's disease: randomized controlled multiple N-of-1 trials.",
        "journal": "Nature communications",
        "publication_date": "2025-09-26",
        "pubmed_id": "41006236",
        "doi": "10.1038/s41467-025-63324-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:42:18"
    },
    {
      "id": 1447,
      "intervention": {
        "name": "placebo",
        "canonical_name": "placebo",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "placebo",
          "layer_2_variant": "placebo",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "no intervention",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled multiple N-of-1 trials",
        "sample_size": 20,
        "duration": "multiple N-of-1 trials",
        "population": "individuals with Parkinson's disease (mean age 62, 10 women, Hoehn-Yahr 1.5-3)",
        "adverse_effects": "95 adverse events occurred, including one moderate and three serious events",
        "cost_category": null
      },
      "paper": {
        "title": "Hypoxic conditioning in Parkinson's disease: randomized controlled multiple N-of-1 trials.",
        "journal": "Nature communications",
        "publication_date": "2025-09-26",
        "pubmed_id": "41006236",
        "doi": "10.1038/s41467-025-63324-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:42:18"
    },
    {
      "id": 1443,
      "intervention": {
        "name": "fibrate therapy",
        "canonical_name": "fibrates",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fibrates",
          "layer_2_variant": "fibrate therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetic retinopathy",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "lipid-lowering effects that modify DR progression",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 17,
        "duration": null,
        "population": "patients with diabetes",
        "adverse_effects": "no significant difference in serious adverse events or all-cause mortality",
        "cost_category": null
      },
      "paper": {
        "title": "Can fibrate therapy redefine the management of diabetic retinopathy? A comprehensive systematic review and meta-analysis of efficacy and safety.",
        "journal": "Journal of diabetes and its complications",
        "publication_date": "2025-09-27",
        "pubmed_id": "41038126",
        "doi": "10.1016/j.jdiacomp.2025.109178"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:39:45"
    },
    {
      "id": 1444,
      "intervention": {
        "name": "fibrate therapy combined with statin",
        "canonical_name": "fibrate therapy combined with statin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fibrate therapy combined with statin",
          "layer_2_variant": "fibrate therapy combined with statin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetic retinopathy",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "synergistic lipid-lowering effects that further reduce DR progression",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 17,
        "duration": null,
        "population": "patients with diabetes",
        "adverse_effects": "no significant difference in serious adverse events or all-cause mortality",
        "cost_category": null
      },
      "paper": {
        "title": "Can fibrate therapy redefine the management of diabetic retinopathy? A comprehensive systematic review and meta-analysis of efficacy and safety.",
        "journal": "Journal of diabetes and its complications",
        "publication_date": "2025-09-27",
        "pubmed_id": "41038126",
        "doi": "10.1016/j.jdiacomp.2025.109178"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:39:45"
    },
    {
      "id": 1441,
      "intervention": {
        "name": "Orem's self-care model nursing",
        "canonical_name": "nursing",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nursing",
          "layer_2_variant": "orem's self-care model nursing",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postoperative recovery in colorectal cancer patients",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced self-care ability and improved quality of life through structured nursing support",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 84,
        "duration": null,
        "population": "postoperative colorectal cancer patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Orem's self-care model nursing combined with nutritional intervention in postoperative patients with colorectal cancer.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-09-27",
        "pubmed_id": "41014371",
        "doi": "10.1007/s00520-025-09944-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:37:50"
    },
    {
      "id": 1442,
      "intervention": {
        "name": "nutritional intervention",
        "canonical_name": "nutritional intervention",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nutritional intervention",
          "layer_2_variant": "nutritional intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postoperative recovery in colorectal cancer patients",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved nutritional status and enhanced recovery through dietary support",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 84,
        "duration": null,
        "population": "postoperative colorectal cancer patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Orem's self-care model nursing combined with nutritional intervention in postoperative patients with colorectal cancer.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-09-27",
        "pubmed_id": "41014371",
        "doi": "10.1007/s00520-025-09944-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:37:50"
    },
    {
      "id": 1439,
      "intervention": {
        "name": "whole blood transfusion",
        "canonical_name": "whole blood transfusion",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "whole blood transfusion",
          "layer_2_variant": "whole blood transfusion",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "traumatic injuries",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "replenishment of blood volume and stabilization of patients",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "meta-analysis",
        "sample_size": 59213,
        "duration": null,
        "population": "individuals suffering from traumatic injuries",
        "adverse_effects": "no significant differences in ARDS, AKI, sepsis, hospital stay, ICU stay, or ventilator days",
        "cost_category": null
      },
      "paper": {
        "title": "Evaluating the safety outcomes of whole blood versus component transfusion in trauma: A meta-analysis of 59,213 patients.",
        "journal": "Thrombosis research",
        "publication_date": "2025-09-27",
        "pubmed_id": "41027124",
        "doi": "10.1016/j.thromres.2025.109495"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:36:01"
    },
    {
      "id": 1440,
      "intervention": {
        "name": "component therapy",
        "canonical_name": "component therapy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "component therapy",
          "layer_2_variant": "component therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "traumatic injuries",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "administration of individual blood components to stabilize patients",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "meta-analysis",
        "sample_size": 59213,
        "duration": null,
        "population": "individuals suffering from traumatic injuries",
        "adverse_effects": "no significant differences in ARDS, AKI, sepsis, hospital stay, ICU stay, or ventilator days",
        "cost_category": null
      },
      "paper": {
        "title": "Evaluating the safety outcomes of whole blood versus component transfusion in trauma: A meta-analysis of 59,213 patients.",
        "journal": "Thrombosis research",
        "publication_date": "2025-09-27",
        "pubmed_id": "41027124",
        "doi": "10.1016/j.thromres.2025.109495"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:36:01"
    },
    {
      "id": 1438,
      "intervention": {
        "name": "human umbilical cord-derived mesenchymal stem cells infusion",
        "canonical_name": "mesenchymal stem cells",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mesenchymal stem cells",
          "layer_2_variant": "human umbilical cord-derived mesenchymal stem cells infusion",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "decompensated liver cirrhosis",
        "canonical_name": null,
        "category": "other",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improvement of liver function and modulation of immune response",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "clinical trial",
        "sample_size": 24,
        "duration": "24 weeks",
        "population": "patients with hepatitis B virus-associated decompensated liver cirrhosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial.",
        "journal": "World journal of gastrointestinal surgery",
        "publication_date": "2025-09-27",
        "pubmed_id": "41024792",
        "doi": "10.4240/wjgs.v17.i9.109980"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:34:07"
    },
    {
      "id": 1436,
      "intervention": {
        "name": "therapist-guided home-based cognitive stimulation via virtual reality rehabilitation system",
        "canonical_name": "cognitive stimulation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive stimulation",
          "layer_2_variant": "therapist-guided home-based cognitive stimulation via virtual reality rehabilitation system",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild cognitive impairment in Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeting memory, attention, executive functions, language, and visuospatial skills through structured cognitive exercises",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 45,
        "duration": "6 months",
        "population": "individuals with Parkinson's disease and mild cognitive impairment",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cognitive stimulation in Parkinson's disease with mild cognitive impairment.",
        "journal": "Journal of neurology",
        "publication_date": "2025-09-27",
        "pubmed_id": "41015632",
        "doi": "10.1007/s00415-025-13374-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:32:37"
    },
    {
      "id": 1437,
      "intervention": {
        "name": "conventional in-person cognitive stimulation",
        "canonical_name": "cognitive stimulation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive stimulation",
          "layer_2_variant": "conventional in-person cognitive stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild cognitive impairment in Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeting memory, attention, executive functions, language, and visuospatial skills through structured cognitive exercises",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 45,
        "duration": "6 months",
        "population": "individuals with Parkinson's disease and mild cognitive impairment",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cognitive stimulation in Parkinson's disease with mild cognitive impairment.",
        "journal": "Journal of neurology",
        "publication_date": "2025-09-27",
        "pubmed_id": "41015632",
        "doi": "10.1007/s00415-025-13374-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:32:37"
    },
    {
      "id": 1434,
      "intervention": {
        "name": "ultrasound-guided continuous intertransverse process block",
        "canonical_name": "intertransverse process block",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "intertransverse process block",
          "layer_2_variant": "ultrasound-guided continuous intertransverse process block",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postoperative pain after uniportal video-assisted thoracoscopic surgery",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "local anesthetic diffusion near paravertebral space for pain relief",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "double-blind, prospective, randomised controlled trial",
        "sample_size": 96,
        "duration": "up to 48 hours post-intervention with follow-up at 3 months",
        "population": "patients undergoing single-port VATS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of ultrasound-guided continuous intertransverse process block and continuous erector spinae plane block for postoperative analgesia after uniportal video-assisted thoracoscopic surgery: protocol for a double-blind, prospective, randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-28",
        "pubmed_id": "41022450",
        "doi": "10.1136/bmjopen-2025-099082"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:30:41"
    },
    {
      "id": 1435,
      "intervention": {
        "name": "ultrasound-guided continuous erector spinae plane block",
        "canonical_name": "erector spinae plane block",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "erector spinae plane block",
          "layer_2_variant": "ultrasound-guided continuous erector spinae plane block",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postoperative pain after uniportal video-assisted thoracoscopic surgery",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "local anesthetic diffusion in erector spinae plane for pain relief",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "double-blind, prospective, randomised controlled trial",
        "sample_size": 96,
        "duration": "up to 48 hours post-intervention with follow-up at 3 months",
        "population": "patients undergoing single-port VATS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of ultrasound-guided continuous intertransverse process block and continuous erector spinae plane block for postoperative analgesia after uniportal video-assisted thoracoscopic surgery: protocol for a double-blind, prospective, randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-28",
        "pubmed_id": "41022450",
        "doi": "10.1136/bmjopen-2025-099082"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:30:41"
    },
    {
      "id": 1432,
      "intervention": {
        "name": "budesonide-formoterol",
        "canonical_name": "budesonide-formoterol",
        "category": "medication",
        "details": "{}",
        "delivery_method": "inhalation",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "budesonide-formoterol",
          "layer_2_variant": "budesonide-formoterol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and bronchodilation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 360,
        "duration": "52 weeks",
        "population": "children aged 5-15 years with mild asthma",
        "adverse_effects": "similar safety profile compared to salbutamol",
        "cost_category": null
      },
      "paper": {
        "title": "Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.",
        "journal": "Lancet (London, England)",
        "publication_date": "2025-09-28",
        "pubmed_id": "41033330",
        "doi": "10.1016/S0140-6736(25)00861-X"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:28:36"
    },
    {
      "id": 1433,
      "intervention": {
        "name": "salbutamol",
        "canonical_name": "beta agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": "inhalation",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "beta agonists",
          "layer_2_variant": "salbutamol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "bronchodilation",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 360,
        "duration": "52 weeks",
        "population": "children aged 5-15 years with mild asthma",
        "adverse_effects": "similar safety profile compared to budesonide-formoterol",
        "cost_category": null
      },
      "paper": {
        "title": "Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.",
        "journal": "Lancet (London, England)",
        "publication_date": "2025-09-28",
        "pubmed_id": "41033330",
        "doi": "10.1016/S0140-6736(25)00861-X"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:28:36"
    },
    {
      "id": 1431,
      "intervention": {
        "name": "energy therapies",
        "canonical_name": "energy therapies",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "energy therapies",
          "layer_2_variant": "energy therapies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic obstructive pulmonary disease",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved exercise capacity and reduced stress and anxiety",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "chronic obstructive pulmonary disease patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Unveiling the Healing Potential of Energy Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis With Implications for Nursing Practice.",
        "journal": "Holistic nursing practice",
        "publication_date": "2025-09-29",
        "pubmed_id": "41020360",
        "doi": "10.1097/HNP.0000000000000755"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:24:24"
    },
    {
      "id": 1429,
      "intervention": {
        "name": "asthma treatment guided by spirometry plus symptoms",
        "canonical_name": "asthma treatment",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "asthma treatment",
          "layer_2_variant": "asthma treatment guided by spirometry plus symptoms",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma attacks",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "objective monitoring of lung function to adjust treatment",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": null,
        "duration": "12 months",
        "population": "children aged 6-15 years with asthma and a history of exacerbation requiring corticosteroids in the previous 12 months",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Spirometry to manage asthma in children: study protocol for a randomised controlled trial (SPIROMAC).",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023717",
        "doi": "10.1186/s13063-025-09104-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:23:06"
    },
    {
      "id": 1430,
      "intervention": {
        "name": "asthma treatment guided by symptoms only",
        "canonical_name": "asthma treatment",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "asthma treatment",
          "layer_2_variant": "asthma treatment guided by symptoms only",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma attacks",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "subjective monitoring of symptoms to adjust treatment",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": null,
        "duration": "12 months",
        "population": "children aged 6-15 years with asthma and a history of exacerbation requiring corticosteroids in the previous 12 months",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Spirometry to manage asthma in children: study protocol for a randomised controlled trial (SPIROMAC).",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023717",
        "doi": "10.1186/s13063-025-09104-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:23:06"
    },
    {
      "id": 1428,
      "intervention": {
        "name": "interpersonal and social rhythm therapy",
        "canonical_name": "interpersonal and social rhythm therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "interpersonal and social rhythm therapy",
          "layer_2_variant": "interpersonal and social rhythm therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "suicidal ideation",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "stabilization of social rhythms and improvement of interpersonal functioning",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "post hoc analysis of randomized controlled trial",
        "sample_size": 92,
        "duration": "20 weeks",
        "population": "adults meeting DSM-IV criteria for bipolar II disorder, currently depressed",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Interpersonal and Social Rhythm Therapy on Suicidal Ideation in Adults With Bipolar II Depression.",
        "journal": "The Journal of clinical psychiatry",
        "publication_date": "2025-09-29",
        "pubmed_id": "41037752",
        "doi": "10.4088/JCP.24m15768"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:21:06"
    },
    {
      "id": 1424,
      "intervention": {
        "name": "multicomponent shared decision making intervention",
        "canonical_name": "shared decision making intervention",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "shared decision making intervention",
          "layer_2_variant": "multicomponent shared decision making intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis disease activity",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhancing patient-clinician communication and patient-centered decision-making",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "stepped-wedge, cluster-randomized trial",
        "sample_size": 400,
        "duration": null,
        "population": "veterans with rheumatoid arthritis at three U.S. Veterans Health Administration rheumatology clinics",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024266",
        "doi": "10.1186/s13063-025-09015-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:19:39"
    },
    {
      "id": 1425,
      "intervention": {
        "name": "rheumatology clinician training and pocket card on SDM",
        "canonical_name": "rheumatology clinician training and shared decision making",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rheumatology clinician training and shared decision making",
          "layer_2_variant": "rheumatology clinician training and pocket card on sdm",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis disease activity",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improving clinician knowledge and use of SDM techniques",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "stepped-wedge, cluster-randomized trial",
        "sample_size": 400,
        "duration": null,
        "population": "veterans with rheumatoid arthritis at three U.S. Veterans Health Administration rheumatology clinics",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024266",
        "doi": "10.1186/s13063-025-09015-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:19:39"
    },
    {
      "id": 1426,
      "intervention": {
        "name": "RA patient activation using AskShareKnow questions",
        "canonical_name": "patient activation",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "patient activation",
          "layer_2_variant": "ra patient activation using askshareknow questions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis disease activity",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increasing patient engagement and knowledge in treatment decisions",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "stepped-wedge, cluster-randomized trial",
        "sample_size": 400,
        "duration": null,
        "population": "veterans with rheumatoid arthritis at three U.S. Veterans Health Administration rheumatology clinics",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024266",
        "doi": "10.1186/s13063-025-09015-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:19:39"
    },
    {
      "id": 1427,
      "intervention": {
        "name": "point-of-care decision aid (RA Choice) and medication summary guide",
        "canonical_name": "point-of-care decision aid",
        "category": "test",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "point-of-care decision aid",
          "layer_2_variant": "point-of-care decision aid (ra choice) and medication summary guide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis disease activity",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "providing patients with structured information to support shared decision-making",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "stepped-wedge, cluster-randomized trial",
        "sample_size": 400,
        "duration": null,
        "population": "veterans with rheumatoid arthritis at three U.S. Veterans Health Administration rheumatology clinics",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024266",
        "doi": "10.1186/s13063-025-09015-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:19:39"
    },
    {
      "id": 1422,
      "intervention": {
        "name": "two-year fixed immune checkpoint inhibitor therapy",
        "canonical_name": "immune checkpoint inhibitor",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "immune checkpoint inhibitor",
          "layer_2_variant": "two-year fixed immune checkpoint inhibitor therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "advanced or metastatic non-small cell lung cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "discontinuation of therapy after 2 years to avoid prolonged exposure",
      "correlation": {
        "type": "neutral",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": 5027,
        "duration": "up to 5 years",
        "population": "adults with advanced or metastatic non-small cell lung cancer treated with immune checkpoint inhibitor therapy",
        "adverse_effects": "increased rates of immune-related adverse events over time",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of two-year fixed versus continuous immune checkpoint inhibitor therapy in advanced or metastatic non-small cell lung cancer: a systematic review.",
        "journal": "Cancer immunology, immunotherapy : CII",
        "publication_date": "2025-09-29",
        "pubmed_id": "41021040",
        "doi": "10.1007/s00262-025-04143-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:16:55"
    },
    {
      "id": 1423,
      "intervention": {
        "name": "continuous immune checkpoint inhibitor therapy",
        "canonical_name": "immune checkpoint inhibitor",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "immune checkpoint inhibitor",
          "layer_2_variant": "continuous immune checkpoint inhibitor therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "advanced or metastatic non-small cell lung cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "continued administration of therapy to maintain immune response",
      "correlation": {
        "type": "neutral",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": 5027,
        "duration": "up to 5 years",
        "population": "adults with advanced or metastatic non-small cell lung cancer treated with immune checkpoint inhibitor therapy",
        "adverse_effects": "increased rates of immune-related adverse events over time",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of two-year fixed versus continuous immune checkpoint inhibitor therapy in advanced or metastatic non-small cell lung cancer: a systematic review.",
        "journal": "Cancer immunology, immunotherapy : CII",
        "publication_date": "2025-09-29",
        "pubmed_id": "41021040",
        "doi": "10.1007/s00262-025-04143-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:16:55"
    },
    {
      "id": 1421,
      "intervention": {
        "name": "indole-3-acetic acid (IAA) supplementation",
        "canonical_name": "indole-3-acetic acid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "indole-3-acetic acid",
          "layer_2_variant": "indole-3-acetic acid (iaa) supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pneumonia",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "aggravates pulmonary damage via aryl hydrocarbon receptor activation and increased reactive oxygen species from neutrophils",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "mouse model experiment",
        "sample_size": 158,
        "duration": null,
        "population": "critically ill patients with severe community-acquired pneumonia and mice",
        "adverse_effects": "aggravates pulmonary damage",
        "cost_category": null
      },
      "paper": {
        "title": "Effect of the gut microbiota-derived tryptophan metabolite indole-3-acetic acid in pneumonia.",
        "journal": "Nature communications",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022731",
        "doi": "10.1038/s41467-025-63611-y"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:15:00"
    },
    {
      "id": 1419,
      "intervention": {
        "name": "NCX 701",
        "canonical_name": "ncx 701",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ncx 701",
          "layer_2_variant": "ncx 701",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "low-grade human endotoxemia",
        "canonical_name": null,
        "category": "infectious",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "nitric oxide release and reduced arterial blood pressure",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 40,
        "duration": null,
        "population": "40 healthy male volunteers",
        "adverse_effects": "61 adverse events reported, mainly related to lipopolysaccharide",
        "cost_category": null
      },
      "paper": {
        "title": "A randomized placebo-controlled trial in healthy volunteers examining the effects of acetaminophen and NO-acetaminophen NCX 701 in human endotoxemia.",
        "journal": "Scientific reports",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023080",
        "doi": "10.1038/s41598-025-19046-y"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:13:32"
    },
    {
      "id": 1420,
      "intervention": {
        "name": "acetaminophen",
        "canonical_name": "acetaminophen",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "acetaminophen",
          "layer_2_variant": "acetaminophen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "low-grade human endotoxemia",
        "canonical_name": null,
        "category": "infectious",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and endothelium activation markers",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 40,
        "duration": null,
        "population": "40 healthy male volunteers",
        "adverse_effects": "61 adverse events reported, mainly related to lipopolysaccharide",
        "cost_category": null
      },
      "paper": {
        "title": "A randomized placebo-controlled trial in healthy volunteers examining the effects of acetaminophen and NO-acetaminophen NCX 701 in human endotoxemia.",
        "journal": "Scientific reports",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023080",
        "doi": "10.1038/s41598-025-19046-y"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:13:32"
    },
    {
      "id": 1413,
      "intervention": {
        "name": "Cognitive Rehabilitation Nursing",
        "canonical_name": "cognitive rehabilitation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive rehabilitation",
          "layer_2_variant": "cognitive rehabilitation nursing",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Cognitive Impairment",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cognitive function through structured rehabilitation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with schizophrenia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Cognitive Rehabilitation Nursing on Cognitive Impairment in Patients With Schizophrenia: A Comprehensive Systematic Review and Meta-Analysis.",
        "journal": "Journal of cognitive psychotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022617",
        "doi": "10.1891/JCP-2025-0012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:11:17"
    },
    {
      "id": 1414,
      "intervention": {
        "name": "computerized cognitive rehabilitation",
        "canonical_name": "cognitive rehabilitation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive rehabilitation",
          "layer_2_variant": "computerized cognitive rehabilitation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Cognitive Impairment",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cognitive function through computerized training",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with schizophrenia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Cognitive Rehabilitation Nursing on Cognitive Impairment in Patients With Schizophrenia: A Comprehensive Systematic Review and Meta-Analysis.",
        "journal": "Journal of cognitive psychotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022617",
        "doi": "10.1891/JCP-2025-0012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:11:17"
    },
    {
      "id": 1415,
      "intervention": {
        "name": "individualized cognitive rehabilitation",
        "canonical_name": "cognitive rehabilitation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive rehabilitation",
          "layer_2_variant": "individualized cognitive rehabilitation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Cognitive Impairment",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cognitive function through personalized training",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with schizophrenia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Cognitive Rehabilitation Nursing on Cognitive Impairment in Patients With Schizophrenia: A Comprehensive Systematic Review and Meta-Analysis.",
        "journal": "Journal of cognitive psychotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022617",
        "doi": "10.1891/JCP-2025-0012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:11:17"
    },
    {
      "id": 1416,
      "intervention": {
        "name": "virtual reality-based cognitive rehabilitation",
        "canonical_name": "virtual reality-based cognitive rehabilitation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "virtual reality-based cognitive rehabilitation",
          "layer_2_variant": "virtual reality-based cognitive rehabilitation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Cognitive Impairment",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cognitive function through immersive virtual reality training",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with schizophrenia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Cognitive Rehabilitation Nursing on Cognitive Impairment in Patients With Schizophrenia: A Comprehensive Systematic Review and Meta-Analysis.",
        "journal": "Journal of cognitive psychotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022617",
        "doi": "10.1891/JCP-2025-0012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:11:17"
    },
    {
      "id": 1417,
      "intervention": {
        "name": "pharmacological intervention",
        "canonical_name": "pharmacological intervention",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pharmacological intervention",
          "layer_2_variant": "pharmacological intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Cognitive Impairment",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved cognitive function through pharmacological means",
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with schizophrenia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Cognitive Rehabilitation Nursing on Cognitive Impairment in Patients With Schizophrenia: A Comprehensive Systematic Review and Meta-Analysis.",
        "journal": "Journal of cognitive psychotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022617",
        "doi": "10.1891/JCP-2025-0012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:11:17"
    },
    {
      "id": 1418,
      "intervention": {
        "name": "game-based cognitive rehabilitation",
        "canonical_name": "cognitive rehabilitation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive rehabilitation",
          "layer_2_variant": "game-based cognitive rehabilitation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Cognitive Impairment",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cognitive function through gamified training",
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with schizophrenia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Cognitive Rehabilitation Nursing on Cognitive Impairment in Patients With Schizophrenia: A Comprehensive Systematic Review and Meta-Analysis.",
        "journal": "Journal of cognitive psychotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022617",
        "doi": "10.1891/JCP-2025-0012"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:11:17"
    },
    {
      "id": 1408,
      "intervention": {
        "name": "structured resilience training",
        "canonical_name": "resilience training",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "resilience training",
          "layer_2_variant": "structured resilience training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhances psychological resilience and coping strategies",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "20 weeks",
        "population": "people with rheumatoid arthritis within 12 months of onset",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:08:44"
    },
    {
      "id": 1409,
      "intervention": {
        "name": "exercise programme",
        "canonical_name": "exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise",
          "layer_2_variant": "exercise programme",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improves physical function and reduces joint inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "20 weeks",
        "population": "people with rheumatoid arthritis within 12 months of onset",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:08:44"
    },
    {
      "id": 1410,
      "intervention": {
        "name": "dietary education",
        "canonical_name": "dietary education",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "dietary education",
          "layer_2_variant": "dietary education",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "promotes healthy eating habits and reduces inflammatory diet components",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "20 weeks",
        "population": "people with rheumatoid arthritis within 12 months of onset",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:08:44"
    },
    {
      "id": 1411,
      "intervention": {
        "name": "smoking cessation programme",
        "canonical_name": "smoking cessation",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "smoking cessation",
          "layer_2_variant": "smoking cessation programme",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces systemic inflammation and improves disease outcomes",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "20 weeks",
        "population": "people with rheumatoid arthritis within 12 months of onset",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:08:44"
    },
    {
      "id": 1412,
      "intervention": {
        "name": "behaviour-change support",
        "canonical_name": "behaviour-change support",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "behaviour-change support",
          "layer_2_variant": "behaviour-change support",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "supports long-term adherence to healthy lifestyle changes",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "20 weeks",
        "population": "people with rheumatoid arthritis within 12 months of onset",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:08:44"
    },
    {
      "id": 1407,
      "intervention": {
        "name": "colonoscopic distal attachment",
        "canonical_name": "colonoscopic distal attachment",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "colonoscopic distal attachment",
          "layer_2_variant": "colonoscopic distal attachment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "polyp detection during colonoscopy",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced visualization and improved inspection of the colon",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective randomized controlled study",
        "sample_size": 264,
        "duration": null,
        "population": "patients undergoing routine colonoscopic examinations at Tongji Hospital endoscopy centers in China",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Application of colonoscopic auxiliary devices in reducing the polyp miss rate: a prospective randomized controlled study.",
        "journal": "BMC gastroenterology",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023652",
        "doi": "10.1186/s12876-025-04313-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:05:48"
    },
    {
      "id": 1406,
      "intervention": {
        "name": "slow movement training with tonic force generation and aerobic exercise",
        "canonical_name": "physical therapy",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "physical therapy",
          "layer_2_variant": "slow movement training with tonic force generation and aerobic exercise",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "functional performance decline in advanced lung cancer patients",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced lower-limb functional performance through targeted physical training",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective, single-center study",
        "sample_size": 17,
        "duration": "4 weeks",
        "population": "patients with suspected advanced lung cancer",
        "adverse_effects": "no adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "Combined effects of slow movement training with tonic force generation and aerobic exercise prior to cancer therapy in patients with lung cancer (START-lung): a pilot feasibility trial.",
        "journal": "BMC cancer",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023950",
        "doi": "10.1186/s12885-025-14728-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:04:20"
    },
    {
      "id": 1405,
      "intervention": {
        "name": "rivaroxaban",
        "canonical_name": "rivaroxaban",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rivaroxaban",
          "layer_2_variant": "rivaroxaban",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "stroke",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "anticoagulation to prevent thrombus formation",
      "correlation": {
        "type": "neutral",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": 2477,
        "duration": "median of 922 days",
        "population": "patients with acute myocardial infarction and new-onset atrial fibrillation receiving dual antiplatelet therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Association between rivaroxaban and the prognosis of patients with acute myocardial infarction and new-onset atrial fibrillation.",
        "journal": "Postgraduate medical journal",
        "publication_date": "2025-09-29",
        "pubmed_id": "41020767",
        "doi": "10.1093/postmj/qgaf163"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:02:48"
    },
    {
      "id": 1402,
      "intervention": {
        "name": "smart pillbox with customisable audio-visual reminders",
        "canonical_name": "smart pillbox",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "smart pillbox",
          "layer_2_variant": "smart pillbox with customisable audio-visual reminders",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "poor end-of-treatment outcomes and recurrence in drug-sensitive tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "real-time dose logging and differentiated response by healthcare workers",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster-randomised controlled trial",
        "sample_size": 3858,
        "duration": "12 months",
        "population": "adults aged 18 years or older with drug-sensitive pulmonary tuberculosis on a fixed-dose combination tuberculosis treatment regimen",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital adherence technology interventions to reduce poor end-of-treatment outcomes and recurrence among adults with drug-sensitive tuberculosis in Ethiopia: a three-arm, pragmatic, cluster-randomised, controlled trial.",
        "journal": "The Lancet. Digital health",
        "publication_date": "2025-09-29",
        "pubmed_id": "41027822",
        "doi": "10.1016/j.landig.2025.100895"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:01:13"
    },
    {
      "id": 1403,
      "intervention": {
        "name": "medication labels with weekly unique code",
        "canonical_name": "medication labels",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "medication labels",
          "layer_2_variant": "medication labels with weekly unique code",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "poor end-of-treatment outcomes and recurrence in drug-sensitive tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "real-time dose logging and differentiated response by healthcare workers",
      "correlation": {
        "type": "neutral",
        "strength": 0.25,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster-randomised controlled trial",
        "sample_size": 3858,
        "duration": "12 months",
        "population": "adults aged 18 years or older with drug-sensitive pulmonary tuberculosis on a fixed-dose combination tuberculosis treatment regimen",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital adherence technology interventions to reduce poor end-of-treatment outcomes and recurrence among adults with drug-sensitive tuberculosis in Ethiopia: a three-arm, pragmatic, cluster-randomised, controlled trial.",
        "journal": "The Lancet. Digital health",
        "publication_date": "2025-09-29",
        "pubmed_id": "41027822",
        "doi": "10.1016/j.landig.2025.100895"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:01:13"
    },
    {
      "id": 1404,
      "intervention": {
        "name": "standard of care",
        "canonical_name": "standard of care",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "standard of care",
          "layer_2_variant": "standard of care",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "poor end-of-treatment outcomes and recurrence in drug-sensitive tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "standard treatment regimen without additional adherence support",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster-randomised controlled trial",
        "sample_size": 3858,
        "duration": "12 months",
        "population": "adults aged 18 years or older with drug-sensitive pulmonary tuberculosis on a fixed-dose combination tuberculosis treatment regimen",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital adherence technology interventions to reduce poor end-of-treatment outcomes and recurrence among adults with drug-sensitive tuberculosis in Ethiopia: a three-arm, pragmatic, cluster-randomised, controlled trial.",
        "journal": "The Lancet. Digital health",
        "publication_date": "2025-09-29",
        "pubmed_id": "41027822",
        "doi": "10.1016/j.landig.2025.100895"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 02:01:13"
    },
    {
      "id": 1400,
      "intervention": {
        "name": "nemolizumab",
        "canonical_name": "nemolizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nemolizumab",
          "layer_2_variant": "nemolizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "prurigo nodularis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeting interleukin-31 receptor A to reduce pruritus",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "population pharmacokinetics and model-based meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with prurigo nodularis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Quantitative Evaluation of Nemolizumab Pharmacokinetics and Efficacy in Prurigo Nodularis: A Population Pharmacokinetics and Model-Based Meta-analysis Approach.",
        "journal": "Dermatology and therapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023527",
        "doi": "10.1007/s13555-025-01554-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:58:48"
    },
    {
      "id": 1401,
      "intervention": {
        "name": "dupilumab",
        "canonical_name": "dupilumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "dupilumab",
          "layer_2_variant": "dupilumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "prurigo nodularis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulating interleukin-4 and interleukin-13 signaling pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "model-based meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with prurigo nodularis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Quantitative Evaluation of Nemolizumab Pharmacokinetics and Efficacy in Prurigo Nodularis: A Population Pharmacokinetics and Model-Based Meta-analysis Approach.",
        "journal": "Dermatology and therapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023527",
        "doi": "10.1007/s13555-025-01554-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:58:48"
    },
    {
      "id": 1399,
      "intervention": {
        "name": "message-based mental health intervention",
        "canonical_name": "message-based mental health intervention",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "message-based mental health intervention",
          "layer_2_variant": "message-based mental health intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "serious mental illness",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced engagement through tailored linguistic and demographic features",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 39,
        "duration": null,
        "population": "individuals with serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, major depressive disorder)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Demographic, clinical, and linguistic features associated with engagement in message-based interventions for serious mental illness.",
        "journal": "Psychiatric rehabilitation journal",
        "publication_date": "2025-09-29",
        "pubmed_id": "41021485",
        "doi": "10.1037/prj0000667"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:57:02"
    },
    {
      "id": 1398,
      "intervention": {
        "name": "progressive muscle relaxation exercises",
        "canonical_name": "progressive muscle relaxation",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "progressive muscle relaxation",
          "layer_2_variant": "progressive muscle relaxation exercises",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anxiety before electroconvulsive therapy",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of physiological arousal and anxiety levels",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "quasi-experimental study",
        "sample_size": 30,
        "duration": "not explicitly stated",
        "population": "in-patients with bipolar disorder and depression receiving ECT for the first time",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Progressive muscle relaxation to reduce anxiety before electroconvulsive therapy (ECT).",
        "journal": "BMC nursing",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023665",
        "doi": "10.1186/s12912-025-03874-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:55:36"
    },
    {
      "id": 1397,
      "intervention": {
        "name": "PARP inhibitors",
        "canonical_name": "parp inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "parp inhibitors",
          "layer_2_variant": "parp inhibitors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "venous thromboembolic events",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased risk of thrombosis through unknown biological pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 15008,
        "duration": null,
        "population": "patients with solid tumors (prostate, breast, ovarian, pancreatic, glioblastoma, small-cell lung, non-small-cell lung, gastric cancers) treated with PARP inhibitors as monotherapy or in combination",
        "adverse_effects": "increased risk of venous thromboembolic events",
        "cost_category": null
      },
      "paper": {
        "title": "Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis.",
        "journal": "ESMO open",
        "publication_date": "2025-09-29",
        "pubmed_id": "41027069",
        "doi": "10.1016/j.esmoop.2025.105811"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:54:07"
    },
    {
      "id": 1396,
      "intervention": {
        "name": "preoperative immunonutrition with oral nutritional supplements",
        "canonical_name": "immunonutrition",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "immunonutrition",
          "layer_2_variant": "preoperative immunonutrition with oral nutritional supplements",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postoperative complications in malnourished patients undergoing colorectal cancer surgery",
        "canonical_name": null,
        "category": "nutritional",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced nutritional and immune response through arginine and ω-3 fatty acids",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "multicenter randomized clinical trial",
        "sample_size": 176,
        "duration": "30 days postoperatively",
        "population": "patients with primary colorectal cancer and Nutritional Risk Screening (NRS) 2002 score of 3-5",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of preoperative immunonutrition in malnourished patients undergoing colorectal cancer surgery: a study protocol for a multicenter randomized clinical trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024239",
        "doi": "10.1186/s13063-025-09082-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:52:30"
    },
    {
      "id": 1395,
      "intervention": {
        "name": "ureteral access sheath (UAS) use during RIRS",
        "canonical_name": "ureteral access sheath",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ureteral access sheath",
          "layer_2_variant": "ureteral access sheath (uas) use during rirs",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "renal stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "facilitates ureteroscopy access and stone removal",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "retrospective multicenter cohort study",
        "sample_size": 1177,
        "duration": null,
        "population": "patients undergoing RIRS for kidney stones at six academic medical centers",
        "adverse_effects": "increased perioperative morbidity, longer operative time, higher likelihood of postoperative stenting",
        "cost_category": null
      },
      "paper": {
        "title": "Does the use of a ureteral access sheath improve perioperative outcomes in ureteroscopy? A real-world multi-institutional study.",
        "journal": "Urolithiasis",
        "publication_date": "2025-09-29",
        "pubmed_id": "41021049",
        "doi": "10.1007/s00240-025-01865-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:50:54"
    },
    {
      "id": 1394,
      "intervention": {
        "name": "Tumor Treating Fields (TTFields) therapy",
        "canonical_name": "tumor treating fields",
        "category": "device",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tumor treating fields",
          "layer_2_variant": "tumor treating fields (ttfields) therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "brain metastases from non-small cell lung cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "disruption of cancer cell division through electric fields",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 3 randomized controlled trial",
        "sample_size": 298,
        "duration": "median of 8.6 months",
        "population": "adults with 1-10 newly-diagnosed NSCLC BM suitable for SRS receiving optimal therapy for extracranial disease",
        "adverse_effects": "device-related AEs were mainly grade ≤2 skin events",
        "cost_category": null
      },
      "paper": {
        "title": "Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study.",
        "journal": "International journal of radiation oncology, biology, physics",
        "publication_date": "2025-09-29",
        "pubmed_id": "41033612",
        "doi": "10.1016/j.ijrobp.2025.08.066"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:49:25"
    },
    {
      "id": 1392,
      "intervention": {
        "name": "mepolizumab",
        "canonical_name": "mepolizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mepolizumab",
          "layer_2_variant": "mepolizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe therapy resistant asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of eosinophilic inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "non-inferiority trial",
        "sample_size": 150,
        "duration": null,
        "population": "children with severe therapy resistant asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Bayesian framework to evaluate non-inferiority in randomised controlled trials of uncommon conditions.",
        "journal": "Journal of clinical epidemiology",
        "publication_date": "2025-09-29",
        "pubmed_id": "41033406",
        "doi": "10.1016/j.jclinepi.2025.112002"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:47:45"
    },
    {
      "id": 1393,
      "intervention": {
        "name": "omalizumab",
        "canonical_name": "omalizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "omalizumab",
          "layer_2_variant": "omalizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe therapy resistant asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of IgE-mediated allergic responses",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "non-inferiority trial",
        "sample_size": 150,
        "duration": null,
        "population": "children with severe therapy resistant asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Bayesian framework to evaluate non-inferiority in randomised controlled trials of uncommon conditions.",
        "journal": "Journal of clinical epidemiology",
        "publication_date": "2025-09-29",
        "pubmed_id": "41033406",
        "doi": "10.1016/j.jclinepi.2025.112002"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:47:45"
    },
    {
      "id": 1391,
      "intervention": {
        "name": "Stress First Aid",
        "canonical_name": "stress first aid",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "stress first aid",
          "layer_2_variant": "stress first aid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic stress",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "peer support actions to mitigate psychosocial impact",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster randomized controlled trial with mixed methods",
        "sample_size": 862,
        "duration": "March 2021 - October 2022",
        "population": "health care workers (HCWs) across eight pairs of hospitals and six pairs of Federally Qualified Health Centers (FQHCs) in nine states",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Health care worker experiences with a brief peer support and well-being intervention during the COVID-19 pandemic.",
        "journal": "BMC health services research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029307",
        "doi": "10.1186/s12913-025-13268-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:45:59"
    },
    {
      "id": 1390,
      "intervention": {
        "name": "acetazolamide",
        "canonical_name": "acetazolamide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "acetazolamide",
          "layer_2_variant": "acetazolamide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "nocturnal cerebral deoxygenation",
        "canonical_name": null,
        "category": "neurological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "mitigation of altitude-related hypoxemia",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 43,
        "duration": "first night at 3100 meters",
        "population": "patients with moderate to severe COPD living < 800 meters",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nocturnal cerebral oxygenation in patients with COPD at altitude: data from a randomized clinical trial of acetazolamide.",
        "journal": "Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41025408",
        "doi": "10.5664/jcsm.11868"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:44:21"
    },
    {
      "id": 1389,
      "intervention": {
        "name": "mavacamten",
        "canonical_name": "mavacamten",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mavacamten",
          "layer_2_variant": "mavacamten",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "obstructive hypertrophic cardiomyopathy",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of cardiac myosin to improve cardiac function",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 3, randomized, placebo-controlled, double-blind, parallel-group, multicenter, international study",
        "sample_size": null,
        "duration": "≤144 weeks",
        "population": "symptomatic adolescent patients (12 years to < 18 years old) with obstructive HCM",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial.",
        "journal": "American heart journal",
        "publication_date": "2025-09-30",
        "pubmed_id": "41038603",
        "doi": "10.1016/j.ahj.2025.107283"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:42:44"
    },
    {
      "id": 1385,
      "intervention": {
        "name": "biologics",
        "canonical_name": "biologics",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "biologics",
          "layer_2_variant": "biologics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2-high asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeting eosinophilic, IgE- and alarmin-mediated inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2-high asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in type 2-high asthma therapy: what remains missing?",
        "journal": "Expert review of respiratory medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029975",
        "doi": "10.1080/17476348.2025.2569844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:41:11"
    },
    {
      "id": 1386,
      "intervention": {
        "name": "small-molecule drugs",
        "canonical_name": "small-molecule drugs",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "small-molecule drugs",
          "layer_2_variant": "small-molecule drugs",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2-high asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulating inflammatory pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2-high asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in type 2-high asthma therapy: what remains missing?",
        "journal": "Expert review of respiratory medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029975",
        "doi": "10.1080/17476348.2025.2569844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:41:11"
    },
    {
      "id": 1387,
      "intervention": {
        "name": "cell-based interventions",
        "canonical_name": "cell-based interventions",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cell-based interventions",
          "layer_2_variant": "cell-based interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2-high asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulating immune responses",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2-high asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in type 2-high asthma therapy: what remains missing?",
        "journal": "Expert review of respiratory medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029975",
        "doi": "10.1080/17476348.2025.2569844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:41:11"
    },
    {
      "id": 1388,
      "intervention": {
        "name": "microbiome-directed interventions",
        "canonical_name": "probiotics",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "probiotics",
          "layer_2_variant": "microbiome-directed interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2-high asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulating gut microbiome and immune responses",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2-high asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in type 2-high asthma therapy: what remains missing?",
        "journal": "Expert review of respiratory medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029975",
        "doi": "10.1080/17476348.2025.2569844"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:41:11"
    },
    {
      "id": 1383,
      "intervention": {
        "name": "robot-assisted total knee arthroplasty with functional alignment",
        "canonical_name": "total knee arthroplasty",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "total knee arthroplasty",
          "layer_2_variant": "robot-assisted total knee arthroplasty with functional alignment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "end-stage osteoarthritis of the knee",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved clinical outcomes and reduced pain through optimized knee alignment",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective non-randomized study",
        "sample_size": 40,
        "duration": "18 months",
        "population": "patients with end-stage osteoarthritis of the knee",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A prospective study to compare clinical and radiological outcomes of functionally versus mechanically aligned knees following robotic total knee arthroplasty.",
        "journal": "The journal of knee surgery",
        "publication_date": "2025-09-30",
        "pubmed_id": "41027465",
        "doi": "10.1055/a-2712-4085"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:39:12"
    },
    {
      "id": 1384,
      "intervention": {
        "name": "robot-assisted total knee arthroplasty with mechanical alignment",
        "canonical_name": "total knee arthroplasty",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "total knee arthroplasty",
          "layer_2_variant": "robot-assisted total knee arthroplasty with mechanical alignment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "end-stage osteoarthritis of the knee",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "standard knee alignment approach for total knee arthroplasty",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective non-randomized study",
        "sample_size": 40,
        "duration": "18 months",
        "population": "patients with end-stage osteoarthritis of the knee",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A prospective study to compare clinical and radiological outcomes of functionally versus mechanically aligned knees following robotic total knee arthroplasty.",
        "journal": "The journal of knee surgery",
        "publication_date": "2025-09-30",
        "pubmed_id": "41027465",
        "doi": "10.1055/a-2712-4085"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:39:12"
    },
    {
      "id": 1382,
      "intervention": {
        "name": "nurse-led health literacy intervention",
        "canonical_name": "health literacy intervention",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "health literacy intervention",
          "layer_2_variant": "nurse-led health literacy intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "self-management in chronic obstructive pulmonary disease",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "personalized nursing support and motivational interviewing to improve health literacy and post-discharge care understanding",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "qualitative process evaluation within a randomized controlled trial",
        "sample_size": 8,
        "duration": null,
        "population": "patients with chronic obstructive pulmonary disease and healthcare personnel",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Patients' and healthcare personnel's experiences of a health-literacy intervention in chronic obstructive pulmonary disease - a qualitative study.",
        "journal": "BMC health services research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029694",
        "doi": "10.1186/s12913-025-13299-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:37:22"
    },
    {
      "id": 1381,
      "intervention": {
        "name": "suraxavir marboxil",
        "canonical_name": "suraxavir",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "suraxavir",
          "layer_2_variant": "suraxavir marboxil",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "influenza virus replication",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "selective inhibition of cap-dependent nucleic acid endonuclease of influenza virus",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase I clinical trial",
        "sample_size": 16,
        "duration": null,
        "population": "healthy Chinese subjects",
        "adverse_effects": "all adverse events recovered without treatment after discontinuation",
        "cost_category": null
      },
      "paper": {
        "title": "A first-in-human phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel anti-influenza agent suraxavir marboxil in healthy Chinese subjects.",
        "journal": "Antimicrobial agents and chemotherapy",
        "publication_date": "2025-09-30",
        "pubmed_id": "41025645",
        "doi": "10.1128/aac.00685-25"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:35:55"
    },
    {
      "id": 1380,
      "intervention": {
        "name": "rusfertide",
        "canonical_name": "rusfertide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rusfertide",
          "layer_2_variant": "rusfertide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "polycythemia vera",
        "canonical_name": null,
        "category": "hematological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "hepcidin mimetic action",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blind, crossover study",
        "sample_size": 60,
        "duration": null,
        "population": "healthy adults",
        "adverse_effects": "mild adverse events including headache, nausea, injection site erythema, injection site pain, and influenza-like illness",
        "cost_category": null
      },
      "paper": {
        "title": "Evaluation of Rusfertide, a Hepcidin Mimetic, on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled Crossover Thorough QT Study in Healthy Participants.",
        "journal": "Clinical therapeutics",
        "publication_date": "2025-09-30",
        "pubmed_id": "41033871",
        "doi": "10.1016/j.clinthera.2025.09.002"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:34:23"
    },
    {
      "id": 1379,
      "intervention": {
        "name": "risankizumab",
        "canonical_name": "risankizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "risankizumab",
          "layer_2_variant": "risankizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psoriatic arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of interleukin-23 (IL-23) activity",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1038,
        "duration": "196 weeks",
        "population": "patients with psoriatic arthritis who had an inadequate response to ≥1 conventional synthetic disease-modifying antirheumatic drug(s) (csDMARD-IR) and/or 1-2 biologic DMARDs (bDMARD-IR)",
        "adverse_effects": "no new safety signals reported",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.",
        "journal": "Rheumatology and therapy",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028616",
        "doi": "10.1007/s40744-025-00793-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:31:17"
    },
    {
      "id": 1377,
      "intervention": {
        "name": "deucravacitinib",
        "canonical_name": "deucravacitinib",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "deucravacitinib",
          "layer_2_variant": "deucravacitinib",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe plaque psoriasis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of phosphodiesterase 4 (PDE4) enzyme activity",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cost-effectiveness analysis using clinical trial data",
        "sample_size": null,
        "duration": null,
        "population": "patients with moderate-to-severe plaque psoriasis in China",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of deucravacitinib versus apremilast of moderate-to-severe plaque psoriasis in China.",
        "journal": "BMC health services research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029430",
        "doi": "10.1186/s12913-025-13403-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:29:29"
    },
    {
      "id": 1378,
      "intervention": {
        "name": "apremilast",
        "canonical_name": "apremilast",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "apremilast",
          "layer_2_variant": "apremilast",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe plaque psoriasis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of phosphodiesterase 4 (PDE4) enzyme activity",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cost-effectiveness analysis using clinical trial data",
        "sample_size": null,
        "duration": null,
        "population": "patients with moderate-to-severe plaque psoriasis in China",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of deucravacitinib versus apremilast of moderate-to-severe plaque psoriasis in China.",
        "journal": "BMC health services research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029430",
        "doi": "10.1186/s12913-025-13403-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:29:29"
    },
    {
      "id": 1376,
      "intervention": {
        "name": "empowerment program",
        "canonical_name": "empowerment program",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "empowerment program",
          "layer_2_variant": "empowerment program",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pain control",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "education on pain management, coping strategies, and goal setting",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "quasi-experimental study",
        "sample_size": 98,
        "duration": "six weeks",
        "population": "patients undergoing total knee arthroplasty in Iran (predominantly women; mean age 62.72 years, mean BMI 29.77, limited formal education)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The effect of an empowerment program on pain control and self-efficacy in patients undergoing total knee arthroplasty in Iran: a quasi-experimental study.",
        "journal": "BMC musculoskeletal disorders",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029288",
        "doi": "10.1186/s12891-025-09150-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:27:35"
    },
    {
      "id": 1375,
      "intervention": {
        "name": "collaborative model of care between orthopaedics and allied health professionals (CONNACT)",
        "canonical_name": "collaborative model of care",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "collaborative model of care",
          "layer_2_variant": "collaborative model of care between orthopaedics and allied health professionals (connact)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "patient education, empowerment, and transdisciplinary care delivery",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "process evaluation of hybrid randomized controlled trial",
        "sample_size": 22,
        "duration": null,
        "population": "patients with knee osteoarthritis and healthcare professionals",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Collaborative model of care between orthopaedics and allied health professionals in knee osteoarthritis (CONNACT): process evaluation of an effectiveness-implementation hybrid randomized control trial.",
        "journal": "BMC musculoskeletal disorders",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029682",
        "doi": "10.1186/s12891-025-08925-0"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:26:00"
    },
    {
      "id": 1372,
      "intervention": {
        "name": "non-operative treatment",
        "canonical_name": "non-operative treatment",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "non-operative treatment",
          "layer_2_variant": "non-operative treatment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "periprosthetic fractures around elbow prosthesis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "stabilization without surgical intervention",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 85,
        "duration": null,
        "population": "patients with periprosthetic fractures around elbow prosthesis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Classification-based treatment of periprosthetic fractures around total elbow arthroplasty: a systematic review and meta-analysis.",
        "journal": "Patient safety in surgery",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029869",
        "doi": "10.1186/s13037-025-00447-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:24:27"
    },
    {
      "id": 1373,
      "intervention": {
        "name": "fracture fixation",
        "canonical_name": "fracture fixation",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fracture fixation",
          "layer_2_variant": "fracture fixation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "periprosthetic fractures around elbow prosthesis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "stabilization through surgical fixation of the fracture",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 85,
        "duration": null,
        "population": "patients with periprosthetic fractures around elbow prosthesis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Classification-based treatment of periprosthetic fractures around total elbow arthroplasty: a systematic review and meta-analysis.",
        "journal": "Patient safety in surgery",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029869",
        "doi": "10.1186/s13037-025-00447-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:24:27"
    },
    {
      "id": 1374,
      "intervention": {
        "name": "revision arthroplasty",
        "canonical_name": "revision arthroplasty",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "revision arthroplasty",
          "layer_2_variant": "revision arthroplasty",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "periprosthetic fractures around elbow prosthesis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "replacement of the elbow prosthesis to stabilize the fracture",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 85,
        "duration": null,
        "population": "patients with periprosthetic fractures around elbow prosthesis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Classification-based treatment of periprosthetic fractures around total elbow arthroplasty: a systematic review and meta-analysis.",
        "journal": "Patient safety in surgery",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029869",
        "doi": "10.1186/s13037-025-00447-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:24:27"
    },
    {
      "id": 1369,
      "intervention": {
        "name": "cabazitaxel",
        "canonical_name": "cabazitaxel",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cabazitaxel",
          "layer_2_variant": "cabazitaxel",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "poor-prognosis metastatic castration-resistant prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of microtubule dynamics and cell division",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2b trial",
        "sample_size": 106,
        "duration": "30.9 months",
        "population": "poor-prognosis metastatic castration-resistant prostate cancer patients progressing on docetaxel",
        "adverse_effects": "grade ≥3 adverse events more frequent",
        "cost_category": null
      },
      "paper": {
        "title": "Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.",
        "journal": "European urology oncology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41033927",
        "doi": "10.1016/j.euo.2025.07.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:22:30"
    },
    {
      "id": 1370,
      "intervention": {
        "name": "abiraterone",
        "canonical_name": "abiraterone",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "abiraterone",
          "layer_2_variant": "abiraterone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "poor-prognosis metastatic castration-resistant prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of androgen biosynthesis",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2b trial",
        "sample_size": 106,
        "duration": "30.9 months",
        "population": "poor-prognosis metastatic castration-resistant prostate cancer patients progressing on docetaxel",
        "adverse_effects": "grade ≥3 adverse events less frequent compared to cabazitaxel",
        "cost_category": null
      },
      "paper": {
        "title": "Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.",
        "journal": "European urology oncology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41033927",
        "doi": "10.1016/j.euo.2025.07.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:22:30"
    },
    {
      "id": 1371,
      "intervention": {
        "name": "enzalutamide",
        "canonical_name": "enzalutamide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "enzalutamide",
          "layer_2_variant": "enzalutamide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "poor-prognosis metastatic castration-resistant prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of androgen receptor signaling",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2b trial",
        "sample_size": 106,
        "duration": "30.9 months",
        "population": "poor-prognosis metastatic castration-resistant prostate cancer patients progressing on docetaxel",
        "adverse_effects": "grade ≥3 adverse events less frequent compared to cabazitaxel",
        "cost_category": null
      },
      "paper": {
        "title": "Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.",
        "journal": "European urology oncology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41033927",
        "doi": "10.1016/j.euo.2025.07.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:22:30"
    },
    {
      "id": 1367,
      "intervention": {
        "name": "oral liposomal iron",
        "canonical_name": "iron",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "iron",
          "layer_2_variant": "oral liposomal iron",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pediatric CKD anemia",
        "canonical_name": null,
        "category": "renal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved iron absorption and utilization",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized parallel study",
        "sample_size": 60,
        "duration": "3 months",
        "population": "CKD pediatric patients",
        "adverse_effects": "no reported side effects",
        "cost_category": null
      },
      "paper": {
        "title": "Liposomal iron dramatic effect on chronic kidney disease pediatric anemia: a randomized clinical trial.",
        "journal": "Pediatric research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028503",
        "doi": "10.1038/s41390-025-04418-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:18:35"
    },
    {
      "id": 1368,
      "intervention": {
        "name": "intravenous iron dextran",
        "canonical_name": "iron",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "iron",
          "layer_2_variant": "intravenous iron dextran",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pediatric CKD anemia",
        "canonical_name": null,
        "category": "renal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct iron supplementation via intravenous route",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized parallel study",
        "sample_size": 60,
        "duration": "3 months",
        "population": "CKD pediatric patients",
        "adverse_effects": "traditional treatment has serious side effects",
        "cost_category": null
      },
      "paper": {
        "title": "Liposomal iron dramatic effect on chronic kidney disease pediatric anemia: a randomized clinical trial.",
        "journal": "Pediatric research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028503",
        "doi": "10.1038/s41390-025-04418-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:18:35"
    },
    {
      "id": 1361,
      "intervention": {
        "name": "GLP-1RA and SGLT2i combination therapy",
        "canonical_name": "glp-1ra and sglt2i combination therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1ra and sglt2i combination therapy",
          "layer_2_variant": "glp-1ra and sglt2i combination therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular and renal outcomes",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved cardiorenal function",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2 diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029853",
        "doi": "10.1186/s12933-025-02900-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:16:45"
    },
    {
      "id": 1362,
      "intervention": {
        "name": "SGLT2i and GLP-1RA combination therapy",
        "canonical_name": "sglt2 inhibitors and glp-1 receptor agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sglt2 inhibitors and glp-1 receptor agonists",
          "layer_2_variant": "sglt2i and glp-1ra combination therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular and renal outcomes",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved cardiorenal function and reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2 diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029853",
        "doi": "10.1186/s12933-025-02900-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:16:45"
    },
    {
      "id": 1363,
      "intervention": {
        "name": "SGLT2i and finerenone combination therapy",
        "canonical_name": "sglt2 inhibitors and finerenone",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sglt2 inhibitors and finerenone",
          "layer_2_variant": "sglt2i and finerenone combination therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular and renal outcomes",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved renal function",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2 diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029853",
        "doi": "10.1186/s12933-025-02900-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:16:45"
    },
    {
      "id": 1364,
      "intervention": {
        "name": "GLP-1RA monotherapy",
        "canonical_name": "glp-1ra",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1ra",
          "layer_2_variant": "glp-1ra monotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular and renal outcomes",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved cardiorenal function",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2 diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029853",
        "doi": "10.1186/s12933-025-02900-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:16:45"
    },
    {
      "id": 1365,
      "intervention": {
        "name": "SGLT2i monotherapy",
        "canonical_name": "sglt2 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sglt2 inhibitors",
          "layer_2_variant": "sglt2i monotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular and renal outcomes",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved cardiorenal function",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2 diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029853",
        "doi": "10.1186/s12933-025-02900-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:16:45"
    },
    {
      "id": 1366,
      "intervention": {
        "name": "finerenone monotherapy",
        "canonical_name": "finerenone",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "finerenone",
          "layer_2_variant": "finerenone monotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular and renal outcomes",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved renal function",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "patients with type 2 diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029853",
        "doi": "10.1186/s12933-025-02900-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:16:45"
    },
    {
      "id": 1356,
      "intervention": {
        "name": "Acetyl-L-Carnitine",
        "canonical_name": "acetyl-l-carnitine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "acetyl-l-carnitine",
          "layer_2_variant": "acetyl-l-carnitine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Polycystic ovary syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved metabolic and hormonal regulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "six months",
        "population": "females diagnosed with PCOS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial.",
        "journal": "Naunyn-Schmiedeberg's archives of pharmacology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026176",
        "doi": "10.1007/s00210-025-04626-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:13:58"
    },
    {
      "id": 1357,
      "intervention": {
        "name": "L-Arginine",
        "canonical_name": "l-arginine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "l-arginine",
          "layer_2_variant": "l-arginine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Polycystic ovary syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved metabolic and hormonal regulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "six months",
        "population": "females diagnosed with PCOS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial.",
        "journal": "Naunyn-Schmiedeberg's archives of pharmacology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026176",
        "doi": "10.1007/s00210-025-04626-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:13:58"
    },
    {
      "id": 1358,
      "intervention": {
        "name": "CoQ10",
        "canonical_name": "coq10",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "coq10",
          "layer_2_variant": "coq10",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Polycystic ovary syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved metabolic and hormonal regulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "six months",
        "population": "females diagnosed with PCOS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial.",
        "journal": "Naunyn-Schmiedeberg's archives of pharmacology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026176",
        "doi": "10.1007/s00210-025-04626-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:13:58"
    },
    {
      "id": 1359,
      "intervention": {
        "name": "Carnitine + Arginine + CoQ10",
        "canonical_name": "carnitine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "carnitine",
          "layer_2_variant": "carnitine + arginine + coq10",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Polycystic ovary syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved metabolic and hormonal regulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "six months",
        "population": "females diagnosed with PCOS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial.",
        "journal": "Naunyn-Schmiedeberg's archives of pharmacology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026176",
        "doi": "10.1007/s00210-025-04626-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:13:58"
    },
    {
      "id": 1360,
      "intervention": {
        "name": "Metformin",
        "canonical_name": "metformin",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "metformin",
          "layer_2_variant": "metformin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Polycystic ovary syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved insulin sensitivity and metabolic regulation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "six months",
        "population": "females diagnosed with PCOS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial.",
        "journal": "Naunyn-Schmiedeberg's archives of pharmacology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026176",
        "doi": "10.1007/s00210-025-04626-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:13:58"
    },
    {
      "id": 1355,
      "intervention": {
        "name": "omeprazole",
        "canonical_name": "proton pump inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "proton pump inhibitors",
          "layer_2_variant": "omeprazole",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gastroesophageal reflux disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of esophageal acid exposure",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized crossover trial",
        "sample_size": 27,
        "duration": null,
        "population": "subjects with gastroesophageal reflux disease and baseline esophageal pH < 4 for more than 10% of a 24-h recording",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Uncovering the Mechanisms of Failure of Proton Pump Inhibitors in GERD: The Role of Esophageal Acid Sensitivity.",
        "journal": "Digestive diseases and sciences",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026367",
        "doi": "10.1007/s10620-025-09450-9"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:11:27"
    },
    {
      "id": 1353,
      "intervention": {
        "name": "bedtime antihypertensive administration",
        "canonical_name": "antihypertensive",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antihypertensive",
          "layer_2_variant": "bedtime antihypertensive administration",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "nocturnal blood pressure elevation",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved nocturnal blood pressure control through timed medication release",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 8,
        "duration": null,
        "population": "older adults aged ≥65",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Improvement in nocturnal blood pressure with bedtime antihypertensive administration in older adults aged 65 and above: a systematic review and meta-analysis.",
        "journal": "Clinical autonomic research : official journal of the Clinical Autonomic Research Society",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028404",
        "doi": "10.1007/s10286-025-01159-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:10:02"
    },
    {
      "id": 1354,
      "intervention": {
        "name": "morning antihypertensive administration",
        "canonical_name": "antihypertensive",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "antihypertensive",
          "layer_2_variant": "morning antihypertensive administration",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "nocturnal blood pressure elevation",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "less effective in controlling nocturnal blood pressure compared to bedtime administration",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 8,
        "duration": null,
        "population": "older adults aged ≥65",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Improvement in nocturnal blood pressure with bedtime antihypertensive administration in older adults aged 65 and above: a systematic review and meta-analysis.",
        "journal": "Clinical autonomic research : official journal of the Clinical Autonomic Research Society",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028404",
        "doi": "10.1007/s10286-025-01159-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:10:02"
    },
    {
      "id": 1352,
      "intervention": {
        "name": "trimetazidine",
        "canonical_name": "trimetazidine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "trimetazidine",
          "layer_2_variant": "trimetazidine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "stroke risk in patients with ischemic heart disease and atrial fibrillation",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prioritizing cardiomyocyte metabolism to glucose oxidation",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": 12527,
        "duration": "1133 days (interquartile range, 442-2454 days)",
        "population": "patients with ischemic heart disease and preexisting atrial fibrillation (mean age, 77.5±10.3 years; 44.6% men)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation.",
        "journal": "Journal of the American Heart Association",
        "publication_date": "2025-09-30",
        "pubmed_id": "41025486",
        "doi": "10.1161/JAHA.125.041629"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:08:09"
    },
    {
      "id": 1349,
      "intervention": {
        "name": "romosozumab",
        "canonical_name": "romosozumab",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "romosozumab",
          "layer_2_variant": "romosozumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "vertebral cortical bone mass deficiency",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased bone formation and decreased bone resorption",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 11,
        "duration": "12 months",
        "population": "postmenopausal women with low bone mineral density (T-score ≤ -2.0, but not <-3.5, at the lumbar spine, total hip, or femoral neck)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Romosozumab significantly improves vertebral cortical bone mass and structure compared with teriparatide, whereas both treatments increase vertebral trabecular bone mass similarly: high-resolution quantitative computed tomography analyses of randomized controlled trial results in postmenopausal women with low bone mineral density.",
        "journal": "JBMR plus",
        "publication_date": "2025-10",
        "pubmed_id": "40978126",
        "doi": "10.1093/jbmrpl/ziaf119"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:06:34"
    },
    {
      "id": 1350,
      "intervention": {
        "name": "teriparatide",
        "canonical_name": "teriparatide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "teriparatide",
          "layer_2_variant": "teriparatide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "vertebral cortical bone mass deficiency",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased bone formation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 12,
        "duration": "12 months",
        "population": "postmenopausal women with low bone mineral density (T-score ≤ -2.0, but not <-3.5, at the lumbar spine, total hip, or femoral neck)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Romosozumab significantly improves vertebral cortical bone mass and structure compared with teriparatide, whereas both treatments increase vertebral trabecular bone mass similarly: high-resolution quantitative computed tomography analyses of randomized controlled trial results in postmenopausal women with low bone mineral density.",
        "journal": "JBMR plus",
        "publication_date": "2025-10",
        "pubmed_id": "40978126",
        "doi": "10.1093/jbmrpl/ziaf119"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:06:34"
    },
    {
      "id": 1351,
      "intervention": {
        "name": "placebo",
        "canonical_name": "placebo",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "placebo",
          "layer_2_variant": "placebo",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "vertebral cortical bone mass deficiency",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "no active treatment effect",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 8,
        "duration": "12 months",
        "population": "postmenopausal women with low bone mineral density (T-score ≤ -2.0, but not <-3.5, at the lumbar spine, total hip, or femoral neck)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Romosozumab significantly improves vertebral cortical bone mass and structure compared with teriparatide, whereas both treatments increase vertebral trabecular bone mass similarly: high-resolution quantitative computed tomography analyses of randomized controlled trial results in postmenopausal women with low bone mineral density.",
        "journal": "JBMR plus",
        "publication_date": "2025-10",
        "pubmed_id": "40978126",
        "doi": "10.1093/jbmrpl/ziaf119"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:06:34"
    },
    {
      "id": 1347,
      "intervention": {
        "name": "6 months isoniazid therapy",
        "canonical_name": "isoniazid",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isoniazid",
          "layer_2_variant": "6 months isoniazid therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tubercular infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prevention of tuberculosis disease progression",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "2 years",
        "population": "children aged 6-14 years who were household contacts of bacteriologically confirmed tuberculosis patients and having tubercular infection",
        "adverse_effects": "no significant symptomatic adverse events or derangement in liver enzymes",
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of 6 months isoniazid versus 3 months isoniazid - rifampicin therapy for prevention of tuberculosis in children suffering from tuberculosis infection - A randomized controlled trial.",
        "journal": "The Indian journal of tuberculosis",
        "publication_date": "2025-10",
        "pubmed_id": "40975579",
        "doi": "10.1016/j.ijtb.2025.02.014"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:04:04"
    },
    {
      "id": 1348,
      "intervention": {
        "name": "3 months isoniazid-rifampicin combination therapy",
        "canonical_name": "isoniazid-rifampicin combination",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "isoniazid-rifampicin combination",
          "layer_2_variant": "3 months isoniazid-rifampicin combination therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "tubercular infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prevention of tuberculosis disease progression",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "2 years",
        "population": "children aged 6-14 years who were household contacts of bacteriologically confirmed tuberculosis patients and having tubercular infection",
        "adverse_effects": "no significant symptomatic adverse events or derangement in liver enzymes",
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of 6 months isoniazid versus 3 months isoniazid - rifampicin therapy for prevention of tuberculosis in children suffering from tuberculosis infection - A randomized controlled trial.",
        "journal": "The Indian journal of tuberculosis",
        "publication_date": "2025-10",
        "pubmed_id": "40975579",
        "doi": "10.1016/j.ijtb.2025.02.014"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:04:04"
    },
    {
      "id": 1346,
      "intervention": {
        "name": "platelet-rich plasma (PRP) injection",
        "canonical_name": "platelet-rich plasma",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "platelet-rich plasma",
          "layer_2_variant": "platelet-rich plasma (prp) injection",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "meniscal injury",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "promotes healing and improves function through growth factor release",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 1143,
        "duration": "3 to 12 months",
        "population": "adult patients with meniscal injury",
        "adverse_effects": "no significant difference in complications",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Platelet-Rich Plasma for Patients With Meniscal Injury: A Systematic Review and Meta-analysis of Randomized Controlled Trials.",
        "journal": "Orthopaedic journal of sports medicine",
        "publication_date": "2025-10",
        "pubmed_id": "41049599",
        "doi": "10.1177/23259671251371233"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:02:08"
    },
    {
      "id": 1344,
      "intervention": {
        "name": "nafithromycin",
        "canonical_name": "nafithromycin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nafithromycin",
          "layer_2_variant": "nafithromycin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "community-acquired bacterial pneumonia",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "high and sustained pulmonary concentrations allowing for once-daily dosing",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase III, randomized, double-blind controlled trial",
        "sample_size": 488,
        "duration": "February 2021 to June 2023",
        "population": "adults with community-acquired bacterial pneumonia (PORT risk class II, III, IV) across 31 sites in India",
        "adverse_effects": "abdominal pain, diarrhoea, headache, nausea (all mild in severity)",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial.",
        "journal": "The Lancet regional health. Southeast Asia",
        "publication_date": "2025-10",
        "pubmed_id": "41050437",
        "doi": "10.1016/j.lansea.2025.100666"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:00:37"
    },
    {
      "id": 1345,
      "intervention": {
        "name": "moxifloxacin",
        "canonical_name": "moxifloxacin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "moxifloxacin",
          "layer_2_variant": "moxifloxacin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "community-acquired bacterial pneumonia",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antibacterial activity against pathogens causing community-acquired bacterial pneumonia",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase III, randomized, double-blind controlled trial",
        "sample_size": 488,
        "duration": "February 2021 to June 2023",
        "population": "adults with community-acquired bacterial pneumonia (PORT risk class II, III, IV) across 31 sites in India",
        "adverse_effects": "abdominal pain, diarrhoea, headache, nausea (all mild in severity)",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial.",
        "journal": "The Lancet regional health. Southeast Asia",
        "publication_date": "2025-10",
        "pubmed_id": "41050437",
        "doi": "10.1016/j.lansea.2025.100666"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 01:00:37"
    },
    {
      "id": 1343,
      "intervention": {
        "name": "catechin",
        "canonical_name": "catechin",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "catechin",
          "layer_2_variant": "catechin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "respiratory tract infections",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced infection incidence",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 5,
        "duration": null,
        "population": "adults",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative effectiveness of oral nutritional supplements in preventing respiratory tract infections among adults: a systematic review and network meta-analysis.",
        "journal": "EClinicalMedicine",
        "publication_date": "2025-10",
        "pubmed_id": "40969681",
        "doi": "10.1016/j.eclinm.2025.103479"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:58:30"
    },
    {
      "id": 1342,
      "intervention": {
        "name": "FenuflakesTM",
        "canonical_name": "fenugreek",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fenugreek",
          "layer_2_variant": "fenuflakestm",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2 diabetes",
        "canonical_name": null,
        "category": "endocrine",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced glycemic variability and improved glycemic control",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized crossover trial",
        "sample_size": 21,
        "duration": "14 days",
        "population": "adults with type 2 diabetes aged 42 to 50 years",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of 'FenuflakesTM' on 24-hour glycemic variability in adults with type 2 diabetes: A randomized crossover continuous glucose monitoring study.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038677",
        "doi": "10.6133/apjcn.202510_34(5).0003"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:55:51"
    },
    {
      "id": 1341,
      "intervention": {
        "name": "Yiqi Chupi powder",
        "canonical_name": "yiqi chupi powder",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "yiqi chupi powder",
          "layer_2_variant": "yiqi chupi powder",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cancer-related fatigue",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of fatigue symptoms and improvement of quality of life",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 78,
        "duration": "12 weeks",
        "population": "patients with colorectal cancer undergoing chemotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Yiqi Chupi powder for alleviating cancer-related fatigue in patients following colorectal cancer surgery: a randomized controlled trial.",
        "journal": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan",
        "publication_date": "2025-10",
        "pubmed_id": "41015810",
        "doi": "10.19852/j.cnki.jtcm.2025.05.017"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:54:23"
    },
    {
      "id": 1328,
      "intervention": {
        "name": "Galohgor",
        "canonical_name": "galohgor",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "galohgor",
          "layer_2_variant": "galohgor",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced oxidative stress and hyperglycemia",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1329,
      "intervention": {
        "name": "Bir Pletok",
        "canonical_name": "bir pletok",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "bir pletok",
          "layer_2_variant": "bir pletok",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced oxidative stress and hyperglycemia",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1330,
      "intervention": {
        "name": "Wedang Uwuh",
        "canonical_name": "wedang uwuh",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "wedang uwuh",
          "layer_2_variant": "wedang uwuh",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced oxidative stress and hyperglycemia",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1331,
      "intervention": {
        "name": "curcumin",
        "canonical_name": "curcumin",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "curcumin",
          "layer_2_variant": "curcumin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1332,
      "intervention": {
        "name": "kaempferol",
        "canonical_name": "kaempferol",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "kaempferol",
          "layer_2_variant": "kaempferol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1333,
      "intervention": {
        "name": "cinnamon",
        "canonical_name": "cinnamon",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cinnamon",
          "layer_2_variant": "cinnamon",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1334,
      "intervention": {
        "name": "saponin",
        "canonical_name": "saponin",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "saponin",
          "layer_2_variant": "saponin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1335,
      "intervention": {
        "name": "quercetin",
        "canonical_name": "quercetin",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "quercetin",
          "layer_2_variant": "quercetin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1336,
      "intervention": {
        "name": "myricetin",
        "canonical_name": "myricetin",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "myricetin",
          "layer_2_variant": "myricetin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1337,
      "intervention": {
        "name": "anthocyanin",
        "canonical_name": "anthocyanin",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "anthocyanin",
          "layer_2_variant": "anthocyanin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1338,
      "intervention": {
        "name": "terpenoid",
        "canonical_name": "terpenoids",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "terpenoids",
          "layer_2_variant": "terpenoid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1339,
      "intervention": {
        "name": "alkaloid",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "alkaloid",
          "layer_2_variant": "alkaloid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1340,
      "intervention": {
        "name": "gallic acid",
        "canonical_name": "gallic acid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "gallic acid",
          "layer_2_variant": "gallic acid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Type 2 diabetes mellitus",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved glucose homeostasis and insulin sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:52:57"
    },
    {
      "id": 1327,
      "intervention": {
        "name": "Interferon Gamma Injection",
        "canonical_name": "interferon gamma",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "interferon gamma",
          "layer_2_variant": "interferon gamma injection",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hospital-acquired pneumonia",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immune modulation",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "placebo-controlled randomized clinical trial",
        "sample_size": 94,
        "duration": "first week under invasive mechanical ventilation",
        "population": "ICU ventilated patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interferon Gamma Injection and Its Effect on the Respiratory Anelloviridae Population in ICU Ventilated Patients.",
        "journal": "Journal of medical virology",
        "publication_date": "2025-10",
        "pubmed_id": "41036698",
        "doi": "10.1002/jmv.70612"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:48:56"
    },
    {
      "id": 1326,
      "intervention": {
        "name": "astegolimab",
        "canonical_name": "astegolimab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "astegolimab",
          "layer_2_variant": "astegolimab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammatory diseases",
        "canonical_name": null,
        "category": "immunological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "blocking ST2/interleukin-33 binding and subsequent inflammatory cascades",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blind, placebo-controlled, Phase I studies",
        "sample_size": 152,
        "duration": null,
        "population": "healthy participants and patients with mild atopic asthma, healthy Japanese and White adults",
        "adverse_effects": "no deaths, serious adverse events, or discontinuations due to adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti-ST2 Monoclonal Antibody, in Randomized, Phase I Clinical Studies.",
        "journal": "Clinical and translational science",
        "publication_date": "2025-10",
        "pubmed_id": "41036707",
        "doi": "10.1111/cts.70338"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:47:30"
    },
    {
      "id": 1325,
      "intervention": {
        "name": "high molecular weight non-cross-linked hyaluronic acid plus succinic acid mesotherapy",
        "canonical_name": "hyaluronic acid",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "hyaluronic acid",
          "layer_2_variant": "high molecular weight non-cross-linked hyaluronic acid plus succinic acid mesotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "anti-inflammatory, regenerative, and vascular modulatory effects",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "non-randomized, controlled interventional study",
        "sample_size": 20,
        "duration": "4 months (with 6-month follow-up)",
        "population": "20 male and female patients, aged 40-45 years, Fitzpatrick skin types I-III, without comorbidities, undergoing topical treatment with Ivermectin 1%, Metronidazole 0.75%, and photoprotection",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Effectiveness of High Molecular Weight Non-Cross-Linked Hyaluronic Acid Plus Succinic Acid Mesotherapy in Rosacea as Adjunct Therapy.",
        "journal": "Journal of cosmetic dermatology",
        "publication_date": "2025-10",
        "pubmed_id": "41039794",
        "doi": "10.1111/jocd.70484"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:45:54"
    },
    {
      "id": 1324,
      "intervention": {
        "name": "Upadacitinib",
        "canonical_name": "upadacitinib",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "upadacitinib",
          "layer_2_variant": "upadacitinib",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "alexithymia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and improved emotional processing",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": 120,
        "duration": "16 weeks",
        "population": "adult patients with moderate-to-severe atopic dermatitis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Upadacitinib is efficacious in reducing the alexithymic trait in adult patients with moderate-to-severe atopic dermatitis: a prospective multicenter real-life study.",
        "journal": "Italian journal of dermatology and venereology",
        "publication_date": "2025-10",
        "pubmed_id": "41041873",
        "doi": "10.23736/S2784-8671.25.08228-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:44:09"
    },
    {
      "id": 1321,
      "intervention": {
        "name": "clofarabine plus cytarabine",
        "canonical_name": "clofarabine plus cytarabine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "clofarabine plus cytarabine",
          "layer_2_variant": "clofarabine plus cytarabine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pediatric acute myeloid leukemia (AML)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induction regimen for AML treatment",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": null,
        "population": "pediatric patients with AML",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.",
        "journal": "JCO precision oncology",
        "publication_date": "2025-10",
        "pubmed_id": "41037765",
        "doi": "10.1200/PO-25-00634"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:42:44"
    },
    {
      "id": 1322,
      "intervention": {
        "name": "daunorubicin and etoposide combined with low-dose cytarabine",
        "canonical_name": "daunorubicin, etoposide, cytarabine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "daunorubicin, etoposide, cytarabine",
          "layer_2_variant": "daunorubicin and etoposide combined with low-dose cytarabine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pediatric acute myeloid leukemia (AML)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induction regimen for AML treatment",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": null,
        "population": "pediatric patients with AML",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.",
        "journal": "JCO precision oncology",
        "publication_date": "2025-10",
        "pubmed_id": "41037765",
        "doi": "10.1200/PO-25-00634"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:42:44"
    },
    {
      "id": 1323,
      "intervention": {
        "name": "daunorubicin and etoposide combined with high-dose cytarabine",
        "canonical_name": "daunorubicin, etoposide, cytarabine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "daunorubicin, etoposide, cytarabine",
          "layer_2_variant": "daunorubicin and etoposide combined with high-dose cytarabine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pediatric acute myeloid leukemia (AML)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induction regimen for AML treatment",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": null,
        "duration": null,
        "population": "pediatric patients with AML",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.",
        "journal": "JCO precision oncology",
        "publication_date": "2025-10",
        "pubmed_id": "41037765",
        "doi": "10.1200/PO-25-00634"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:42:44"
    },
    {
      "id": 1319,
      "intervention": {
        "name": "intra-articular pulsed radiofrequency combined with intra-articular steroid injection",
        "canonical_name": "intra-articular pulsed radiofrequency combined with steroid injection",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "intra-articular pulsed radiofrequency combined with steroid injection",
          "layer_2_variant": "intra-articular pulsed radiofrequency combined with intra-articular steroid injection",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "painful knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced pain and improved functional activities through combined anti-inflammatory and neuro-modulatory effects",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 54,
        "duration": "12 weeks",
        "population": "patients with knee pain persisting for more than 3 months with stage II-III knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The effectiveness of intra-articular pulsed radiofrequency in patients with painful knee osteoarthritis: A randomized controlled trial.",
        "journal": "Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology",
        "publication_date": "2025-10",
        "pubmed_id": "41042043",
        "doi": "10.14744/agri.2025.90757"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:39:13"
    },
    {
      "id": 1320,
      "intervention": {
        "name": "intra-articular steroid injection",
        "canonical_name": "steroids",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "steroids",
          "layer_2_variant": "intra-articular steroid injection",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "painful knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and pain through corticosteroid action",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 54,
        "duration": "12 weeks",
        "population": "patients with knee pain persisting for more than 3 months with stage II-III knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The effectiveness of intra-articular pulsed radiofrequency in patients with painful knee osteoarthritis: A randomized controlled trial.",
        "journal": "Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology",
        "publication_date": "2025-10",
        "pubmed_id": "41042043",
        "doi": "10.14744/agri.2025.90757"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:39:13"
    },
    {
      "id": 1318,
      "intervention": {
        "name": "personal vaccination recommendation letter",
        "canonical_name": "vaccination",
        "category": "test",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vaccination",
          "layer_2_variant": "personal vaccination recommendation letter",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "vaccination status in liver transplant recipients",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced communication and targeted information delivery to improve vaccination adherence",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 289,
        "duration": "2 years",
        "population": "liver transplant recipients and their family physicians",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of a Personal Vaccination Recommendation Letter to Liver Transplant Patients and Family Physicians for Improving the Vaccination Status: Improving Vaccinations: Whom to Contact?",
        "journal": "Clinical transplantation",
        "publication_date": "2025-10",
        "pubmed_id": "41004142",
        "doi": "10.1111/ctr.70239"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:37:15"
    },
    {
      "id": 1316,
      "intervention": {
        "name": "firsekibart",
        "canonical_name": "firsekibart",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "firsekibart",
          "layer_2_variant": "firsekibart",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gout flares",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of interleukin (IL)-1β",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2, multicenter, open-label, active-controlled, randomized non-inferiority trial",
        "sample_size": 123,
        "duration": "up to 8 days",
        "population": "adults with gout according to ACR and EULAR 2015 criteria experiencing frequent flares (≥ 2 flares within 12 months pre-screening)",
        "adverse_effects": "hypertriglyceridemia",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial.",
        "journal": "Rheumatology and therapy",
        "publication_date": "2025-10",
        "pubmed_id": "40833487",
        "doi": "10.1007/s40744-025-00790-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:32:40"
    },
    {
      "id": 1317,
      "intervention": {
        "name": "etoricoxib",
        "canonical_name": "coxibs",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "coxibs",
          "layer_2_variant": "etoricoxib",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gout flares",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of cyclooxygenase-2 (COX-2)",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2, multicenter, open-label, active-controlled, randomized non-inferiority trial",
        "sample_size": 123,
        "duration": "up to 8 days",
        "population": "adults with gout according to ACR and EULAR 2015 criteria experiencing frequent flares (≥ 2 flares within 12 months pre-screening)",
        "adverse_effects": "hypertriglyceridemia",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial.",
        "journal": "Rheumatology and therapy",
        "publication_date": "2025-10",
        "pubmed_id": "40833487",
        "doi": "10.1007/s40744-025-00790-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:32:40"
    },
    {
      "id": 1315,
      "intervention": {
        "name": "tadalafil",
        "canonical_name": "tadalafil",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tadalafil",
          "layer_2_variant": "tadalafil",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "dyspnea in COPD-PH",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "restoration of NO signaling and improvement of hemodynamics",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blind, multi-center clinical trial",
        "sample_size": null,
        "duration": "6 months",
        "population": "patients with COPD-PH",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Study Design and Rationale for The Breathe Easier With Tadalafil Therapy for Exercise-Related Dyspnea in COPD-PH (BETTER COPD-PH).",
        "journal": "Pulmonary circulation",
        "publication_date": "2025-10",
        "pubmed_id": "41036079",
        "doi": "10.1002/pul2.70167"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:30:31"
    },
    {
      "id": 1313,
      "intervention": {
        "name": "Hewei Jiangni recipe",
        "canonical_name": "hewei jiangni recipe",
        "category": "diet",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "hewei jiangni recipe",
          "layer_2_variant": "hewei jiangni recipe",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "nonerosive gastroesophageal reflux disease with cold-heat complex syndrome",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "restoration of intestinal flora balance and regulation of metabolic pathways",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blinded study",
        "sample_size": 72,
        "duration": "8 weeks",
        "population": "patients with nonerosive gastroesophageal reflux disease and the Traditional Chinese Medicine syndrome of intermingled heat and cold",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Hewei Jiangni recipe improved the quality of life in patients with cold-heat mixed nonerosive reflux disease: a randomized, double-blinded study.",
        "journal": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan",
        "publication_date": "2025-10",
        "pubmed_id": "41015809",
        "doi": "10.19852/j.cnki.jtcm.20250107.001"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:29:02"
    },
    {
      "id": 1314,
      "intervention": {
        "name": "omeprazole",
        "canonical_name": "proton pump inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "proton pump inhibitors",
          "layer_2_variant": "omeprazole",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "nonerosive gastroesophageal reflux disease with cold-heat complex syndrome",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of gastric acid secretion",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double-blinded study",
        "sample_size": 72,
        "duration": "8 weeks",
        "population": "patients with nonerosive gastroesophageal reflux disease and the Traditional Chinese Medicine syndrome of intermingled heat and cold",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Hewei Jiangni recipe improved the quality of life in patients with cold-heat mixed nonerosive reflux disease: a randomized, double-blinded study.",
        "journal": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan",
        "publication_date": "2025-10",
        "pubmed_id": "41015809",
        "doi": "10.19852/j.cnki.jtcm.20250107.001"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:29:02"
    },
    {
      "id": 1311,
      "intervention": {
        "name": "tele-genetic counseling",
        "canonical_name": "telehealth",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "telehealth",
          "layer_2_variant": "tele-genetic counseling",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "APOE genotype disclosure for Alzheimer's disease risk",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "provision of genetic information and support through remote communication",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 93,
        "duration": "6 months",
        "population": "first-degree relatives of people with Alzheimer's disease in Greece",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Tele-Genetic Versus Onsite Counseling for APOE Disclosure: A 6-Month Study of Empowerment, Psychological Distress, and Behavioral Outcomes in Cognitively Diverse Individuals.",
        "journal": "The journal of gene medicine",
        "publication_date": "2025-10",
        "pubmed_id": "41035143",
        "doi": "10.1002/jgm.70041"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:27:11"
    },
    {
      "id": 1312,
      "intervention": {
        "name": "onsite genetic counseling",
        "canonical_name": "genetic counseling",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "genetic counseling",
          "layer_2_variant": "onsite genetic counseling",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "APOE genotype disclosure for Alzheimer's disease risk",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "provision of genetic information and support through in-person communication",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 93,
        "duration": "6 months",
        "population": "first-degree relatives of people with Alzheimer's disease in Greece",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Tele-Genetic Versus Onsite Counseling for APOE Disclosure: A 6-Month Study of Empowerment, Psychological Distress, and Behavioral Outcomes in Cognitively Diverse Individuals.",
        "journal": "The journal of gene medicine",
        "publication_date": "2025-10",
        "pubmed_id": "41035143",
        "doi": "10.1002/jgm.70041"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:27:11"
    },
    {
      "id": 1310,
      "intervention": {
        "name": "simvastatin",
        "canonical_name": "statins",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "statins",
          "layer_2_variant": "simvastatin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "disability progression in secondary progressive multiple sclerosis",
        "canonical_name": null,
        "category": "neurological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced brain atrophy rate",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 3, randomised, double-blind, placebo-controlled trial",
        "sample_size": 964,
        "duration": "up to 4.5 years",
        "population": "participants aged 18-65 years with a diagnosis of secondary progressive multiple sclerosis and an Expanded Disability Status Scale (EDSS) of between 4.0 and 6.5",
        "adverse_effects": "one serious adverse reaction (rhabdomyolysis) in the simvastatin group; 12 (2%) of 482 participants in the placebo group and five (1%) of 482 participants in the simvastatin group had a cardiovascular serious adverse event",
        "cost_category": null
      },
      "paper": {
        "title": "Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.",
        "journal": "Lancet (London, England)",
        "publication_date": "2025-10-01",
        "pubmed_id": "41045938",
        "doi": "10.1016/S0140-6736(25)01039-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:25:22"
    },
    {
      "id": 1308,
      "intervention": {
        "name": "ruxolitinib cream",
        "canonical_name": "ruxolitinib",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ruxolitinib",
          "layer_2_variant": "ruxolitinib cream",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild to moderate atopic dermatitis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of JAK1/JAK2 pathways, reducing inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2, randomized, dose-ranging study",
        "sample_size": null,
        "duration": "8 weeks (data reported up to week 4)",
        "population": "adults with mild to moderate atopic dermatitis for ≥2 years",
        "adverse_effects": "mild/moderate; nasopharyngitis and headache (4.0% each)",
        "cost_category": null
      },
      "paper": {
        "title": "Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis.",
        "journal": "Journal of drugs in dermatology : JDD",
        "publication_date": "2025-10-01",
        "pubmed_id": "41037525",
        "doi": "10.36849/JDD.8920"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:23:31"
    },
    {
      "id": 1309,
      "intervention": {
        "name": "triamcinolone cream",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "corticosteroids",
          "layer_2_variant": "triamcinolone cream",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "mild to moderate atopic dermatitis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "anti-inflammatory effects through corticosteroid action",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 2, randomized, dose-ranging study",
        "sample_size": null,
        "duration": "8 weeks (data reported up to week 4)",
        "population": "adults with mild to moderate atopic dermatitis for ≥2 years",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis.",
        "journal": "Journal of drugs in dermatology : JDD",
        "publication_date": "2025-10-01",
        "pubmed_id": "41037525",
        "doi": "10.36849/JDD.8920"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:23:31"
    },
    {
      "id": 1306,
      "intervention": {
        "name": "1% colloidal oatmeal-containing cream",
        "canonical_name": "colloidal oatmeal",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "colloidal oatmeal",
          "layer_2_variant": "1% colloidal oatmeal-containing cream",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atopic dermatitis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved skin barrier function and reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "open-label, single-arm study",
        "sample_size": 31,
        "duration": "4 weeks",
        "population": "children 3 to 72 months old with mild-to-moderate atopic dermatitis",
        "adverse_effects": "papular rash; contact dermatitis",
        "cost_category": null
      },
      "paper": {
        "title": "1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use.",
        "journal": "Journal of drugs in dermatology : JDD",
        "publication_date": "2025-10-01",
        "pubmed_id": "41037526",
        "doi": "10.36849/JDD.9095"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:21:30"
    },
    {
      "id": 1307,
      "intervention": {
        "name": "gentle baby wash",
        "canonical_name": "gentle baby wash",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "gentle baby wash",
          "layer_2_variant": "gentle baby wash",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atopic dermatitis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved skin barrier function and reduced inflammation",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "open-label, single-arm study",
        "sample_size": 31,
        "duration": "4 weeks",
        "population": "children 3 to 72 months old with mild-to-moderate atopic dermatitis",
        "adverse_effects": "papular rash; contact dermatitis",
        "cost_category": null
      },
      "paper": {
        "title": "1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use.",
        "journal": "Journal of drugs in dermatology : JDD",
        "publication_date": "2025-10-01",
        "pubmed_id": "41037526",
        "doi": "10.36849/JDD.9095"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:21:30"
    },
    {
      "id": 1304,
      "intervention": {
        "name": "selective laser trabeculoplasty",
        "canonical_name": "selective laser trabeculoplasty",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "selective laser trabeculoplasty",
          "layer_2_variant": "selective laser trabeculoplasty",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "visual field progression in ocular hypertension and open angle glaucoma",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces intraocular pressure and preserves visual field",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 710,
        "duration": "6 years",
        "population": "patients with newly diagnosed ocular hypertension or open angle glaucoma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Six-year rate of visual field progression in the Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial.",
        "journal": "Ophthalmology",
        "publication_date": "2025-10-01",
        "pubmed_id": "41043781",
        "doi": "10.1016/j.ophtha.2025.09.023"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:19:37"
    },
    {
      "id": 1305,
      "intervention": {
        "name": "eye drops (medication)",
        "canonical_name": "eye drops",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "eye drops",
          "layer_2_variant": "eye drops (medication)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "visual field progression in ocular hypertension and open angle glaucoma",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces intraocular pressure",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 710,
        "duration": "6 years",
        "population": "patients with newly diagnosed ocular hypertension or open angle glaucoma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Six-year rate of visual field progression in the Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial.",
        "journal": "Ophthalmology",
        "publication_date": "2025-10-01",
        "pubmed_id": "41043781",
        "doi": "10.1016/j.ophtha.2025.09.023"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:19:37"
    },
    {
      "id": 1302,
      "intervention": {
        "name": "Baduanjin exercise",
        "canonical_name": "baduanjin exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "baduanjin exercise",
          "layer_2_variant": "baduanjin exercise",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chemotherapy-related cognitive impairment",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "integration of physical movement with cognitive engagement",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 70,
        "duration": "12 weeks",
        "population": "women diagnosed with breast cancer and scheduled for chemotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Baduanjin on cognitive performance and upper limb function in patients receiving chemotherapy after breast cancer surgery: a randomized controlled trial.",
        "journal": "Complementary therapies in medicine",
        "publication_date": "2025-10-01",
        "pubmed_id": "41043592",
        "doi": "10.1016/j.ctim.2025.103252"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:16:09"
    },
    {
      "id": 1303,
      "intervention": {
        "name": "Baduanjin exercise",
        "canonical_name": "baduanjin exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "baduanjin exercise",
          "layer_2_variant": "baduanjin exercise",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "upper limb dysfunction",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improves shoulder function and range of motion",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 70,
        "duration": "12 weeks",
        "population": "women diagnosed with breast cancer and scheduled for chemotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Baduanjin on cognitive performance and upper limb function in patients receiving chemotherapy after breast cancer surgery: a randomized controlled trial.",
        "journal": "Complementary therapies in medicine",
        "publication_date": "2025-10-01",
        "pubmed_id": "41043592",
        "doi": "10.1016/j.ctim.2025.103252"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:16:09"
    },
    {
      "id": 1300,
      "intervention": {
        "name": "accelerated kidney replacement therapy initiation",
        "canonical_name": "kidney replacement therapy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "kidney replacement therapy",
          "layer_2_variant": "accelerated kidney replacement therapy initiation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe acute kidney injury",
        "canonical_name": null,
        "category": "renal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "early initiation of renal replacement therapy",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "economic evaluation based on randomized clinical trial",
        "sample_size": 73,
        "duration": null,
        "population": "critically ill patients with severe acute kidney injury",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-Utility Analysis of Accelerated and Standard Strategies for Renal Replacement Therapy Initiation.",
        "journal": "JAMA network open",
        "publication_date": "2025-10-01",
        "pubmed_id": "41042508",
        "doi": "10.1001/jamanetworkopen.2025.35343"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:14:15"
    },
    {
      "id": 1301,
      "intervention": {
        "name": "standard kidney replacement therapy initiation",
        "canonical_name": "kidney replacement therapy",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "kidney replacement therapy",
          "layer_2_variant": "standard kidney replacement therapy initiation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe acute kidney injury",
        "canonical_name": null,
        "category": "renal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "delayed initiation of renal replacement therapy",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "economic evaluation based on randomized clinical trial",
        "sample_size": 73,
        "duration": null,
        "population": "critically ill patients with severe acute kidney injury",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-Utility Analysis of Accelerated and Standard Strategies for Renal Replacement Therapy Initiation.",
        "journal": "JAMA network open",
        "publication_date": "2025-10-01",
        "pubmed_id": "41042508",
        "doi": "10.1001/jamanetworkopen.2025.35343"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:14:15"
    },
    {
      "id": 1298,
      "intervention": {
        "name": "ecological momentary assessment",
        "canonical_name": "ecological momentary assessment",
        "category": "test",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ecological momentary assessment",
          "layer_2_variant": "ecological momentary assessment",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic low back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "monitoring pain fluctuations in real-time to improve treatment personalization",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "people with chronic low back pain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Circadian rhythmicity and biopsychosocial characteristics influence opioid use in chronic low back pain.",
        "journal": "The Journal of clinical investigation",
        "publication_date": "2025-10-01",
        "pubmed_id": "41031896",
        "doi": "10.1172/JCI188620"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:12:19"
    },
    {
      "id": 1299,
      "intervention": {
        "name": "questionnaires",
        "canonical_name": "questionnaires",
        "category": "test",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "questionnaires",
          "layer_2_variant": "questionnaires",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic low back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "assessing biopsychosocial characteristics to guide personalized treatment",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": "people with chronic low back pain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Circadian rhythmicity and biopsychosocial characteristics influence opioid use in chronic low back pain.",
        "journal": "The Journal of clinical investigation",
        "publication_date": "2025-10-01",
        "pubmed_id": "41031896",
        "doi": "10.1172/JCI188620"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:12:19"
    },
    {
      "id": 1296,
      "intervention": {
        "name": "suprapatellar intramedullary nailing",
        "canonical_name": "intramedullary nailing",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "intramedullary nailing",
          "layer_2_variant": "suprapatellar intramedullary nailing",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "extra-articular tibial fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced operative and fluoroscopy time, lower pain scores, improved knee function metrics",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with extra-articular tibial fractures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of suprapatellar and infrapatellar intramedullary nailing for tibial fractures: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "BMC musculoskeletal disorders",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034881",
        "doi": "10.1186/s12891-025-09162-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:10:09"
    },
    {
      "id": 1297,
      "intervention": {
        "name": "infrapatellar intramedullary nailing",
        "canonical_name": "intramedullary nailing",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "intramedullary nailing",
          "layer_2_variant": "infrapatellar intramedullary nailing",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "extra-articular tibial fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "conventional surgical approach for tibial fractures",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with extra-articular tibial fractures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of suprapatellar and infrapatellar intramedullary nailing for tibial fractures: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "BMC musculoskeletal disorders",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034881",
        "doi": "10.1186/s12891-025-09162-1"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:10:09"
    },
    {
      "id": 1294,
      "intervention": {
        "name": "active video games",
        "canonical_name": "active video games",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "active video games",
          "layer_2_variant": "active video games",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "behavioral intention to participate in physical activity",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced engagement and motivation through interactive gameplay",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 82,
        "duration": "6 weeks",
        "population": "patients with schizophrenia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Active Video Games to Improve Behavioral Intentions and Cognitive Function in Patients With Schizophrenia: Randomized Controlled Trial.",
        "journal": "JMIR serious games",
        "publication_date": "2025-10-01",
        "pubmed_id": "41032869",
        "doi": "10.2196/69116"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:08:16"
    },
    {
      "id": 1295,
      "intervention": {
        "name": "active video games",
        "canonical_name": "active video games",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "active video games",
          "layer_2_variant": "active video games",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cognitive function",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "stimulation of cognitive domains such as orientation and language",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 82,
        "duration": "6 weeks",
        "population": "patients with schizophrenia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Active Video Games to Improve Behavioral Intentions and Cognitive Function in Patients With Schizophrenia: Randomized Controlled Trial.",
        "journal": "JMIR serious games",
        "publication_date": "2025-10-01",
        "pubmed_id": "41032869",
        "doi": "10.2196/69116"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:08:16"
    },
    {
      "id": 1293,
      "intervention": {
        "name": "VA CALM-S",
        "canonical_name": "va calm s",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "va calm s",
          "layer_2_variant": "va calm-s",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anxiety and substance use disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cognitive behavioral techniques targeting anxiety and substance use behaviors",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 26,
        "duration": null,
        "population": "veterans with co-occurring anxiety and substance use disorders",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Feasibility, Acceptability, and Preliminary Clinical Impact of a Computer-Assisted Transdiagnostic CBT Intervention for Veterans with Co-Occurring Anxiety and Substance Use Disorders.",
        "journal": "Journal of dual diagnosis",
        "publication_date": "2025-10-01",
        "pubmed_id": "41033342",
        "doi": "10.1080/15504263.2025.2559174"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:06:25"
    },
    {
      "id": 1291,
      "intervention": {
        "name": "imaging tools",
        "canonical_name": "imaging tools",
        "category": "device",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "imaging tools",
          "layer_2_variant": "imaging tools",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "enthesitis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved detection of inflammatory enthesitis",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "GRAPPA Debate: Be it Resolved That Clinical Enthesitis Indices Do Not Reflect True Enthesitis and Hence Should Be Discontinued.",
        "journal": "The Journal of rheumatology",
        "publication_date": "2025-10-01",
        "pubmed_id": "41033825",
        "doi": "10.3899/jrheum.2025-0910"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:04:58"
    },
    {
      "id": 1292,
      "intervention": {
        "name": "ultrasound",
        "canonical_name": "ultrasound",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ultrasound",
          "layer_2_variant": "ultrasound",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "enthesitis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "evaluation of inflammation at entheses",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "GRAPPA Debate: Be it Resolved That Clinical Enthesitis Indices Do Not Reflect True Enthesitis and Hence Should Be Discontinued.",
        "journal": "The Journal of rheumatology",
        "publication_date": "2025-10-01",
        "pubmed_id": "41033825",
        "doi": "10.3899/jrheum.2025-0910"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:04:58"
    },
    {
      "id": 1290,
      "intervention": {
        "name": "montelukast",
        "canonical_name": "leukotriene receptor antagonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "leukotriene receptor antagonists",
          "layer_2_variant": "montelukast",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "doxorubicin-induced cardiotoxicity",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation and cardioprotective effects",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, randomized, controlled clinical study",
        "sample_size": 50,
        "duration": null,
        "population": "individuals with a confirmed diagnosis of breast cancer scheduled to receive doxorubicin and cyclophosphamide",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034674",
        "doi": "10.1007/s00520-025-09947-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:03:21"
    },
    {
      "id": 1289,
      "intervention": {
        "name": "trastuzumab deruxtecan",
        "canonical_name": "trastuzumab deruxtecan",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "trastuzumab deruxtecan",
          "layer_2_variant": "trastuzumab deruxtecan",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "HER2-mutant metastatic non-small cell lung cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted delivery of cytotoxic payload to HER2-expressing cells",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with HER2-mutant metastatic NSCLC who received prior systemic therapy",
        "adverse_effects": "interstitial lung disease (ILD)",
        "cost_category": null
      },
      "paper": {
        "title": "Trastuzumab deruxtecan: An antibody-drug conjugates for non-small cell lung cancer.",
        "journal": "Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners",
        "publication_date": "2025-10-01",
        "pubmed_id": "41032684",
        "doi": "10.1177/10781552251383762"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:01:47"
    },
    {
      "id": 1287,
      "intervention": {
        "name": "monthly minodronate",
        "canonical_name": "minodronate",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "minodronate",
          "layer_2_variant": "monthly minodronate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "osteoporosis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased bone mineral density through bisphosphonate action",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double blind, positive-controlled, multicenter phase III clinical trial",
        "sample_size": 330,
        "duration": "48 weeks",
        "population": "Chinese postmenopausal women with osteoporosis",
        "adverse_effects": "no new safety risks compared with alendronate",
        "cost_category": null
      },
      "paper": {
        "title": "A phase III clinical trial of monthly minodronate in the treatment of Chinese postmenopausal women with osteoporosis.",
        "journal": "Acta pharmacologica Sinica",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034401",
        "doi": "10.1038/s41401-025-01661-0"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:00:15"
    },
    {
      "id": 1288,
      "intervention": {
        "name": "weekly alendronate",
        "canonical_name": "alendronate",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "alendronate",
          "layer_2_variant": "weekly alendronate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "osteoporosis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased bone mineral density through bisphosphonate action",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, double blind, positive-controlled, multicenter phase III clinical trial",
        "sample_size": 330,
        "duration": "48 weeks",
        "population": "Chinese postmenopausal women with osteoporosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A phase III clinical trial of monthly minodronate in the treatment of Chinese postmenopausal women with osteoporosis.",
        "journal": "Acta pharmacologica Sinica",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034401",
        "doi": "10.1038/s41401-025-01661-0"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-07 00:00:15"
    },
    {
      "id": 1286,
      "intervention": {
        "name": "high-fat-high-glucose mixed-meal challenge",
        "canonical_name": "high-fat-high-glucose mixed-meal challenge",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "high-fat-high-glucose mixed-meal challenge",
          "layer_2_variant": "high-fat-high-glucose mixed-meal challenge",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "metabolic pathways in adipose tissue",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of gene expression related to energy metabolism and oxidative phosphorylation",
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "secondary analysis of a randomized clinical trial",
        "sample_size": 66,
        "duration": null,
        "population": "middle-aged participants with varying levels of intrahepatic lipids (IHL)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Mixed-meal challenge differentially modulates metabolic pathways in adipose tissue in healthy abdominally obese subjects with high versus low liver fat: a secondary analysis of a randomized clinical trial.",
        "journal": "Nutrition & metabolism",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034990",
        "doi": "10.1186/s12986-025-01010-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:58:15"
    },
    {
      "id": 1285,
      "intervention": {
        "name": "digital intervention",
        "canonical_name": "digital intervention",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "digital intervention",
          "layer_2_variant": "digital intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "type 2 diabetes",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "prevention through lifestyle and behavioural modification",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster-randomised controlled trial",
        "sample_size": 3240,
        "duration": "24 months",
        "population": "individuals with pre-diabetes in urban and rural settings in Tamil Nadu and Delhi",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Evaluating a digital intervention for prevention of type 2 diabetes: protocol for a cluster-randomised controlled trial in urban and rural India.",
        "journal": "BMC public health",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034772",
        "doi": "10.1186/s12889-025-24337-0"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:56:43"
    },
    {
      "id": 1284,
      "intervention": {
        "name": "SUGAR Handshake",
        "canonical_name": "sugar handshake",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sugar handshake",
          "layer_2_variant": "sugar handshake",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hypoglycaemia",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "educational support to avoid hypoglycaemia and manage antidiabetic medication side-effects",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "pragmatic randomized controlled trial",
        "sample_size": 106,
        "duration": "not explicitly stated",
        "population": "elderly people with type 2 diabetes mellitus",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The SUGAR handshake intervention to prevent hypoglycaemia in elderly people with type 2 diabetes: process evaluation within a pragmatic randomised controlled trial.",
        "journal": "BMC geriatrics",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034834",
        "doi": "10.1186/s12877-025-06361-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:55:12"
    },
    {
      "id": 1282,
      "intervention": {
        "name": "overdose education and naloxone distribution (OEND)",
        "canonical_name": "naloxone",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "naloxone",
          "layer_2_variant": "overdose education and naloxone distribution (oend)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "opioid overdose fatalities",
        "canonical_name": null,
        "category": "toxicological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "provision of naloxone and education on overdose prevention",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster randomized waitlist-controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "highly impacted communities in New York State",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities.",
        "journal": "Addiction science & clinical practice",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034965",
        "doi": "10.1186/s13722-025-00606-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:53:39"
    },
    {
      "id": 1283,
      "intervention": {
        "name": "safer opioid prescribing",
        "canonical_name": "opioid prescribing",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "opioid prescribing",
          "layer_2_variant": "safer opioid prescribing",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "opioid overdose fatalities",
        "canonical_name": null,
        "category": "toxicological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of opioid-related risks through clinical guidelines",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "cluster randomized waitlist-controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "highly impacted communities in New York State",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities.",
        "journal": "Addiction science & clinical practice",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034965",
        "doi": "10.1186/s13722-025-00606-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:53:39"
    },
    {
      "id": 1281,
      "intervention": {
        "name": "inulin/oligofructose mixture",
        "canonical_name": "inulin/oligofructose mixture",
        "category": "diet",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "inulin/oligofructose mixture",
          "layer_2_variant": "inulin/oligofructose mixture",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "constipation-predominant irritable bowel syndrome",
        "canonical_name": null,
        "category": "digestive",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation and reduced symptom severity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, single-blind, placebo-controlled clinical trial",
        "sample_size": 34,
        "duration": "8 weeks",
        "population": "individuals aged between 21 and 63 years with constipation-predominant IBS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomized trial of inulin for bowel symptoms, depression and quality of life in constipation predominant IBS.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034384",
        "doi": "10.1038/s41598-025-16321-w"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:51:40"
    },
    {
      "id": 1280,
      "intervention": {
        "name": "privacy-by-design avatars technique",
        "canonical_name": "privacy-by-design avatars technique",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "privacy-by-design avatars technique",
          "layer_2_variant": "privacy-by-design avatars technique",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "multiple sclerosis",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "generative artificial intelligence to create synthetic datasets that replicate clinical trial data while preserving privacy",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "evaluation study",
        "sample_size": 2160,
        "duration": null,
        "population": "patients with multiple sclerosis from two phase 3 RCTs (NCT00213135 and NCT00906399)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Privacy-by-Design Approach to Generate Two Virtual Clinical Trials for Multiple Sclerosis and Release Them as Open Datasets: Evaluation Study.",
        "journal": "Journal of medical Internet research",
        "publication_date": "2025-10-01",
        "pubmed_id": "41032725",
        "doi": "10.2196/71297"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:50:04"
    },
    {
      "id": 1277,
      "intervention": {
        "name": "home-based exergames",
        "canonical_name": "exergames",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exergames",
          "layer_2_variant": "home-based exergames",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cognitive dysfunction",
        "canonical_name": null,
        "category": "neurological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved executive function and dynamic balance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomised, rater-blinded, sham-controlled trial",
        "sample_size": 34,
        "duration": "8 weeks",
        "population": "people with multiple sclerosis and impaired processing speed",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Home-based EXergames To impRovE cognitive function in MUltiple Sclerosis (EXTREMUS).",
        "journal": "Journal of neurology, neurosurgery, and psychiatry",
        "publication_date": "2025-10-01",
        "pubmed_id": "41033785",
        "doi": "10.1136/jnnp-2025-336609"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:48:37"
    },
    {
      "id": 1278,
      "intervention": {
        "name": "adaptive Cognitive Training Kit (COGNI-TRAcK)",
        "canonical_name": "cognitive training",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cognitive training",
          "layer_2_variant": "adaptive cognitive training kit (cogni-track)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cognitive dysfunction",
        "canonical_name": null,
        "category": "neurological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "working memory enhancement",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomised, rater-blinded, sham-controlled trial",
        "sample_size": 34,
        "duration": "8 weeks",
        "population": "people with multiple sclerosis and impaired processing speed",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Home-based EXergames To impRovE cognitive function in MUltiple Sclerosis (EXTREMUS).",
        "journal": "Journal of neurology, neurosurgery, and psychiatry",
        "publication_date": "2025-10-01",
        "pubmed_id": "41033785",
        "doi": "10.1136/jnnp-2025-336609"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:48:37"
    },
    {
      "id": 1279,
      "intervention": {
        "name": "sham intervention",
        "canonical_name": "sham intervention",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sham intervention",
          "layer_2_variant": "sham intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cognitive dysfunction",
        "canonical_name": null,
        "category": "neurological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "no active intervention",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomised, rater-blinded, sham-controlled trial",
        "sample_size": 34,
        "duration": "8 weeks",
        "population": "people with multiple sclerosis and impaired processing speed",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Home-based EXergames To impRovE cognitive function in MUltiple Sclerosis (EXTREMUS).",
        "journal": "Journal of neurology, neurosurgery, and psychiatry",
        "publication_date": "2025-10-01",
        "pubmed_id": "41033785",
        "doi": "10.1136/jnnp-2025-336609"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:48:37"
    },
    {
      "id": 1274,
      "intervention": {
        "name": "nocturnal levetiracetam",
        "canonical_name": "levetiracetam",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "levetiracetam",
          "layer_2_variant": "nocturnal levetiracetam",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "self-limited epilepsy with centrotemporal spikes",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "seizure control and electroencephalogram normalization",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, open-label, non-inferiority study",
        "sample_size": 192,
        "duration": "6-12 months",
        "population": "children with self-limited epilepsy with centrotemporal spikes",
        "adverse_effects": "no difference in adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of one-dose nocturnal levetiracetam for the treatment of self-limited epilepsy with centrotemporal spikes: a randomized clinical trial.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034293",
        "doi": "10.1038/s41598-025-11906-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:46:22"
    },
    {
      "id": 1275,
      "intervention": {
        "name": "split-dose levetiracetam",
        "canonical_name": "levetiracetam",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "levetiracetam",
          "layer_2_variant": "split-dose levetiracetam",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "self-limited epilepsy with centrotemporal spikes",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "seizure control and electroencephalogram normalization",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, open-label, non-inferiority study",
        "sample_size": 192,
        "duration": "6-12 months",
        "population": "children with self-limited epilepsy with centrotemporal spikes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of one-dose nocturnal levetiracetam for the treatment of self-limited epilepsy with centrotemporal spikes: a randomized clinical trial.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034293",
        "doi": "10.1038/s41598-025-11906-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:46:22"
    },
    {
      "id": 1276,
      "intervention": {
        "name": "split-dose levetiracetam",
        "canonical_name": "levetiracetam",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "levetiracetam",
          "layer_2_variant": "split-dose levetiracetam",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "self-limited epilepsy with centrotemporal spikes",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "seizure control and electroencephalogram normalization",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, open-label, non-inferiority study",
        "sample_size": 192,
        "duration": "6-12 months",
        "population": "children with self-limited epilepsy with centrotemporal spikes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of one-dose nocturnal levetiracetam for the treatment of self-limited epilepsy with centrotemporal spikes: a randomized clinical trial.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034293",
        "doi": "10.1038/s41598-025-11906-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:46:22"
    },
    {
      "id": 1268,
      "intervention": {
        "name": "pulmonary vasodilators",
        "canonical_name": "pulmonary vasodilators",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pulmonary vasodilators",
          "layer_2_variant": "pulmonary vasodilators",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pulmonary hypertension",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of pulmonary vascular resistance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "infants with congenital diaphragmatic hernia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:43:58"
    },
    {
      "id": 1269,
      "intervention": {
        "name": "inotropes",
        "canonical_name": "inotropes",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "inotropes",
          "layer_2_variant": "inotropes",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "impaired myocardial function",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhancement of cardiac contractility",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "infants with congenital diaphragmatic hernia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:43:58"
    },
    {
      "id": 1270,
      "intervention": {
        "name": "vasopressors",
        "canonical_name": "vasopressors",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vasopressors",
          "layer_2_variant": "vasopressors",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hypotension",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased systemic vascular resistance",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "infants with congenital diaphragmatic hernia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:43:58"
    },
    {
      "id": 1271,
      "intervention": {
        "name": "prostaglandins",
        "canonical_name": "prostaglandins",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "prostaglandins",
          "layer_2_variant": "prostaglandins",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pulmonary hypertension",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "vasodilation of pulmonary arteries",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "infants with congenital diaphragmatic hernia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:43:58"
    },
    {
      "id": 1272,
      "intervention": {
        "name": "corticosteroids",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "corticosteroids",
          "layer_2_variant": "corticosteroids",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammation",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "suppression of inflammatory response",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "infants with congenital diaphragmatic hernia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:43:58"
    },
    {
      "id": 1273,
      "intervention": {
        "name": "targeted neonatal echocardiography",
        "canonical_name": "neonatal echocardiography",
        "category": "test",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "neonatal echocardiography",
          "layer_2_variant": "targeted neonatal echocardiography",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiovascular management",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "real-time assessment of ventricular performance and hemodynamic status",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "infants with congenital diaphragmatic hernia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:43:58"
    },
    {
      "id": 1266,
      "intervention": {
        "name": "Drug-Coated Balloon (DCB)",
        "canonical_name": "drug-coated balloon",
        "category": "device",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "drug-coated balloon",
          "layer_2_variant": "drug-coated balloon (dcb)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "de novo lesions of large coronary arteries",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "angioplasty with drug delivery to prevent restenosis",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 9745,
        "duration": "17 ± 8 months",
        "population": "patients with de novo lesions of large coronary arteries",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Drug-Coated Balloon Versus Drug-Eluting Stent for De Novo Lesions of Large Coronary Arteries: A Systematic Review and Meta-Analysis of Angiographic and Clinical Outcomes.",
        "journal": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions",
        "publication_date": "2025-10-01",
        "pubmed_id": "41031479",
        "doi": "10.1002/ccd.70223"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:41:28"
    },
    {
      "id": 1267,
      "intervention": {
        "name": "Drug-Eluting Stent (DES)",
        "canonical_name": "drug-eluting stent",
        "category": "device",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "drug-eluting stent",
          "layer_2_variant": "drug-eluting stent (des)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "de novo lesions of large coronary arteries",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "stent placement with drug elution to prevent restenosis",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 9745,
        "duration": "16 ± 4 months",
        "population": "patients with de novo lesions of large coronary arteries",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Drug-Coated Balloon Versus Drug-Eluting Stent for De Novo Lesions of Large Coronary Arteries: A Systematic Review and Meta-Analysis of Angiographic and Clinical Outcomes.",
        "journal": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions",
        "publication_date": "2025-10-01",
        "pubmed_id": "41031479",
        "doi": "10.1002/ccd.70223"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:41:28"
    },
    {
      "id": 1265,
      "intervention": {
        "name": "mindfulness-based meditation",
        "canonical_name": "mindfulness-based meditation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "mindfulness-based meditation",
          "layer_2_variant": "mindfulness-based meditation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "immune function",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reducing inflammation, increasing immune cell counts and activity, promoting telomere length and activity",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and three-level meta-analysis",
        "sample_size": 991,
        "duration": null,
        "population": "cancer patients (primarily breast cancer, >87%)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Mindfulness-Based Meditation on the Immune Function of Breast Cancer Patients: A Systematic Review and Three-Level Meta-Analysis.",
        "journal": "Neuroscience and biobehavioral reviews",
        "publication_date": "2025-10-02",
        "pubmed_id": "41046005",
        "doi": "10.1016/j.neubiorev.2025.106396"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:39:38"
    },
    {
      "id": 1262,
      "intervention": {
        "name": "high-dose propofol-supplemented cardioplegia",
        "canonical_name": "propofol",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "propofol",
          "layer_2_variant": "high-dose propofol-supplemented cardioplegia",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiac troponin release",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cardioprotective effects during cardioplegic arrest",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "blinded, parallel group randomized controlled trial",
        "sample_size": 240,
        "duration": "12 months",
        "population": "adults undergoing first-time coronary artery bypass grafting surgery",
        "adverse_effects": "adverse events which prolonged the hospital stay, or were life-threatening",
        "cost_category": null
      },
      "paper": {
        "title": "Propofol-supplemented cardioplegia: a multi-center blinded three-group randomized trial (ProMPT2).",
        "journal": "The Journal of thoracic and cardiovascular surgery",
        "publication_date": "2025-10-02",
        "pubmed_id": "41046123",
        "doi": "10.1016/j.jtcvs.2025.09.040"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:38:13"
    },
    {
      "id": 1263,
      "intervention": {
        "name": "low-dose propofol-supplemented cardioplegia",
        "canonical_name": "propofol",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "propofol",
          "layer_2_variant": "low-dose propofol-supplemented cardioplegia",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiac troponin release",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cardioprotective effects during cardioplegic arrest",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "blinded, parallel group randomized controlled trial",
        "sample_size": 240,
        "duration": "12 months",
        "population": "adults undergoing first-time coronary artery bypass grafting surgery",
        "adverse_effects": "adverse events which prolonged the hospital stay, or were life-threatening",
        "cost_category": null
      },
      "paper": {
        "title": "Propofol-supplemented cardioplegia: a multi-center blinded three-group randomized trial (ProMPT2).",
        "journal": "The Journal of thoracic and cardiovascular surgery",
        "publication_date": "2025-10-02",
        "pubmed_id": "41046123",
        "doi": "10.1016/j.jtcvs.2025.09.040"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:38:13"
    },
    {
      "id": 1264,
      "intervention": {
        "name": "placebo (saline)-supplemented cardioplegia",
        "canonical_name": "cardioplegia",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "cardioplegia",
          "layer_2_variant": "placebo (saline)-supplemented cardioplegia",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiac troponin release",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "no cardioprotective effects",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "blinded, parallel group randomized controlled trial",
        "sample_size": 240,
        "duration": "12 months",
        "population": "adults undergoing first-time coronary artery bypass grafting surgery",
        "adverse_effects": "adverse events which prolonged the hospital stay, or were life-threatening",
        "cost_category": null
      },
      "paper": {
        "title": "Propofol-supplemented cardioplegia: a multi-center blinded three-group randomized trial (ProMPT2).",
        "journal": "The Journal of thoracic and cardiovascular surgery",
        "publication_date": "2025-10-02",
        "pubmed_id": "41046123",
        "doi": "10.1016/j.jtcvs.2025.09.040"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:38:13"
    },
    {
      "id": 1261,
      "intervention": {
        "name": "DialBetesPlus app",
        "canonical_name": "dialbetesplus app",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "dialbetesplus app",
          "layer_2_variant": "dialbetesplus app",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "dietary fiber intake in type 2 diabetes",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "dietary self-monitoring and basic nutritional feedback",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 47,
        "duration": "12 months",
        "population": "patients with type 2 diabetes in Japan",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dietary Fiber Estimate of DialBetesPlus App Users: Secondary Analysis of Data From a Randomized Controlled Trial.",
        "journal": "JMIR formative research",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037783",
        "doi": "10.2196/69340"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:35:44"
    },
    {
      "id": 1258,
      "intervention": {
        "name": "Paleolithic diet",
        "canonical_name": "paleolithic diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "paleolithic diet",
          "layer_2_variant": "paleolithic diet",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "abdominal obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of dietary intake to align with Paleolithic food patterns",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 57,
        "duration": "24 months",
        "population": "participants with increased waist circumference and at least one additional risk factor for cardiovascular disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Paleolithic diet fraction and score in post hoc data analysis of a randomized controlled trial with lifestyle interventions for abdominal obesity.",
        "journal": "BMC nutrition",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039470",
        "doi": "10.1186/s40795-025-01165-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:34:08"
    },
    {
      "id": 1259,
      "intervention": {
        "name": "physical exercise",
        "canonical_name": "physical exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "physical exercise",
          "layer_2_variant": "physical exercise",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "abdominal obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved metabolic and cardiovascular health through physical activity",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 57,
        "duration": "24 months",
        "population": "participants with increased waist circumference and at least one additional risk factor for cardiovascular disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Paleolithic diet fraction and score in post hoc data analysis of a randomized controlled trial with lifestyle interventions for abdominal obesity.",
        "journal": "BMC nutrition",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039470",
        "doi": "10.1186/s40795-025-01165-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:34:08"
    },
    {
      "id": 1260,
      "intervention": {
        "name": "diet based on current dietary guidelines",
        "canonical_name": "diet based on current dietary guidelines",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "diet based on current dietary guidelines",
          "layer_2_variant": "diet based on current dietary guidelines",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "abdominal obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "promotion of balanced nutritional intake aligned with modern dietary recommendations",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 57,
        "duration": "24 months",
        "population": "participants with increased waist circumference and at least one additional risk factor for cardiovascular disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Paleolithic diet fraction and score in post hoc data analysis of a randomized controlled trial with lifestyle interventions for abdominal obesity.",
        "journal": "BMC nutrition",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039470",
        "doi": "10.1186/s40795-025-01165-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:34:08"
    },
    {
      "id": 1256,
      "intervention": {
        "name": "telerehabilitation-supported lifestyle modification program",
        "canonical_name": "lifestyle modification program",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "lifestyle modification program",
          "layer_2_variant": "telerehabilitation-supported lifestyle modification program",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postsurgical recovery after total knee arthroplasty",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced adherence to rehabilitation and improved physical function through remote monitoring and behavioral support",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 52,
        "duration": "22 weeks",
        "population": "patients undergoing primary total knee arthroplasty",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Lifestyle Modification Through Web-Based Telerehabilitation Monitoring Combined With Supervised Sensorimotor Training After Total Knee Arthroplasty: Randomized Controlled Trial.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037782",
        "doi": "10.2196/64643"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:31:50"
    },
    {
      "id": 1257,
      "intervention": {
        "name": "supervised sensorimotor training",
        "canonical_name": "sensorimotor training",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sensorimotor training",
          "layer_2_variant": "supervised sensorimotor training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postsurgical recovery after total knee arthroplasty",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved joint position sense and balance through targeted physical exercises",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 52,
        "duration": "22 weeks",
        "population": "patients undergoing primary total knee arthroplasty",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Lifestyle Modification Through Web-Based Telerehabilitation Monitoring Combined With Supervised Sensorimotor Training After Total Knee Arthroplasty: Randomized Controlled Trial.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037782",
        "doi": "10.2196/64643"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:31:50"
    },
    {
      "id": 1254,
      "intervention": {
        "name": "pembrolizumab",
        "canonical_name": "pembrolizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pembrolizumab",
          "layer_2_variant": "pembrolizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "metastatic triple-negative breast cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "immune checkpoint inhibition",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 3 randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "previously treated metastatic TNBC participants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.",
        "journal": "NPJ breast cancer",
        "publication_date": "2025-10-02",
        "pubmed_id": "41038856",
        "doi": "10.1038/s41523-025-00814-y"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:29:45"
    },
    {
      "id": 1255,
      "intervention": {
        "name": "investigator's choice of chemotherapy",
        "canonical_name": "chemotherapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "chemotherapy",
          "layer_2_variant": "investigator's choice of chemotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "metastatic triple-negative breast cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "cytotoxic effects on cancer cells",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 3 randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "previously treated metastatic TNBC participants",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.",
        "journal": "NPJ breast cancer",
        "publication_date": "2025-10-02",
        "pubmed_id": "41038856",
        "doi": "10.1038/s41523-025-00814-y"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:29:45"
    },
    {
      "id": 1251,
      "intervention": {
        "name": "intrinsic antitachycardia pacing (iATP) protocol",
        "canonical_name": "intrinsic antitachycardia pacing",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "intrinsic antitachycardia pacing",
          "layer_2_variant": "intrinsic antitachycardia pacing (iatp) protocol",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atrial flutter (AFl)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "introduction of premature wavefronts into the excitable gap",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, randomized crossover trial",
        "sample_size": 17,
        "duration": null,
        "population": "patients undergoing AFl ablation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Management of Atrial Flutter (AFL) Using Intrinsic Antitachycardia Pacing (iATP) Protocol.",
        "journal": "Journal of cardiovascular electrophysiology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039805",
        "doi": "10.1111/jce.70115"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:27:58"
    },
    {
      "id": 1252,
      "intervention": {
        "name": "ramp pacing at 91% of tachycardia cycle length (TCL)",
        "canonical_name": "ramp pacing",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ramp pacing",
          "layer_2_variant": "ramp pacing at 91% of tachycardia cycle length (tcl)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atrial flutter (AFl)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "rate control through electrical stimulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, randomized crossover trial",
        "sample_size": 17,
        "duration": null,
        "population": "patients undergoing AFl ablation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Management of Atrial Flutter (AFL) Using Intrinsic Antitachycardia Pacing (iATP) Protocol.",
        "journal": "Journal of cardiovascular electrophysiology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039805",
        "doi": "10.1111/jce.70115"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:27:58"
    },
    {
      "id": 1253,
      "intervention": {
        "name": "ramp pacing at 81% of tachycardia cycle length (TCL)",
        "canonical_name": "ramp pacing",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ramp pacing",
          "layer_2_variant": "ramp pacing at 81% of tachycardia cycle length (tcl)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atrial flutter (AFl)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "rate control through electrical stimulation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective, randomized crossover trial",
        "sample_size": 17,
        "duration": null,
        "population": "patients undergoing AFl ablation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Management of Atrial Flutter (AFL) Using Intrinsic Antitachycardia Pacing (iATP) Protocol.",
        "journal": "Journal of cardiovascular electrophysiology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039805",
        "doi": "10.1111/jce.70115"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:27:58"
    },
    {
      "id": 1249,
      "intervention": {
        "name": "remote Graded Motor Imagery (GMI) therapy",
        "canonical_name": "graded motor imagery",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "graded motor imagery",
          "layer_2_variant": "remote graded motor imagery (gmi) therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "central sensitisation low back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "retraining the brain's representation of the body to reduce pain sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": null,
        "duration": "6 weeks (intensive phase) + 6 months (maintenance phase)",
        "population": "adults aged 20-50 years with persistent low back pain for at least 6 months",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of remote graded motor imagery therapy for patients with central sensitisation low back pain: study protocol for a randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-10-02",
        "pubmed_id": "41043843",
        "doi": "10.1136/bmjopen-2024-097693"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:23:54"
    },
    {
      "id": 1250,
      "intervention": {
        "name": "conventional in-clinic therapy",
        "canonical_name": "conventional in-clinic therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "conventional in-clinic therapy",
          "layer_2_variant": "conventional in-clinic therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "central sensitisation low back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "physical aids for cognitive tasks and mirror therapy to manage pain sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": null,
        "duration": "6 weeks (intensive phase) + 6 months (maintenance phase)",
        "population": "adults aged 20-50 years with persistent low back pain for at least 6 months",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of remote graded motor imagery therapy for patients with central sensitisation low back pain: study protocol for a randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-10-02",
        "pubmed_id": "41043843",
        "doi": "10.1136/bmjopen-2024-097693"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:23:54"
    },
    {
      "id": 1245,
      "intervention": {
        "name": "probiotics",
        "canonical_name": "probiotics",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "probiotics",
          "layer_2_variant": "probiotics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Autism Spectrum Disorder",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "individuals with Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of gut microbiota-based therapy for autism Spectrum Disorder and attention Deficit Hyperactivity Disorder: a systematic review and meta-analysis.",
        "journal": "Psychology, health & medicine",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037658",
        "doi": "10.1080/13548506.2025.2565181"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:21:50"
    },
    {
      "id": 1246,
      "intervention": {
        "name": "prebiotics",
        "canonical_name": "prebiotics",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "prebiotics",
          "layer_2_variant": "prebiotics",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Autism Spectrum Disorder",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "individuals with Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of gut microbiota-based therapy for autism Spectrum Disorder and attention Deficit Hyperactivity Disorder: a systematic review and meta-analysis.",
        "journal": "Psychology, health & medicine",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037658",
        "doi": "10.1080/13548506.2025.2565181"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:21:50"
    },
    {
      "id": 1247,
      "intervention": {
        "name": "dietary changes",
        "canonical_name": "dietary changes",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "dietary changes",
          "layer_2_variant": "dietary changes",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Autism Spectrum Disorder",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "individuals with Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of gut microbiota-based therapy for autism Spectrum Disorder and attention Deficit Hyperactivity Disorder: a systematic review and meta-analysis.",
        "journal": "Psychology, health & medicine",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037658",
        "doi": "10.1080/13548506.2025.2565181"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:21:50"
    },
    {
      "id": 1248,
      "intervention": {
        "name": "fecal transplants",
        "canonical_name": "fecal microbiota transplantation",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "fecal microbiota transplantation",
          "layer_2_variant": "fecal transplants",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Autism Spectrum Disorder",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation",
      "correlation": {
        "type": "positive",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "individuals with Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of gut microbiota-based therapy for autism Spectrum Disorder and attention Deficit Hyperactivity Disorder: a systematic review and meta-analysis.",
        "journal": "Psychology, health & medicine",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037658",
        "doi": "10.1080/13548506.2025.2565181"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:21:50"
    },
    {
      "id": 1244,
      "intervention": {
        "name": "Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis synbiotic formulation",
        "canonical_name": "probiotics",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "probiotics",
          "layer_2_variant": "lactiplantibacillus plantarum and bifidobacterium longum subspecies infantis synbiotic formulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "infection-related morbidity and mortality in newborns",
        "canonical_name": null,
        "category": "infectious",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "gut microbiome modulation and enhanced immune response",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 244,
        "duration": "6 months",
        "population": "healthy neonates (<72 h old) in the Eastern Highlands Province of Papua New Guinea",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial.",
        "journal": "JMIR research protocols",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037809",
        "doi": "10.2196/73926"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:14:48"
    },
    {
      "id": 1243,
      "intervention": {
        "name": "early TIPS implantation",
        "canonical_name": "tips",
        "category": "device",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tips",
          "layer_2_variant": "early tips implantation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ascites",
        "canonical_name": null,
        "category": "digestive",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduction of portal hypertension and prevention of further decompensation",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with liver cirrhosis and ascites at first decompensation with grade 2 ascites and MELD score ≥15, or grade 3 ascites irrespective of MELD score",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Early implantation of a transjugular intrahepatic portosystemic shunt (TIPS) in patients with liver cirrhosis and ascites (eTIPS): a multicentre, randomised controlled trial.",
        "journal": "Trials",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039580",
        "doi": "10.1186/s13063-025-09038-8"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:13:02"
    },
    {
      "id": 1236,
      "intervention": {
        "name": "exercise interventions",
        "canonical_name": "exercise interventions",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise interventions",
          "layer_2_variant": "exercise interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "fatigue",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved physiological functions",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2696,
        "duration": null,
        "population": "breast cancer patients receiving adjuvant therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Exercise Interventions on Breast Cancer Patients During Adjuvant Therapy: A Systematic Review and Meta-Analysis.",
        "journal": "Cancer research and treatment",
        "publication_date": "2025-10-02",
        "pubmed_id": "41035214",
        "doi": "10.4143/crt.2025.762"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:09:45"
    },
    {
      "id": 1237,
      "intervention": {
        "name": "exercise interventions",
        "canonical_name": "exercise interventions",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise interventions",
          "layer_2_variant": "exercise interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "muscular strength",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved physiological functions",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2696,
        "duration": null,
        "population": "breast cancer patients receiving adjuvant therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Exercise Interventions on Breast Cancer Patients During Adjuvant Therapy: A Systematic Review and Meta-Analysis.",
        "journal": "Cancer research and treatment",
        "publication_date": "2025-10-02",
        "pubmed_id": "41035214",
        "doi": "10.4143/crt.2025.762"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:09:45"
    },
    {
      "id": 1238,
      "intervention": {
        "name": "exercise interventions",
        "canonical_name": "exercise interventions",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise interventions",
          "layer_2_variant": "exercise interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiorespiratory fitness",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved physiological functions",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2696,
        "duration": null,
        "population": "breast cancer patients receiving adjuvant therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Exercise Interventions on Breast Cancer Patients During Adjuvant Therapy: A Systematic Review and Meta-Analysis.",
        "journal": "Cancer research and treatment",
        "publication_date": "2025-10-02",
        "pubmed_id": "41035214",
        "doi": "10.4143/crt.2025.762"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:09:45"
    },
    {
      "id": 1239,
      "intervention": {
        "name": "exercise interventions",
        "canonical_name": "exercise interventions",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise interventions",
          "layer_2_variant": "exercise interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammation",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2696,
        "duration": null,
        "population": "breast cancer patients receiving adjuvant therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Exercise Interventions on Breast Cancer Patients During Adjuvant Therapy: A Systematic Review and Meta-Analysis.",
        "journal": "Cancer research and treatment",
        "publication_date": "2025-10-02",
        "pubmed_id": "41035214",
        "doi": "10.4143/crt.2025.762"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:09:45"
    },
    {
      "id": 1240,
      "intervention": {
        "name": "exercise interventions",
        "canonical_name": "exercise interventions",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise interventions",
          "layer_2_variant": "exercise interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "quality of life",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved physiological and psychological functions",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2696,
        "duration": null,
        "population": "breast cancer patients receiving adjuvant therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Exercise Interventions on Breast Cancer Patients During Adjuvant Therapy: A Systematic Review and Meta-Analysis.",
        "journal": "Cancer research and treatment",
        "publication_date": "2025-10-02",
        "pubmed_id": "41035214",
        "doi": "10.4143/crt.2025.762"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:09:45"
    },
    {
      "id": 1241,
      "intervention": {
        "name": "exercise interventions",
        "canonical_name": "exercise interventions",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise interventions",
          "layer_2_variant": "exercise interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "anxiety",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved psychological functions",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2696,
        "duration": null,
        "population": "breast cancer patients receiving adjuvant therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Exercise Interventions on Breast Cancer Patients During Adjuvant Therapy: A Systematic Review and Meta-Analysis.",
        "journal": "Cancer research and treatment",
        "publication_date": "2025-10-02",
        "pubmed_id": "41035214",
        "doi": "10.4143/crt.2025.762"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:09:45"
    },
    {
      "id": 1242,
      "intervention": {
        "name": "exercise interventions",
        "canonical_name": "exercise interventions",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "exercise interventions",
          "layer_2_variant": "exercise interventions",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "depressive symptoms",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved psychological functions",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2696,
        "duration": null,
        "population": "breast cancer patients receiving adjuvant therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Exercise Interventions on Breast Cancer Patients During Adjuvant Therapy: A Systematic Review and Meta-Analysis.",
        "journal": "Cancer research and treatment",
        "publication_date": "2025-10-02",
        "pubmed_id": "41035214",
        "doi": "10.4143/crt.2025.762"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:09:45"
    },
    {
      "id": 1235,
      "intervention": {
        "name": "smartphone intervention apps",
        "canonical_name": "smartphone intervention apps",
        "category": "device",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "smartphone intervention apps",
          "layer_2_variant": "smartphone intervention apps",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "schizophrenia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "provision of tools for daily management and support",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.5,
        "study_confidence": 0.25
      },
      "study": {
        "type": "narrative review",
        "sample_size": null,
        "duration": null,
        "population": "people with schizophrenia and psychosis-spectrum disorders",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Smartphone intervention apps for schizophrenia: A review of the academic literature and app stores.",
        "journal": "Schizophrenia research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41045689",
        "doi": "10.1016/j.schres.2025.09.007"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:06:48"
    },
    {
      "id": 1234,
      "intervention": {
        "name": "saffron extract supplementation",
        "canonical_name": "saffron extract",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "saffron extract",
          "layer_2_variant": "saffron extract supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "subclinical depressive symptoms",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "modulated N-acetyl-phenylalanine levels",
      "correlation": {
        "type": "neutral",
        "strength": 0.25,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized, double-blind, placebo-controlled study",
        "sample_size": 51,
        "duration": "6 weeks",
        "population": "healthy individuals with subclinical neuropsychiatric symptoms",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of saffron extract supplementation on mood in healthy adults with subclinical symptoms of depression: A randomized, double-blind placebo-controlled study.",
        "journal": "The American journal of clinical nutrition",
        "publication_date": "2025-10-03",
        "pubmed_id": "41047129",
        "doi": "10.1016/j.ajcnut.2025.09.050"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:05:25"
    },
    {
      "id": 1233,
      "intervention": {
        "name": "radical prostatectomy with pelvic lymph-node dissection",
        "canonical_name": "prostatectomy",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "prostatectomy",
          "layer_2_variant": "radical prostatectomy with pelvic lymph-node dissection",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "oligometastatic prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "local tumor removal and lymph-node dissection to reduce cancer progression",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 132,
        "duration": "5 years",
        "population": "men with oligometastatic prostate cancer with low metastatic burden (1-5 bone metastases with/without nodal involvement)",
        "adverse_effects": "Clavien-Dindo grade ≥III surgery-related complications occurred in 14% of patients",
        "cost_category": null
      },
      "paper": {
        "title": "Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial.",
        "journal": "European urology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41046179",
        "doi": "10.1016/j.eururo.2025.09.4144"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:03:53"
    },
    {
      "id": 1232,
      "intervention": {
        "name": "vitamin C supplementation",
        "canonical_name": "vitamin c",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vitamin c",
          "layer_2_variant": "vitamin c supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "childhood lung function",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "alteration of asthma- and allergy-associated DNA methylation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 137,
        "duration": "5 years",
        "population": "pregnant smokers and their children",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Vitamin C supplementation to pregnant smokers alters asthma- and allergy-associated CpGs in child buccal DNA at 5 years of age.",
        "journal": "Clinical epigenetics",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044653",
        "doi": "10.1186/s13148-025-01965-2"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:01:53"
    },
    {
      "id": 1231,
      "intervention": {
        "name": "family-centered training and counselling",
        "canonical_name": "family-centered training and counselling",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "family-centered training and counselling",
          "layer_2_variant": "family-centered training and counselling",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetes foot",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved foot care practices through family education",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 54,
        "duration": "nine months",
        "population": "persons with diabetes mellitus aged 18-60 years and their family members",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Family-centered training and counselling for enhancing foot self-care knowledge and practices towards prevention of diabetes foot - a randomized controlled trial in urban Jodhpur.",
        "journal": "BMC public health",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044716",
        "doi": "10.1186/s12889-025-24652-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 23:00:21"
    },
    {
      "id": 1228,
      "intervention": {
        "name": "high-intensity interval training",
        "canonical_name": "high-intensity interval training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "high-intensity interval training",
          "layer_2_variant": "high-intensity interval training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiorespiratory fitness",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced aerobic capacity and metabolic efficiency",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.25
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 15,
        "duration": "8-12 weeks",
        "population": "breast cancer survivors",
        "adverse_effects": "no major exercise-related adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "A systematic review and meta-analysis of randomized controlled trials on the effects of high-intensity interval training in breast cancer survivors.",
        "journal": "Clinical rehabilitation",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042936",
        "doi": "10.1177/02692155251383151"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:56:53"
    },
    {
      "id": 1229,
      "intervention": {
        "name": "high-intensity interval training",
        "canonical_name": "high-intensity interval training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "high-intensity interval training",
          "layer_2_variant": "high-intensity interval training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "quality of life",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved physical and psychological well-being",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.25
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 15,
        "duration": "8-12 weeks",
        "population": "breast cancer survivors",
        "adverse_effects": "no major exercise-related adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "A systematic review and meta-analysis of randomized controlled trials on the effects of high-intensity interval training in breast cancer survivors.",
        "journal": "Clinical rehabilitation",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042936",
        "doi": "10.1177/02692155251383151"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:56:53"
    },
    {
      "id": 1230,
      "intervention": {
        "name": "high-intensity interval training",
        "canonical_name": "high-intensity interval training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "high-intensity interval training",
          "layer_2_variant": "high-intensity interval training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammation",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammatory markers",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.25
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 15,
        "duration": "8-12 weeks",
        "population": "breast cancer survivors",
        "adverse_effects": "no major exercise-related adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "A systematic review and meta-analysis of randomized controlled trials on the effects of high-intensity interval training in breast cancer survivors.",
        "journal": "Clinical rehabilitation",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042936",
        "doi": "10.1177/02692155251383151"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:56:53"
    },
    {
      "id": 1227,
      "intervention": {
        "name": "complete revascularization",
        "canonical_name": "revascularization",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "revascularization",
          "layer_2_variant": "complete revascularization",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "myocardial infarction with multivessel disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "restoration of blood flow to all affected coronary vessels",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1445,
        "duration": "3 years",
        "population": "older patients with myocardial infarction and multivessel disease",
        "adverse_effects": "contrast-associated acute kidney injury, stroke, Bleeding Academic Research Consortium 3 to 5",
        "cost_category": null
      },
      "paper": {
        "title": "Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions.",
        "journal": "Circulation. Cardiovascular interventions",
        "publication_date": "2025-10-03",
        "pubmed_id": "41039960",
        "doi": "10.1161/CIRCINTERVENTIONS.125.015902"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:54:39"
    },
    {
      "id": 1226,
      "intervention": {
        "name": "goal-directed perfusion",
        "canonical_name": "goal-directed perfusion",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "goal-directed perfusion",
          "layer_2_variant": "goal-directed perfusion",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic inflammatory response syndrome",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced inflammation by improving oxygen delivery",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational study",
        "sample_size": 908,
        "duration": null,
        "population": "patients undergoing cardiac surgery with cardiopulmonary bypass",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Inadequate oxygen delivery during cardiopulmonary bypass drives inflammatory reaction after cardiac surgery.",
        "journal": "European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042893",
        "doi": "10.1093/ejcts/ezaf340"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:53:05"
    },
    {
      "id": 1223,
      "intervention": {
        "name": "blood flow restriction training combined with electrical muscle stimulation",
        "canonical_name": "blood flow restriction training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "blood flow restriction training",
          "layer_2_variant": "blood flow restriction training combined with electrical muscle stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improves muscle volume and neuromuscular recruitment",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "parallel randomized controlled trial",
        "sample_size": 64,
        "duration": "8 weeks",
        "population": "university football players with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of blood flow restriction combined with electrical stimulation on muscle functions and performance in university football players with knee osteoarthritis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044340",
        "doi": "10.1038/s41598-025-18089-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:51:37"
    },
    {
      "id": 1224,
      "intervention": {
        "name": "blood flow restriction training",
        "canonical_name": "blood flow restriction training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "blood flow restriction training",
          "layer_2_variant": "blood flow restriction training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improves muscle volume and neuromuscular recruitment",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "parallel randomized controlled trial",
        "sample_size": 64,
        "duration": "8 weeks",
        "population": "university football players with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of blood flow restriction combined with electrical stimulation on muscle functions and performance in university football players with knee osteoarthritis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044340",
        "doi": "10.1038/s41598-025-18089-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:51:37"
    },
    {
      "id": 1225,
      "intervention": {
        "name": "electrical muscle stimulation",
        "canonical_name": "electrical muscle stimulation",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "electrical muscle stimulation",
          "layer_2_variant": "electrical muscle stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhances muscle activation and neuromuscular recruitment",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "parallel randomized controlled trial",
        "sample_size": 64,
        "duration": "8 weeks",
        "population": "university football players with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of blood flow restriction combined with electrical stimulation on muscle functions and performance in university football players with knee osteoarthritis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044340",
        "doi": "10.1038/s41598-025-18089-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:51:37"
    },
    {
      "id": 1218,
      "intervention": {
        "name": "calorie restriction",
        "canonical_name": "calorie restriction",
        "category": "diet",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "calorie restriction",
          "layer_2_variant": "calorie restriction",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "bone health",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "high turnover bone loss",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "people living with obesity",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of weight-loss interventions on bone health in people living with obesity.",
        "journal": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042228",
        "doi": "10.1093/jbmr/zjaf135"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:47:44"
    },
    {
      "id": 1219,
      "intervention": {
        "name": "metabolic and bariatric surgery (MBS)",
        "canonical_name": "metabolic and bariatric surgery",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "metabolic and bariatric surgery",
          "layer_2_variant": "metabolic and bariatric surgery (mbs)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "bone health",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "nutritional factors, mechanical unloading, hormonal factors, adipokines, and alterations in the gut microbiome",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "people living with obesity",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of weight-loss interventions on bone health in people living with obesity.",
        "journal": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042228",
        "doi": "10.1093/jbmr/zjaf135"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:47:44"
    },
    {
      "id": 1220,
      "intervention": {
        "name": "glucagon-like peptide-1 receptor agonists (GLP-1Ra)",
        "canonical_name": "glucagon-like peptide-1 receptor agonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glucagon-like peptide-1 receptor agonists",
          "layer_2_variant": "glucagon-like peptide-1 receptor agonists (glp-1ra)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "bone health",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhance bone metabolism and improve bone quality",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "people living with obesity",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of weight-loss interventions on bone health in people living with obesity.",
        "journal": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042228",
        "doi": "10.1093/jbmr/zjaf135"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:47:44"
    },
    {
      "id": 1221,
      "intervention": {
        "name": "liraglutide",
        "canonical_name": "glp-1 receptor agonists",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "liraglutide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "bone health",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhance bone metabolism and improve bone quality",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "people living with obesity",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of weight-loss interventions on bone health in people living with obesity.",
        "journal": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042228",
        "doi": "10.1093/jbmr/zjaf135"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:47:44"
    },
    {
      "id": 1222,
      "intervention": {
        "name": "semaglutide",
        "canonical_name": "glp-1 receptor agonists",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "semaglutide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "bone health",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "accelerated bone turnover and bone loss",
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "people living with obesity",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of weight-loss interventions on bone health in people living with obesity.",
        "journal": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042228",
        "doi": "10.1093/jbmr/zjaf135"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:47:44"
    },
    {
      "id": 1217,
      "intervention": {
        "name": "vagus nerve stimulation",
        "canonical_name": "vagus nerve stimulation",
        "category": "device",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vagus nerve stimulation",
          "layer_2_variant": "vagus nerve stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "drug-resistant epilepsy",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "electrical stimulation of the vagus nerve to modulate seizure activity",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": null,
        "duration": null,
        "population": "patients with drug-resistant epilepsy who received VNS between 2000 and 2023",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Outcome and predictors of response to vagus nerve stimulation for drug-resistant epilepsy: a retrospective cohort study.",
        "journal": "Neurosurgical review",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042470",
        "doi": "10.1007/s10143-025-03839-w"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:45:29"
    },
    {
      "id": 1216,
      "intervention": {
        "name": "participation in a community orchestra",
        "canonical_name": "community orchestra participation",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "community orchestra participation",
          "layer_2_variant": "participation in a community orchestra",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "depressive symptoms",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "emotional engagement and social interaction",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "non-randomized clinical trial",
        "sample_size": 22,
        "duration": null,
        "population": "individuals with Parkinson's disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "PARKinSOUND: Impact of participation in an orchestra in patients with Parkinson's disease.",
        "journal": "Journal of Parkinson's disease",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042999",
        "doi": "10.1177/1877718X251381089"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:44:05"
    },
    {
      "id": 1213,
      "intervention": {
        "name": "transcatheter aortic valve replacement (TAVR)",
        "canonical_name": "transcatheter aortic valve replacement",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "transcatheter aortic valve replacement",
          "layer_2_variant": "transcatheter aortic valve replacement (tavr)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "aortic valve stenosis",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "replaces aortic valve without open-heart surgery",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "low, intermediate, and high-risk patients with aortic valve stenosis",
        "adverse_effects": "higher transprosthetic gradients and hospital stay duration",
        "cost_category": null
      },
      "paper": {
        "title": "Sutureless versus transcatheter valves for the treatment of aortic valve stenosis: a systematic review and meta-analysis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044191",
        "doi": "10.1038/s41598-025-17857-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:42:47"
    },
    {
      "id": 1214,
      "intervention": {
        "name": "surgical aortic valve replacement (SAVR)",
        "canonical_name": "surgical aortic valve replacement",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "surgical aortic valve replacement",
          "layer_2_variant": "surgical aortic valve replacement (savr)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "aortic valve stenosis",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "replaces aortic valve through open-heart surgery",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "low, intermediate, and high-risk patients with aortic valve stenosis",
        "adverse_effects": "higher rates of moderate and severe aortic regurgitation and permanent pacemaker implantation",
        "cost_category": null
      },
      "paper": {
        "title": "Sutureless versus transcatheter valves for the treatment of aortic valve stenosis: a systematic review and meta-analysis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044191",
        "doi": "10.1038/s41598-025-17857-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:42:47"
    },
    {
      "id": 1215,
      "intervention": {
        "name": "sutureless aortic valve replacement (SU-AVR)",
        "canonical_name": "sutureless aortic valve replacement",
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sutureless aortic valve replacement",
          "layer_2_variant": "sutureless aortic valve replacement (su-avr)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "aortic valve stenosis",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "replaces aortic valve with sutureless bioprosthetic valve",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "low, intermediate, and high-risk patients with aortic valve stenosis",
        "adverse_effects": "higher transprosthetic gradients and hospital stay duration",
        "cost_category": null
      },
      "paper": {
        "title": "Sutureless versus transcatheter valves for the treatment of aortic valve stenosis: a systematic review and meta-analysis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044191",
        "doi": "10.1038/s41598-025-17857-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:42:47"
    },
    {
      "id": 1211,
      "intervention": {
        "name": "NUT combination containing Monacolin K (MK) and Morus alba",
        "canonical_name": "nutritional supplements",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nutritional supplements",
          "layer_2_variant": "nut combination containing monacolin k (mk) and morus alba",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiometabolic risk",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "dual modulation of lipid and glucose metabolism",
      "correlation": {
        "type": "negative",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 359,
        "duration": "3 months",
        "population": "patients at cardiometabolic risk",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044582",
        "doi": "10.1186/s12933-025-02920-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:40:39"
    },
    {
      "id": 1212,
      "intervention": {
        "name": "NUT combination containing Monacolin K (MK) alone",
        "canonical_name": "nutritional supplement",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "nutritional supplement",
          "layer_2_variant": "nut combination containing monacolin k (mk) alone",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "cardiometabolic risk",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "lipid reduction with potential negative impact on glycemia",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 359,
        "duration": "3 months",
        "population": "patients at cardiometabolic risk",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044582",
        "doi": "10.1186/s12933-025-02920-4"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:40:39"
    },
    {
      "id": 1210,
      "intervention": {
        "name": "rituximab",
        "canonical_name": "rituximab",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "rituximab",
          "layer_2_variant": "rituximab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "steroid-sensitive nephrotic syndrome",
        "canonical_name": null,
        "category": "renal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "B-cell depletion and immune modulation",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "target trial emulation",
        "sample_size": 104,
        "duration": "4.9 years",
        "population": "children and young adults (aged 1-40 years) with steroid-sensitive nephrotic syndrome",
        "adverse_effects": "hypertension risk reduction",
        "cost_category": null
      },
      "paper": {
        "title": "Steroid-sparing drugs in children and young adults with nephrotic syndrome: a target trial emulation.",
        "journal": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042242",
        "doi": "10.1093/ndt/gfaf207"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:38:48"
    },
    {
      "id": 1207,
      "intervention": {
        "name": "liraglutide",
        "canonical_name": "glp-1 receptor agonists",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "glp-1 receptor agonists",
          "layer_2_variant": "liraglutide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "activation of GLP-1 receptor",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "individuals with obesity and pre-diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of a GLP-1 Receptor Polymorphism on Responses to Liraglutide.",
        "journal": "The Journal of endocrinology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042549",
        "doi": "10.1530/JOE-25-0174"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:36:53"
    },
    {
      "id": 1208,
      "intervention": {
        "name": "sitagliptin",
        "canonical_name": "dipeptidyl peptidase-4 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "dipeptidyl peptidase-4 inhibitors",
          "layer_2_variant": "sitagliptin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibition of dipeptidyl peptidase 4",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "individuals with obesity and pre-diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of a GLP-1 Receptor Polymorphism on Responses to Liraglutide.",
        "journal": "The Journal of endocrinology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042549",
        "doi": "10.1530/JOE-25-0174"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:36:53"
    },
    {
      "id": 1209,
      "intervention": {
        "name": "hypocaloric diet",
        "canonical_name": "hypocaloric diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "hypocaloric diet",
          "layer_2_variant": "hypocaloric diet",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "caloric restriction",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "individuals with obesity and pre-diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of a GLP-1 Receptor Polymorphism on Responses to Liraglutide.",
        "journal": "The Journal of endocrinology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042549",
        "doi": "10.1530/JOE-25-0174"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:36:53"
    },
    {
      "id": 1206,
      "intervention": {
        "name": "postoperative home-based pulmonary rehabilitation",
        "canonical_name": "pulmonary rehabilitation",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "pulmonary rehabilitation",
          "layer_2_variant": "postoperative home-based pulmonary rehabilitation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "postoperative recovery in lung cancer patients",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved respiratory function and physical conditioning through structured home-based rehabilitation",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "Delphi-based study",
        "sample_size": 18,
        "duration": null,
        "population": "postoperative lung cancer patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Construction of a postoperative home-based pulmonary rehabilitation program protocol for lung cancer patients delivered using the internet: A Delphi-based study.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-10-04",
        "pubmed_id": "41045360",
        "doi": "10.1007/s00520-025-09916-6"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:33:18"
    },
    {
      "id": 1205,
      "intervention": {
        "name": "empagliflozin",
        "canonical_name": "empagliflozin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "empagliflozin",
          "layer_2_variant": "empagliflozin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "all-cause hospitalizations",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced risk of hospitalization through multiple pathways including cardiovascular, renal, and metabolic benefits",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 6609,
        "duration": null,
        "population": "patients with chronic kidney disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Empagliflozin Reduces Risk of Hospitalization in Patients With Chronic Kidney Disease in the EMPA-KIDNEY Trial.",
        "journal": "Clinical therapeutics",
        "publication_date": "2025-10-04",
        "pubmed_id": "41047325",
        "doi": "10.1016/j.clinthera.2025.09.005"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:31:49"
    },
    {
      "id": 1203,
      "intervention": {
        "name": "spinal cord stimulation",
        "canonical_name": "spinal cord stimulation",
        "category": "device",
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "spinal cord stimulation",
          "layer_2_variant": "spinal cord stimulation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe, non-surgical, refractory back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "pain modulation through electrical stimulation of the spinal cord",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial followed by crossover",
        "sample_size": 147,
        "duration": "12 months",
        "population": "patients with non-surgical, refractory back pain (with or without leg pain)",
        "adverse_effects": "serious adverse events related to SCS, including 5 (3.6%) implant site infections resulting in explant",
        "cost_category": null
      },
      "paper": {
        "title": "Spinal cord stimulation plus conventional medical management versus conventional medical management alone for severe, non-surgical, refractory back pain: a randomized clinical trial followed by crossover.",
        "journal": "Regional anesthesia and pain medicine",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047246",
        "doi": "10.1136/rapm-2024-106335"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:30:18"
    },
    {
      "id": 1204,
      "intervention": {
        "name": "conventional medical management",
        "canonical_name": "conventional medical management",
        "category": "medication",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "conventional medical management",
          "layer_2_variant": "conventional medical management",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe, non-surgical, refractory back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "standard non-surgical pain management strategies",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial followed by crossover",
        "sample_size": 147,
        "duration": "12 months",
        "population": "patients with non-surgical, refractory back pain (with or without leg pain)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Spinal cord stimulation plus conventional medical management versus conventional medical management alone for severe, non-surgical, refractory back pain: a randomized clinical trial followed by crossover.",
        "journal": "Regional anesthesia and pain medicine",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047246",
        "doi": "10.1136/rapm-2024-106335"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:30:18"
    },
    {
      "id": 1202,
      "intervention": {
        "name": "remote rehabilitation weekend training",
        "canonical_name": "remote rehabilitation",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "digital",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "remote rehabilitation",
          "layer_2_variant": "remote rehabilitation weekend training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "motor function impairment post-stroke",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "provision of continuous, therapist-guided rehabilitation during weekends",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 168,
        "duration": "not explicitly stated",
        "population": "stroke patients from three hospitals in Shanghai",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of remote rehabilitation weekend training for stroke patients in China: a randomised controlled trial protocol.",
        "journal": "BMJ open",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047267",
        "doi": "10.1136/bmjopen-2025-105002"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:28:16"
    },
    {
      "id": 1201,
      "intervention": {
        "name": "ramipril",
        "canonical_name": "angiotensin converting enzyme inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "angiotensin converting enzyme inhibitors",
          "layer_2_variant": "ramipril",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammation",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antihypertensive effects",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized, open-label, parallel-group, active-controlled trial",
        "sample_size": 70,
        "duration": "12 weeks",
        "population": "patients with diabetes and newly diagnosed hypertension",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Anti-inflammatory potential of telmisartan compared to other antihypertensives: secondary outcomes from a randomized trial.",
        "journal": "Inflammopharmacology",
        "publication_date": "2025-10-05",
        "pubmed_id": "41046489",
        "doi": "10.1007/s10787-025-01995-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:26:50"
    },
    {
      "id": 1198,
      "intervention": {
        "name": "telmisartan",
        "canonical_name": "angiotensin ii receptor antagonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "angiotensin ii receptor antagonists",
          "layer_2_variant": "telmisartan",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammation",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "anti-inflammatory effects through PPAR-γ agonist activity",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized, open-label, parallel-group, active-controlled trial",
        "sample_size": 70,
        "duration": "12 weeks",
        "population": "patients with diabetes and newly diagnosed hypertension",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Anti-inflammatory potential of telmisartan compared to other antihypertensives: secondary outcomes from a randomized trial.",
        "journal": "Inflammopharmacology",
        "publication_date": "2025-10-05",
        "pubmed_id": "41046489",
        "doi": "10.1007/s10787-025-01995-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:26:49"
    },
    {
      "id": 1199,
      "intervention": {
        "name": "amlodipine",
        "canonical_name": "calcium channel blockers",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "calcium channel blockers",
          "layer_2_variant": "amlodipine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammation",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antihypertensive effects",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized, open-label, parallel-group, active-controlled trial",
        "sample_size": 70,
        "duration": "12 weeks",
        "population": "patients with diabetes and newly diagnosed hypertension",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Anti-inflammatory potential of telmisartan compared to other antihypertensives: secondary outcomes from a randomized trial.",
        "journal": "Inflammopharmacology",
        "publication_date": "2025-10-05",
        "pubmed_id": "41046489",
        "doi": "10.1007/s10787-025-01995-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:26:49"
    },
    {
      "id": 1200,
      "intervention": {
        "name": "cilnidipine",
        "canonical_name": "calcium channel blockers",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "calcium channel blockers",
          "layer_2_variant": "cilnidipine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "inflammation",
        "canonical_name": null,
        "category": "immunological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "antihypertensive effects",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized, open-label, parallel-group, active-controlled trial",
        "sample_size": 70,
        "duration": "12 weeks",
        "population": "patients with diabetes and newly diagnosed hypertension",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Anti-inflammatory potential of telmisartan compared to other antihypertensives: secondary outcomes from a randomized trial.",
        "journal": "Inflammopharmacology",
        "publication_date": "2025-10-05",
        "pubmed_id": "41046489",
        "doi": "10.1007/s10787-025-01995-5"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:26:49"
    },
    {
      "id": 1197,
      "intervention": {
        "name": "BEdside ultraSound-guided ultrafiltration (BEST)",
        "canonical_name": "ultrafiltration",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "ultrafiltration",
          "layer_2_variant": "bedside ultrasound-guided ultrafiltration (best)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute kidney injury with fluid overload",
        "canonical_name": null,
        "category": "renal",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "accurate ultrafiltration guided by critical care ultrasound (CCUS) assessment of volume status",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 132,
        "duration": "from September 2024",
        "population": "AKI patients receiving CRRT due to fluid overload in the intensive care unit of a university-affiliated medical centre",
        "adverse_effects": "overultrafiltration and underultrafiltration are associated with adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "BEdside ultraSound-guided ulTrafiltration for Acute Kidney Injury patients receiving CRRT: protocol for a randomised controlled trial (the BEST-AKI study).",
        "journal": "BMJ open",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047266",
        "doi": "10.1136/bmjopen-2024-093198"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:22:11"
    },
    {
      "id": 1196,
      "intervention": {
        "name": "modified Mediterranean diet",
        "canonical_name": "modified mediterranean diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "modified mediterranean diet",
          "layer_2_variant": "modified mediterranean diet",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Parkinson's disease symptoms",
        "canonical_name": null,
        "category": "neurological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "improved motor and non-motor function through immune system modulation, metabolomics, and microbiome changes",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 44,
        "duration": "6 months",
        "population": "PD patients aged between 40 years and 85 years",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modified Mediterranean diet effects on Parkinson's disease (MED-PARK): a single-centre randomised controlled trial protocol.",
        "journal": "BMJ open",
        "publication_date": "2025-10-05",
        "pubmed_id": "41047258",
        "doi": "10.1136/bmjopen-2025-101946"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:20:22"
    },
    {
      "id": 1195,
      "intervention": {
        "name": "iMAgery Focused Therapy for PSychosis (iMAPS)",
        "canonical_name": "imagery focused therapy for psychosis",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "imagery focused therapy for psychosis",
          "layer_2_variant": "imagery focused therapy for psychosis (imaps)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "psychotic experiences with distressing intrusive mental imagery",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "targeting intrusive mental images and negative schematic beliefs",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "assessor-blind randomized controlled trial",
        "sample_size": 45,
        "duration": "28 weeks",
        "population": "help seeking participants with hallucinations or delusions who reported distressing intrusive mental imagery",
        "adverse_effects": "two serious adverse events in the iMAPS therapy arm deemed unrelated to treatment",
        "cost_category": null
      },
      "paper": {
        "title": "iMAgery Focused Therapy for PSychosis (iMAPS-2): An Assessor-blind Feasibility Randomized Controlled Clinical Trial.",
        "journal": "Schizophrenia bulletin",
        "publication_date": "2025-10-06",
        "pubmed_id": "41051872",
        "doi": "10.1093/schbul/sbaf060"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:18:42"
    },
    {
      "id": 1194,
      "intervention": {
        "name": "Continuous Care Program (CCP)",
        "canonical_name": "continuous care program",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "continuous care program",
          "layer_2_variant": "continuous care program (ccp)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "self-efficacy in women with breast cancer",
        "canonical_name": null,
        "category": "other",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "ongoing support and education enhancing self-efficacy",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 76,
        "duration": "not explicitly stated",
        "population": "women aged 20-60 diagnosed with stage two, three, or four breast cancer in Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Empowering outpatients with breast cancer: The impact of a Continuous Care Program on self-efficacy-a randomized clinical trial.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-10-06",
        "pubmed_id": "41051405",
        "doi": "10.1007/s00520-025-09951-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:17:06"
    },
    {
      "id": 1192,
      "intervention": {
        "name": "combination therapy (anticoagulant plus antiplatelet)",
        "canonical_name": "combination therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "combination therapy",
          "layer_2_variant": "combination therapy (anticoagulant plus antiplatelet)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ischemic stroke with concurrent nonvalvular atrial fibrillation and atherosclerotic cardiovascular disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "dual antithrombotic action through anticoagulant and antiplatelet effects",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 316,
        "duration": "2 years",
        "population": "patients with ischemic stroke or transient ischemic attack within 8 to 360 days of onset, nonvalvular atrial fibrillation, and at least 1 manifestation of atherosclerotic cardiovascular disease",
        "adverse_effects": "higher risk of major and clinically relevant nonmajor bleeding",
        "cost_category": null
      },
      "paper": {
        "title": "Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.",
        "journal": "JAMA neurology",
        "publication_date": "2025-10-06",
        "pubmed_id": "41051787",
        "doi": "10.1001/jamaneurol.2025.3662"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:15:28"
    },
    {
      "id": 1193,
      "intervention": {
        "name": "anticoagulant monotherapy",
        "canonical_name": "anticoagulants",
        "category": "medication",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "anticoagulants",
          "layer_2_variant": "anticoagulant monotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "ischemic stroke with concurrent nonvalvular atrial fibrillation and atherosclerotic cardiovascular disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "anticoagulant action to prevent thrombosis",
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 316,
        "duration": "2 years",
        "population": "patients with ischemic stroke or transient ischemic attack within 8 to 360 days of onset, nonvalvular atrial fibrillation, and at least 1 manifestation of atherosclerotic cardiovascular disease",
        "adverse_effects": "lower risk of major and clinically relevant nonmajor bleeding compared to combination therapy",
        "cost_category": null
      },
      "paper": {
        "title": "Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.",
        "journal": "JAMA neurology",
        "publication_date": "2025-10-06",
        "pubmed_id": "41051787",
        "doi": "10.1001/jamaneurol.2025.3662"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:15:28"
    },
    {
      "id": 1191,
      "intervention": {
        "name": "tagraxofusp",
        "canonical_name": "tagraxofusp",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "tagraxofusp",
          "layer_2_variant": "tagraxofusp",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic myelomonocytic leukemia",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "CD123-targeted therapy",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase 1/2 trial",
        "sample_size": 37,
        "duration": null,
        "population": "patients with chronic myelomonocytic leukemia (CMML)",
        "adverse_effects": "fatigue (49%), hypoalbuminemia (46%), nausea, hypokalemia, decreased appetite (44% each), capillary leak syndrome (23%), tumor lysis syndrome (13%), thrombocytopenia (28%), anemia (13%), leukocytosis (15%), neutropenia (13%)",
        "cost_category": null
      },
      "paper": {
        "title": "Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study.",
        "journal": "Blood neoplasia",
        "publication_date": "2025-11",
        "pubmed_id": "40919483",
        "doi": "10.1016/j.bneo.2025.100115"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:12:59"
    },
    {
      "id": 1190,
      "intervention": {
        "name": "alteplase",
        "canonical_name": "alteplase",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "alteplase",
          "layer_2_variant": "alteplase",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "minor ischemic stroke",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "thrombolysis to dissolve blood clots",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "prospective cohort study",
        "sample_size": 2489,
        "duration": "90 days",
        "population": "patients with minor ischemic stroke (NIHSS score ≤5) with consciousness impairment, motor deficits, limb ataxia or communication deficits",
        "adverse_effects": "in-hospital bleeding (3.0% in alteplase group vs. 1.4% in standard treatment group)",
        "cost_category": null
      },
      "paper": {
        "title": "Alteplase treatment in patients with minor ischemic stroke: a nationwide registry analysis.",
        "journal": "EClinicalMedicine",
        "publication_date": "2025-11",
        "pubmed_id": "41048664",
        "doi": "10.1016/j.eclinm.2025.103523"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:11:14"
    },
    {
      "id": 1187,
      "intervention": {
        "name": "professional obligation framing",
        "canonical_name": "professional obligation framing",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "professional obligation framing",
          "layer_2_variant": "professional obligation framing",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "smoking cessation",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced sense of duty and intention to provide support",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "between-subjects online experiment",
        "sample_size": 300,
        "duration": null,
        "population": "UK-based GPs and medical students",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Investigating attitudes and framing moral responsibility in healthcare professionals for smoking cessation interventions.",
        "journal": "British journal of health psychology",
        "publication_date": "2025-11",
        "pubmed_id": "41039821",
        "doi": "10.1111/bjhp.70025"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:07:36"
    },
    {
      "id": 1188,
      "intervention": {
        "name": "shared responsibility framing",
        "canonical_name": "shared responsibility framing",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "shared responsibility framing",
          "layer_2_variant": "shared responsibility framing",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "smoking cessation",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "shared perception of responsibility for smoking cessation",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "between-subjects online experiment",
        "sample_size": 300,
        "duration": null,
        "population": "UK-based GPs and medical students",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Investigating attitudes and framing moral responsibility in healthcare professionals for smoking cessation interventions.",
        "journal": "British journal of health psychology",
        "publication_date": "2025-11",
        "pubmed_id": "41039821",
        "doi": "10.1111/bjhp.70025"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:07:36"
    },
    {
      "id": 1189,
      "intervention": {
        "name": "neutral control framing",
        "canonical_name": "neutral control framing",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "neutral control framing",
          "layer_2_variant": "neutral control framing",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "smoking cessation",
        "canonical_name": null,
        "category": "other",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "no specific framing applied",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "between-subjects online experiment",
        "sample_size": 300,
        "duration": null,
        "population": "UK-based GPs and medical students",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Investigating attitudes and framing moral responsibility in healthcare professionals for smoking cessation interventions.",
        "journal": "British journal of health psychology",
        "publication_date": "2025-11",
        "pubmed_id": "41039821",
        "doi": "10.1111/bjhp.70025"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:07:36"
    },
    {
      "id": 1184,
      "intervention": {
        "name": "lower body resistance training",
        "canonical_name": "lower body resistance training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "lower body resistance training",
          "layer_2_variant": "lower body resistance training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induces exercise-induced hypoalgesia",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomised controlled feasibility trial",
        "sample_size": 36,
        "duration": null,
        "population": "people with knee osteoarthritis (n = 36, 60 ± 11 years, WOMAC total 51.7 ± 36.6)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Training Modalities and Additional Pain Education on Exercise-Induced Hypoalgesia in People With Osteoarthritis of the Knee: A Randomised Controlled Feasibility Trial.",
        "journal": "European journal of pain (London, England)",
        "publication_date": "2025-11",
        "pubmed_id": "41041935",
        "doi": "10.1002/ejp.70141"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:05:25"
    },
    {
      "id": 1185,
      "intervention": {
        "name": "upper body resistance training",
        "canonical_name": "upper body resistance training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "upper body resistance training",
          "layer_2_variant": "upper body resistance training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induces exercise-induced hypoalgesia",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomised controlled feasibility trial",
        "sample_size": 36,
        "duration": null,
        "population": "people with knee osteoarthritis (n = 36, 60 ± 11 years, WOMAC total 51.7 ± 36.6)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Training Modalities and Additional Pain Education on Exercise-Induced Hypoalgesia in People With Osteoarthritis of the Knee: A Randomised Controlled Feasibility Trial.",
        "journal": "European journal of pain (London, England)",
        "publication_date": "2025-11",
        "pubmed_id": "41041935",
        "doi": "10.1002/ejp.70141"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:05:25"
    },
    {
      "id": 1186,
      "intervention": {
        "name": "aerobic training",
        "canonical_name": "aerobic training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "aerobic training",
          "layer_2_variant": "aerobic training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "induces exercise-induced hypoalgesia",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.75,
        "study_confidence": 0.5
      },
      "study": {
        "type": "randomised controlled feasibility trial",
        "sample_size": 36,
        "duration": null,
        "population": "people with knee osteoarthritis (n = 36, 60 ± 11 years, WOMAC total 51.7 ± 36.6)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Training Modalities and Additional Pain Education on Exercise-Induced Hypoalgesia in People With Osteoarthritis of the Knee: A Randomised Controlled Feasibility Trial.",
        "journal": "European journal of pain (London, England)",
        "publication_date": "2025-11",
        "pubmed_id": "41041935",
        "doi": "10.1002/ejp.70141"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:05:25"
    },
    {
      "id": 1183,
      "intervention": {
        "name": "LD-TLF complex stretching",
        "canonical_name": "stretching",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "stretching",
          "layer_2_variant": "ld-tlf complex stretching",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic low back pain",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced pain thresholds and reduced pain sensitivity",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 30,
        "duration": "4 weeks",
        "population": "patients with chronic low back pain (CLBP)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Role of Latissimus Dorsi-Thoracolumbar Fascia Complex Stretching on Pain and Pain-Related Parameters in Patients With Chronic Low Back Pain: A Randomised Clinical Trial.",
        "journal": "European journal of pain (London, England)",
        "publication_date": "2025-11",
        "pubmed_id": "41035304",
        "doi": "10.1002/ejp.70143"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:02:50"
    },
    {
      "id": 1182,
      "intervention": {
        "name": "sofosbuvir/daclatasvir regimen",
        "canonical_name": "sofosbuvir/daclatasvir",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sofosbuvir/daclatasvir",
          "layer_2_variant": "sofosbuvir/daclatasvir regimen",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "hepatitis C",
        "canonical_name": null,
        "category": "infectious",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct-acting antiviral therapy targeting HCV replication",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "observational cohort study",
        "sample_size": 1201,
        "duration": "12 weeks",
        "population": "people who inject drugs (PWID) in Vietnam with detectable HCV RNA",
        "adverse_effects": "not explicitly mentioned",
        "cost_category": null
      },
      "paper": {
        "title": "High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam.",
        "journal": "Journal of viral hepatitis",
        "publication_date": "2025-11",
        "pubmed_id": "41017776",
        "doi": "10.1111/jvh.70090"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 22:01:09"
    },
    {
      "id": 1179,
      "intervention": {
        "name": "Potassium-competitive acid blockers",
        "canonical_name": "potassium-competitive acid blockers",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "potassium-competitive acid blockers",
          "layer_2_variant": "potassium-competitive acid blockers",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gastroesophageal reflux disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "profound acid suppression through competitive inhibition of potassium channels in parietal cells",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with gastroesophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection",
        "adverse_effects": "hypergastrinemia and increased risk of gastrointestinal infections",
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 21:57:52"
    },
    {
      "id": 1180,
      "intervention": {
        "name": "Potassium-competitive acid blockers",
        "canonical_name": "potassium-competitive acid blockers",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "potassium-competitive acid blockers",
          "layer_2_variant": "potassium-competitive acid blockers",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "peptic ulcer disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "profound acid suppression through competitive inhibition of potassium channels in parietal cells",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with gastroesophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection",
        "adverse_effects": "hypergastrinemia and increased risk of gastrointestinal infections",
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 21:57:52"
    },
    {
      "id": 1181,
      "intervention": {
        "name": "Potassium-competitive acid blockers",
        "canonical_name": "potassium-competitive acid blockers",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "potassium-competitive acid blockers",
          "layer_2_variant": "potassium-competitive acid blockers",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "profound acid suppression through competitive inhibition of potassium channels in parietal cells",
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with gastroesophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection",
        "adverse_effects": "hypergastrinemia and increased risk of gastrointestinal infections",
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 21:57:52"
    },
    {
      "id": 1177,
      "intervention": {
        "name": "high fibre supplementation",
        "canonical_name": "high fibre",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "high fibre",
          "layer_2_variant": "high fibre supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "colorectal cancer risk reduction",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "increased dietary fibre intake to modulate gut microbiota and reduce CRC risk",
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised trial",
        "sample_size": null,
        "duration": "4 weeks",
        "population": "Alaska Native peoples",
        "adverse_effects": "more flatulence than usual",
        "cost_category": null
      },
      "paper": {
        "title": "Tolerance of high fibre supplementation among participants in a randomised trial to reduce cancer risk among Alaska Native peoples: Alaska FIRST.",
        "journal": "International journal of circumpolar health",
        "publication_date": "2025-12",
        "pubmed_id": "40999949",
        "doi": "10.1080/22423982.2025.2561283"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 21:55:27"
    },
    {
      "id": 1178,
      "intervention": {
        "name": "low fibre supplementation",
        "canonical_name": "low fibre",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "low fibre",
          "layer_2_variant": "low fibre supplementation",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "colorectal cancer risk reduction",
        "canonical_name": null,
        "category": "oncological",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "minimal impact on CRC risk due to low fibre intake",
      "correlation": {
        "type": "neutral",
        "strength": 0.1,
        "extraction_confidence": 0.75,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomised trial",
        "sample_size": null,
        "duration": "4 weeks",
        "population": "Alaska Native peoples",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Tolerance of high fibre supplementation among participants in a randomised trial to reduce cancer risk among Alaska Native peoples: Alaska FIRST.",
        "journal": "International journal of circumpolar health",
        "publication_date": "2025-12",
        "pubmed_id": "40999949",
        "doi": "10.1080/22423982.2025.2561283"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 21:55:27"
    },
    {
      "id": 1176,
      "intervention": {
        "name": "dapagliflozin",
        "canonical_name": "sodium-glucose cotransporter 2 inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "sodium-glucose cotransporter 2 inhibitors",
          "layer_2_variant": "dapagliflozin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "symptomatic myxomatous mitral valve disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "moderate",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reverse remodeling and improved cardiac function",
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.5
      },
      "study": {
        "type": "prospective, randomized, single-blind study",
        "sample_size": 5,
        "duration": "140 days",
        "population": "dogs with stage C MMVD",
        "adverse_effects": "glucosuria",
        "cost_category": null
      },
      "paper": {
        "title": "Pilot study on the effects of dapagliflozin on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease.",
        "journal": "Veterinary and animal science",
        "publication_date": "2025-12",
        "pubmed_id": "41050558",
        "doi": "10.1016/j.vas.2025.100510"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 21:50:49"
    },
    {
      "id": 1175,
      "intervention": {
        "name": "vunakizumab",
        "canonical_name": "vunakizumab",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "vunakizumab",
          "layer_2_variant": "vunakizumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe plaque psoriasis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "severe",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced psoriasis severity through targeted biological action",
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "phase-III trial",
        "sample_size": 461,
        "duration": null,
        "population": "patients with moderate-to-severe plaque psoriasis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Early response to vunakizumab and its baseline predictors in patients with moderate-to-severe plaque psoriasis: a",
        "journal": "The Journal of dermatological treatment",
        "publication_date": "2025-12",
        "pubmed_id": "40995857",
        "doi": "10.1080/09546634.2025.2564810"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 18:08:05"
    },
    {
      "id": 1173,
      "intervention": {
        "name": "azithromycin therapy",
        "canonical_name": "azithromycin",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "azithromycin",
          "layer_2_variant": "azithromycin therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acute exacerbations in PA colonized COPD patients",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced bacterial load and inflammation in the lower respiratory tract",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 32753,
        "duration": null,
        "population": "patients with chronic obstructive pulmonary disease (COPD)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prevalence, Risk Factors, and Antibiotic Intervention of Lower Airway",
        "journal": "COPD",
        "publication_date": "2025-12",
        "pubmed_id": "41037326",
        "doi": "10.1080/15412555.2025.2564743"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 18:06:11"
    },
    {
      "id": 1174,
      "intervention": {
        "name": "inhaled antibiotics (IAs)",
        "canonical_name": "inhaled antibiotics",
        "category": "procedure",
        "details": "{}",
        "delivery_method": "inhalation",
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": "inhaled antibiotics",
          "layer_2_variant": "inhaled antibiotics (ias)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "PA colonization in COPD patients",
        "canonical_name": null,
        "category": "infectious",
        "severity": null,
        "hierarchy": {
          "layer_0_category": null,
          "layer_1_canonical": null,
          "layer_2_variant": null,
          "layer_3_detail": null
        }
      },
      "mechanism": "direct targeting of PA in the lower respiratory tract",
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 0.9,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 32753,
        "duration": null,
        "population": "patients with chronic obstructive pulmonary disease (COPD)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prevalence, Risk Factors, and Antibiotic Intervention of Lower Airway",
        "journal": "COPD",
        "publication_date": "2025-12",
        "pubmed_id": "41037326",
        "doi": "10.1080/15412555.2025.2564743"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-06 18:06:11"
    }
  ]
}